Home Alzheimer's Genes AD risk factors Bipolar Genes BP risk factors Autism risk factors.Schizophrenia Genes SZ Risk factors Anorexia genes and risk factors .Chronic Fatigue Risk Factors. Multiple sclerosis risk factors . Parkinson's disease genes and risk factors Cystic Fibrosis Herpes simplex database Helicobacter pylori interactions Jobs in genetics and bioinformatics Pathogens KEGG pathways and interactomes Useful links Videos . Subscribe to Site Updates by Email  Subscribe in a reader . Enhanced links are provided by

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. Please cite if you find it useful: Thank you

These maps are generated by Kegg pathways from the Kanehisa laboratories, with thanks, and are subject to their copyright conditions:

Yellow gene products interact with HIV-1 from NCBI HIV/host interactions..............Click on "show all objects" for gene definitions and on the pathway title for legends.

As well as etching out the pathways of the viral life cycle, these pathways are relevant to conditions such as NeuroAIDS or HIV-1 dementia (e.g. Alzheimer's pathway) or HIV-1 psychosis (e.g. ERBB or LTP pathways) and to multiple comorbid conditions. Pathogen defense and entry pathways suggest that the AIDS virus may affect opportunistic infections not only via effects on the immune system, but also because of a role of HIV-1 interactinmg proteins in these processes.

Other pathways like this

Pathway Search Result

hsa05200 Pathways in cancer - Homo sapiens (human) (140)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1017 CDK2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22]
hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:1026 CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A
hsa:1027 CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B
hsa:10319 LAMC3, DKFZp434E202; laminin, gamma 3; K06247 laminin, gamma 3
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1282 COL4A1, arresten; collagen, type IV, alpha 1; K06237 collagen, type IV, alpha
hsa:1284 COL4A2, DKFZp686I14213, FLJ22259; collagen, type IV, alpha 2; K06237 collagen, type IV, alpha
hsa:1286 COL4A4, CA44; collagen, type IV, alpha 4; K06237 collagen, type IV, alpha
hsa:1287 COL4A5, ASLN, ATS, CA54, MGC167109, MGC42377; collagen, type IV, alpha 5; K06237 collagen, type IV, alpha
hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:1436 CSF1R, C-FMS, CD115, CSFR, FIM2, FMS; colony stimulating factor 1 receptor (EC:2.7.10.1); K05090 macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
hsa:1495 CTNNA1, CAP102, FLJ36832, FLJ52416; catenin (cadherin-associated protein), alpha 1, 102kDa; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1869 E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K06620 E2F transcription factor 1/3
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2246 FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1; fibroblast growth factor 1 (acidic); K04358 fibroblast growth factor
hsa:2247 FGF2, BFGF, FGFB, HBGF-2; fibroblast growth factor 2 (basic); K04358 fibroblast growth factor
hsa:22798 LAMB4; laminin, beta 4; K06245 laminin, beta 4
hsa:2335 FN1, CIG, DKFZp686F10164, DKFZp686H0342, DKFZp686I1370, DKFZp686O13149, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF; fibronectin 1; K05717 fibronectin 1
hsa:2353 FOS, AP-1, C-FOS; FBJ murine osteosarcoma viral oncogene homolog; K04379 proto-oncogene protein c-fos
hsa:2475 MTOR, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein
hsa:2736 GLI2, HPE9, THP1, THP2; GLI family zinc finger 2; K06230 zinc finger protein GLI
hsa:284217 LAMA1, LAMA; laminin, alpha 1; K05637 laminin, alpha 1/2
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3065 HDAC1, DKFZp686H12203, GON-10, HD1, RPD3, RPD3L1; histone deacetylase 1 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98]
hsa:3082 HGF, DFNB39, F-TCF, HGFB, HPTA, SF; hepatocyte growth factor (hepapoietin A; scatter factor); K05460 hepatocyte growth factor
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:329 BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat-containing 2; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:330 BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat-containing 3; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:332 BIRC5, API4, EPR-1; baculoviral IAP repeat-containing 5; K08731 baculoviral IAP repeat-containing 5
hsa:3320 HSP90AA1, FLJ31884, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2; heat shock protein 90kDa alpha (cytosolic), class A member 1; K04079 molecular chaperone HtpG
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3480 IGF1R, CD221, IGFIR, IGFR, JTK13, MGC142170, MGC142172, MGC18216; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3655 ITGA6, CD49f, DKFZp686J01244, FLJ18737, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6
hsa:3675 ITGA3, CD49C, FLJ34631, FLJ34704, GAP-B3, GAPB3, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3
hsa:3685 ITGAV, CD51, DKFZp686A08142, MSK8, VNRA; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); K06487 integrin alpha V
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3716 JAK1, JAK1A, JAK1B, JTK3; Janus kinase 1 (EC:2.7.10.2); K11217 Janus kinase 1 [EC:2.7.10.2]
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:3908 LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2
hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:3910 LAMA4, DKFZp686D23145, LAMA3, LAMA4*-1; laminin, alpha 4; K06241 laminin, alpha 4
hsa:3911 LAMA5, KIAA1907; laminin, alpha 5; K06240 laminin, alpha 3/5
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:3913 LAMB2, LAMS; laminin, beta 2 (laminin S); K06243 laminin, beta 2
hsa:3914 LAMB3, BM600-125KDA, FLJ99565, LAM5, LAMNB1; laminin, beta 3; K06244 laminin, beta 3
hsa:3915 LAMC1, LAMB2, MGC87297; laminin, gamma 1 (formerly LAMB2); K05635 laminin, gamma 1
hsa:3918 LAMC2, B2T, BM600, CSF, EBR2, EBR2A, LAMB2T, LAMNB2, MGC138491, MGC141938; laminin, gamma 2; K06246 laminin, gamma 2
hsa:4087 SMAD2, JV18, JV18-1, MADH2, MADR2, MGC22139, MGC34440, hMAD-2, hSMAD2; SMAD family member 2; K04500 SMAD, mothers against DPP 2/3
hsa:4088 SMAD3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396; SMAD family member 3; K04500 SMAD, mothers against DPP 2/3
hsa:4089 SMAD4, DPC4, JIP, MADH4; SMAD family member 4; K04501 SMAD, mothers against DPP 4
hsa:4149 MAX, MGC10775, MGC11225, MGC18164, MGC34679, MGC36767, bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8, orf1; MYC associated factor X; K04453 Max protein
hsa:4193 MDM2, HDMX, MGC5370, MGC71221, hdm2; Mdm2 p53 binding protein homolog (mouse); K06643 transformed 3T3 cell double minute 2, p53-binding protein [EC:6.3.2.19]
hsa:4312 MMP1, CLG, CLGN; matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7); K01388 matrix metalloproteinase-1 (interstitial collagenase) [EC:3.4.24.7]
hsa:4313 MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]
hsa:4318 MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4791 NFKB2, LYT-10, LYT10, p52; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100); K04469 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5371 PML, MYL, PP8675, RNF71, TRIM19; promyelocytic leukemia; K10054 probable transcription factor PML
hsa:54205 CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c
hsa:5468 PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:581 BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX, membrane protein (BCL2-associated)
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5888 RAD51, BRCC5, HRAD51, HsRad51, HsT16930, RAD51A, RECA; RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae); K04482 DNA repair protein RAD51
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5925 RB1, OSRC, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:598 BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, DKFZp781P2092, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X)
hsa:637 BID, FP497, MGC15319, MGC42355; BH3 interacting domain death agonist; K04726 BH3 interacting domain death agonist
hsa:650 BMP2, BMP2A; bone morphogenetic protein 2; K04662 bone morphogenetic protein 2/4
hsa:6502 SKP2, FBL1, FBXL1, FLB1, MGC1366; S-phase kinase-associated protein 2 (p45); K03875 F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2)
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:6776 STAT5A, MGF, STAT5; signal transducer and activator of transcription 5A; K11223 signal transducer and activator of transcription 5A
hsa:6777 STAT5B, STAT5; signal transducer and activator of transcription 5B; K11224 signal transducer and activator of transcription 5B
hsa:6921 TCEB1, SIII; transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C); K03872 transcription elongation factor B, polypeptide 1
hsa:6923 TCEB2, ELOB, SIII; transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B); K03873 transcription elongation factor B, polypeptide 2
hsa:6934 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2
hsa:7039 TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:7170 TPM3, FLJ41118, MGC14582, MGC3261, MGC72094, NEM1, OK/SW-cl.5, TM-5, TM3, TM30, TM30nm, TPMsk3, TRK, hscp30; tropomyosin 3; K09290 tropomyosin 3
hsa:7185 TRAF1, EBI6, MGC:10353; TNF receptor-associated factor 1; K03172 TNF receptor-associated factor 1
hsa:7188 TRAF5, MGC:39780, RNF84; TNF receptor-associated factor 5; K09849 TNF receptor-associated factor 5
hsa:7422 VEGFA, MGC70609, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A/B, PGF
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:867 CBL, C-CBL, CBL2, RNF55; Cas-Br-M (murine) ecotropic retroviral transforming sequence; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:8900 CCNA1; cyclin A1; K06627 cyclin A
hsa:898 CCNE1, CCNE; cyclin E1; K06626 cyclin E
hsa:9618 TRAF4, CART1, MLN62, RNF83; TNF receptor-associated factor 4; K09848 TNF receptor-associated factor 4
hsa:9978 RBX1, BA554C12.1, FLJ60363, MGC13357, MGC1481, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42
hsa:999 CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin

hsa01100 Metabolic pathways - Homo sapiens (human) (125)

hsa:100 ADA; adenosine deaminase (EC:3.5.4.4); K01488 adenosine deaminase [EC:3.5.4.4]
hsa:10317 B3GALT5, B3GalT-V, B3GalTx, B3T5, GLCT5, beta3Gal-T5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; K03877 beta-1,3-galactosyltransferase 5 [EC:2.4.1.-]
hsa:1056 CEL, BAL, BSDL, BSSL, CELL, CEase, FAP, FAPP, LIPA, MODY8; carboxyl ester lipase (bile salt-stimulated lipase) (EC:3.1.1.13 3.1.1.3); K12298 bile salt-stimulated lipase [EC:3.1.1.3 3.1.1.13]
hsa:10621 POLR3F, MGC13517, RPC39, RPC6; polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa; K03025 DNA-directed RNA polymerase III subunit C34 [EC:2.7.7.6]
hsa:10622 POLR3G, RPC32, RPC7; polymerase (RNA) III (DNA directed) polypeptide G (32kD); K03024 DNA-directed RNA polymerase III subunit C31 [EC:2.7.7.6]
hsa:10623 POLR3C, RPC3, RPC62; polymerase (RNA) III (DNA directed) polypeptide C (62kD); K03023 DNA-directed RNA polymerase III subunit C3 [EC:2.7.7.6]
hsa:10855 HPSE, HPA, HPA1, HPR1, HPSE1, HSE1; heparanase; K07964 heparanase 1 [EC:3.2.1.-]
hsa:10905 MAN1A2, MAN1B; mannosidase, alpha, class 1A, member 2 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:11128 POLR3A, RPC1, RPC155, hRPC155; polymerase (RNA) III (DNA directed) polypeptide A, 155kDa (EC:2.7.7.6); K03018 DNA-directed RNA polymerase III subunit C1 [EC:2.7.7.6]
hsa:11253 MAN1B1, ERMan1, MANA-ER; mannosidase, alpha, class 1B, member 1 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:11282 MGAT4B, GNT-IV, GNT-IVB; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B (EC:2.4.1.145); K00738 alpha-1,3-mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferase A/B [EC:2.4.1.145]
hsa:113026 PLCD3, MGC71172; phospholipase C, delta 3 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:11320 MGAT4A, GNT-IV, GNT-IVA; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A (EC:2.4.1.145); K00738 alpha-1,3-mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferase A/B [EC:2.4.1.145]
hsa:146664 MGAT5B, FLJ25132, GnT-IX, GnT-VB, KIAA2008; mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B (EC:2.4.1.155); K09661 mannosyl alpha-1,6-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B [EC:2.4.1.-]
hsa:1537 CYC1, UQCR4; cytochrome c-1; K00413 ubiquinol-cytochrome c reductase cytochrome c1 subunit [EC:1.10.2.2]
hsa:1594 CYP27B1, CP2B, CYP1, CYP1alpha, CYP27B, P450c1, PDDR, VDD1, VDDR, VDDRI, VDR; cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13); K07438 cytochrome P450, family 27, subfamily B (25-hydroxyvitamin D3 1alpha-hydroxylase) [EC:1.14.13.13]
hsa:1595 CYP51A1, CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1; cytochrome P450, family 51, subfamily A, polypeptide 1 (EC:1.14.13.70); K05917 cytochrome P450, family 51 (sterol 14-demethylase) [EC:1.14.13.70]
hsa:171568 POLR3H, KIAA1665, MGC111097, MGC29654, RPC22.9, RPC8; polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) (EC:2.7.7.6); K03022 DNA-directed RNA polymerase III subunit C25 [EC:2.7.7.6]
hsa:2023 ENO1, ENO1L1, MPB1, NNE, PPH; enolase 1, (alpha) (EC:4.2.1.11); K01689 enolase [EC:4.2.1.11]
hsa:2203 FBP1, FBP; fructose-1,6-bisphosphatase 1 (EC:3.1.3.11); K03841 fructose-1,6-bisphosphatase I [EC:3.1.3.11]
hsa:23193 GANAB, G2AN, GLUII, KIAA0088; glucosidase, alpha; neutral AB (EC:3.2.1.84); K05546 alpha 1,3-glucosidase [EC:3.2.1.84]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:240 ALOX5, 5-LO, 5-LOX, 5LPG, LOG5, MGC163204; arachidonate 5-lipoxygenase (EC:1.13.11.34); K00461 arachidonate 5-lipoxygenase [EC:1.13.11.34]
hsa:248 ALPI, IAP; alkaline phosphatase, intestinal (EC:3.1.3.1); K01077 alkaline phosphatase [EC:3.1.3.1]
hsa:249 ALPL, AP-TNAP, APTNAP, FLJ40094, FLJ93059, HOPS, MGC161443, MGC167935, TNAP, TNSALP; alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1); K01077 alkaline phosphatase [EC:3.1.3.1]
hsa:250 ALPP, ALP, FLJ61142, PALP, PLAP; alkaline phosphatase, placental (EC:3.1.3.1); K01077 alkaline phosphatase [EC:3.1.3.1]
hsa:2530 FUT8, MGC26465; fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (EC:2.4.1.68); K00717 glycoprotein 6-alpha-L-fucosyltransferase [EC:2.4.1.68]
hsa:2539 G6PD, G6PD1; glucose-6-phosphate dehydrogenase (EC:1.1.1.49); K00036 glucose-6-phosphate 1-dehydrogenase [EC:1.1.1.49]
hsa:2548 GAA, LYAG; glucosidase, alpha; acid (EC:3.2.1.20); K12316 lysosomal alpha-glucosidase [EC:3.2.1.20]
hsa:25834 MGAT4C, GNTIVH, HGNT-IV-H; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) (EC:2.4.1.145); K13748 alpha-1,3-mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferase C [EC:2.4.1.201 2.4.1.145]
hsa:2595 GANC, MGC138256; glucosidase, alpha; neutral C (EC:3.2.1.20); K12317 neutral alpha-glucosidase C [EC:3.2.1.20]
hsa:262 AMD1, ADOMETDC, AMD, DKFZp313L1234, FLJ26964, SAMDC; adenosylmethionine decarboxylase 1 (EC:4.1.1.50); K01611 S-adenosylmethionine decarboxylase [EC:4.1.1.50]
hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:2629 GBA, GBA1, GCB, GLUC; glucosidase, beta, acid (EC:3.2.1.45); K01201 glucosylceramidase [EC:3.2.1.45]
hsa:2683 B4GALT1, B4GAL-T1, CDG2D, DKFZp686N19253, GGTB2, GT1, GTB, MGC50983, beta4Gal-T1; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07966 beta-1,4-galactosyltransferase 1 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]
hsa:2821 GPI, AMF, DKFZp686C13233, GNPI, NLK, PGI, PHI, SA-36, SA36; glucose-6-phosphate isomerase (EC:5.3.1.9); K01810 glucose-6-phosphate isomerase [EC:5.3.1.9]
hsa:2937 GSS, GSHS, MGC14098; glutathione synthetase (EC:6.3.2.3); K01920 glutathione synthase [EC:6.3.2.3]
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:3156 HMGCR, LDLCQ3; 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34); K00021 hydroxymethylglutaryl-CoA reductase (NADPH) [EC:1.1.1.34]
hsa:3620 IDO1, IDO, INDO; indoleamine 2,3-dioxygenase 1 (EC:1.13.11.52); K00463 indoleamine 2,3-dioxygenase [EC:1.13.11.52]
hsa:3704 ITPA, C20orf37, HLC14-06-P, ITPase, dJ794I6.3; inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (EC:3.6.1.19); K01519 nucleoside-triphosphate pyrophosphatase [EC:3.6.1.19]
hsa:3939 LDHA, GSD11, LDH1, LDHM; lactate dehydrogenase A (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:3945 LDHB, LDH-H, TRG-5; lactate dehydrogenase B (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:3948 LDHC, CT32, LDH3, LDHX, MGC111073; lactate dehydrogenase C (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:4121 MAN1A1, HUMM3, HUMM9, MAN9; mannosidase, alpha, class 1A, member 1 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:4122 MAN2A2, MANA2X; mannosidase, alpha, class 2A, member 2 (EC:3.2.1.114); K01231 alpha-mannosidase II [EC:3.2.1.114]
hsa:4124 MAN2A1, GOLIM7, MANA2, MANII; mannosidase, alpha, class 2A, member 1 (EC:3.2.1.114); K01231 alpha-mannosidase II [EC:3.2.1.114]
hsa:4247 MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2; mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143); K00736 alpha-1,6-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase [EC:2.4.1.143]
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:4846 NOS3, ECNOS, eNOS; nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39); K13242 nitric-oxide synthase, endothelial [EC:1.14.13.39]
hsa:5048 PAFAH1B1, LIS1, LIS2, MDCR, MDS, PAFAH; platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) (EC:3.1.1.47); K01062 1-alkyl-2-acetylglycerophosphocholine esterase [EC:3.1.1.47]
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5105 PCK1, MGC22652, PEPCK-C, PEPCK1, PEPCKC; phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32]
hsa:51196 PLCE1, FLJ23659, KIAA1516, MGC167842, NPHS3, PLCE, PPLC; phospholipase C, epsilon 1 (EC:3.1.4.11); K05860 phospholipase C, epsilon
hsa:51606 ATP6V1H, MSTP042, NBP1, SFD, SFDalpha, SFDbeta, VMA13; ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H (EC:3.6.3.14); K02144 V-type H+-transporting ATPase 54 kD subunit [EC:3.6.3.14]
hsa:51728 POLR3K, C11, C11-RNP3, RPC10, RPC11, RPC12.5, hRPC11; polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa; K03019 DNA-directed RNA polymerase III subunit C11 [EC:2.7.7.6]
hsa:5286 PIK3C2A, CPK, DKFZp686L193, MGC142218, PI3-K-C2(ALPHA), PI3-K-C2A; phosphoinositide-3-kinase, class 2, alpha polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5287 PIK3C2B, C2-PI3K, DKFZp686G16234; phosphoinositide-3-kinase, class 2, beta polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5288 PIK3C2G, MGC163149, PI3K-C2GAMMA; phosphoinositide-3-kinase, class 2, gamma polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5289 PIK3C3, MGC61518, VPS34, hVps34; phosphoinositide-3-kinase, class 3 (EC:2.7.1.137); K00914 phosphatidylinositol 3-kinase [EC:2.7.1.137]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5333 PLCD1; phospholipase C, delta 1 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5426 POLE, DKFZp434F222, FLJ21434, POLE1; polymerase (DNA directed), epsilon (EC:2.7.7.7); K02324 DNA polymerase epsilon subunit 1 [EC:2.7.7.7]
hsa:5430 POLR2A, MGC75453, POLR2, POLRA, RPB1, RPBh1, RPO2, RPOL2, RpIILS, hRPB220, hsRPB1; polymerase (RNA) II (DNA directed) polypeptide A, 220kDa (EC:2.7.7.6 2.7.7.48); K03006 DNA-directed RNA polymerase II subunit A [EC:2.7.7.6]
hsa:5431 POLR2B, POL2RB, RPB2, hRPB140, hsRPB2; polymerase (RNA) II (DNA directed) polypeptide B, 140kDa (EC:2.7.7.6); K03010 DNA-directed RNA polymerase II subunit B [EC:2.7.7.6]
hsa:5432 POLR2C, RPB3, RPB31, hRPB33, hsRPB3; polymerase (RNA) II (DNA directed) polypeptide C, 33kDa (EC:2.7.7.6); K03011 DNA-directed RNA polymerase II subunit C
hsa:5433 POLR2D, HSRBP4, HSRPB4, RBP4, RPB16; polymerase (RNA) II (DNA directed) polypeptide D (EC:2.7.7.6); K03012 DNA-directed RNA polymerase II subunit D
hsa:5434 POLR2E, RPABC1, RPB5, XAP4, hRPB25, hsRPB5; polymerase (RNA) II (DNA directed) polypeptide E, 25kDa (EC:2.7.7.6); K03013 DNA-directed RNA polymerase II subunit E
hsa:5435 POLR2F, HRBP14.4, POLRF, RPABC2, RPB14.4, RPB6; polymerase (RNA) II (DNA directed) polypeptide F (EC:2.7.7.6); K03014 DNA-directed RNA Polymerase II subunit F
hsa:5436 POLR2G, MGC138367, MGC138369, RPB19, RPB7, hRPB19, hsRPB7; polymerase (RNA) II (DNA directed) polypeptide G (EC:2.7.7.6); K03015 DNA-directed RNA polymerase II subunit G
hsa:5437 POLR2H, RPABC3, RPB17, RPB8, hsRPB8; polymerase (RNA) II (DNA directed) polypeptide H (EC:2.7.7.6); K03016 DNA-directed RNA polymerase II subunit H
hsa:5438 POLR2I, RPB9, hRPB14.5; polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa (EC:2.7.7.6); K03017 DNA-directed RNA polymerase II subunit I
hsa:5439 POLR2J, MGC71910, POLR2J1, RPB11, RPB11A, RPB11m, hRPB14; polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa (EC:2.7.7.6); K03008 DNA-directed RNA polymerase II subunit J
hsa:5440 POLR2K, ABC10-alpha, RPABC4, RPB10alpha, RPB12, RPB7.0, hRPB7.0, hsRPB10a; polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa (EC:2.7.7.6); K03009 DNA-directed RNA Polymerase II subunit K
hsa:5441 POLR2L, RBP10, RPABC5, RPB10, RPB10beta, RPB7.6, hRPB7.6, hsRPB10b; polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa (EC:2.7.7.6); K03007 DNA-directed RNA Polymerase II subunit L
hsa:55512 SMPD3, FLJ22593, MGC138443, NSMASE2; sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (EC:3.1.4.12); K12352 sphingomyelin phosphodiesterase 3 [EC:3.1.4.12]
hsa:55627 SMPD4, FLJ20297, FLJ20756, KIAA1418, NET13, NSMASE-3, NSMASE3; sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3) (EC:3.1.4.12); K12353 sphingomyelin phosphodiesterase 4 [EC:3.1.4.12]
hsa:55703 POLR3B, C128, DKFZp686B10117, FLJ10388, RPC2; polymerase (RNA) III (DNA directed) polypeptide B (EC:2.7.7.6); K03021 DNA-directed RNA polymerase III subunit C2 [EC:2.7.7.6]
hsa:56623 INPP5E, CORS1, JBTS1, MGC117201, MORMS, PPI5PIV; inositol polyphosphate-5-phosphatase, 72 kDa (EC:3.1.3.36); K01099 phosphatidylinositol-bisphosphatase [EC:3.1.3.36]
hsa:57134 MAN1C1, HMIC, MAN1A3, MAN1C, pp6318; mannosidase, alpha, class 1C, member 1 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:5742 PTGS1, COX1, COX3, PCOX1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS; prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K00509 prostaglandin-endoperoxide synthase 1 [EC:1.14.99.1]
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:6303 SAT1, DC21, KFSD, KFSDX, SAT, SSAT, SSAT-1; spermidine/spermine N1-acetyltransferase 1 (EC:2.3.1.57); K00657 diamine N-acetyltransferase [EC:2.3.1.57]
hsa:6390 SDHB, FLJ92337, IP, PGL4, SDH, SDH1, SDH2, SDHIP; succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (EC:1.3.5.1); K00235 succinate dehydrogenase (ubiquinone) iron-sulfur protein [EC:1.3.5.1]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:6482 ST3GAL1, DKFZp666E036, DKFZp779K2051, FLJ36548, Gal-NAc6S, MGC9183, SIAT4A, SIATFL, ST3GalA, ST3GalA.1, ST3GalIA, ST3GalIA,1, ST3O; ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4); K00780 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4A) [EC:2.4.99.4]
hsa:6483 ST3GAL2, Gal-NAc6S, SIAT4B, ST3GALII, ST3GalA.2; ST3 beta-galactoside alpha-2,3-sialyltransferase 2 (EC:2.4.99.4); K03368 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4B) [EC:2.4.99.4]
hsa:6484 ST3GAL4, CGS23, FLJ11867, FLJ46764, NANTA3, SAT3, SIAT4, SIAT4C, ST3GalIV, STZ; ST3 beta-galactoside alpha-2,3-sialyltransferase 4 (EC:2.4.99.4); K03494 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4C) [EC:2.4.99.4]
hsa:6487 ST3GAL3, SIAT6, ST3GALII, ST3GalIII, ST3N; ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (EC:2.4.99.6); K00781 N-acetyllactosaminide alpha-2,3-sialyltransferase (sialyltransferase 6) [EC:2.4.99.6]
hsa:6609 SMPD1, ASM, ASMASE, NPD; sphingomyelin phosphodiesterase 1, acid lysosomal (EC:3.1.4.12); K12350 sphingomyelin phosphodiesterase [EC:3.1.4.12]
hsa:661 POLR3D, BN51T, RPC4, RPC53, TSBN51; polymerase (RNA) III (DNA directed) polypeptide D, 44kDa (EC:2.7.7.6); K03026 DNA-directed RNA polymerase III subunit C4 [EC:2.7.7.6]
hsa:6610 SMPD2, ISC1, NSMASE, NSMASE1; sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase) (EC:3.1.4.12); K12351 sphingomyelin phosphodiesterase 2 [EC:3.1.4.12]
hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2]
hsa:7368 UGT8, CGT, UGT4; UDP glycosyltransferase 8 (EC:2.4.1.45); K04628 2-hydroxyacylsphingosine 1-beta-galactosyltransferase [EC:2.4.1.45]
hsa:7841 MOGS, CDG2B, GCS1; mannosyl-oligosaccharide glucosidase (EC:3.2.1.106); K01228 mannosyl-oligosaccharide glucosidase [EC:3.2.1.106]
hsa:7941 PLA2G7, LDL-PLA2, LP-PLA2, PAFAH; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (EC:3.1.1.47); K01062 1-alkyl-2-acetylglycerophosphocholine esterase [EC:3.1.1.47]
hsa:79868 ALG13, CXorf45, FLJ23018, FLJ31785, GLT28D1, MDS031, MGC12423, YGL047W; asparagine-linked glycosylation 13 homolog (S. cerevisiae) (EC:2.4.1.141); K07432 beta-1,4-N-acetylglucosaminyltransferase [EC:2.4.1.141]
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:847 CAT, MGC138422, MGC138424; catalase (EC:1.11.1.6); K03781 catalase [EC:1.11.1.6]
hsa:84812 PLCD4, MGC12837; phospholipase C, delta 4 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8702 B4GALT4, B4Gal-T4, beta4Gal-T4; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 (EC:2.4.1.90); K07969 beta-1,4-galactosyltransferase 4 [EC:2.4.1.90 2.4.1.-]
hsa:8703 B4GALT3, beta4Gal-T3; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 (EC:2.4.1.90 2.4.1.38); K07968 beta-1,4-galactosyltransferase 3 [EC:2.4.1.90 2.4.1.38 2.4.1.-]
hsa:8704 B4GALT2, B4Gal-T2, B4Gal-T3, beta4Gal-T2; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07967 beta-1,4-galactosyltransferase 2 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]
hsa:8705 B3GALT4, BETA3GALT4, GALT2, GALT4; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 (EC:2.4.1.62); K00715 ganglioside galactosyltransferase [EC:2.4.1.62]
hsa:8706 B3GALNT1, B3GALT3, GLCT3, GLOB, Gb4Cer, P, P1, beta3Gal-T3, galT3; beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) (EC:2.4.1.79); K00719 galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase [EC:2.4.1.79]
hsa:8707 B3GALT2, BETA3GALT2, GLCT2, beta3Gal-T2; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2; K07820 beta-1,3-galactosyltransferase 2 [EC:2.4.1.-]
hsa:8708 B3GALT1, MGC126594, beta3Gal-T1; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 (EC:2.4.1.79); K07819 beta-1,3-galactosyltransferase 1 [EC:2.4.1.-]
hsa:8789 FBP2, MGC142192; fructose-1,6-bisphosphatase 2 (EC:3.1.3.11); K03841 fructose-1,6-bisphosphatase I [EC:3.1.3.11]
hsa:89869 PLCZ1, MGC149685, NYD-SP27, PLCzeta; phospholipase C, zeta 1 (EC:3.1.4.11); K05861 phospholipase C, zeta
hsa:9331 B4GALT6, B4Gal-T6, beta4Gal-T6; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6; K07553 beta-1,4-galactosyltransferase 6 [EC:2.4.1.-]
hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]
hsa:9536 PTGES, MGC10317, MGST-IV, MGST1-L1, MGST1L1, MPGES, PGES, PIG12, PP102, PP1294, TP53I12, mPGES-1; prostaglandin E synthase (EC:5.3.99.3); K05309 prostaglandin-E synthase [EC:5.3.99.3]

hsa05322 Systemic lupus erythematosus - Homo sapiens (human) (112)



hsa:121504 HIST4H4, H4/p, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, MGC24116; histone cluster 4, H4; K11254 histone H4
hsa:126961 HIST2H3C, H3, H3.2, H3/M, H3F2, H3FM, H3FN, HIST2H3A, HIST2H3D, MGC9629; histone cluster 2, H3c; K11253 histone H3
hsa:128312 HIST3H2BB; histone cluster 3, H2bb; K11252 histone H2B
hsa:1991 ELANE, ELA2, GE, HLE, HNE, NE, PMN-E, SCN1; elastase, neutrophil expressed (EC:3.4.21.37); K01327 leukocyte elastase [EC:3.4.21.37]
hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I
hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b
hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:221613 HIST1H2AA, H2AA, H2AFR, bA317E16.2; histone cluster 1, H2aa; K11251 histone H2A
hsa:255626 HIST1H2BA, H2BFU, STBP, TSH2B, bA317E16.3; histone cluster 1, H2ba; K11252 histone H2B
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:3012 HIST1H2AE, H2A.1, H2A.2, H2A/a, H2AFA, HIST1H2AB; histone cluster 1, H2ae; K11251 histone H2A
hsa:3013 HIST1H2AD, H2A.3, H2A/g, H2AFG, HIST1H3D; histone cluster 1, H2ad; K11251 histone H2A
hsa:3014 H2AFX, H2A.X, H2A/X, H2AX; H2A histone family, member X; K11251 histone H2A
hsa:3015 H2AFZ, H2A.z, H2A/z, H2AZ, MGC117173; H2A histone family, member Z; K11251 histone H2A
hsa:3017 HIST1H2BD, H2B.1B, H2B/b, H2BFB, HIRIP2, MGC90432, dJ221C16.6; histone cluster 1, H2bd; K11252 histone H2B
hsa:3018 HIST1H2BB, H2B.1, H2B/f, H2BFF, MGC119804; histone cluster 1, H2bb; K11252 histone H2B
hsa:3020 H3F3A, H3.3A, H3F3, H3F3B, MGC87782, MGC87783; H3 histone, family 3A; K11253 histone H3
hsa:3021 H3F3B, H3.3B, H3F3A; H3 histone, family 3B (H3.3B); K11253 histone H3
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:317772 HIST2H2AB; histone cluster 2, H2ab; K11251 histone H2A
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:55506 H2AFY2, macroH2A2; H2A histone family, member Y2; K11251 histone H2A
hsa:55766 H2AFJ, FLJ10903, FLJ52230, H2AJ, MGC921; H2A histone family, member J; K11251 histone H2A
hsa:6628 SNRPB, COD, SNRPB1, Sm-B/B', SmB/B', SmB/SmB', snRNP-B; small nuclear ribonucleoprotein polypeptides B and B1; K11086 small nuclear ribonucleoprotein B and B'
hsa:6632 SNRPD1, HsT2456, SMD1, SNRPD, Sm-D1; small nuclear ribonucleoprotein D1 polypeptide 16kDa; K11087 small nuclear ribonucleoprotein D1
hsa:6634 SNRPD3, SMD3, Sm-D3; small nuclear ribonucleoprotein D3 polypeptide 18kDa; K11088 small nuclear ribonucleoprotein D3
hsa:6737 TRIM21, RNF81, RO52, SSA, SSA1; tripartite motif-containing 21; K10651 tripartite motif-containing protein 21
hsa:6741 SSB, LARP3, La; Sjogren syndrome antigen B (autoantigen La); K11090 lupus La protein
hsa:712 C1QA; complement component 1, q subcomponent, A chain; K03986 complement C1q subcomponent subunit A
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:713 C1QB; complement component 1, q subcomponent, B chain; K03987 complement C1q subcomponent subunit B
hsa:714 C1QC, C1Q-C, C1QG, FLJ27103; complement component 1, q subcomponent, C chain; K03988 complement C1q subcomponent subunit C
hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3
hsa:721 C4B, C4B1, C4B12, C4B2, C4B3, C4B5, C4F, CH, CO4, CPAMD3, FLJ60561, MGC164979; complement component 4B (Chido blood group); K03989 complement component 4
hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5
hsa:735 C9; complement component 9; K04000 complement component 9
hsa:81 ACTN4, ACTININ-4, DKFZp686K23158, FSGS, FSGS1; actinin, alpha 4; K05699 actinin alpha
hsa:8290 HIST3H3, H3.4, H3/g, H3FT, H3t, MGC126886, MGC126888; histone cluster 3, H3; K11253 histone H3
hsa:8294 HIST1H4I, H4/m, H4FM, H4M, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4; histone cluster 1, H4i; K11254 histone H4
hsa:8329 HIST1H2AI, FLJ92027, H2A/c, H2AFC, HIST1H2AG, HIST1H2AK, HIST1H2AL, HIST1H2AM; histone cluster 1, H2ai; K11251 histone H2A
hsa:8330 HIST1H2AK, H2A/d, H2AFD, HIST1H2AG, HIST1H2AJ, HIST1H2AL, HIST1H2AM; histone cluster 1, H2ak; K11251 histone H2A
hsa:8331 HIST1H2AJ, H2A/E, H2AFE, dJ160A22.4; histone cluster 1, H2aj; K11251 histone H2A
hsa:8332 HIST1H2AL, H2A.i, H2A/i, H2AFI, HIST1H2AG, HIST1H2AI, HIST1H2AK, HIST1H2AM, dJ193B12.9; histone cluster 1, H2al; K11251 histone H2A
hsa:8334 HIST1H2AC, H2A/l, H2AFL, MGC99519, dJ221C16.4; histone cluster 1, H2ac; K11251 histone H2A
hsa:8335 HIST1H2AB, H2A/m, H2AFM, HIST1H2AE; histone cluster 1, H2ab; K11251 histone H2A
hsa:8336 HIST1H2AM, H2A.1, H2A/n, H2AFN, HIST1H2AG, HIST1H2AI, HIST1H2AK, HIST1H2AL, dJ193B12.1; histone cluster 1, H2am; K11251 histone H2A
hsa:8337 HIST2H2AA3, H2A, H2A.2, H2A/O, H2A/q, H2AFO, H2a-615, HIST2H2AA; histone cluster 2, H2aa3; K11251 histone H2A
hsa:8338 HIST2H2AC, H2A, H2A-GL101, H2A/q, H2AFQ, MGC74460; histone cluster 2, H2ac; K11251 histone H2A
hsa:8339 HIST1H2BG, H2B.1A, H2B/a, H2B/g, H2B/h, H2B/k, H2B/l, H2BFA, HIST1H2BC, HIST1H2BE, HIST1H2BF, HIST1H2BI, dJ221C16.8; histone cluster 1, H2bg; K11252 histone H2B
hsa:8340 HIST1H2BL, H2B/c, H2BFC, dJ97D16.4; histone cluster 1, H2bl; K11252 histone H2B
hsa:8341 HIST1H2BN, H2B/d, H2BFD, HIST1H3I, MGC125414, MGC125415, MGC125416, MGC9388; histone cluster 1, H2bn; K11252 histone H2B
hsa:8342 HIST1H2BM, H2B/e, H2BFE, dJ160A22.3; histone cluster 1, H2bm; K11252 histone H2B
hsa:8343 HIST1H2BF, H2B/a, H2B/g, H2B/h, H2B/k, H2B/l, H2BFG, HIST1H2BC, HIST1H2BE, HIST1H2BG, HIST1H2BI; histone cluster 1, H2bf; K11252 histone H2B
hsa:8344 HIST1H2BE, H2B.h, H2B/a, H2B/g, H2B/h, H2B/k, H2B/l, H2BFH, H2BFN, HIST1H2BC, HIST1H2BF, HIST1H2BG, HIST1H2BI, dJ221C16.8; histone cluster 1, H2be; K11252 histone H2B
hsa:8345 HIST1H2BH, H2B/j, H2BFJ; histone cluster 1, H2bh; K11252 histone H2B
hsa:8346 HIST1H2BI, H2B/a, H2B/g, H2B/h, H2B/k, H2B/l, H2BFK, HIST1H2BC, HIST1H2BE, HIST1H2BF, HIST1H2BG; histone cluster 1, H2bi; K11252 histone H2B
hsa:8347 HIST1H2BC, H2B.1, H2B/a, H2B/g, H2B/h, H2B/k, H2B/l, H2BFL, HIST1H2BE, HIST1H2BF, HIST1H2BG, HIST1H2BI, MGC104246, dJ221C16.3; histone cluster 1, H2bc; K11252 histone H2B
hsa:8348 HIST1H2BO, H2B.2, H2B/n, H2BFN, MGC119806, dJ193B12.2; histone cluster 1, H2bo; K11252 histone H2B
hsa:8349 HIST2H2BE, GL105, H2B, H2B.1, H2BFQ, H2BGL105, H2BQ, MGC119802, MGC119804, MGC129733, MGC129734; histone cluster 2, H2be; K11252 histone H2B
hsa:8350 HIST1H3A, H3/A, H3FA, HIST1H3B, HIST1H3C, HIST1H3D, HIST1H3E, HIST1H3F, HIST1H3G, HIST1H3H, HIST1H3I, HIST1H3J; histone cluster 1, H3a; K11253 histone H3
hsa:8351 HIST1H3D, H3/b, H3FB; histone cluster 1, H3d; K11253 histone H3
hsa:8352 HIST1H3C, H3.1, H3/c, H3FC, HIST1H3A, HIST1H3B, HIST1H3D, HIST1H3E, HIST1H3F, HIST1H3G, HIST1H3H, HIST1H3I, HIST1H3J; histone cluster 1, H3c; K11253 histone H3
hsa:8353 HIST1H3E, H3.1, H3/d, H3FD, HIST1H3A, HIST1H3B, HIST1H3C, HIST1H3D, HIST1H3F, HIST1H3G, HIST1H3H, HIST1H3I, HIST1H3J; histone cluster 1, H3e; K11253 histone H3
hsa:8354 HIST1H3I, H3.f, H3/f, H3FF, HIST1H3A, HIST1H3B, HIST1H3C, HIST1H3D, HIST1H3E, HIST1H3F, HIST1H3G, HIST1H3H, HIST1H3J; histone cluster 1, H3i; K11253 histone H3
hsa:8355 HIST1H3G, H3/h, H3FH, HIST1H3A, HIST1H3B, HIST1H3C, HIST1H3D, HIST1H3E, HIST1H3F, HIST1H3H, HIST1H3I, HIST1H3J; histone cluster 1, H3g; K11253 histone H3
hsa:8356 HIST1H3J, H3/j, H3FJ, HIST1H3A, HIST1H3B, HIST1H3C, HIST1H3D, HIST1H3E, HIST1H3F, HIST1H3G, HIST1H3H, HIST1H3I; histone cluster 1, H3j; K11253 histone H3
hsa:8357 HIST1H3H, FLJ92264, H3/k, H3F1K, H3FK, HIST1H3A, HIST1H3B, HIST1H3C, HIST1H3D, HIST1H3E, HIST1H3F, HIST1H3G, HIST1H3I, HIST1H3J; histone cluster 1, H3h; K11253 histone H3
hsa:8358 HIST1H3B, H3/l, H3FL, HIST1H3A, HIST1H3C, HIST1H3D, HIST1H3E, HIST1H3F, HIST1H3G, HIST1H3H, HIST1H3I, HIST1H3J; histone cluster 1, H3b; K11253 histone H3
hsa:8359 HIST1H4A, H4/a, H4FA, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4; histone cluster 1, H4a; K11254 histone H4
hsa:8360 HIST1H4D, H4/b, H4FB, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4, dJ221C16.9; histone cluster 1, H4d; K11254 histone H4
hsa:8361 HIST1H4F, H4, H4/c, H4FC, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4; histone cluster 1, H4f; K11254 histone H4
hsa:8362 HIST1H4K, H4/d, H4F2iii, H4FD, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4, dJ160A22.1; histone cluster 1, H4k; K11254 histone H4
hsa:8363 HIST1H4J, H4/e, H4F2iv, H4FE, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4, MGC166960, MGC29783, dJ160A22.2; histone cluster 1, H4j; K11254 histone H4
hsa:8364 HIST1H4C, H4/g, H4FG, HIST1H4A, HIST1H4B, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4, dJ221C16.1; histone cluster 1, H4c; K11254 histone H4
hsa:8365 HIST1H4H, H4/h, H4FH, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4; histone cluster 1, H4h; K11254 histone H4
hsa:8366 HIST1H4B, H4/I, H4FI, HIST1H4A, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4; histone cluster 1, H4b; K11254 histone H4
hsa:8367 HIST1H4E, H4/j, H4FJ, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4; histone cluster 1, H4e; K11254 histone H4
hsa:8368 HIST1H4L, H4.k, H4/k, H4FK, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST2H4A, HIST2H4B, HIST4H4; histone cluster 1, H4l; K11254 histone H4
hsa:8369 HIST1H4G, H4/l, H4FL; histone cluster 1, H4g; K11254 histone H4
hsa:8370 HIST2H4A, FO108, H4, H4/n, H4F2, H4FN, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4, HIST2H4B, HIST4H4; histone cluster 2, H4a; K11254 histone H4
hsa:83740 H2AFB3, H2ABBD, H2AFB, H2AFB2; H2A histone family, member B3; K11251 histone H2A
hsa:85235 HIST1H2AH, H2A/S, H2AFALii, MGC171151, dJ86C11.1; histone cluster 1, H2ah; K11251 histone H2A
hsa:85236 HIST1H2BK, H2B/S, H2BFAiii, H2BFT, MGC131989; histone cluster 1, H2bk; K11252 histone H2B
hsa:87 ACTN1, FLJ40884, FLJ54432; actinin, alpha 1; K05699 actinin alpha
hsa:8968 HIST1H3F, H3/i, H3FI, HIST1H3A, HIST1H3B, HIST1H3C, HIST1H3D, HIST1H3E, HIST1H3G, HIST1H3H, HIST1H3I, HIST1H3J; histone cluster 1, H3f; K11253 histone H3
hsa:8969 HIST1H2AG, H2A.1b, H2A/p, H2AFP, HIST1H2AI, HIST1H2AK, HIST1H2AL, HIST1H2AM, pH2A/f; histone cluster 1, H2ag; K11251 histone H2A
hsa:8970 HIST1H2BJ, H2B/r, H2BFR; histone cluster 1, H2bj; K11252 histone H2B
hsa:92815 HIST3H2A, MGC3165; histone cluster 3, H2a; K11251 histone H2A
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen
hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen
hsa:94239 H2AFV, FLJ26479, H2AV, MGC10170, MGC10831, MGC1947; H2A histone family, member V; K11251 histone H2A
hsa:9555 H2AFY, H2A.y, H2A/y, H2AF12M, H2AFJ, MACROH2A1.1, mH2A1, macroH2A1.2; H2A histone family, member Y; K11251 histone H2A
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5

hsa04510 Focal adhesion - Homo sapiens (human) (103)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:10319 LAMC3, DKFZp434E202; laminin, gamma 3; K06247 laminin, gamma 3
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:1277 COL1A1, OI4; collagen, type I, alpha 1; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1278 COL1A2, OI4; collagen, type I, alpha 2; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1281 COL3A1, EDS4A, FLJ34534; collagen, type III, alpha 1; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1282 COL4A1, arresten; collagen, type IV, alpha 1; K06237 collagen, type IV, alpha
hsa:1284 COL4A2, DKFZp686I14213, FLJ22259; collagen, type IV, alpha 2; K06237 collagen, type IV, alpha
hsa:1286 COL4A4, CA44; collagen, type IV, alpha 4; K06237 collagen, type IV, alpha
hsa:1287 COL4A5, ASLN, ATS, CA54, MGC167109, MGC42377; collagen, type IV, alpha 5; K06237 collagen, type IV, alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2002 ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:22798 LAMB4; laminin, beta 4; K06245 laminin, beta 4
hsa:2316 FLNA, ABP-280, ABPX, CVD1, DKFZp434P031, FLN, FLN-A, FLN1, FMD, MNS, NHBP, OPD, OPD1, OPD2, XLVD, XMVD; filamin A, alpha; K04437 filamin
hsa:2317 FLNB, ABP-278, ABP-280, AOI, DKFZp686A1668, DKFZp686O033, FH1, FLN1L, LRS1, SCT, TABP, TAP; filamin B, beta; K04437 filamin
hsa:2318 FLNC, ABP-280, ABP280A, ABPA, ABPL, FLJ10186, FLN2; filamin C, gamma; K04437 filamin
hsa:2321 FLT1, FLT, VEGFR1; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (EC:2.7.10.1); K05096 FMS-like tyrosine kinase 1 [EC:2.7.10.1]
hsa:2335 FN1, CIG, DKFZp686F10164, DKFZp686H0342, DKFZp686I1370, DKFZp686O13149, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF; fibronectin 1; K05717 fibronectin 1
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:284217 LAMA1, LAMA; laminin, alpha 1; K05637 laminin, alpha 1/2
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3082 HGF, DFNB39, F-TCF, HGFB, HPTA, SF; hepatocyte growth factor (hepapoietin A; scatter factor); K05460 hepatocyte growth factor
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:329 BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat-containing 2; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:330 BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat-containing 3; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3480 IGF1R, CD221, IGFIR, IGFR, JTK13, MGC142170, MGC142172, MGC18216; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]
hsa:3655 ITGA6, CD49f, DKFZp686J01244, FLJ18737, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6
hsa:3675 ITGA3, CD49C, FLJ34631, FLJ34704, GAP-B3, GAPB3, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5
hsa:3685 ITGAV, CD51, DKFZp686A08142, MSK8, VNRA; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); K06487 integrin alpha V
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3691 ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4
hsa:3693 ITGB5, FLJ26658; integrin, beta 5; K06588 integrin beta 5
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:3791 KDR, CD309, FLK1, VEGFR, VEGFR2; kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1); K05098 kinase insert domain protein receptor [EC:2.7.10.1]
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:3908 LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2
hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:3910 LAMA4, DKFZp686D23145, LAMA3, LAMA4*-1; laminin, alpha 4; K06241 laminin, alpha 4
hsa:3911 LAMA5, KIAA1907; laminin, alpha 5; K06240 laminin, alpha 3/5
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:3913 LAMB2, LAMS; laminin, beta 2 (laminin S); K06243 laminin, beta 2
hsa:3914 LAMB3, BM600-125KDA, FLJ99565, LAM5, LAMNB1; laminin, beta 3; K06244 laminin, beta 3
hsa:3915 LAMC1, LAMB2, MGC87297; laminin, gamma 1 (formerly LAMB2); K05635 laminin, gamma 1
hsa:3918 LAMC2, B2T, BM600, CSF, EBR2, EBR2A, LAMB2T, LAMNB2, MGC138491, MGC141938; laminin, gamma 2; K06246 laminin, gamma 2
hsa:5058 PAK1, MGC130000, MGC130001, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1]
hsa:5062 PAK2, PAK65, PAKgamma; p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1); K04410 p21-activated kinase 2 [EC:2.7.11.1]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:53358 SHC3, DKFZp686H1544, FLJ45325, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K06279 src homology 2 domain-containing transforming protein C
hsa:5499 PPP1CA, MGC15877, MGC1674, PP-1A, PP1alpha, PPP1A; protein phosphatase 1, catalytic subunit, alpha isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5500 PPP1CB, MGC3672, PP-1B, PP1beta, PPP1CD; protein phosphatase 1, catalytic subunit, beta isozyme (EC:3.1.3.16 3.1.3.53); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5501 PPP1CC, PP1gamma, PPP1G; protein phosphatase 1, catalytic subunit, gamma isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:5829 PXN, FLJ16691; paxillin; K05760 paxillin
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5923 RASGRF1, CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187; Ras protein-specific guanine nucleotide-releasing factor 1; K04349 Ras-specific guanine nucleotide-releasing factor 1
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:6464 SHC1, FLJ26504, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 src homology 2 domain-containing transforming protein C
hsa:6714 SRC, ASV, SRC1, c-SRC, p60-Src; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (EC:2.7.10.2); K05704 proto-oncogene tyrosine-protein kinase Src [EC:2.7.10.2]
hsa:7057 THBS1, THBS, THBS-1, TSP, TSP-1, TSP1; thrombospondin 1; K04659 thrombospondin
hsa:7094 TLN1, ILWEQ, KIAA1027, TLN; talin 1; K06271 talin
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7414 VCL, CMD1W, CMH15, MVCL; vinculin; K05700 vinculin
hsa:7422 VEGFA, MGC70609, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A/B, PGF
hsa:7448 VTN, V75, VN, VNT; vitronectin; K06251 vitronectin
hsa:81 ACTN4, ACTININ-4, DKFZp686K23158, FSGS, FSGS1; actinin, alpha 4; K05699 actinin alpha
hsa:824 CAPN2, CANP2, CANPL2, CANPml, FLJ39928, mCANP; calpain 2, (m/II) large subunit (EC:3.4.22.53); K03853 calpain-2 [EC:3.4.22.53]
hsa:83660 TLN2, DKFZp451B1011, DKFZp686I0976, DKFZp686K0979, ILWEQ, KIAA0320; talin 2; K06271 talin
hsa:857 CAV1, BSCL3, CGL3, MSTP085, VIP21; caveolin 1, caveolae protein, 22kDa; K06278 caveolin 1
hsa:87 ACTN1, FLJ40884, FLJ54432; actinin, alpha 1; K05699 actinin alpha
hsa:896 CCND3; cyclin D3; K10152 cyclin D3
hsa:9564 BCAR1, CAS, CAS1, CASS1, CRKAS, FLJ12176, FLJ45059, P130Cas; breast cancer anti-estrogen resistance 1; K05726 breast cancer anti-estrogen resistance 1
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa05145 Toxoplasmosis - Homo sapiens (human) (102)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:10319 LAMC3, DKFZp434E202; laminin, gamma 3; K06247 laminin, gamma 3
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:22798 LAMB4; laminin, beta 4; K06245 laminin, beta 4
hsa:240 ALOX5, 5-LO, 5-LOX, 5LPG, LOG5, MGC163204; arachidonate 5-lipoxygenase (EC:1.13.11.34); K00461 arachidonate 5-lipoxygenase [EC:1.13.11.34]
hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:2770 GNAI1, Gi; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1; K04630 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide
hsa:2775 GNAO1, DKFZp686O0962, G-ALPHA-o, GNAO; guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O; K04534 guanine nucleotide binding protein (G protein), alpha o polypeptide
hsa:284217 LAMA1, LAMA; laminin, alpha 1; K05637 laminin, alpha 1/2
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:329 BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat-containing 2; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:330 BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat-containing 3; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:3303 HSPA1A, FLJ54303, FLJ54370, FLJ54392, FLJ54408, FLJ75127, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1, HSPA1B; heat shock 70kDa protein 1A; K03283 heat shock 70kDa protein 1/8
hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8
hsa:3306 HSPA2, HSP70-2, HSP70-3; heat shock 70kDa protein 2; K03283 heat shock 70kDa protein 1/8
hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8
hsa:3312 HSPA8, HSC54, HSC70, HSC71, HSP71, HSP73, HSPA10, LAP1, MGC131511, MGC29929, NIP71; heat shock 70kDa protein 8; K03283 heat shock 70kDa protein 1/8
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3655 ITGA6, CD49f, DKFZp686J01244, FLJ18737, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3716 JAK1, JAK1A, JAK1B, JTK3; Janus kinase 1 (EC:2.7.10.2); K11217 Janus kinase 1 [EC:2.7.10.2]
hsa:3908 LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2
hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:3910 LAMA4, DKFZp686D23145, LAMA3, LAMA4*-1; laminin, alpha 4; K06241 laminin, alpha 4
hsa:3911 LAMA5, KIAA1907; laminin, alpha 5; K06240 laminin, alpha 3/5
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:3913 LAMB2, LAMS; laminin, beta 2 (laminin S); K06243 laminin, beta 2
hsa:3914 LAMB3, BM600-125KDA, FLJ99565, LAM5, LAMNB1; laminin, beta 3; K06244 laminin, beta 3
hsa:3915 LAMC1, LAMB2, MGC87297; laminin, gamma 1 (formerly LAMB2); K05635 laminin, gamma 1
hsa:3918 LAMC2, B2T, BM600, CSF, EBR2, EBR2A, LAMB2T, LAMNB2, MGC138491, MGC141938; laminin, gamma 2; K06246 laminin, gamma 2
hsa:3949 LDLR, FH, FHC, LDLCQ2; low density lipoprotein receptor; K12473 low-density lipoprotein receptor
hsa:4261 CIITA, C2TA, CIITAIV, MHC2TA, NLRA; class II, major histocompatibility complex, transactivator; K08060 class II, major histocompatibility complex, transactivator
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4793 NFKBIB, IKBB, TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; K02581 NF-kappa-B inhibitor beta
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:54205 CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:598 BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, DKFZp781P2092, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X)
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8651 SOCS1, CIS1, CISH1, JAB, SOCS-1, SSI-1, SSI1, TIP3; suppressor of cytokine signaling 1; K04694 suppressor of cytokine signaling 1
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5

hsa04062 Chemokine signaling pathway - Homo sapiens (human) (101)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:10663 CXCR6, BONZO, CD186, STRL33, TYMSTR; chemokine (C-X-C motif) receptor 6; K04191 C-X-C chemokine receptor type 6
hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:1230 CCR1, CD191, CKR-1, CKR1, CMKBR1, HM145, MIP1aR, SCYAR1; chemokine (C-C motif) receptor 1; K04176 C-C chemokine receptor type 1
hsa:1232 CCR3, CC-CKR-3, CD193, CKR3, CMKBR3, MGC102841; chemokine (C-C motif) receptor 3; K04178 C-C chemokine receptor type 3
hsa:1233 CCR4, CC-CKR-4, CD194, CKR4, CMKBR4, ChemR13, HGCN:14099, K5-5, MGC88293; chemokine (C-C motif) receptor 4; K04179 C-C chemokine receptor type 4
hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5
hsa:1235 CCR6, BN-1, C-C_CKR-6, CC-CKR-6, CCR-6, CD196, CKR-L3, CKRL3, CMKBR6, DCR2, DRY6, GPR29, GPRCY4, STRL22; chemokine (C-C motif) receptor 6; K04181 C-C chemokine receptor type 6
hsa:1236 CCR7, BLR2, CD197, CDw197, CMKBR7, EBI1; chemokine (C-C motif) receptor 7; K04182 C-C chemokine receptor type 7
hsa:1237 CCR8, CC-CKR-8, CCR-8, CDw198, CKRL1, CMKBR8, CMKBRL2, CY6, GPRCY6, MGC129966, MGC129973, TER1; chemokine (C-C motif) receptor 8; K04183 C-C chemokine receptor type 8
hsa:1445 CSK, MGC117393; c-src tyrosine kinase (EC:2.7.10.2); K05728 c-src tyrosine kinase [EC:2.7.10.2]
hsa:1524 CX3CR1, CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28; chemokine (C-X3-C motif) receptor 1; K04192 CX3C chemokine receptor 1
hsa:1794 DOCK2, FLJ46592, KIAA0209; dedicator of cytokinesis 2; K12367 dedicator of cytokinesis 2
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2185 PTK2B, CADTK, CAKB, FADK2, FAK2, PKB, PTK, PYK2, RAFTK; PTK2B protein tyrosine kinase 2 beta (EC:2.7.10.2); K05871 protein tyrosine kinase 2 beta [EC:2.7.10.2]
hsa:2309 FOXO3, AF6q21, DKFZp781A0677, FKHRL1, FKHRL1P2, FOXO2, FOXO3A, MGC12739, MGC31925; forkhead box O3; K09408 forkhead box protein O3
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:2770 GNAI1, Gi; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1; K04630 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide
hsa:2833 CXCR3, CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR; chemokine (C-X-C motif) receptor 3; K04188 C-X-C chemokine receptor type 3
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2919 CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha); K05505 C-X-C motif chemokine 1/2/3
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3055 HCK, JTK9; hemopoietic cell kinase (EC:2.7.10.2); K08893 hemopoietic cell kinase [EC:2.7.10.2]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3627 CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1; chemokine (C-X-C motif) ligand 10; K12671 C-X-C motif chemokine 10
hsa:3718 JAK3, JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK; Janus kinase 3 (EC:2.7.10.2); K11218 Janus kinase 3 [EC:2.7.10.2]
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:4067 LYN, FLJ26625, JTK8; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2); K05854 tyrosine-protein kinase Lyn [EC:2.7.10.2]
hsa:4283 CXCL9, CMK, Humig, MIG, SCYB9, crg-10; chemokine (C-X-C motif) ligand 9; K05416 C-X-C motif chemokine 9
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4793 NFKBIB, IKBB, TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; K02581 NF-kappa-B inhibitor beta
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5058 PAK1, MGC130000, MGC130001, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:53358 SHC3, DKFZp686H1544, FLJ45325, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K06279 src homology 2 domain-containing transforming protein C
hsa:5473 PPBP, B-TG1, Beta-TG, CTAP-III, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, PBP, SCYB7, TC1, TC2, TGB, TGB1, THBGB, THBGB1; pro-platelet basic protein (chemokine (C-X-C motif) ligand 7); K10029 platelet basic protein
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5580 PRKCD, MAY1, MGC49908, PKCD, nPKC-delta; protein kinase C, delta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5590 PRKCZ, PKC-ZETA, PKC2; protein kinase C, zeta (EC:2.7.11.13); K06069 atypical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:5829 PXN, FLJ16691; paxillin; K05760 paxillin
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6346 CCL1, I-309, P500, SCYA1, SISe, TCA3; chemokine (C-C motif) ligand 1; K05514 C-C motif chemokine, other
hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:6348 CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3; chemokine (C-C motif) ligand 3; K05408 C-C motif chemokine 3
hsa:6351 CCL4, ACT2, AT744.1, G-26, LAG1, MGC104418, MGC126025, MGC126026, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4; chemokine (C-C motif) ligand 4; K12964 C-C motif chemokine 4
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:6354 CCL7, FIC, MARC, MCP-3, MCP3, MGC138463, MGC138465, NC28, SCYA6, SCYA7; chemokine (C-C motif) ligand 7; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6355 CCL8, HC14, MCP-2, MCP2, SCYA10, SCYA8; chemokine (C-C motif) ligand 8; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6356 CCL11, MGC22554, SCYA11; chemokine (C-C motif) ligand 11; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6364 CCL20, CKb4, LARC, MIP-3a, MIP3A, SCYA20, ST38; chemokine (C-C motif) ligand 20; K14625 C-C motif chemokine 20
hsa:6366 CCL21, 6Ckine, CKb9, ECL, MGC34555, SCYA21, SLC, TCA4; chemokine (C-C motif) ligand 21; K05512 C-C motif chemokine 19/21
hsa:6367 CCL22, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1; chemokine (C-C motif) ligand 22; K05514 C-C motif chemokine, other
hsa:6375 XCL1, ATAC, LPTN, LTN, SCM-1, SCM-1a, SCM1, SCM1A, SCYC1; chemokine (C motif) ligand 1; K05507 C motif chemokine 1/2
hsa:6376 CX3CL1, ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1, fractalkine, neurotactin; chemokine (C-X3-C motif) ligand 1; K05508 C-X3-C motif chemokine 1
hsa:6387 CXCL12, IRH, PBSF, SCYB12, SDF1, SDF1A, SDF1B, TLSF, TPAR1; chemokine (C-X-C motif) ligand 12; K10031 C-X-C motif chemokine 12
hsa:6464 SHC1, FLJ26504, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 src homology 2 domain-containing transforming protein C
hsa:653361 NCF1, FLJ79451, NCF1A, NOXO2, SH3PXD1A, p47phox; neutrophil cytosolic factor 1; K08011 neutrophil cytosolic factor 1
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:6777 STAT5B, STAT5; signal transducer and activator of transcription 5B; K11224 signal transducer and activator of transcription 5B
hsa:729230 CCR2, CC-CKR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, FLJ78302, MCP-1-R, MGC103828, MGC111760, MGC168006; chemokine (C-C motif) receptor 2; K04177 C-C chemokine receptor type 2
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:8976 WASL, DKFZp779G0847, MGC48327, N-WASP, NWASP; Wiskott-Aldrich syndrome-like; K05747 Wiskott-Aldrich syndrome protein
hsa:9564 BCAR1, CAS, CAS1, CASS1, CRKAS, FLJ12176, FLJ45059, P130Cas; breast cancer anti-estrogen resistance 1; K05726 breast cancer anti-estrogen resistance 1
hsa:9844 ELMO1, CED-12, CED12, ELMO-1, KIAA0281, MGC126406; engulfment and cell motility 1; K12366 engulfment and cell motility protein 1
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa04010 MAPK signaling pathway - Homo sapiens (human) (100)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1386 ATF2, CRE-BP1, CREB2, HB16, MGC111558, TREB7; activating transcription factor 2; K04450 activating transcription factor 2
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1647 GADD45A, DDIT1, GADD45; growth arrest and DNA-damage-inducible, alpha; K04402 growth arrest and DNA-damage-inducible protein
hsa:1649 DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153, MGC4154; DNA-damage-inducible transcript 3; K04452 DNA damage-inducible transcript 3
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2002 ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2246 FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1; fibroblast growth factor 1 (acidic); K04358 fibroblast growth factor
hsa:2247 FGF2, BFGF, FGFB, HBGF-2; fibroblast growth factor 2 (basic); K04358 fibroblast growth factor
hsa:2316 FLNA, ABP-280, ABPX, CVD1, DKFZp434P031, FLN, FLN-A, FLN1, FMD, MNS, NHBP, OPD, OPD1, OPD2, XLVD, XMVD; filamin A, alpha; K04437 filamin
hsa:2317 FLNB, ABP-278, ABP-280, AOI, DKFZp686A1668, DKFZp686O033, FH1, FLN1L, LRS1, SCT, TABP, TAP; filamin B, beta; K04437 filamin
hsa:2318 FLNC, ABP-280, ABP280A, ABPA, ABPL, FLJ10186, FLN2; filamin C, gamma; K04437 filamin
hsa:2353 FOS, AP-1, C-FOS; FBJ murine osteosarcoma viral oncogene homolog; K04379 proto-oncogene protein c-fos
hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:2872 MKNK2, GPRK7, MNK2; MAP kinase interacting serine/threonine kinase 2 (EC:2.7.11.1); K04372 MAP kinase interacting serine/threonine kinase [EC:2.7.11.1]
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:3164 NR4A1, GFRP1, HMR, MGC9485, N10, NAK-1, NGFIB, NP10, NUR77, TR3; nuclear receptor subfamily 4, group A, member 1; K04465 nuclear receptor subfamily 4 group A member 1
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3303 HSPA1A, FLJ54303, FLJ54370, FLJ54392, FLJ54408, FLJ75127, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1, HSPA1B; heat shock 70kDa protein 1A; K03283 heat shock 70kDa protein 1/8
hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8
hsa:3306 HSPA2, HSP70-2, HSP70-3; heat shock 70kDa protein 2; K03283 heat shock 70kDa protein 1/8
hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8
hsa:3312 HSPA8, HSC54, HSC70, HSC71, HSP71, HSP73, HSPA10, LAP1, MGC131511, MGC29929, NIP71; heat shock 70kDa protein 8; K03283 heat shock 70kDa protein 1/8
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4149 MAX, MGC10775, MGC11225, MGC18164, MGC34679, MGC36767, bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8, orf1; MYC associated factor X; K04453 Max protein
hsa:4217 MAP3K5, ASK1, MAPKKK5, MEKK5; mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25); K04426 mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
hsa:4296 MAP3K11, MEKK11, MGC17114, MLK-3, MLK3, PTK1, SPRK; mitogen-activated protein kinase kinase kinase 11 (EC:2.7.11.25); K04419 mitogen-activated protein kinase kinase kinase 11 [EC:2.7.11.25]
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:468 ATF4, CREB-2, CREB2, TAXREB67, TXREB; activating transcription factor 4 (tax-responsive enhancer element B67); K04374 activating transcription factor 4
hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4776 NFATC4, NF-ATc4, NFAT3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4791 NFKB2, LYT-10, LYT10, p52; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100); K04469 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5058 PAK1, MGC130000, MGC130001, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1]
hsa:5062 PAK2, PAK65, PAKgamma; p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1); K04410 p21-activated kinase 2 [EC:2.7.11.1]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5598 MAPK7, BMK1, ERK4, ERK5, PRKM7; mitogen-activated protein kinase 7 (EC:2.7.11.24); K04464 mitogen-activated protein kinase 7 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5923 RASGRF1, CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187; Ras protein-specific guanine nucleotide-releasing factor 1; K04349 Ras-specific guanine nucleotide-releasing factor 1
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:5971 RELB, I-REL, IREL, REL-B; v-rel reticuloendotheliosis viral oncogene homolog B; K09253 transcription factor RelB
hsa:627 BDNF, MGC34632; brain-derived neurotrophic factor; K04355 brain-derived neurotrophic factor
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:6722 SRF, MCM1; serum response factor (c-fos serum response element-binding transcription factor); K04378 serum response factor
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]
hsa:9020 MAP3K14, FTDCR1B, HS, HSNIK, NIK; mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25); K04466 mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa04060 Cytokine-cytokine receptor interaction - Homo sapiens (human) (94)



hsa:10663 CXCR6, BONZO, CD186, STRL33, TYMSTR; chemokine (C-X-C motif) receptor 6; K04191 C-X-C chemokine receptor type 6
hsa:10673 TNFSF13B, BAFF, BLYS, CD257, DTL, TALL-1, TALL1, THANK, TNFSF20, ZTNF4; tumor necrosis factor (ligand) superfamily, member 13b; K05476 tumor necrosis factor (ligand) superfamily, member 13B
hsa:1230 CCR1, CD191, CKR-1, CKR1, CMKBR1, HM145, MIP1aR, SCYAR1; chemokine (C-C motif) receptor 1; K04176 C-C chemokine receptor type 1
hsa:1232 CCR3, CC-CKR-3, CD193, CKR3, CMKBR3, MGC102841; chemokine (C-C motif) receptor 3; K04178 C-C chemokine receptor type 3
hsa:1233 CCR4, CC-CKR-4, CD194, CKR4, CMKBR4, ChemR13, HGCN:14099, K5-5, MGC88293; chemokine (C-C motif) receptor 4; K04179 C-C chemokine receptor type 4
hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5
hsa:1235 CCR6, BN-1, C-C_CKR-6, CC-CKR-6, CCR-6, CD196, CKR-L3, CKRL3, CMKBR6, DCR2, DRY6, GPR29, GPRCY4, STRL22; chemokine (C-C motif) receptor 6; K04181 C-C chemokine receptor type 6
hsa:1236 CCR7, BLR2, CD197, CDw197, CMKBR7, EBI1; chemokine (C-C motif) receptor 7; K04182 C-C chemokine receptor type 7
hsa:1237 CCR8, CC-CKR-8, CCR-8, CDw198, CKRL1, CMKBR8, CMKBRL2, CY6, GPRCY6, MGC129966, MGC129973, TER1; chemokine (C-C motif) receptor 8; K04183 C-C chemokine receptor type 8
hsa:1436 CSF1R, C-FMS, CD115, CSFR, FIM2, FMS; colony stimulating factor 1 receptor (EC:2.7.10.1); K05090 macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
hsa:1437 CSF2, GMCSF, MGC131935, MGC138897; colony stimulating factor 2 (granulocyte-macrophage); K05427 granulocyte-macrophage colony-stimulating factor
hsa:1524 CX3CR1, CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28; chemokine (C-X3-C motif) receptor 1; K04192 CX3C chemokine receptor 1
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2056 EPO, EP, MGC138142, MVCD2; erythropoietin; K05437 erythropoietin
hsa:2321 FLT1, FLT, VEGFR1; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (EC:2.7.10.1); K05096 FMS-like tyrosine kinase 1 [EC:2.7.10.1]
hsa:2688 GH1, GH, GH-N, GHN, IGHD1B, hGH-N; growth hormone 1; K05438 growth hormone
hsa:2833 CXCR3, CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR; chemokine (C-X-C motif) receptor 3; K04188 C-X-C chemokine receptor type 3
hsa:2919 CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha); K05505 C-X-C motif chemokine 1/2/3
hsa:29949 IL19, IL-10C, MDA1, NG.1, ZMDA1; interleukin 19; K05444 interleukin 19/20/24
hsa:3082 HGF, DFNB39, F-TCF, HGFB, HPTA, SF; hepatocyte growth factor (hepapoietin A; scatter factor); K05460 hepatocyte growth factor
hsa:3439 IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@, MGC138207, MGC138505, MGC138507; interferon, alpha 1; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3444 IFNA7, IFN-alphaJ, IFNA-J; interferon, alpha 7; K05414 interferon, alpha
hsa:3449 IFNA16, IFN-alphaO; interferon, alpha 16; K05414 interferon, alpha
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3456 IFNB1, IFB, IFF, IFNB, MGC96956; interferon, beta 1, fibroblast; K05415 interferon, beta
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3467 IFNW1; interferon, omega 1; K05440 interferon, omega 1
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:3559 IL2RA, CD25, IDDM10, IL2R, TCGFR; interleukin 2 receptor, alpha; K05068 interleukin 2 receptor alpha
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta
hsa:3561 IL2RG, CD132, IL-2RG, IMD4, P64, SCIDX, SCIDX1; interleukin 2 receptor, gamma; K05070 interleukin 2 receptor gamma
hsa:3562 IL3, IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF; interleukin 3 (colony-stimulating factor, multiple); K04736 interleukin 3
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3566 IL4R, CD124, IL4RA; interleukin 4 receptor; K05071 interleukin 4 receptor
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3570 IL6R, CD126, IL-6R-1, IL-6R-alpha, IL6RA, MGC104991; interleukin 6 receptor; K05055 interleukin 6 receptor
hsa:3574 IL7, IL-7; interleukin 7; K05431 interleukin 7
hsa:3575 IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA; interleukin 7 receptor; K05072 interleukin 7 receptor
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3596 IL13, ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600; interleukin 13; K05435 interleukin 13
hsa:3600 IL15, IL-15, MGC9721; interleukin 15; K05433 interleukin 15
hsa:3627 CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1; chemokine (C-X-C motif) ligand 10; K12671 C-X-C motif chemokine 10
hsa:3791 KDR, CD309, FLK1, VEGFR, VEGFR2; kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1); K05098 kinase insert domain protein receptor [EC:2.7.10.1]
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
hsa:3976 LIF, CDF, DIA, HILDA; leukemia inhibitory factor (cholinergic differentiation factor); K05419 leukemia inhibitory factor
hsa:4049 LTA, LT, TNFB, TNFSF1; lymphotoxin alpha (TNF superfamily, member 1); K05468 lymphotoxin alpha (TNF superfamily, member 1)
hsa:4283 CXCL9, CMK, Humig, MIG, SCYB9, crg-10; chemokine (C-X-C motif) ligand 9; K05416 C-X-C motif chemokine 9
hsa:50604 IL20, IL-20, IL10D, MGC96907, ZCYTO10; interleukin 20; K05444 interleukin 19/20/24
hsa:5473 PPBP, B-TG1, Beta-TG, CTAP-III, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, PBP, SCYB7, TC1, TC2, TGB, TGB1, THBGB, THBGB1; pro-platelet basic protein (chemokine (C-X-C motif) ligand 7); K10029 platelet basic protein
hsa:6346 CCL1, I-309, P500, SCYA1, SISe, TCA3; chemokine (C-C motif) ligand 1; K05514 C-C motif chemokine, other
hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:6348 CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3; chemokine (C-C motif) ligand 3; K05408 C-C motif chemokine 3
hsa:6351 CCL4, ACT2, AT744.1, G-26, LAG1, MGC104418, MGC126025, MGC126026, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4; chemokine (C-C motif) ligand 4; K12964 C-C motif chemokine 4
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:6354 CCL7, FIC, MARC, MCP-3, MCP3, MGC138463, MGC138465, NC28, SCYA6, SCYA7; chemokine (C-C motif) ligand 7; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6355 CCL8, HC14, MCP-2, MCP2, SCYA10, SCYA8; chemokine (C-C motif) ligand 8; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6356 CCL11, MGC22554, SCYA11; chemokine (C-C motif) ligand 11; K05509 C-C motif chemokine 7/8/11/12/13
hsa:6364 CCL20, CKb4, LARC, MIP-3a, MIP3A, SCYA20, ST38; chemokine (C-C motif) ligand 20; K14625 C-C motif chemokine 20
hsa:6366 CCL21, 6Ckine, CKb9, ECL, MGC34555, SCYA21, SLC, TCA4; chemokine (C-C motif) ligand 21; K05512 C-C motif chemokine 19/21
hsa:6367 CCL22, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1; chemokine (C-C motif) ligand 22; K05514 C-C motif chemokine, other
hsa:6375 XCL1, ATAC, LPTN, LTN, SCM-1, SCM-1a, SCM1, SCM1A, SCYC1; chemokine (C motif) ligand 1; K05507 C motif chemokine 1/2
hsa:6376 CX3CL1, ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1, fractalkine, neurotactin; chemokine (C-X3-C motif) ligand 1; K05508 C-X3-C motif chemokine 1
hsa:6387 CXCL12, IRH, PBSF, SCYB12, SDF1, SDF1A, SDF1B, TLSF, TPAR1; chemokine (C-X-C motif) ligand 12; K10031 C-X-C motif chemokine 12
hsa:650 BMP2, BMP2A; bone morphogenetic protein 2; K04662 bone morphogenetic protein 2/4
hsa:659 BMPR2, BMPR-II, BMPR3, BMR2, BRK-3, FLJ41585, FLJ76945, PPH1, T-ALK; bone morphogenetic protein receptor, type II (serine/threonine kinase) (EC:2.7.11.30); K04671 bone morphogenetic protein receptor type-2 [EC:2.7.11.30]
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7133 TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR; tumor necrosis factor receptor superfamily, member 1B; K05141 tumor necrosis factor receptor superfamily member 1B
hsa:729230 CCR2, CC-CKR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, FLJ78302, MCP-1-R, MGC103828, MGC111760, MGC168006; chemokine (C-C motif) receptor 2; K04177 C-C chemokine receptor type 2
hsa:7422 VEGFA, MGC70609, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A/B, PGF
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:8600 TNFSF11, CD254, ODF, OPGL, OPTB2, RANKL, TRANCE, hRANKL2, sOdf; tumor necrosis factor (ligand) superfamily, member 11; K05473 tumor necrosis factor (ligand) superfamily, member 11
hsa:8740 TNFSF14, CD258, HVEML, LIGHT, LTg, TR2; tumor necrosis factor (ligand) superfamily, member 14; K05477 tumor necrosis factor (ligand) superfamily, member 14
hsa:8743 TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL; tumor necrosis factor (ligand) superfamily, member 10; K04721 tumor necrosis factor superfamily, member 10
hsa:8793 TNFRSF10D, CD264, DCR2, TRAILR4, TRUNDD; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; K04722 tumor necrosis factor receptor superfamily member 10
hsa:8794 TNFRSF10C, CD263, DCR1, DCR1-TNFR, LIT, MGC149501, MGC149502, TRAIL-R3, TRAILR3, TRID; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain; K04722 tumor necrosis factor receptor superfamily member 10
hsa:8795 TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9; tumor necrosis factor receptor superfamily, member 10b; K04722 tumor necrosis factor receptor superfamily member 10
hsa:8797 TNFRSF10A, APO2, CD261, DR4, MGC9365, TRAILR-1, TRAILR1; tumor necrosis factor receptor superfamily, member 10a; K04722 tumor necrosis factor receptor superfamily member 10
hsa:939 CD27, MGC20393, S152, T14, TNFRSF7, Tp55; CD27 molecule; K05144 tumor necrosis factor receptor superfamily member 7
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5

hsa04145 Phagosome - Homo sapiens (human) (76)



hsa:10332 CLEC4M, CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, L-SIGN, LSIGN, MGC129964, MGC47866; C-type lectin domain family 4, member M; K06563 CD209 antigen
hsa:10376 TUBA1B, K-ALPHA-1; tubulin, alpha 1b; K07374 tubulin alpha
hsa:10381 TUBB3, CFEOM3A, TUBB4, beta-4; tubulin, beta 3; K07375 tubulin beta
hsa:10382 TUBB4, TUBB5, beta-5; tubulin, beta 4; K07375 tubulin beta
hsa:10383 TUBB2C, TUBB2; tubulin, beta 2C; K07375 tubulin beta
hsa:1536 CYBB, CGD, GP91-1, GP91-PHOX, GP91PHOX, NOX2, p91-PHOX; cytochrome b-245, beta polypeptide; K08008 NADPH oxidase
hsa:203068 TUBB, M40, MGC117247, MGC16435, OK/SW-cl.56, TUBB1, TUBB5; tubulin, beta; K07375 tubulin beta
hsa:2204 FCAR, CD89; Fc fragment of IgA, receptor for; K06513 CD89 antigen
hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I
hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b
hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:27035 NOX1, GP91-2, MOX1, NOH-1, NOH1; NADPH oxidase 1; K08008 NADPH oxidase
hsa:30835 CD209, CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1, MGC129965; CD209 molecule; K06563 CD209 antigen
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I
hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I
hsa:3135 HLA-G, MHC-G; major histocompatibility complex, class I, G; K06751 major histocompatibility complex, class I
hsa:347688 TUBB8, FLJ40100; tubulin, beta 8; K07375 tubulin beta
hsa:347733 TUBB2B, DKFZp566F223, FLJ98847, MGC8685, bA506K6.1; tubulin, beta 2B; K07375 tubulin beta
hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5
hsa:3684 ITGAM, CD11B, CR3A, MAC-1, MAC1A, MGC117044, MO1A, SLEB6; integrin, alpha M (complement component 3 receptor 3 subunit); K06461 integrin alpha M
hsa:3685 ITGAV, CD51, DKFZp686A08142, MSK8, VNRA; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); K06487 integrin alpha V
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3689 ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); K06464 integrin beta 2
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3693 ITGB5, FLJ26658; integrin, beta 5; K06588 integrin beta 5
hsa:3916 LAMP1, CD107a, LAMPA, LGP120; lysosomal-associated membrane protein 1; K06528 lysosomal-associated membrane protein 1/2
hsa:4153 MBL2, COLEC1, HSMBPC, MBL, MBP, MBP1, MGC116832, MGC116833; mannose-binding lectin (protein C) 2, soluble (opsonic defect); K03991 mannose-binding lectin
hsa:4360 MRC1, CD206, CLEC13D, MMR; mannose receptor, C type 1; K06560 mannose receptor, C type
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:50508 NOX3, GP91-3, MOX-2; NADPH oxidase 3; K08008 NADPH oxidase
hsa:51606 ATP6V1H, MSTP042, NBP1, SFD, SFDalpha, SFDbeta, VMA13; ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H (EC:3.6.3.14); K02144 V-type H+-transporting ATPase 54 kD subunit [EC:3.6.3.14]
hsa:51807 TUBA8, TUBAL2; tubulin, alpha 8; K07374 tubulin alpha
hsa:5289 PIK3C3, MGC61518, VPS34, hVps34; phosphoinositide-3-kinase, class 3 (EC:2.7.1.137); K00914 phosphatidylinositol 3-kinase [EC:2.7.1.137]
hsa:56604 TUBB4Q; tubulin, beta polypeptide 4, member Q; K07375 tubulin beta
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:6441 SFTPD, COLEC7, PSP-D, SFTP4, SP-D; surfactant protein D; K10068 surfactant, pulmonary-associated protein D
hsa:653361 NCF1, FLJ79451, NCF1A, NOXO2, SH3PXD1A, p47phox; neutrophil cytosolic factor 1; K08011 neutrophil cytosolic factor 1
hsa:6890 TAP1, ABC17, ABCB2, APT1, D6S114E, FLJ26666, FLJ41500, PSF1, RING4, TAP1*0102N, TAP1N; transporter 1, ATP-binding cassette, sub-family B (MDR/TAP); K05653 ATP-binding cassette, subfamily B (MDR/TAP), member 2
hsa:7037 TFRC, CD71, TFR, TFR1, TRFR; transferrin receptor (p90, CD71); K06503 transferrin receptor
hsa:7057 THBS1, THBS, THBS-1, TSP, TSP-1, TSP1; thrombospondin 1; K04659 thrombospondin
hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3
hsa:7277 TUBA4A, FLJ30169, H2-ALPHA, TUBA1; tubulin, alpha 4a; K07374 tubulin alpha
hsa:7278 TUBA3C, TUBA2, TUBA3D, bA408E5.3; tubulin, alpha 3c; K07374 tubulin alpha
hsa:7280 TUBB2A, TUBB, TUBB2, dJ40E16.7; tubulin, beta 2A; K07375 tubulin beta
hsa:7846 TUBA1A, B-ALPHA-1, FLJ25113, LIS3, TUBA3; tubulin, alpha 1a; K07374 tubulin alpha
hsa:81027 TUBB1; tubulin, beta 1; K07375 tubulin beta
hsa:811 CALR, CRT, FLJ26680, RO, SSA, cC1qR; calreticulin; K08057 calreticulin
hsa:821 CANX, CNX, FLJ26570, IP90, P90; calnexin; K08054 calnexin
hsa:84617 TUBB6, HsT1601, MGC132410, MGC4083, TUBB-5; tubulin, beta 6; K07375 tubulin beta
hsa:84790 TUBA1C, MGC10851, MGC14580, TUBA6, bcm948; tubulin, alpha 1c; K07374 tubulin alpha
hsa:8685 MARCO, SCARA2; macrophage receptor with collagenous structure; K13884 macrophage receptor with collagenous structure
hsa:9146 HGS, FLJ11421, FLJ39878, HRS; hepatocyte growth factor-regulated tyrosine kinase substrate; K12182 hepatocyte growth factor-regulated tyrosine kinase substrate
hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:9902 MRC2, CD280, CLEC13E, ENDO180, FLJ35911, KIAA0709, UPARAP; mannose receptor, C type 2; K06560 mannose receptor, C type

hsa04660 T cell receptor signaling pathway - Homo sapiens (human) (74)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1437 CSF2, GMCSF, MGC131935, MGC138897; colony stimulating factor 2 (granulocyte-macrophage); K05427 granulocyte-macrophage colony-stimulating factor
hsa:1493 CTLA4, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, ICOS, IDDM12; cytotoxic T-lymphocyte-associated protein 4; K06538 cytotoxic T-lymphocyte-associated protein 4
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2353 FOS, AP-1, C-FOS; FBJ murine osteosarcoma viral oncogene homolog; K04379 proto-oncogene protein c-fos
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:3932 LCK, LSK, YT16, p56lck, pp58lck; lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2); K05856 lymphocyte-specific protein tyrosine kinase [EC:2.7.10.2]
hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4775 NFATC3, NFAT4, NFATX; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4776 NFATC4, NF-ATc4, NFAT3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4793 NFKBIB, IKBB, TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; K02581 NF-kappa-B inhibitor beta
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5058 PAK1, MGC130000, MGC130001, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1]
hsa:5062 PAK2, PAK65, PAKgamma; p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1); K04410 p21-activated kinase 2 [EC:2.7.11.1]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5588 PRKCQ, MGC126514, MGC141919, PRKCT, nPKC-theta; protein kinase C, theta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
hsa:5788 PTPRC, B220, CD45, CD45R, GP180, LCA, LY5, T200; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48); K06478 protein tyrosine phosphatase, receptor type, C [EC:3.1.3.48]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7535 ZAP70, FLJ17670, FLJ17679, SRK, STD, TZK, ZAP-70; zeta-chain (TCR) associated protein kinase 70kDa (EC:2.7.10.2); K07360 zeta-chain (TCR) associated protein kinase [EC:2.7.10.2]
hsa:867 CBL, C-CBL, CBL2, RNF55; Cas-Br-M (murine) ecotropic retroviral transforming sequence; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:9020 MAP3K14, FTDCR1B, HS, HSNIK, NIK; mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25); K04466 mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
hsa:915 CD3D, CD3-DELTA, T3D; CD3d molecule, delta (CD3-TCR complex); K06450 CD3D antigen, delta polypeptide
hsa:916 CD3E, FLJ18683, T3E, TCRE; CD3e molecule, epsilon (CD3-TCR complex); K06451 CD3E antigen, epsilon polypeptide
hsa:917 CD3G, CD3-GAMMA, FLJ17620, FLJ17664, FLJ79544, FLJ94613, MGC138597, T3G; CD3g molecule, gamma (CD3-TCR complex); K06452 CD3G antigen, gamma polypeptide
hsa:919 CD247, CD3-ZETA, CD3H, CD3Q, CD3Z, T3Z, TCRZ; CD247 molecule; K06453 CD3Z antigen, zeta polypeptide
hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen
hsa:925 CD8A, CD8, Leu2, MAL, p32; CD8a molecule; K06458 CD8A antigen, alpha polypeptide
hsa:926 CD8B, CD8B1, LEU2, LY3, LYT3, MGC119115, P37; CD8b molecule; K06459 CD8B antigen, beta polypeptide
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa05142 Chagas disease (American trypanosomiasis) - Homo sapiens (human) (74)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1636 ACE, ACE1, CD143, DCP, DCP1, MGC26566, MVCD3; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1); K01283 peptidyl-dipeptidase A [EC:3.4.15.1]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:2353 FOS, AP-1, C-FOS; FBJ murine osteosarcoma viral oncogene homolog; K04379 proto-oncogene protein c-fos
hsa:2770 GNAI1, Gi; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1; K04630 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide
hsa:2775 GNAO1, DKFZp686O0962, G-ALPHA-o, GNAO; guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O; K04534 guanine nucleotide binding protein (G protein), alpha o polypeptide
hsa:3456 IFNB1, IFB, IFF, IFNB, MGC96956; interferon, beta 1, fibroblast; K05415 interferon, beta
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:4087 SMAD2, JV18, JV18-1, MADH2, MADR2, MGC22139, MGC34440, hMAD-2, hSMAD2; SMAD family member 2; K04500 SMAD, mothers against DPP 2/3
hsa:4088 SMAD3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396; SMAD family member 3; K04500 SMAD, mothers against DPP 2/3
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5054 SERPINE1, PAI, PAI-1, PAI1, PLANH1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; K03982 plasminogen activator inhibitor-1
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5515 PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C; protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5516 PPP2CB, PP2Abeta, PP2CB; protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5518 PPP2R1A, MGC786, PP2A-Aalpha, PP2AAALPHA, PR65A; protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5519 PPP2R1B, MGC26454, PP2A-Abeta, PR65B; protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5520 PPP2R2A, B55A, B55ALPHA, DKFZp686N05117, FLJ26613, FLJ41727, MGC52248, PR52A, PR55A; protein phosphatase 2, regulatory subunit B, alpha (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5521 PPP2R2B, B55BETA, FLJ95686, MGC24888, PP2AB55BETA, PP2ABBETA, PP2APR55B, PP2APR55BETA, PR2AB55BETA, PR2ABBETA, PR2APR55BETA, PR52B, PR55-BETA, PR55BETA, SCA12; protein phosphatase 2, regulatory subunit B, beta (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5522 PPP2R2C, B55-GAMMA, IMYPNO, IMYPNO1, MGC33570, PR52, PR55G; protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:6348 CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3; chemokine (C-C motif) ligand 3; K05408 C-C motif chemokine 3
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4
hsa:712 C1QA; complement component 1, q subcomponent, A chain; K03986 complement C1q subcomponent subunit A
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:713 C1QB; complement component 1, q subcomponent, B chain; K03987 complement C1q subcomponent subunit B
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:714 C1QC, C1Q-C, C1QG, FLJ27103; complement component 1, q subcomponent, C chain; K03988 complement C1q subcomponent subunit C
hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3
hsa:811 CALR, CRT, FLJ26680, RO, SSA, cC1qR; calreticulin; K08057 calreticulin
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:915 CD3D, CD3-DELTA, T3D; CD3d molecule, delta (CD3-TCR complex); K06450 CD3D antigen, delta polypeptide
hsa:916 CD3E, FLJ18683, T3E, TCRE; CD3e molecule, epsilon (CD3-TCR complex); K06451 CD3E antigen, epsilon polypeptide
hsa:917 CD3G, CD3-GAMMA, FLJ17620, FLJ17664, FLJ79544, FLJ94613, MGC138597, T3G; CD3g molecule, gamma (CD3-TCR complex); K06452 CD3G antigen, gamma polypeptide
hsa:919 CD247, CD3-ZETA, CD3H, CD3Q, CD3Z, T3Z, TCRZ; CD247 molecule; K06453 CD3Z antigen, zeta polypeptide

hsa04650 Natural killer cell mediated cytotoxicity - Homo sapiens (human) (73)



hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:1437 CSF2, GMCSF, MGC131935, MGC138897; colony stimulating factor 2 (granulocyte-macrophage); K05427 granulocyte-macrophage colony-stimulating factor
hsa:2185 PTK2B, CADTK, CAKB, FADK2, FAK2, PKB, PTK, PYK2, RAFTK; PTK2B protein tyrosine kinase 2 beta (EC:2.7.10.2); K05871 protein tyrosine kinase 2 beta [EC:2.7.10.2]
hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I
hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I
hsa:3135 HLA-G, MHC-G; major histocompatibility complex, class I, G; K06751 major histocompatibility complex, class I
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:3439 IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@, MGC138207, MGC138505, MGC138507; interferon, alpha 1; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3444 IFNA7, IFN-alphaJ, IFNA-J; interferon, alpha 7; K05414 interferon, alpha
hsa:3449 IFNA16, IFN-alphaO; interferon, alpha 16; K05414 interferon, alpha
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3456 IFNB1, IFB, IFF, IFNB, MGC96956; interferon, beta 1, fibroblast; K05415 interferon, beta
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L
hsa:3689 ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); K06464 integrin beta 2
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:3932 LCK, LSK, YT16, p56lck, pp58lck; lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2); K05856 lymphocyte-specific protein tyrosine kinase [EC:2.7.10.2]
hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4775 NFATC3, NFAT4, NFATX; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4776 NFATC4, NF-ATc4, NFAT3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5058 PAK1, MGC130000, MGC130001, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:53358 SHC3, DKFZp686H1544, FLJ45325, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K06279 src homology 2 domain-containing transforming protein C
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5781 PTPN11, BPTP3, CFC, MGC14433, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2; protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48); K07293 protein tyrosine phosphatase, non-receptor type 11 [EC:3.1.3.48]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:637 BID, FP497, MGC15319, MGC42355; BH3 interacting domain death agonist; K04726 BH3 interacting domain death agonist
hsa:6464 SHC1, FLJ26504, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 src homology 2 domain-containing transforming protein C
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7535 ZAP70, FLJ17670, FLJ17679, SRK, STD, TZK, ZAP-70; zeta-chain (TCR) associated protein kinase 70kDa (EC:2.7.10.2); K07360 zeta-chain (TCR) associated protein kinase [EC:2.7.10.2]
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:8743 TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL; tumor necrosis factor (ligand) superfamily, member 10; K04721 tumor necrosis factor superfamily, member 10
hsa:8793 TNFRSF10D, CD264, DCR2, TRAILR4, TRUNDD; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; K04722 tumor necrosis factor receptor superfamily member 10
hsa:8794 TNFRSF10C, CD263, DCR1, DCR1-TNFR, LIT, MGC149501, MGC149502, TRAIL-R3, TRAILR3, TRID; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain; K04722 tumor necrosis factor receptor superfamily member 10
hsa:8795 TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9; tumor necrosis factor receptor superfamily, member 10b; K04722 tumor necrosis factor receptor superfamily member 10
hsa:8797 TNFRSF10A, APO2, CD261, DR4, MGC9365, TRAILR-1, TRAILR1; tumor necrosis factor receptor superfamily, member 10a; K04722 tumor necrosis factor receptor superfamily member 10
hsa:919 CD247, CD3-ZETA, CD3H, CD3Q, CD3Z, T3Z, TCRZ; CD247 molecule; K06453 CD3Z antigen, zeta polypeptide

hsa04810 Regulation of actin cytoskeleton - Homo sapiens (human) (70)



hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:1072 CFL1, CFL; cofilin 1 (non-muscle); K05765 cofilin
hsa:1073 CFL2, NEM7; cofilin 2 (muscle); K05765 cofilin
hsa:10787 NCKAP1, FLJ11291, HEM2, KIAA0587, MGC8981, NAP1, NAP125; NCK-associated protein 1; K05750 NCK-associated protein 1
hsa:1445 CSK, MGC117393; c-src tyrosine kinase (EC:2.7.10.2); K05728 c-src tyrosine kinase [EC:2.7.10.2]
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2147 F2, PT; coagulation factor II (thrombin) (EC:3.4.21.5); K01313 coagulation factor II (thrombin) [EC:3.4.21.5]
hsa:2246 FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1; fibroblast growth factor 1 (acidic); K04358 fibroblast growth factor
hsa:2247 FGF2, BFGF, FGFB, HBGF-2; fibroblast growth factor 2 (basic); K04358 fibroblast growth factor
hsa:2335 FN1, CIG, DKFZp686F10164, DKFZp686H0342, DKFZp686I1370, DKFZp686O13149, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF; fibronectin 1; K05717 fibronectin 1
hsa:2934 GSN, DKFZp313L0718; gelsolin; K05768 gelsolin
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3630 INS, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin
hsa:3655 ITGA6, CD49f, DKFZp686J01244, FLJ18737, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6
hsa:3675 ITGA3, CD49C, FLJ34631, FLJ34704, GAP-B3, GAPB3, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5
hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L
hsa:3684 ITGAM, CD11B, CR3A, MAC-1, MAC1A, MGC117044, MO1A, SLEB6; integrin, alpha M (complement component 3 receptor 3 subunit); K06461 integrin alpha M
hsa:3685 ITGAV, CD51, DKFZp686A08142, MSK8, VNRA; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); K06487 integrin alpha V
hsa:3687 ITGAX, CD11C, SLEB6; integrin, alpha X (complement component 3 receptor 4 subunit); K06462 integrin alpha X
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3689 ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); K06464 integrin beta 2
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3691 ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4
hsa:3693 ITGB5, FLJ26658; integrin, beta 5; K06588 integrin beta 5
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:4478 MSN; moesin; K05763 moesin
hsa:4627 MYH9, DFNA17, EPSTS, FTNS, MGC104539, MHA, NMHC-II-A, NMMHCA; myosin, heavy chain 9, non-muscle; K10352 myosin heavy chain
hsa:4628 MYH10, MGC134913, MGC134914, NMMHCB; myosin, heavy chain 10, non-muscle; K10352 myosin heavy chain
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5058 PAK1, MGC130000, MGC130001, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1]
hsa:5062 PAK2, PAK65, PAKgamma; p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1); K04410 p21-activated kinase 2 [EC:2.7.11.1]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5499 PPP1CA, MGC15877, MGC1674, PP-1A, PP1alpha, PPP1A; protein phosphatase 1, catalytic subunit, alpha isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5500 PPP1CB, MGC3672, PP-1B, PP1beta, PPP1CD; protein phosphatase 1, catalytic subunit, beta isozyme (EC:3.1.3.16 3.1.3.53); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5501 PPP1CC, PP1gamma, PPP1G; protein phosphatase 1, catalytic subunit, gamma isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:5829 PXN, FLJ16691; paxillin; K05760 paxillin
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5962 RDX, DFNB24; radixin; K05762 radixin
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7414 VCL, CMD1W, CMH15, MVCL; vinculin; K05700 vinculin
hsa:7430 EZR, CVIL, CVL, DKFZp762H157, FLJ26216, MGC1584, VIL2; ezrin; K08007 villin 2 (ezrin)
hsa:79784 MYH14, DFNA4, DKFZp667A1311, FLJ13881, FLJ43092, KIAA2034, MHC16, MYH17, NMHC-II-C, myosin; myosin, heavy chain 14, non-muscle (EC:3.6.4.1); K10352 myosin heavy chain
hsa:81 ACTN4, ACTININ-4, DKFZp686K23158, FSGS, FSGS1; actinin, alpha 4; K05699 actinin alpha
hsa:87 ACTN1, FLJ40884, FLJ54432; actinin, alpha 1; K05699 actinin alpha
hsa:8874 ARHGEF7, BETA-PIX, COOL-1, COOL1, DKFZp686C12170, DKFZp761K1021, KIAA0142, KIAA0412, Nbla10314, P50, P50BP, P85, P85COOL1, P85SPR, PAK3, PIXB; Rho guanine nucleotide exchange factor (GEF) 7; K13710 Rho guanine nucleotide exchange factor 7
hsa:8976 WASL, DKFZp779G0847, MGC48327, N-WASP, NWASP; Wiskott-Aldrich syndrome-like; K05747 Wiskott-Aldrich syndrome protein
hsa:9138 ARHGEF1, GEF1, LBCL2, LSC, P115-RHOGEF, SUB1.5; Rho guanine nucleotide exchange factor (GEF) 1; K12330 Rho guanine nucleotide exchange factor 1
hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:9459 ARHGEF6, COOL2, Cool-2, KIAA0006, MRX46, PIXA, alpha-PIX, alphaPIX; Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6; K05729 Rho guanine nucleotide exchange factor 6
hsa:9564 BCAR1, CAS, CAS1, CASS1, CRKAS, FLJ12176, FLJ45059, P130Cas; breast cancer anti-estrogen resistance 1; K05726 breast cancer anti-estrogen resistance 1
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa05160 Hepatitis C - Homo sapiens (human) (70)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:10197 PSME3, Ki, PA28-gamma, PA28G, REG-GAMMA; proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki); K06698 proteasome activator subunit 3 (PA28 gamma)
hsa:1026 CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1366 CLDN7, CEPTRL2, CLDN-7, CPETRL2, Hs.84359, claudin-1; claudin 7; K06087 claudin
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:1965 EIF2S1, EIF-2, EIF-2A, EIF-2alpha, EIF2, EIF2A; eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa; K03237 translation initiation factor eIF-2 alpha subunit
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3439 IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@, MGC138207, MGC138505, MGC138507; interferon, alpha 1; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3444 IFNA7, IFN-alphaJ, IFNA-J; interferon, alpha 7; K05414 interferon, alpha
hsa:3449 IFNA16, IFN-alphaO; interferon, alpha 16; K05414 interferon, alpha
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3456 IFNB1, IFB, IFF, IFNB, MGC96956; interferon, beta 1, fibroblast; K05415 interferon, beta
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3659 IRF1, IRF-1, MAR; interferon regulatory factor 1; K09444 interferon regulatory factor 1
hsa:3661 IRF3; interferon regulatory factor 3; K05411 interferon regulatory factor 3
hsa:3665 IRF7, IRF-7H, IRF7A; interferon regulatory factor 7; K09447 interferon regulatory factor 7
hsa:3716 JAK1, JAK1A, JAK1B, JTK3; Janus kinase 1 (EC:2.7.10.2); K11217 Janus kinase 1 [EC:2.7.10.2]
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:3949 LDLR, FH, FHC, LDLCQ2; low density lipoprotein receptor; K12473 low-density lipoprotein receptor
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:4938 OAS1, IFI-4, OIAS, OIASI; 2',5'-oligoadenylate synthetase 1, 40/46kDa (EC:2.7.7.-); K14216 2'-5'-oligoadenylate synthetase
hsa:4939 OAS2, MGC78578; 2'-5'-oligoadenylate synthetase 2, 69/71kDa (EC:2.7.7.-); K14216 2'-5'-oligoadenylate synthetase
hsa:4940 OAS3, MGC133260, p100; 2'-5'-oligoadenylate synthetase 3, 100kDa; K14216 2'-5'-oligoadenylate synthetase
hsa:4950 OCLN; occludin (EC:2.1.1.67); K06088 occludin
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5515 PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C; protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5516 PPP2CB, PP2Abeta, PP2CB; protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5518 PPP2R1A, MGC786, PP2A-Aalpha, PP2AAALPHA, PR65A; protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5519 PPP2R1B, MGC26454, PP2A-Abeta, PR65B; protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5520 PPP2R2A, B55A, B55ALPHA, DKFZp686N05117, FLJ26613, FLJ41727, MGC52248, PR52A, PR55A; protein phosphatase 2, regulatory subunit B, alpha (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5521 PPP2R2B, B55BETA, FLJ95686, MGC24888, PP2AB55BETA, PP2ABBETA, PP2APR55B, PP2APR55BETA, PR2AB55BETA, PR2ABBETA, PR2APR55BETA, PR52B, PR55-BETA, PR55BETA, SCA12; protein phosphatase 2, regulatory subunit B, beta (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5522 PPP2R2C, B55-GAMMA, IMYPNO, IMYPNO1, MGC33570, PR52, PR55G; protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5610 EIF2AK2, EIF2AK1, MGC126524, PKR, PRKR; eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1); K08860 eukaryotic translation initiation factor 2-alpha kinase [EC:2.7.11.1]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:7122 CLDN5, AWAL, BEC1, CPETRL1, TMVCF; claudin 5; K06087 claudin
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:8717 TRADD, Hs.89862, MGC11078; TNFRSF1A-associated via death domain; K03171 tnfrsf1a-associated via death domain
hsa:9076 CLDN1, CLD1, ILVASC, SEMP1; claudin 1; K06087 claudin
hsa:9641 IKBKE, IKK-E, IKK-i, IKKE, IKKI, KIAA0151, MGC125294, MGC125295, MGC125297; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (EC:2.7.11.10); K07211 inhibitor of nuclear factor kappa-B kinase epsilon subunit [EC:2.7.11.10]
hsa:975 CD81, CVID6, S5.7, TAPA1, TSPAN28; CD81 molecule; K06508 CD81 antigen

hsa04380 Osteoclast differentiation - Homo sapiens (human) (68)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1436 CSF1R, C-FMS, CD115, CSFR, FIM2, FMS; colony stimulating factor 1 receptor (EC:2.7.10.1); K05090 macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
hsa:1536 CYBB, CGD, GP91-1, GP91-PHOX, GP91PHOX, NOX2, p91-PHOX; cytochrome b-245, beta polypeptide; K08008 NADPH oxidase
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I
hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b
hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:2353 FOS, AP-1, C-FOS; FBJ murine osteosarcoma viral oncogene homolog; K04379 proto-oncogene protein c-fos
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:27035 NOX1, GP91-2, MOX1, NOH-1, NOH1; NADPH oxidase 1; K08008 NADPH oxidase
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3456 IFNB1, IFB, IFF, IFNB, MGC96956; interferon, beta 1, fibroblast; K05415 interferon, beta
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3716 JAK1, JAK1A, JAK1B, JTK3; Janus kinase 1 (EC:2.7.10.2); K11217 Janus kinase 1 [EC:2.7.10.2]
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:3932 LCK, LSK, YT16, p56lck, pp58lck; lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2); K05856 lymphocyte-specific protein tyrosine kinase [EC:2.7.10.2]
hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4791 NFKB2, LYT-10, LYT10, p52; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100); K04469 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:50508 NOX3, GP91-3, MOX-2; NADPH oxidase 3; K08008 NADPH oxidase
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5468 PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:5971 RELB, I-REL, IREL, REL-B; v-rel reticuloendotheliosis viral oncogene homolog B; K09253 transcription factor RelB
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:653361 NCF1, FLJ79451, NCF1A, NOXO2, SH3PXD1A, p47phox; neutrophil cytosolic factor 1; K08011 neutrophil cytosolic factor 1
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:8600 TNFSF11, CD254, ODF, OPGL, OPTB2, RANKL, TRANCE, hRANKL2, sOdf; tumor necrosis factor (ligand) superfamily, member 11; K05473 tumor necrosis factor (ligand) superfamily, member 11
hsa:8651 SOCS1, CIS1, CISH1, JAB, SOCS-1, SSI-1, SSI1, TIP3; suppressor of cytokine signaling 1; K04694 suppressor of cytokine signaling 1
hsa:9020 MAP3K14, FTDCR1B, HS, HSNIK, NIK; mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25); K04466 mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]

hsa04722 Neurotrophin signaling pathway - Homo sapiens (human) (67) Pubmed



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:10971 YWHAQ, 14-3-3, 1C5, HS1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1445 CSK, MGC117393; c-src tyrosine kinase (EC:2.7.10.2); K05728 c-src tyrosine kinase [EC:2.7.10.2]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2309 FOXO3, AF6q21, DKFZp781A0677, FKHRL1, FKHRL1P2, FOXO2, FOXO3A, MGC12739, MGC31925; forkhead box O3; K09408 forkhead box protein O3
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:396 ARHGDIA, GDIA1, MGC117248, RHOGDI, RHOGDI-1; Rho GDP dissociation inhibitor (GDI) alpha; K12462 Rho GDP-dissociation inhibitor
hsa:4217 MAP3K5, ASK1, MAPKKK5, MEKK5; mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25); K04426 mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
hsa:468 ATF4, CREB-2, CREB2, TAXREB67, TXREB; activating transcription factor 4 (tax-responsive enhancer element B67); K04374 activating transcription factor 4
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4793 NFKBIB, IKBB, TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; K02581 NF-kappa-B inhibitor beta
hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:53358 SHC3, DKFZp686H1544, FLJ45325, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K06279 src homology 2 domain-containing transforming protein C
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5580 PRKCD, MAY1, MGC49908, PKCD, nPKC-delta; protein kinase C, delta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5598 MAPK7, BMK1, ERK4, ERK5, PRKM7; mitogen-activated protein kinase 7 (EC:2.7.11.24); K04464 mitogen-activated protein kinase 7 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5781 PTPN11, BPTP3, CFC, MGC14433, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2; protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48); K07293 protein tyrosine phosphatase, non-receptor type 11 [EC:3.1.3.48]
hsa:581 BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX, membrane protein (BCL2-associated)
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:627 BDNF, MGC34632; brain-derived neurotrophic factor; K04355 brain-derived neurotrophic factor
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:6464 SHC1, FLJ26504, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 src homology 2 domain-containing transforming protein C
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:7161 TP73, P73; tumor protein p73; K10148 tumor protein p73
hsa:7529 YWHAB, GW128, HS1, KCIP-1, YWHAA; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7531 YWHAE, 14-3-3E, FLJ45465, FLJ53559, KCIP-1, MDCR, MDS; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7532 YWHAG, 14-3-3GAMMA; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7533 YWHAH, YWHA1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7534 YWHAZ, 14-3-3-zeta, KCIP-1, MGC111427, MGC126532, MGC138156, YWHAD; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:815 CAMK2A, CAMKA, KIAA0968; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:816 CAMK2B, CAM2, CAMK2, CAMKB, MGC29528; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa04912 GnRH signaling pathway - Homo sapiens (human) (66)



hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:2002 ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1
hsa:2185 PTK2B, CADTK, CAKB, FADK2, FAK2, PKB, PTK, PYK2, RAFTK; PTK2B protein tyrosine kinase 2 beta (EC:2.7.10.2); K05871 protein tyrosine kinase 2 beta [EC:2.7.10.2]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4313 MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]
hsa:468 ATF4, CREB-2, CREB2, TAXREB67, TXREB; activating transcription factor 4 (tax-responsive enhancer element B67); K04374 activating transcription factor 4
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5580 PRKCD, MAY1, MGC49908, PKCD, nPKC-delta; protein kinase C, delta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5598 MAPK7, BMK1, ERK4, ERK5, PRKM7; mitogen-activated protein kinase 7 (EC:2.7.11.24); K04464 mitogen-activated protein kinase 7 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:6714 SRC, ASV, SRC1, c-SRC, p60-Src; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (EC:2.7.10.2); K05704 proto-oncogene tyrosine-protein kinase Src [EC:2.7.10.2]
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:815 CAMK2A, CAMKA, KIAA0968; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:816 CAMK2B, CAM2, CAMK2, CAMKB, MGC29528; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa05146 Amoebiasis - Homo sapiens (human) (65)



hsa:10319 LAMC3, DKFZp434E202; laminin, gamma 3; K06247 laminin, gamma 3
hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:1277 COL1A1, OI4; collagen, type I, alpha 1; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1278 COL1A2, OI4; collagen, type I, alpha 2; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1281 COL3A1, EDS4A, FLJ34534; collagen, type III, alpha 1; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1282 COL4A1, arresten; collagen, type IV, alpha 1; K06237 collagen, type IV, alpha
hsa:1284 COL4A2, DKFZp686I14213, FLJ22259; collagen, type IV, alpha 2; K06237 collagen, type IV, alpha
hsa:1286 COL4A4, CA44; collagen, type IV, alpha 4; K06237 collagen, type IV, alpha
hsa:1287 COL4A5, ASLN, ATS, CA54, MGC167109, MGC42377; collagen, type IV, alpha 5; K06237 collagen, type IV, alpha
hsa:1437 CSF2, GMCSF, MGC131935, MGC138897; colony stimulating factor 2 (granulocyte-macrophage); K05427 granulocyte-macrophage colony-stimulating factor
hsa:22798 LAMB4; laminin, beta 4; K06245 laminin, beta 4
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:2335 FN1, CIG, DKFZp686F10164, DKFZp686H0342, DKFZp686I1370, DKFZp686O13149, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF; fibronectin 1; K05717 fibronectin 1
hsa:284217 LAMA1, LAMA; laminin, alpha 1; K05637 laminin, alpha 1/2
hsa:2919 CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha); K05505 C-X-C motif chemokine 1/2/3
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3684 ITGAM, CD11B, CR3A, MAC-1, MAC1A, MGC117044, MO1A, SLEB6; integrin, alpha M (complement component 3 receptor 3 subunit); K06461 integrin alpha M
hsa:3689 ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); K06464 integrin beta 2
hsa:3908 LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2
hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:3910 LAMA4, DKFZp686D23145, LAMA3, LAMA4*-1; laminin, alpha 4; K06241 laminin, alpha 4
hsa:3911 LAMA5, KIAA1907; laminin, alpha 5; K06240 laminin, alpha 3/5
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:3913 LAMB2, LAMS; laminin, beta 2 (laminin S); K06243 laminin, beta 2
hsa:3914 LAMB3, BM600-125KDA, FLJ99565, LAM5, LAMNB1; laminin, beta 3; K06244 laminin, beta 3
hsa:3915 LAMC1, LAMB2, MGC87297; laminin, gamma 1 (formerly LAMB2); K05635 laminin, gamma 1
hsa:3918 LAMC2, B2T, BM600, CSF, EBR2, EBR2A, LAMB2T, LAMNB2, MGC138491, MGC141938; laminin, gamma 2; K06246 laminin, gamma 2
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5055 SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2; serpin peptidase inhibitor, clade B (ovalbumin), member 2; K13963 serpin B
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:735 C9; complement component 9; K04000 complement component 9
hsa:7414 VCL, CMD1W, CMH15, MVCL; vinculin; K05700 vinculin
hsa:81 ACTN4, ACTININ-4, DKFZp686K23158, FSGS, FSGS1; actinin, alpha 4; K05699 actinin alpha
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:87 ACTN1, FLJ40884, FLJ54432; actinin, alpha 1; K05699 actinin alpha
hsa:912 CD1D, CD1A, MGC34622, R3; CD1d molecule; K06448 CD1 antigen
hsa:929 CD14; CD14 molecule; K04391 CD14 antigen

hsa04210 Apoptosis - Homo sapiens (human) (63)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1676 DFFA, DFF-45, DFF1, ICAD; DNA fragmentation factor, 45kDa, alpha polypeptide; K02310 DNA fragmentation factor, 45 kD, alpha subunit
hsa:1677 DFFB, CAD, CPAN, DFF-40, DFF2, DFF40; DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase); K02311 DNA fragmentation factor, 40 kD, beta subunit [EC:3.-.-.-]
hsa:2021 ENDOG, FLJ27463; endonuclease G; K01173 endonuclease [EC:3.1.30.-]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:317 APAF1, APAF-1, CED4, DKFZp781B1145; apoptotic peptidase activating factor 1; K02084 apoptotic protease-activating factor
hsa:329 BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat-containing 2; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:330 BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat-containing 3; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3562 IL3, IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF; interleukin 3 (colony-stimulating factor, multiple); K04736 interleukin 3
hsa:472 ATM, AT1, ATA, ATC, ATD, ATDC, ATE, DKFZp781A0353, MGC74674, TEL1, TELO1; ataxia telangiectasia mutated (EC:2.7.11.1); K04728 ataxia telangectasia mutated family protein [EC:2.7.11.1]
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:54205 CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5573 PRKAR1A, CAR, CNC, CNC1, DKFZp779L0468, MGC17251, PKR1, PPNAD1, PRKAR1, TSE1; protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator
hsa:5575 PRKAR1B, PRKAR1; protein kinase, cAMP-dependent, regulatory, type I, beta (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator
hsa:5576 PRKAR2A, MGC3606, PKR2, PRKAR2; protein kinase, cAMP-dependent, regulatory, type II, alpha (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator
hsa:5577 PRKAR2B, PRKAR2, RII-BETA; protein kinase, cAMP-dependent, regulatory, type II, beta (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:581 BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX, membrane protein (BCL2-associated)
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:598 BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, DKFZp781P2092, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X)
hsa:637 BID, FP497, MGC15319, MGC42355; BH3 interacting domain death agonist; K04726 BH3 interacting domain death agonist
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:823 CAPN1, CANP, CANP1, CANPL1, muCANP, muCL; calpain 1, (mu/I) large subunit (EC:3.4.22.52); K01367 calpain-1 [EC:3.4.22.52]
hsa:824 CAPN2, CANP2, CANPL2, CANPml, FLJ39928, mCANP; calpain 2, (m/II) large subunit (EC:3.4.22.53); K03853 calpain-2 [EC:3.4.22.53]
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:839 CASP6, MCH2; caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59); K04396 caspase 6 [EC:3.4.22.59]
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:8717 TRADD, Hs.89862, MGC11078; TNFRSF1A-associated via death domain; K03171 tnfrsf1a-associated via death domain
hsa:8743 TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL; tumor necrosis factor (ligand) superfamily, member 10; K04721 tumor necrosis factor superfamily, member 10
hsa:8793 TNFRSF10D, CD264, DCR2, TRAILR4, TRUNDD; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; K04722 tumor necrosis factor receptor superfamily member 10
hsa:8794 TNFRSF10C, CD263, DCR1, DCR1-TNFR, LIT, MGC149501, MGC149502, TRAIL-R3, TRAILR3, TRID; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain; K04722 tumor necrosis factor receptor superfamily member 10
hsa:8795 TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9; tumor necrosis factor receptor superfamily, member 10b; K04722 tumor necrosis factor receptor superfamily member 10
hsa:8797 TNFRSF10A, APO2, CD261, DR4, MGC9365, TRAILR-1, TRAILR1; tumor necrosis factor receptor superfamily, member 10a; K04722 tumor necrosis factor receptor superfamily member 10
hsa:9020 MAP3K14, FTDCR1B, HS, HSNIK, NIK; mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25); K04466 mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
hsa:9131 AIFM1, AIF, COXPD6, MGC111425, PDCD8; apoptosis-inducing factor, mitochondrion-associated, 1; K04727 programmed cell death 8 (apoptosis-inducing factor) [EC:1.-.-.-]

hsa04114 Oocyte meiosis - Homo sapiens (human) (61)



hsa:1017 CDK2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22]
hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:10971 YWHAQ, 14-3-3, 1C5, HS1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:23291 FBXW11, BTRC2, BTRCP2, FBW1B, FBXW1B, Fbw11, Hos, KIAA0696; F-box and WD repeat domain containing 11; K03362 F-box and WD-40 domain protein 1/11
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3480 IGF1R, CD221, IGFIR, IGFR, JTK13, MGC142170, MGC142172, MGC18216; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]
hsa:3630 INS, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:5499 PPP1CA, MGC15877, MGC1674, PP-1A, PP1alpha, PPP1A; protein phosphatase 1, catalytic subunit, alpha isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5500 PPP1CB, MGC3672, PP-1B, PP1beta, PPP1CD; protein phosphatase 1, catalytic subunit, beta isozyme (EC:3.1.3.16 3.1.3.53); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5501 PPP1CC, PP1gamma, PPP1G; protein phosphatase 1, catalytic subunit, gamma isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5515 PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C; protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5516 PPP2CB, PP2Abeta, PP2CB; protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5518 PPP2R1A, MGC786, PP2A-Aalpha, PP2AAALPHA, PR65A; protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5519 PPP2R1B, MGC26454, PP2A-Abeta, PR65B; protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5525 PPP2R5A, B56A, MGC131915, PR61A; protein phosphatase 2, regulatory subunit B', alpha; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5526 PPP2R5B, B56B, FLJ35411, PR61B; protein phosphatase 2, regulatory subunit B', beta; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5527 PPP2R5C, B56G, MGC23064, PR61G; protein phosphatase 2, regulatory subunit B', gamma; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5528 PPP2R5D, B56D, MGC2134, MGC8949; protein phosphatase 2, regulatory subunit B', delta; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5529 PPP2R5E; protein phosphatase 2, regulatory subunit B', epsilon isoform; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:7529 YWHAB, GW128, HS1, KCIP-1, YWHAA; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7531 YWHAE, 14-3-3E, FLJ45465, FLJ53559, KCIP-1, MDCR, MDS; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7532 YWHAG, 14-3-3GAMMA; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7533 YWHAH, YWHA1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7534 YWHAZ, 14-3-3-zeta, KCIP-1, MGC111427, MGC126532, MGC138156, YWHAD; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:815 CAMK2A, CAMKA, KIAA0968; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:816 CAMK2B, CAM2, CAMK2, CAMKB, MGC29528; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:891 CCNB1, CCNB; cyclin B1; K05868 cyclin B
hsa:8945 BTRC, BETA-TRCP, FBW1A, FBXW1, FBXW1A, FWD1, MGC4643, bTrCP, bTrCP1, betaTrCP; beta-transducin repeat containing; K03362 F-box and WD-40 domain protein 1/11
hsa:898 CCNE1, CCNE; cyclin E1; K06626 cyclin E
hsa:89869 PLCZ1, MGC149685, NYD-SP27, PLCzeta; phospholipase C, zeta 1 (EC:3.1.4.11); K05861 phospholipase C, zeta
hsa:9133 CCNB2, HsT17299; cyclin B2; K05868 cyclin B
hsa:983 CDK1, CDC2, CDC28A, DKFZp686L20222, MGC111195, P34CDC2; cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22); K02087 cyclin-dependent kinase 1 [EC:2.7.11.22]
hsa:991 CDC20, CDC20A, MGC102824, bA276H19.3, p55CDC; cell division cycle 20 homolog (S. cerevisiae); K03363 cell division cycle 20, cofactor of APC complex
hsa:995 CDC25C, CDC25; cell division cycle 25 homolog C (S. pombe) (EC:3.1.3.48); K05867 cell division cycle 25C [EC:3.1.3.48]
hsa:9978 RBX1, BA554C12.1, FLJ60363, MGC13357, MGC1481, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1

hsa04370 VEGF signaling pathway - Homo sapiens (human) (60)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3791 KDR, CD309, FLK1, VEGFR, VEGFR2; kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1); K05098 kinase insert domain protein receptor [EC:2.7.10.1]
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4775 NFATC3, NFAT4, NFATX; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4776 NFATC4, NF-ATc4, NFAT3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4846 NOS3, ECNOS, eNOS; nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39); K13242 nitric-oxide synthase, endothelial [EC:1.14.13.39]
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:5829 PXN, FLJ16691; paxillin; K05760 paxillin
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:6714 SRC, ASV, SRC1, c-SRC, p60-Src; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (EC:2.7.10.2); K05704 proto-oncogene tyrosine-protein kinase Src [EC:2.7.10.2]
hsa:7422 VEGFA, MGC70609, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A/B, PGF
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa04144 Endocytosis - Homo sapiens (human) (60)



hsa:10015 PDCD6IP, AIP1, Alix, DRIP4, HP95, MGC17003; programmed cell death 6 interacting protein; K12200 programmed cell death 6-interacting protein
hsa:1173 AP2M1, AP50, CLAPM1, mu2; adaptor-related protein complex 2, mu 1 subunit; K11826 AP-2 complex subunit mu-1
hsa:1175 AP2S1, AP17, AP17-DELTA, CLAPS2; adaptor-related protein complex 2, sigma 1 subunit; K11827 AP-2 complex subunit sigma-1
hsa:1213 CLTC, CHC, CHC17, CLH-17, CLTCL2, Hc, KIAA0034; clathrin, heavy chain (Hc); K04646 clathrin, heavy polypeptide
hsa:1234 CCR5, CC-CKR-5, CCCKR5, CD195, CKR-5, CKR5, CMKBR5, FLJ78003, IDDM22; chemokine (C-C motif) receptor 5; K04180 C-C chemokine receptor type 5
hsa:128866 CHMP4B, C20orf178, CHMP4A, CTPP3, SNF7, SNF7-2, Shax1, VPS32B, Vps32-2, dJ553F4.4; chromatin modifying protein 4B; K12194 charged multivesicular body protein 4
hsa:1436 CSF1R, C-FMS, CD115, CSFR, FIM2, FMS; colony stimulating factor 1 receptor (EC:2.7.10.1); K05090 macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
hsa:160 AP2A1, ADTAA, AP2-ALPHA, CLAPA1; adaptor-related protein complex 2, alpha 1 subunit; K11824 AP-2 complex subunit alpha
hsa:161 AP2A2, ADTAB, CLAPA2, HIP9, HYPJ; adaptor-related protein complex 2, alpha 2 subunit; K11824 AP-2 complex subunit alpha
hsa:163 AP2B1, ADTB2, AP105B, AP2-BETA, CLAPB1, DKFZp781K0743; adaptor-related protein complex 2, beta 1 subunit; K11825 AP-2 complex subunit beta-1
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2321 FLT1, FLT, VEGFR1; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (EC:2.7.10.1); K05096 FMS-like tyrosine kinase 1 [EC:2.7.10.1]
hsa:29082 CHMP4A, C14orf123, CHMP4, CHMP4B, FLJ61658, HSPC134, MGC142093, MGC142095, SHAX2, SNF7, SNF7-1, VPS32-1, VPS32A; chromatin modifying protein 4A; K12194 charged multivesicular body protein 4
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I
hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I
hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I
hsa:3135 HLA-G, MHC-G; major histocompatibility complex, class I, G; K06751 major histocompatibility complex, class I
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3303 HSPA1A, FLJ54303, FLJ54370, FLJ54392, FLJ54408, FLJ75127, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1, HSPA1B; heat shock 70kDa protein 1A; K03283 heat shock 70kDa protein 1/8
hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8
hsa:3306 HSPA2, HSP70-2, HSP70-3; heat shock 70kDa protein 2; K03283 heat shock 70kDa protein 1/8
hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8
hsa:3312 HSPA8, HSC54, HSC70, HSC71, HSP71, HSP73, HSPA10, LAP1, MGC131511, MGC29929, NIP71; heat shock 70kDa protein 8; K03283 heat shock 70kDa protein 1/8
hsa:3480 IGF1R, CD221, IGFIR, IGFR, JTK13, MGC142170, MGC142172, MGC18216; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]
hsa:3559 IL2RA, CD25, IDDM10, IL2R, TCGFR; interleukin 2 receptor, alpha; K05068 interleukin 2 receptor alpha
hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta
hsa:3561 IL2RG, CD132, IL-2RG, IMD4, P64, SCIDX, SCIDX1; interleukin 2 receptor, gamma; K05070 interleukin 2 receptor gamma
hsa:3791 KDR, CD309, FLK1, VEGFR, VEGFR2; kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1); K05098 kinase insert domain protein receptor [EC:2.7.10.1]
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
hsa:382 ARF6, DKFZp564M0264; ADP-ribosylation factor 6; K07941 ADP-ribosylation factor 6
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:3949 LDLR, FH, FHC, LDLCQ2; low density lipoprotein receptor; K12473 low-density lipoprotein receptor
hsa:4087 SMAD2, JV18, JV18-1, MADH2, MADR2, MGC22139, MGC34440, hMAD-2, hSMAD2; SMAD family member 2; K04500 SMAD, mothers against DPP 2/3
hsa:4088 SMAD3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396; SMAD family member 3; K04500 SMAD, mothers against DPP 2/3
hsa:4091 SMAD6, HsT17432, MADH6, MADH7; SMAD family member 6; K04677 SMAD, mothers against DPP 6/7
hsa:4092 SMAD7, CRCS3, FLJ16482, MADH7, MADH8; SMAD family member 7; K04677 SMAD, mothers against DPP 6/7
hsa:4193 MDM2, HDMX, MGC5370, MGC71221, hdm2; Mdm2 p53 binding protein homolog (mouse); K06643 transformed 3T3 cell double minute 2, p53-binding protein [EC:6.3.2.19]
hsa:4734 NEDD4, KIAA0093, MGC176705, NEDD4-1, RPF1; neural precursor cell expressed, developmentally down-regulated 4 (EC:6.3.2.-); K10591 E3 ubiquitin-protein ligase NEDD4 [EC:6.3.2.19]
hsa:51160 VPS28, MGC60323; vacuolar protein sorting 28 homolog (S. cerevisiae); K12184 ESCRT-I complex subunit VPS28
hsa:51652 VPS24, CHMP3, FLJ38114, NEDF; vacuolar protein sorting 24 homolog (S. cerevisiae); K12193 charged multivesicular body protein 3
hsa:5371 PML, MYL, PP8675, RNF71, TRIM19; promyelocytic leukemia; K10054 probable transcription factor PML
hsa:5584 PRKCI, DXS1179E, MGC26534, PKCI, nPKC-iota; protein kinase C, iota (EC:2.7.11.13); K06069 atypical protein kinase C [EC:2.7.11.13]
hsa:5590 PRKCZ, PKC-ZETA, PKC2; protein kinase C, zeta (EC:2.7.11.13); K06069 atypical protein kinase C [EC:2.7.11.13]
hsa:6714 SRC, ASV, SRC1, c-SRC, p60-Src; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (EC:2.7.10.2); K05704 proto-oncogene tyrosine-protein kinase Src [EC:2.7.10.2]
hsa:7037 TFRC, CD71, TFR, TFR1, TRFR; transferrin receptor (p90, CD71); K06503 transferrin receptor
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7251 TSG101, TSG10, VPS23; tumor susceptibility gene 101; K12183 ESCRT-I complex subunit TSG101
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:79720 VPS37B, FLJ12750; vacuolar protein sorting 37 homolog B (S. cerevisiae); K12185 ESCRT-I complex subunit VPS37
hsa:83737 ITCH, AIF4, AIP4, NAPP1, dJ468O1.1; itchy E3 ubiquitin protein ligase homolog (mouse); K05632 atrophin-1 interacting protein 4 [EC:6.3.2.19]
hsa:857 CAV1, BSCL3, CGL3, MSTP085, VIP21; caveolin 1, caveolae protein, 22kDa; K06278 caveolin 1
hsa:867 CBL, C-CBL, CBL2, RNF55; Cas-Br-M (murine) ecotropic retroviral transforming sequence; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:8766 RAB11A, MGC1490, YL8; RAB11A, member RAS oncogene family; K07904 Ras-related protein Rab-11A
hsa:9146 HGS, FLJ11421, FLJ39878, HRS; hepatocyte growth factor-regulated tyrosine kinase substrate; K12182 hepatocyte growth factor-regulated tyrosine kinase substrate
hsa:92421 CHMP4C, MGC22825, SNF7-3, Shax3, VPS32C; chromatin modifying protein 4C; K12194 charged multivesicular body protein 4
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa05222 Small cell lung cancer - Homo sapiens (human) (60)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1017 CDK2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22]
hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:1027 CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B
hsa:10319 LAMC3, DKFZp434E202; laminin, gamma 3; K06247 laminin, gamma 3
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1282 COL4A1, arresten; collagen, type IV, alpha 1; K06237 collagen, type IV, alpha
hsa:1284 COL4A2, DKFZp686I14213, FLJ22259; collagen, type IV, alpha 2; K06237 collagen, type IV, alpha
hsa:1286 COL4A4, CA44; collagen, type IV, alpha 4; K06237 collagen, type IV, alpha
hsa:1287 COL4A5, ASLN, ATS, CA54, MGC167109, MGC42377; collagen, type IV, alpha 5; K06237 collagen, type IV, alpha
hsa:1869 E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K06620 E2F transcription factor 1/3
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:22798 LAMB4; laminin, beta 4; K06245 laminin, beta 4
hsa:2335 FN1, CIG, DKFZp686F10164, DKFZp686H0342, DKFZp686I1370, DKFZp686O13149, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF; fibronectin 1; K05717 fibronectin 1
hsa:284217 LAMA1, LAMA; laminin, alpha 1; K05637 laminin, alpha 1/2
hsa:317 APAF1, APAF-1, CED4, DKFZp781B1145; apoptotic peptidase activating factor 1; K02084 apoptotic protease-activating factor
hsa:329 BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat-containing 2; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:330 BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat-containing 3; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3655 ITGA6, CD49f, DKFZp686J01244, FLJ18737, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6
hsa:3675 ITGA3, CD49C, FLJ34631, FLJ34704, GAP-B3, GAPB3, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3
hsa:3685 ITGAV, CD51, DKFZp686A08142, MSK8, VNRA; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); K06487 integrin alpha V
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3908 LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2
hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:3910 LAMA4, DKFZp686D23145, LAMA3, LAMA4*-1; laminin, alpha 4; K06241 laminin, alpha 4
hsa:3911 LAMA5, KIAA1907; laminin, alpha 5; K06240 laminin, alpha 3/5
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:3913 LAMB2, LAMS; laminin, beta 2 (laminin S); K06243 laminin, beta 2
hsa:3914 LAMB3, BM600-125KDA, FLJ99565, LAM5, LAMNB1; laminin, beta 3; K06244 laminin, beta 3
hsa:3915 LAMC1, LAMB2, MGC87297; laminin, gamma 1 (formerly LAMB2); K05635 laminin, gamma 1
hsa:3918 LAMC2, B2T, BM600, CSF, EBR2, EBR2A, LAMB2T, LAMNB2, MGC138491, MGC141938; laminin, gamma 2; K06246 laminin, gamma 2
hsa:4149 MAX, MGC10775, MGC11225, MGC18164, MGC34679, MGC36767, bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8, orf1; MYC associated factor X; K04453 Max protein
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:54205 CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:5925 RB1, OSRC, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:598 BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, DKFZp781P2092, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X)
hsa:6502 SKP2, FBL1, FBXL1, FLB1, MGC1366; S-phase kinase-associated protein 2 (p45); K03875 F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2)
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:7185 TRAF1, EBI6, MGC:10353; TNF receptor-associated factor 1; K03172 TNF receptor-associated factor 1
hsa:7188 TRAF5, MGC:39780, RNF84; TNF receptor-associated factor 5; K09849 TNF receptor-associated factor 5
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:898 CCNE1, CCNE; cyclin E1; K06626 cyclin E
hsa:9618 TRAF4, CART1, MLN62, RNF83; TNF receptor-associated factor 4; K09848 TNF receptor-associated factor 4

hsa04270 Vascular smooth muscle contraction - Homo sapiens (human) (60)



hsa:10242 KCNMB2, MGC22431; potassium large conductance calcium-activated channel, subfamily M, beta member 2; K04938 potassium large conductance calcium-activated channel subfamily M beta member 2
hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:135 ADORA2A, ADORA2, RDC8, hA2aR; adenosine A2a receptor; K04266 adenosine receptor A2a
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:27094 KCNMB3, BKBETA3, HBETA3, KCNMB2, KCNMBL, SLOBETA3; potassium large conductance calcium-activated channel, subfamily M beta member 3; K04939 potassium large conductance calcium-activated channel subfamily M beta member 3
hsa:27345 KCNMB4; potassium large conductance calcium-activated channel, subfamily M, beta member 4; K04941 potassium large conductance calcium-activated channel subfamily M beta member 4
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:3778 KCNMA1, BKTM, DKFZp686K1437, KCa1.1, MGC71881, MaxiK, SAKCA, SLO, SLO-ALPHA, SLO1, bA205K10.1, mSLO1; potassium large conductance calcium-activated channel, subfamily M, alpha member 1; K04936 potassium large conductance calcium-activated channel subfamily M alpha member 1
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:4629 MYH11, AAT4, DKFZp686D10126, DKFZp686D19237, FAA4, FLJ35232, MGC126726, MGC32963, SMHC, SMMHC; myosin, heavy chain 11, smooth muscle; K10352 myosin heavy chain
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5499 PPP1CA, MGC15877, MGC1674, PP-1A, PP1alpha, PPP1A; protein phosphatase 1, catalytic subunit, alpha isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5500 PPP1CB, MGC3672, PP-1B, PP1beta, PPP1CD; protein phosphatase 1, catalytic subunit, beta isozyme (EC:3.1.3.16 3.1.3.53); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5501 PPP1CC, PP1gamma, PPP1G; protein phosphatase 1, catalytic subunit, gamma isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5580 PRKCD, MAY1, MGC49908, PKCD, nPKC-delta; protein kinase C, delta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5581 PRKCE, MGC125656, MGC125657, PKCE, nPKC-epsilon; protein kinase C, epsilon (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5583 PRKCH, MGC26269, MGC5363, PKC-L, PKCL, PRKCL, nPKC-eta; protein kinase C, eta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5588 PRKCQ, MGC126514, MGC141919, PRKCT, nPKC-theta; protein kinase C, theta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:59 ACTA2, AAT6, ACTSA; actin, alpha 2, smooth muscle, aorta; K12313 actin, aortic smooth muscle
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:72 ACTG2, ACT, ACTA3, ACTE, ACTL3, ACTSG; actin, gamma 2, smooth muscle, enteric; K12315 actin, gamma-enteric smooth muscle
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]
hsa:9138 ARHGEF1, GEF1, LBCL2, LSC, P115-RHOGEF, SUB1.5; Rho guanine nucleotide exchange factor (GEF) 1; K12330 Rho guanine nucleotide exchange factor 1

hsa04910 Insulin signaling pathway - Homo sapiens (human) (59)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1977 EIF4E, CBP, EIF4E1, EIF4EL1, EIF4F, MGC111573; eukaryotic translation initiation factor 4E; K03259 translation initiation factor eIF-4E
hsa:2002 ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2203 FBP1, FBP; fructose-1,6-bisphosphatase 1 (EC:3.1.3.11); K03841 fructose-1,6-bisphosphatase I [EC:3.1.3.11]
hsa:2475 MTOR, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein
hsa:2872 MKNK2, GPRK7, MNK2; MAP kinase interacting serine/threonine kinase 2 (EC:2.7.11.1); K04372 MAP kinase interacting serine/threonine kinase [EC:2.7.11.1]
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3630 INS, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5105 PCK1, MGC22652, PEPCK-C, PEPCK1, PEPCKC; phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32]
hsa:5139 PDE3A, CGI-PDE; phosphodiesterase 3A, cGMP-inhibited (EC:3.1.4.17); K13296 cGMP-inhibited 3',5'-cyclic phosphodiesterase [EC:3.1.4.17]
hsa:5140 PDE3B, HcGIP1, cGIPDE1; phosphodiesterase 3B, cGMP-inhibited (EC:3.1.4.17); K13296 cGMP-inhibited 3',5'-cyclic phosphodiesterase [EC:3.1.4.17]
hsa:51422 PRKAG2, AAKG, AAKG2, CMH6, H91620p, WPWS; protein kinase, AMP-activated, gamma 2 non-catalytic subunit; K07200 5'-AMP-activated protein kinase, regulatory gamma subunit
hsa:5255 PHKA1, MGC132604, PHKA; phosphorylase kinase, alpha 1 (muscle) (EC:2.7.11.19); K07190 phosphorylase kinase alpha/beta subunit
hsa:5256 PHKA2, GSD9A, MGC133071, PHK, PYK, PYKL, XLG, XLG2; phosphorylase kinase, alpha 2 (liver) (EC:2.7.11.19); K07190 phosphorylase kinase alpha/beta subunit
hsa:5257 PHKB, DKFZp781E15103, FLJ41698; phosphorylase kinase, beta (EC:2.7.11.19 2.7.1.38); K07190 phosphorylase kinase alpha/beta subunit
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:53358 SHC3, DKFZp686H1544, FLJ45325, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K06279 src homology 2 domain-containing transforming protein C
hsa:5499 PPP1CA, MGC15877, MGC1674, PP-1A, PP1alpha, PPP1A; protein phosphatase 1, catalytic subunit, alpha isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5500 PPP1CB, MGC3672, PP-1B, PP1beta, PPP1CD; protein phosphatase 1, catalytic subunit, beta isozyme (EC:3.1.3.16 3.1.3.53); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5501 PPP1CC, PP1gamma, PPP1G; protein phosphatase 1, catalytic subunit, gamma isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5571 PRKAG1, AMPKG, MGC8666; protein kinase, AMP-activated, gamma 1 non-catalytic subunit; K07200 5'-AMP-activated protein kinase, regulatory gamma subunit
hsa:5573 PRKAR1A, CAR, CNC, CNC1, DKFZp779L0468, MGC17251, PKR1, PPNAD1, PRKAR1, TSE1; protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator
hsa:5575 PRKAR1B, PRKAR1; protein kinase, cAMP-dependent, regulatory, type I, beta (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator
hsa:5576 PRKAR2A, MGC3606, PKR2, PRKAR2; protein kinase, cAMP-dependent, regulatory, type II, alpha (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator
hsa:5577 PRKAR2B, PRKAR2, RII-BETA; protein kinase, cAMP-dependent, regulatory, type II, beta (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator
hsa:5584 PRKCI, DXS1179E, MGC26534, PKCI, nPKC-iota; protein kinase C, iota (EC:2.7.11.13); K06069 atypical protein kinase C [EC:2.7.11.13]
hsa:5590 PRKCZ, PKC-ZETA, PKC2; protein kinase C, zeta (EC:2.7.11.13); K06069 atypical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:6198 RPS6KB1, PS6K, S6K, S6K1, STK14A, p70(S6K)-alpha, p70-S6K, p70-alpha; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1]
hsa:6464 SHC1, FLJ26504, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 src homology 2 domain-containing transforming protein C
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:8651 SOCS1, CIS1, CISH1, JAB, SOCS-1, SSI-1, SSI1, TIP3; suppressor of cytokine signaling 1; K04694 suppressor of cytokine signaling 1
hsa:867 CBL, C-CBL, CBL2, RNF55; Cas-Br-M (murine) ecotropic retroviral transforming sequence; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:8789 FBP2, MGC142192; fructose-1,6-bisphosphatase 2 (EC:3.1.3.11); K03841 fructose-1,6-bisphosphatase I [EC:3.1.3.11]

hsa04020 Calcium signaling pathway - Homo sapiens (human) (59)



hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:113026 PLCD3, MGC71172; phospholipase C, delta 3 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:135 ADORA2A, ADORA2, RDC8, hA2aR; adenosine A2a receptor; K04266 adenosine receptor A2a
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:2185 PTK2B, CADTK, CAKB, FADK2, FAK2, PKB, PTK, PYK2, RAFTK; PTK2B protein tyrosine kinase 2 beta (EC:2.7.10.2); K05871 protein tyrosine kinase 2 beta [EC:2.7.10.2]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2905 GRIN2C, NMDAR2C, NR2C; glutamate receptor, ionotropic, N-methyl D-aspartate 2C; K05211 glutamate receptor, ionotropic, N-methyl-D-aspartate 2C
hsa:2906 GRIN2D, EB11, NMDAR2D, NR2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; K05212 glutamate receptor, ionotropic, N-methyl-D-aspartate 2D
hsa:291 SLC25A4, AAC1, ANT, ANT1, PEO2, PEO3, T1; solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4; K05863 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator)
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:4846 NOS3, ECNOS, eNOS; nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39); K13242 nitric-oxide synthase, endothelial [EC:1.14.13.39]
hsa:51196 PLCE1, FLJ23659, KIAA1516, MGC167842, NPHS3, PLCE, PPLC; phospholipase C, epsilon 1 (EC:3.1.4.11); K05860 phospholipase C, epsilon
hsa:5136 PDE1A, HCAM1, HSPDE1A, MGC26303; phosphodiesterase 1A, calmodulin-dependent (EC:3.1.4.17); K13755 calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5137 PDE1C, Hcam3; phosphodiesterase 1C, calmodulin-dependent 70kDa (EC:3.1.4.17); K13755 calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5153 PDE1B, PDE1B1, PDES1B; phosphodiesterase 1B, calmodulin-dependent (EC:3.1.4.17); K13755 calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5255 PHKA1, MGC132604, PHKA; phosphorylase kinase, alpha 1 (muscle) (EC:2.7.11.19); K07190 phosphorylase kinase alpha/beta subunit
hsa:5256 PHKA2, GSD9A, MGC133071, PHK, PYK, PYKL, XLG, XLG2; phosphorylase kinase, alpha 2 (liver) (EC:2.7.11.19); K07190 phosphorylase kinase alpha/beta subunit
hsa:5257 PHKB, DKFZp781E15103, FLJ41698; phosphorylase kinase, beta (EC:2.7.11.19 2.7.1.38); K07190 phosphorylase kinase alpha/beta subunit
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5333 PLCD1; phospholipase C, delta 1 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:7125 TNNC2; troponin C type 2 (fast); K12042 troponin C, skeletal muscle
hsa:7134 TNNC1, CMD1Z, CMH13, TN-C, TNC, TNNC; troponin C type 1 (slow); K05865 troponin C, slow skeletal and cardiac muscles
hsa:7416 VDAC1, MGC111064, PORIN, VDAC-1; voltage-dependent anion channel 1; K05862 voltage-dependent anion channel
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:815 CAMK2A, CAMKA, KIAA0968; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:816 CAMK2B, CAM2, CAMK2, CAMKB, MGC29528; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:84812 PLCD4, MGC12837; phospholipase C, delta 4 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:89869 PLCZ1, MGC149685, NYD-SP27, PLCzeta; phospholipase C, zeta 1 (EC:3.1.4.11); K05861 phospholipase C, zeta
hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]

hsa04664 Fc epsilon RI signaling pathway - Homo sapiens (human) (57)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1437 CSF2, GMCSF, MGC131935, MGC138897; colony stimulating factor 2 (granulocyte-macrophage); K05427 granulocyte-macrophage colony-stimulating factor
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3562 IL3, IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF; interleukin 3 (colony-stimulating factor, multiple); K04736 interleukin 3
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3596 IL13, ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600; interleukin 13; K05435 interleukin 13
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4067 LYN, FLJ26625, JTK8; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2); K05854 tyrosine-protein kinase Lyn [EC:2.7.10.2]
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5580 PRKCD, MAY1, MGC49908, PKCD, nPKC-delta; protein kinase C, delta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5581 PRKCE, MGC125656, MGC125657, PKCE, nPKC-epsilon; protein kinase C, epsilon (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]

hsa04310 Wnt signaling pathway - Homo sapiens (human) (57)



hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:1457 CSNK2A1, CK2A1, CKII; casein kinase 2, alpha 1 polypeptide (EC:2.7.11.1); K03097 casein kinase 2, alpha polypeptide [EC:2.7.11.1]
hsa:1459 CSNK2A2, CK2A2, CSNK2A1, FLJ43934; casein kinase 2, alpha prime polypeptide (EC:2.7.11.1); K03097 casein kinase 2, alpha polypeptide [EC:2.7.11.1]
hsa:1460 CSNK2B, CK2B, CK2N, CSK2B, G5A, MGC138222, MGC138224; casein kinase 2, beta polypeptide (EC:2.7.11.1); K03115 casein kinase 2, beta polypeptide
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:23291 FBXW11, BTRC2, BTRCP2, FBW1B, FBXW1B, Fbw11, Hos, KIAA0696; F-box and WD repeat domain containing 11; K03362 F-box and WD-40 domain protein 1/11
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:4087 SMAD2, JV18, JV18-1, MADH2, MADR2, MGC22139, MGC34440, hMAD-2, hSMAD2; SMAD family member 2; K04500 SMAD, mothers against DPP 2/3
hsa:4088 SMAD3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396; SMAD family member 3; K04500 SMAD, mothers against DPP 2/3
hsa:4089 SMAD4, DPC4, JIP, MADH4; SMAD family member 4; K04501 SMAD, mothers against DPP 4
hsa:4316 MMP7, MMP-7, MPSL1, PUMP-1; matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23); K01397 matrix metalloproteinase-7 (matrilysin, uterine) [EC:3.4.24.23]
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4775 NFATC3, NFAT4, NFATX; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4776 NFATC4, NF-ATc4, NFAT3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5515 PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C; protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5516 PPP2CB, PP2Abeta, PP2CB; protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5518 PPP2R1A, MGC786, PP2A-Aalpha, PP2AAALPHA, PR65A; protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5519 PPP2R1B, MGC26454, PP2A-Abeta, PR65B; protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5525 PPP2R5A, B56A, MGC131915, PR61A; protein phosphatase 2, regulatory subunit B', alpha; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5526 PPP2R5B, B56B, FLJ35411, PR61B; protein phosphatase 2, regulatory subunit B', beta; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5527 PPP2R5C, B56G, MGC23064, PR61G; protein phosphatase 2, regulatory subunit B', gamma; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5528 PPP2R5D, B56D, MGC2134, MGC8949; protein phosphatase 2, regulatory subunit B', delta; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5529 PPP2R5E; protein phosphatase 2, regulatory subunit B', epsilon isoform; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:6422 SFRP1, FRP, FRP-1, FRP1, FrzA, SARP2; secreted frizzled-related protein 1; K02166 secreted frizzled-related protein 1
hsa:6934 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:815 CAMK2A, CAMKA, KIAA0968; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:816 CAMK2B, CAM2, CAMK2, CAMKB, MGC29528; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:8945 BTRC, BETA-TRCP, FBW1A, FBXW1, FBXW1A, FWD1, MGC4643, bTrCP, bTrCP1, betaTrCP; beta-transducin repeat containing; K03362 F-box and WD-40 domain protein 1/11
hsa:896 CCND3; cyclin D3; K10152 cyclin D3
hsa:9978 RBX1, BA554C12.1, FLJ60363, MGC13357, MGC1481, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1

hsa04670 Leukocyte transendothelial migration - Homo sapiens (human) (57)



hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:1366 CLDN7, CEPTRL2, CLDN-7, CPETRL2, Hs.84359, claudin-1; claudin 7; K06087 claudin
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1495 CTNNA1, CAP102, FLJ36832, FLJ52416; catenin (cadherin-associated protein), alpha 1, 102kDa; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1536 CYBB, CGD, GP91-1, GP91-PHOX, GP91PHOX, NOX2, p91-PHOX; cytochrome b-245, beta polypeptide; K08008 NADPH oxidase
hsa:2185 PTK2B, CADTK, CAKB, FADK2, FAK2, PKB, PTK, PYK2, RAFTK; PTK2B protein tyrosine kinase 2 beta (EC:2.7.10.2); K05871 protein tyrosine kinase 2 beta [EC:2.7.10.2]
hsa:27035 NOX1, GP91-2, MOX1, NOH-1, NOH1; NADPH oxidase 1; K08008 NADPH oxidase
hsa:2770 GNAI1, Gi; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1; K04630 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L
hsa:3684 ITGAM, CD11B, CR3A, MAC-1, MAC1A, MGC117044, MO1A, SLEB6; integrin, alpha M (complement component 3 receptor 3 subunit); K06461 integrin alpha M
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3689 ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); K06464 integrin beta 2
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:4313 MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]
hsa:4318 MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
hsa:4478 MSN; moesin; K05763 moesin
hsa:4950 OCLN; occludin (EC:2.1.1.67); K06088 occludin
hsa:50508 NOX3, GP91-3, MOX-2; NADPH oxidase 3; K08008 NADPH oxidase
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:5781 PTPN11, BPTP3, CFC, MGC14433, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2; protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48); K07293 protein tyrosine phosphatase, non-receptor type 11 [EC:3.1.3.48]
hsa:5829 PXN, FLJ16691; paxillin; K05760 paxillin
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:6387 CXCL12, IRH, PBSF, SCYB12, SDF1, SDF1A, SDF1B, TLSF, TPAR1; chemokine (C-X-C motif) ligand 12; K10031 C-X-C motif chemokine 12
hsa:653361 NCF1, FLJ79451, NCF1A, NOXO2, SH3PXD1A, p47phox; neutrophil cytosolic factor 1; K08011 neutrophil cytosolic factor 1
hsa:7070 THY1, CD90, FLJ33325; Thy-1 cell surface antigen; K06514 Thy-1 cell surface antigen
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:7122 CLDN5, AWAL, BEC1, CPETRL1, TMVCF; claudin 5; K06087 claudin
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7412 VCAM1, CD106, DKFZp779G2333, INCAM-100, MGC99561; vascular cell adhesion molecule 1; K06527 vascular cell adhesion molecule 1
hsa:7414 VCL, CMD1W, CMH15, MVCL; vinculin; K05700 vinculin
hsa:7430 EZR, CVIL, CVL, DKFZp762H157, FLJ26216, MGC1584, VIL2; ezrin; K08007 villin 2 (ezrin)
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:81 ACTN4, ACTININ-4, DKFZp686K23158, FSGS, FSGS1; actinin, alpha 4; K05699 actinin alpha
hsa:87 ACTN1, FLJ40884, FLJ54432; actinin, alpha 1; K05699 actinin alpha
hsa:9076 CLDN1, CLD1, ILVASC, SEMP1; claudin 1; K06087 claudin
hsa:9564 BCAR1, CAS, CAS1, CASS1, CRKAS, FLJ12176, FLJ45059, P130Cas; breast cancer anti-estrogen resistance 1; K05726 breast cancer anti-estrogen resistance 1
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa04630 Jak-STAT signaling pathway - Homo sapiens (human) (57)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:1437 CSF2, GMCSF, MGC131935, MGC138897; colony stimulating factor 2 (granulocyte-macrophage); K05427 granulocyte-macrophage colony-stimulating factor
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:2056 EPO, EP, MGC138142, MVCD2; erythropoietin; K05437 erythropoietin
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2688 GH1, GH, GH-N, GHN, IGHD1B, hGH-N; growth hormone 1; K05438 growth hormone
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:29949 IL19, IL-10C, MDA1, NG.1, ZMDA1; interleukin 19; K05444 interleukin 19/20/24
hsa:3439 IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@, MGC138207, MGC138505, MGC138507; interferon, alpha 1; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3444 IFNA7, IFN-alphaJ, IFNA-J; interferon, alpha 7; K05414 interferon, alpha
hsa:3449 IFNA16, IFN-alphaO; interferon, alpha 16; K05414 interferon, alpha
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3456 IFNB1, IFB, IFF, IFNB, MGC96956; interferon, beta 1, fibroblast; K05415 interferon, beta
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3467 IFNW1; interferon, omega 1; K05440 interferon, omega 1
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:3559 IL2RA, CD25, IDDM10, IL2R, TCGFR; interleukin 2 receptor, alpha; K05068 interleukin 2 receptor alpha
hsa:3560 IL2RB, CD122, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta
hsa:3561 IL2RG, CD132, IL-2RG, IMD4, P64, SCIDX, SCIDX1; interleukin 2 receptor, gamma; K05070 interleukin 2 receptor gamma
hsa:3562 IL3, IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF; interleukin 3 (colony-stimulating factor, multiple); K04736 interleukin 3
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3566 IL4R, CD124, IL4RA; interleukin 4 receptor; K05071 interleukin 4 receptor
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3570 IL6R, CD126, IL-6R-1, IL-6R-alpha, IL6RA, MGC104991; interleukin 6 receptor; K05055 interleukin 6 receptor
hsa:3574 IL7, IL-7; interleukin 7; K05431 interleukin 7
hsa:3575 IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA; interleukin 7 receptor; K05072 interleukin 7 receptor
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3596 IL13, ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600; interleukin 13; K05435 interleukin 13
hsa:3600 IL15, IL-15, MGC9721; interleukin 15; K05433 interleukin 15
hsa:3716 JAK1, JAK1A, JAK1B, JTK3; Janus kinase 1 (EC:2.7.10.2); K11217 Janus kinase 1 [EC:2.7.10.2]
hsa:3718 JAK3, JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK; Janus kinase 3 (EC:2.7.10.2); K11218 Janus kinase 3 [EC:2.7.10.2]
hsa:3976 LIF, CDF, DIA, HILDA; leukemia inhibitory factor (cholinergic differentiation factor); K05419 leukemia inhibitory factor
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:50604 IL20, IL-20, IL10D, MGC96907, ZCYTO10; interleukin 20; K05444 interleukin 19/20/24
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5781 PTPN11, BPTP3, CFC, MGC14433, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2; protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48); K07293 protein tyrosine phosphatase, non-receptor type 11 [EC:3.1.3.48]
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:598 BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, DKFZp781P2092, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X)
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:6776 STAT5A, MGF, STAT5; signal transducer and activator of transcription 5A; K11223 signal transducer and activator of transcription 5A
hsa:6777 STAT5B, STAT5; signal transducer and activator of transcription 5B; K11224 signal transducer and activator of transcription 5B
hsa:6778 STAT6, D12S1644, IL-4-STAT, STAT6B, STAT6C; signal transducer and activator of transcription 6, interleukin-4 induced; K11225 signal transducer and activator of transcription 6
hsa:8651 SOCS1, CIS1, CISH1, JAB, SOCS-1, SSI-1, SSI1, TIP3; suppressor of cytokine signaling 1; K04694 suppressor of cytokine signaling 1
hsa:867 CBL, C-CBL, CBL2, RNF55; Cas-Br-M (murine) ecotropic retroviral transforming sequence; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:896 CCND3; cyclin D3; K10152 cyclin D3

hsa04514 Cell adhesion molecules (CAMs) - Homo sapiens (human) (56)



hsa:1366 CLDN7, CEPTRL2, CLDN-7, CPETRL2, Hs.84359, claudin-1; claudin 7; K06087 claudin
hsa:1493 CTLA4, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, ICOS, IDDM12; cytotoxic T-lymphocyte-associated protein 4; K06538 cytotoxic T-lymphocyte-associated protein 4
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I
hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I
hsa:3135 HLA-G, MHC-G; major histocompatibility complex, class I, G; K06751 major histocompatibility complex, class I
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:3655 ITGA6, CD49f, DKFZp686J01244, FLJ18737, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L
hsa:3684 ITGAM, CD11B, CR3A, MAC-1, MAC1A, MGC117044, MO1A, SLEB6; integrin, alpha M (complement component 3 receptor 3 subunit); K06461 integrin alpha M
hsa:3685 ITGAV, CD51, DKFZp686A08142, MSK8, VNRA; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); K06487 integrin alpha V
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3689 ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); K06464 integrin beta 2
hsa:4099 MAG, GMA, S-MAG, SIGLEC-4A, SIGLEC4A; myelin associated glycoprotein; K06771 myelin associated glycoprotein
hsa:4950 OCLN; occludin (EC:2.1.1.67); K06088 occludin
hsa:5788 PTPRC, B220, CD45, CD45R, GP180, LCA, LY5, T200; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48); K06478 protein tyrosine phosphatase, receptor type, C [EC:3.1.3.48]
hsa:6382 SDC1, CD138, SDC, SYND1, syndecan; syndecan 1; K06257 syndecan
hsa:6383 SDC2, HSPG, HSPG1, SYND2; syndecan 2; K06257 syndecan
hsa:6385 SDC4, MGC22217, SYND4; syndecan 4; K06257 syndecan
hsa:6401 SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2; selectin E; K06494 selectin, endothelial cell
hsa:6402 SELL, CD62L, LAM1, LECAM1, LEU8, LNHR, LSEL, LYAM1, PLNHR, TQ1; selectin L; K06495 selectin, lymphocyte
hsa:6403 SELP, CD62, CD62P, FLJ45155, GMP140, GRMP, LECAM3, PADGEM, PSEL; selectin P (granule membrane protein 140kDa, antigen CD62); K06496 selectin, platele
hsa:6693 SPN, CD43, GPL115, LSN; sialophorin; K06477 sialophorin
hsa:7122 CLDN5, AWAL, BEC1, CPETRL1, TMVCF; claudin 5; K06087 claudin
hsa:7412 VCAM1, CD106, DKFZp779G2333, INCAM-100, MGC99561; vascular cell adhesion molecule 1; K06527 vascular cell adhesion molecule 1
hsa:9076 CLDN1, CLD1, ILVASC, SEMP1; claudin 1; K06087 claudin
hsa:914 CD2, FLJ46032, SRBC, T11; CD2 molecule; K06449 CD2 antigen
hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen
hsa:925 CD8A, CD8, Leu2, MAL, p32; CD8a molecule; K06458 CD8A antigen, alpha polypeptide
hsa:926 CD8B, CD8B1, LEU2, LY3, LYT3, MGC119115, P37; CD8b molecule; K06459 CD8B antigen, beta polypeptide
hsa:933 CD22, FLJ22814, MGC130020, SIGLEC-2, SIGLEC2; CD22 molecule; K06467 CD22 antigen
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen
hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5
hsa:965 CD58, FLJ23181, FLJ43722, LFA-3, LFA3; CD58 molecule; K06492 CD58 antigen
hsa:9672 SDC3, SDCN, SYND3; syndecan 3; K06257 syndecan
hsa:999 CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin

hsa04620 Toll-like receptor signaling pathway - Homo sapiens (human) (56)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2353 FOS, AP-1, C-FOS; FBJ murine osteosarcoma viral oncogene homolog; K04379 proto-oncogene protein c-fos
hsa:3439 IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@, MGC138207, MGC138505, MGC138507; interferon, alpha 1; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3444 IFNA7, IFN-alphaJ, IFNA-J; interferon, alpha 7; K05414 interferon, alpha
hsa:3449 IFNA16, IFN-alphaO; interferon, alpha 16; K05414 interferon, alpha
hsa:3454 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1
hsa:3456 IFNB1, IFB, IFF, IFNB, MGC96956; interferon, beta 1, fibroblast; K05415 interferon, beta
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3627 CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1; chemokine (C-X-C motif) ligand 10; K12671 C-X-C motif chemokine 10
hsa:3661 IRF3; interferon regulatory factor 3; K05411 interferon regulatory factor 3
hsa:3665 IRF7, IRF-7H, IRF7A; interferon regulatory factor 7; K09447 interferon regulatory factor 7
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:4283 CXCL9, CMK, Humig, MIG, SCYB9, crg-10; chemokine (C-X-C motif) ligand 9; K05416 C-X-C motif chemokine 9
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:6348 CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3; chemokine (C-C motif) ligand 3; K05408 C-C motif chemokine 3
hsa:6351 CCL4, ACT2, AT744.1, G-26, LAG1, MGC104418, MGC126025, MGC126026, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4; chemokine (C-C motif) ligand 4; K12964 C-C motif chemokine 4
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen
hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:9641 IKBKE, IKK-E, IKK-i, IKKE, IKKI, KIAA0151, MGC125294, MGC125295, MGC125297; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (EC:2.7.11.10); K07211 inhibitor of nuclear factor kappa-B kinase epsilon subunit [EC:2.7.11.10]

hsa04540 Gap junction - Homo sapiens (human) (55)



hsa:10376 TUBA1B, K-ALPHA-1; tubulin, alpha 1b; K07374 tubulin alpha
hsa:10381 TUBB3, CFEOM3A, TUBB4, beta-4; tubulin, beta 3; K07375 tubulin beta
hsa:10382 TUBB4, TUBB5, beta-5; tubulin, beta 4; K07375 tubulin beta
hsa:10383 TUBB2C, TUBB2; tubulin, beta 2C; K07375 tubulin beta
hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:203068 TUBB, M40, MGC117247, MGC16435, OK/SW-cl.56, TUBB1, TUBB5; tubulin, beta; K07375 tubulin beta
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:2770 GNAI1, Gi; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1; K04630 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:347688 TUBB8, FLJ40100; tubulin, beta 8; K07375 tubulin beta
hsa:347733 TUBB2B, DKFZp566F223, FLJ98847, MGC8685, bA506K6.1; tubulin, beta 2B; K07375 tubulin beta
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:51807 TUBA8, TUBAL2; tubulin, alpha 8; K07374 tubulin alpha
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5598 MAPK7, BMK1, ERK4, ERK5, PRKM7; mitogen-activated protein kinase 7 (EC:2.7.11.24); K04464 mitogen-activated protein kinase 7 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:56604 TUBB4Q; tubulin, beta polypeptide 4, member Q; K07375 tubulin beta
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:6714 SRC, ASV, SRC1, c-SRC, p60-Src; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (EC:2.7.10.2); K05704 proto-oncogene tyrosine-protein kinase Src [EC:2.7.10.2]
hsa:7082 TJP1, DKFZp686M05161, MGC133289, ZO-1; tight junction protein 1 (zona occludens 1); K05701 tight junction protein 1
hsa:7277 TUBA4A, FLJ30169, H2-ALPHA, TUBA1; tubulin, alpha 4a; K07374 tubulin alpha
hsa:7278 TUBA3C, TUBA2, TUBA3D, bA408E5.3; tubulin, alpha 3c; K07374 tubulin alpha
hsa:7280 TUBB2A, TUBB, TUBB2, dJ40E16.7; tubulin, beta 2A; K07375 tubulin beta
hsa:7846 TUBA1A, B-ALPHA-1, FLJ25113, LIS3, TUBA3; tubulin, alpha 1a; K07374 tubulin alpha
hsa:81027 TUBB1; tubulin, beta 1; K07375 tubulin beta
hsa:84617 TUBB6, HsT1601, MGC132410, MGC4083, TUBB-5; tubulin, beta 6; K07375 tubulin beta
hsa:84790 TUBA1C, MGC10851, MGC14580, TUBA6, bcm948; tubulin, alpha 1c; K07374 tubulin alpha
hsa:983 CDK1, CDC2, CDC28A, DKFZp686L20222, MGC111195, P34CDC2; cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22); K02087 cyclin-dependent kinase 1 [EC:2.7.11.22]

hsa05140 Leishmaniasis - Homo sapiens (human) (54)



hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:2002 ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1
hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I
hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:2353 FOS, AP-1, C-FOS; FBJ murine osteosarcoma viral oncogene homolog; K04379 proto-oncogene protein c-fos
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3460 IFNGR2, AF-1, IFGR2, IFNGT1; interferon gamma receptor 2 (interferon gamma transducer 1); K05133 interferon gamma receptor 2
hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3684 ITGAM, CD11B, CR3A, MAC-1, MAC1A, MGC117044, MO1A, SLEB6; integrin, alpha M (complement component 3 receptor 3 subunit); K06461 integrin alpha M
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3689 ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); K06464 integrin beta 2
hsa:3716 JAK1, JAK1A, JAK1B, JTK3; Janus kinase 1 (EC:2.7.10.2); K11217 Janus kinase 1 [EC:2.7.10.2]
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4793 NFKBIB, IKBB, TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; K02581 NF-kappa-B inhibitor beta
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:653361 NCF1, FLJ79451, NCF1A, NOXO2, SH3PXD1A, p47phox; neutrophil cytosolic factor 1; K08011 neutrophil cytosolic factor 1
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3

hsa05016 Huntington's disease - Homo sapiens (human) (52)



hsa:10488 CREB3, LUMAN, LZIP, MGC15333, MGC19782; cAMP responsive element binding protein 3; K09048 cAMP response element-binding protein 3
hsa:1173 AP2M1, AP50, CLAPM1, mu2; adaptor-related protein complex 2, mu 1 subunit; K11826 AP-2 complex subunit mu-1
hsa:1175 AP2S1, AP17, AP17-DELTA, CLAPS2; adaptor-related protein complex 2, sigma 1 subunit; K11827 AP-2 complex subunit sigma-1
hsa:1213 CLTC, CHC, CHC17, CLH-17, CLTCL2, Hc, KIAA0034; clathrin, heavy chain (Hc); K04646 clathrin, heavy polypeptide
hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:1537 CYC1, UQCR4; cytochrome c-1; K00413 ubiquinol-cytochrome c reductase cytochrome c1 subunit [EC:1.10.2.2]
hsa:160 AP2A1, ADTAA, AP2-ALPHA, CLAPA1; adaptor-related protein complex 2, alpha 1 subunit; K11824 AP-2 complex subunit alpha
hsa:161 AP2A2, ADTAB, CLAPA2, HIP9, HYPJ; adaptor-related protein complex 2, alpha 2 subunit; K11824 AP-2 complex subunit alpha
hsa:163 AP2B1, ADTB2, AP105B, AP2-BETA, CLAPB1, DKFZp781K0743; adaptor-related protein complex 2, beta 1 subunit; K11825 AP-2 complex subunit beta-1
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:27113 BBC3, FLJ42994, JFY1, PUMA; BCL2 binding component 3; K10132 BCL2-binding component 3
hsa:2876 GPX1, GSHPX1, MGC14399, MGC88245; glutathione peroxidase 1 (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:291 SLC25A4, AAC1, ANT, ANT1, PEO2, PEO3, T1; solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4; K05863 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator)
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:3065 HDAC1, DKFZp686H12203, GON-10, HD1, RPD3, RPD3L1; histone deacetylase 1 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98]
hsa:317 APAF1, APAF-1, CED4, DKFZp781B1145; apoptotic peptidase activating factor 1; K02084 apoptotic protease-activating factor
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:54205 CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c
hsa:5430 POLR2A, MGC75453, POLR2, POLRA, RPB1, RPBh1, RPO2, RPOL2, RpIILS, hRPB220, hsRPB1; polymerase (RNA) II (DNA directed) polypeptide A, 220kDa (EC:2.7.7.6 2.7.7.48); K03006 DNA-directed RNA polymerase II subunit A [EC:2.7.7.6]
hsa:5431 POLR2B, POL2RB, RPB2, hRPB140, hsRPB2; polymerase (RNA) II (DNA directed) polypeptide B, 140kDa (EC:2.7.7.6); K03010 DNA-directed RNA polymerase II subunit B [EC:2.7.7.6]
hsa:5432 POLR2C, RPB3, RPB31, hRPB33, hsRPB3; polymerase (RNA) II (DNA directed) polypeptide C, 33kDa (EC:2.7.7.6); K03011 DNA-directed RNA polymerase II subunit C
hsa:5433 POLR2D, HSRBP4, HSRPB4, RBP4, RPB16; polymerase (RNA) II (DNA directed) polypeptide D (EC:2.7.7.6); K03012 DNA-directed RNA polymerase II subunit D
hsa:5434 POLR2E, RPABC1, RPB5, XAP4, hRPB25, hsRPB5; polymerase (RNA) II (DNA directed) polypeptide E, 25kDa (EC:2.7.7.6); K03013 DNA-directed RNA polymerase II subunit E
hsa:5435 POLR2F, HRBP14.4, POLRF, RPABC2, RPB14.4, RPB6; polymerase (RNA) II (DNA directed) polypeptide F (EC:2.7.7.6); K03014 DNA-directed RNA Polymerase II subunit F
hsa:5436 POLR2G, MGC138367, MGC138369, RPB19, RPB7, hRPB19, hsRPB7; polymerase (RNA) II (DNA directed) polypeptide G (EC:2.7.7.6); K03015 DNA-directed RNA polymerase II subunit G
hsa:5437 POLR2H, RPABC3, RPB17, RPB8, hsRPB8; polymerase (RNA) II (DNA directed) polypeptide H (EC:2.7.7.6); K03016 DNA-directed RNA polymerase II subunit H
hsa:5438 POLR2I, RPB9, hRPB14.5; polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa (EC:2.7.7.6); K03017 DNA-directed RNA polymerase II subunit I
hsa:5439 POLR2J, MGC71910, POLR2J1, RPB11, RPB11A, RPB11m, hRPB14; polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa (EC:2.7.7.6); K03008 DNA-directed RNA polymerase II subunit J
hsa:5440 POLR2K, ABC10-alpha, RPABC4, RPB10alpha, RPB12, RPB7.0, hRPB7.0, hsRPB10a; polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa (EC:2.7.7.6); K03009 DNA-directed RNA Polymerase II subunit K
hsa:5441 POLR2L, RBP10, RPABC5, RPB10, RPB10beta, RPB7.6, hRPB7.6, hsRPB10b; polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa (EC:2.7.7.6); K03007 DNA-directed RNA Polymerase II subunit L
hsa:5468 PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma
hsa:581 BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX, membrane protein (BCL2-associated)
hsa:627 BDNF, MGC34632; brain-derived neurotrophic factor; K04355 brain-derived neurotrophic factor
hsa:6390 SDHB, FLJ92337, IP, PGL4, SDH, SDH1, SDH2, SDHIP; succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (EC:1.3.5.1); K00235 succinate dehydrogenase (ubiquinone) iron-sulfur protein [EC:1.3.5.1]
hsa:6647 SOD1, ALS, ALS1, IPOA, SOD, homodimer; superoxide dismutase 1, soluble (EC:1.15.1.1); K04565 Cu/Zn superoxide dismutase [EC:1.15.1.1]
hsa:6648 SOD2, IPOB, MNSOD, MVCD6; superoxide dismutase 2, mitochondrial (EC:1.15.1.1); K04564 superoxide dismutase, Fe-Mn family [EC:1.15.1.1]
hsa:6667 SP1; Sp1 transcription factor; K04684 transcription factor Sp1
hsa:6874 TAF4, FLJ41943, TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135; TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa; K03129 transcription initiation factor TFIID subunit D3
hsa:6908 TBP, GTF2D, GTF2D1, HDL4, MGC117320, MGC126054, MGC126055, SCA17, TFIID; TATA box binding protein; K03120 transcription initiation factor TFIID TATA-box-binding protein
hsa:7052 TGM2, G-ALPHA-h, GNAH, TG2, TGC; transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) (EC:2.3.2.13); K05625 transglutaminase 2 [EC:2.3.2.13]
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:7416 VDAC1, MGC111064, PORIN, VDAC-1; voltage-dependent anion channel 1; K05862 voltage-dependent anion channel
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]

hsa05215 Prostate cancer - Homo sapiens (human) (52)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1017 CDK2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22]
hsa:1026 CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A
hsa:1027 CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B
hsa:10488 CREB3, LUMAN, LZIP, MGC15333, MGC19782; cAMP responsive element binding protein 3; K09048 cAMP response element-binding protein 3
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1869 E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K06620 E2F transcription factor 1/3
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2475 MTOR, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3320 HSP90AA1, FLJ31884, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2; heat shock protein 90kDa alpha (cytosolic), class A member 1; K04079 molecular chaperone HtpG
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3480 IGF1R, CD221, IGFIR, IGFR, JTK13, MGC142170, MGC142172, MGC18216; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3630 INS, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4193 MDM2, HDMX, MGC5370, MGC71221, hdm2; Mdm2 p53 binding protein homolog (mouse); K06643 transformed 3T3 cell double minute 2, p53-binding protein [EC:6.3.2.19]
hsa:468 ATF4, CREB-2, CREB2, TAXREB67, TXREB; activating transcription factor 4 (tax-responsive enhancer element B67); K04374 activating transcription factor 4
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5925 RB1, OSRC, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6934 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2
hsa:7039 TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:898 CCNE1, CCNE; cyclin E1; K06626 cyclin E

hsa04530 Tight junction - Homo sapiens (human) (51)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:1366 CLDN7, CEPTRL2, CLDN-7, CPETRL2, Hs.84359, claudin-1; claudin 7; K06087 claudin
hsa:1457 CSNK2A1, CK2A1, CKII; casein kinase 2, alpha 1 polypeptide (EC:2.7.11.1); K03097 casein kinase 2, alpha polypeptide [EC:2.7.11.1]
hsa:1459 CSNK2A2, CK2A2, CSNK2A1, FLJ43934; casein kinase 2, alpha prime polypeptide (EC:2.7.11.1); K03097 casein kinase 2, alpha polypeptide [EC:2.7.11.1]
hsa:1460 CSNK2B, CK2B, CK2N, CSK2B, G5A, MGC138222, MGC138224; casein kinase 2, beta polypeptide (EC:2.7.11.1); K03115 casein kinase 2, beta polypeptide
hsa:1495 CTNNA1, CAP102, FLJ36832, FLJ52416; catenin (cadherin-associated protein), alpha 1, 102kDa; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2770 GNAI1, Gi; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1; K04630 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:4624 MYH6, ASD3, CMD1EE, CMH14, MYHC, MYHCA, alpha-MHC; myosin, heavy chain 6, cardiac muscle, alpha; K10352 myosin heavy chain
hsa:4625 MYH7, CMD1S, CMH1, DKFZp451F047, MGC138376, MGC138378, MPD1, MYHCB, SPMD, SPMM; myosin, heavy chain 7, cardiac muscle, beta; K10352 myosin heavy chain
hsa:4627 MYH9, DFNA17, EPSTS, FTNS, MGC104539, MHA, NMHC-II-A, NMMHCA; myosin, heavy chain 9, non-muscle; K10352 myosin heavy chain
hsa:4628 MYH10, MGC134913, MGC134914, NMMHCB; myosin, heavy chain 10, non-muscle; K10352 myosin heavy chain
hsa:4629 MYH11, AAT4, DKFZp686D10126, DKFZp686D19237, FAA4, FLJ35232, MGC126726, MGC32963, SMHC, SMMHC; myosin, heavy chain 11, smooth muscle; K10352 myosin heavy chain
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:4950 OCLN; occludin (EC:2.1.1.67); K06088 occludin
hsa:5515 PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C; protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5516 PPP2CB, PP2Abeta, PP2CB; protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5518 PPP2R1A, MGC786, PP2A-Aalpha, PP2AAALPHA, PR65A; protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5519 PPP2R1B, MGC26454, PP2A-Abeta, PR65B; protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5520 PPP2R2A, B55A, B55ALPHA, DKFZp686N05117, FLJ26613, FLJ41727, MGC52248, PR52A, PR55A; protein phosphatase 2, regulatory subunit B, alpha (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5521 PPP2R2B, B55BETA, FLJ95686, MGC24888, PP2AB55BETA, PP2ABBETA, PP2APR55B, PP2APR55BETA, PR2AB55BETA, PR2ABBETA, PR2APR55BETA, PR52B, PR55-BETA, PR55BETA, SCA12; protein phosphatase 2, regulatory subunit B, beta (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5522 PPP2R2C, B55-GAMMA, IMYPNO, IMYPNO1, MGC33570, PR52, PR55G; protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5580 PRKCD, MAY1, MGC49908, PKCD, nPKC-delta; protein kinase C, delta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5581 PRKCE, MGC125656, MGC125657, PKCE, nPKC-epsilon; protein kinase C, epsilon (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5583 PRKCH, MGC26269, MGC5363, PKC-L, PKCL, PRKCL, nPKC-eta; protein kinase C, eta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5584 PRKCI, DXS1179E, MGC26534, PKCI, nPKC-iota; protein kinase C, iota (EC:2.7.11.13); K06069 atypical protein kinase C [EC:2.7.11.13]
hsa:5588 PRKCQ, MGC126514, MGC141919, PRKCT, nPKC-theta; protein kinase C, theta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5590 PRKCZ, PKC-ZETA, PKC2; protein kinase C, zeta (EC:2.7.11.13); K06069 atypical protein kinase C [EC:2.7.11.13]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:6709 SPTAN1, EIEE5, FLJ17738, FLJ44613, NEAS, SPTA2; spectrin, alpha, non-erythrocytic 1 (alpha-fodrin); K06114 spectrin alpha
hsa:6714 SRC, ASV, SRC1, c-SRC, p60-Src; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (EC:2.7.10.2); K05704 proto-oncogene tyrosine-protein kinase Src [EC:2.7.10.2]
hsa:7082 TJP1, DKFZp686M05161, MGC133289, ZO-1; tight junction protein 1 (zona occludens 1); K05701 tight junction protein 1
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:7122 CLDN5, AWAL, BEC1, CPETRL1, TMVCF; claudin 5; K06087 claudin
hsa:79784 MYH14, DFNA4, DKFZp667A1311, FLJ13881, FLJ43092, KIAA2034, MHC16, MYH17, NMHC-II-C, myosin; myosin, heavy chain 14, non-muscle (EC:3.6.4.1); K10352 myosin heavy chain
hsa:81 ACTN4, ACTININ-4, DKFZp686K23158, FSGS, FSGS1; actinin, alpha 4; K05699 actinin alpha
hsa:87 ACTN1, FLJ40884, FLJ54432; actinin, alpha 1; K05699 actinin alpha
hsa:8735 MYH13, MyHC-eo; myosin, heavy chain 13, skeletal muscle; K10352 myosin heavy chain
hsa:9076 CLDN1, CLD1, ILVASC, SEMP1; claudin 1; K06087 claudin
hsa:9414 TJP2, MGC26306, X104, ZO2; tight junction protein 2 (zona occludens 2); K06098 tight junction protein 2
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa05416 Viral myocarditis - Homo sapiens (human) (51)



hsa:1604 CD55, CR, CROM, DAF, TC; CD55 molecule, decay accelerating factor for complement (Cromer blood group); K04006 decay accelerating factor
hsa:1981 EIF4G1, DKFZp686A1451, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220; eukaryotic translation initiation factor 4 gamma, 1; K03260 translation initiation factor eIF-4F
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I
hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I
hsa:3135 HLA-G, MHC-G; major histocompatibility complex, class I, G; K06751 major histocompatibility complex, class I
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L
hsa:3689 ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); K06464 integrin beta 2
hsa:3908 LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2
hsa:4624 MYH6, ASD3, CMD1EE, CMH14, MYHC, MYHCA, alpha-MHC; myosin, heavy chain 6, cardiac muscle, alpha; K10352 myosin heavy chain
hsa:4625 MYH7, CMD1S, CMH1, DKFZp451F047, MGC138376, MGC138378, MPD1, MYHCB, SPMD, SPMM; myosin, heavy chain 7, cardiac muscle, beta; K10352 myosin heavy chain
hsa:4627 MYH9, DFNA17, EPSTS, FTNS, MGC104539, MHA, NMHC-II-A, NMMHCA; myosin, heavy chain 9, non-muscle; K10352 myosin heavy chain
hsa:4628 MYH10, MGC134913, MGC134914, NMMHCB; myosin, heavy chain 10, non-muscle; K10352 myosin heavy chain
hsa:4629 MYH11, AAT4, DKFZp686D10126, DKFZp686D19237, FAA4, FLJ35232, MGC126726, MGC32963, SMHC, SMMHC; myosin, heavy chain 11, smooth muscle; K10352 myosin heavy chain
hsa:54205 CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:637 BID, FP497, MGC15319, MGC42355; BH3 interacting domain death agonist; K04726 BH3 interacting domain death agonist
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:79784 MYH14, DFNA4, DKFZp667A1311, FLJ13881, FLJ43092, KIAA2034, MHC16, MYH17, NMHC-II-C, myosin; myosin, heavy chain 14, non-muscle (EC:3.6.4.1); K10352 myosin heavy chain
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:857 CAV1, BSCL3, CGL3, MSTP085, VIP21; caveolin 1, caveolae protein, 22kDa; K06278 caveolin 1
hsa:8735 MYH13, MyHC-eo; myosin, heavy chain 13, skeletal muscle; K10352 myosin heavy chain
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen
hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5

hsa04640 Hematopoietic cell lineage - Homo sapiens (human) (50)



hsa:1380 CR2, C3DR, CD21, SLEB9; complement component (3d/Epstein Barr virus) receptor 2; K04012 complement component (3d/Epstein Barr virus) receptor 2
hsa:1436 CSF1R, C-FMS, CD115, CSFR, FIM2, FMS; colony stimulating factor 1 receptor (EC:2.7.10.1); K05090 macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
hsa:1437 CSF2, GMCSF, MGC131935, MGC138897; colony stimulating factor 2 (granulocyte-macrophage); K05427 granulocyte-macrophage colony-stimulating factor
hsa:1604 CD55, CR, CROM, DAF, TC; CD55 molecule, decay accelerating factor for complement (Cromer blood group); K04006 decay accelerating factor
hsa:2056 EPO, EP, MGC138142, MVCD2; erythropoietin; K05437 erythropoietin
hsa:2208 FCER2, CD23, CD23A, CLEC4J, FCE2, IGEBF; Fc fragment of IgE, low affinity II, receptor for (CD23); K06468 Fc receptor, IgE, low affinity II
hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I
hsa:2993 GYPA, CD235a, GPA, GPErik, GPSAT, GpMiIII, HGpMiIII, HGpMiV, HGpMiX, HGpMiXI, HGpSta(C), MN, MNS, PAS-2; glycophorin A (MNS blood group); K06575 glycophorin
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3554 IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I
hsa:3559 IL2RA, CD25, IDDM10, IL2R, TCGFR; interleukin 2 receptor, alpha; K05068 interleukin 2 receptor alpha
hsa:3562 IL3, IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF; interleukin 3 (colony-stimulating factor, multiple); K04736 interleukin 3
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3566 IL4R, CD124, IL4RA; interleukin 4 receptor; K05071 interleukin 4 receptor
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3570 IL6R, CD126, IL-6R-1, IL-6R-alpha, IL6RA, MGC104991; interleukin 6 receptor; K05055 interleukin 6 receptor
hsa:3574 IL7, IL-7; interleukin 7; K05431 interleukin 7
hsa:3575 IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA; interleukin 7 receptor; K05072 interleukin 7 receptor
hsa:3655 ITGA6, CD49f, DKFZp686J01244, FLJ18737, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6
hsa:3675 ITGA3, CD49C, FLJ34631, FLJ34704, GAP-B3, GAPB3, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5
hsa:3684 ITGAM, CD11B, CR3A, MAC-1, MAC1A, MGC117044, MO1A, SLEB6; integrin, alpha M (complement component 3 receptor 3 subunit); K06461 integrin alpha M
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
hsa:4311 MME, CALLA, CD10, DKFZp686O16152, MGC126681, MGC126707, NEP; membrane metallo-endopeptidase (EC:3.4.24.11); K01389 neprilysin [EC:3.4.24.11]
hsa:7037 TFRC, CD71, TFR, TFR1, TRFR; transferrin receptor (p90, CD71); K06503 transferrin receptor
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:909 CD1A, CD1, FCB6, HTA1, R4, T6; CD1a molecule; K06448 CD1 antigen
hsa:912 CD1D, CD1A, MGC34622, R3; CD1d molecule; K06448 CD1 antigen
hsa:914 CD2, FLJ46032, SRBC, T11; CD2 molecule; K06449 CD2 antigen
hsa:915 CD3D, CD3-DELTA, T3D; CD3d molecule, delta (CD3-TCR complex); K06450 CD3D antigen, delta polypeptide
hsa:916 CD3E, FLJ18683, T3E, TCRE; CD3e molecule, epsilon (CD3-TCR complex); K06451 CD3E antigen, epsilon polypeptide
hsa:917 CD3G, CD3-GAMMA, FLJ17620, FLJ17664, FLJ79544, FLJ94613, MGC138597, T3G; CD3g molecule, gamma (CD3-TCR complex); K06452 CD3G antigen, gamma polypeptide
hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen
hsa:925 CD8A, CD8, Leu2, MAL, p32; CD8a molecule; K06458 CD8A antigen, alpha polypeptide
hsa:926 CD8B, CD8B1, LEU2, LY3, LYT3, MGC119115, P37; CD8b molecule; K06459 CD8B antigen, beta polypeptide
hsa:928 CD9, 5H9, BA2, BTCC-1, DRAP-27, MIC3, MRP-1, P24, TSPAN29; CD9 molecule; K06460 CD9 antigen
hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:933 CD22, FLJ22814, MGC130020, SIGLEC-2, SIGLEC2; CD22 molecule; K06467 CD22 antigen
hsa:945 CD33, FLJ00391, SIGLEC-3, SIGLEC3, p67; CD33 molecule; K06473 CD33 antigen
hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]
hsa:960 CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MGC10468, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen
hsa:966 CD59, 16.3A5, 1F5, EJ16, EJ30, EL32, FLJ38134, FLJ92039, G344, HRF-20, HRF20, MAC-IP, MACIF, MEM43, MGC2354, MIC11, MIN1, MIN2, MIN3, MIRL, MSK21, p18-20; CD59 molecule, complement regulatory protein; K04008 CD59 antigen

hsa04012 ErbB signaling pathway - Homo sapiens (human) (50)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1026 CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A
hsa:1027 CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2002 ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2475 MTOR, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5058 PAK1, MGC130000, MGC130001, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1]
hsa:5062 PAK2, PAK65, PAKgamma; p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1); K04410 p21-activated kinase 2 [EC:2.7.11.1]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:53358 SHC3, DKFZp686H1544, FLJ45325, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K06279 src homology 2 domain-containing transforming protein C
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:6198 RPS6KB1, PS6K, S6K, S6K1, STK14A, p70(S6K)-alpha, p70-S6K, p70-alpha; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1]
hsa:6464 SHC1, FLJ26504, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 src homology 2 domain-containing transforming protein C
hsa:6714 SRC, ASV, SRC1, c-SRC, p60-Src; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (EC:2.7.10.2); K05704 proto-oncogene tyrosine-protein kinase Src [EC:2.7.10.2]
hsa:6776 STAT5A, MGF, STAT5; signal transducer and activator of transcription 5A; K11223 signal transducer and activator of transcription 5A
hsa:6777 STAT5B, STAT5; signal transducer and activator of transcription 5B; K11224 signal transducer and activator of transcription 5B
hsa:7039 TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha
hsa:815 CAMK2A, CAMKA, KIAA0968; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:816 CAMK2B, CAM2, CAMK2, CAMKB, MGC29528; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:867 CBL, C-CBL, CBL2, RNF55; Cas-Br-M (murine) ecotropic retroviral transforming sequence; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]

hsa04110 Cell cycle - Homo sapiens (human) (50)



hsa:1017 CDK2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22]
hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:1022 CDK7, CAK1, CDKN7, MO15, STK1, p39MO15; cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22); K02202 cyclin-dependent kinase 7 [EC:2.7.11.22]
hsa:1026 CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A
hsa:1027 CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B
hsa:10971 YWHAQ, 14-3-3, 1C5, HS1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:1111 CHEK1, CHK1; CHK1 checkpoint homolog (S. pombe) (EC:2.7.11.1); K02216 serine/threonine-protein kinase Chk1 [EC:2.7.11.1]
hsa:11200 CHEK2, CDS1, CHK2, HuCds1, LFS2, PP1425, RAD53; CHK2 checkpoint homolog (S. pombe) (EC:2.7.11.1); K06641 serine/threonine-protein kinase Chk2 [EC:2.7.11.1]
hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:1647 GADD45A, DDIT1, GADD45; growth arrest and DNA-damage-inducible, alpha; K04402 growth arrest and DNA-damage-inducible protein
hsa:1869 E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K06620 E2F transcription factor 1/3
hsa:1874 E2F4, E2F-4; E2F transcription factor 4, p107/p130-binding; K04682 E2F transcription factor 4/5
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3065 HDAC1, DKFZp686H12203, GON-10, HD1, RPD3, RPD3L1; histone deacetylase 1 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98]
hsa:4087 SMAD2, JV18, JV18-1, MADH2, MADR2, MGC22139, MGC34440, hMAD-2, hSMAD2; SMAD family member 2; K04500 SMAD, mothers against DPP 2/3
hsa:4088 SMAD3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396; SMAD family member 3; K04500 SMAD, mothers against DPP 2/3
hsa:4089 SMAD4, DPC4, JIP, MADH4; SMAD family member 4; K04501 SMAD, mothers against DPP 4
hsa:4193 MDM2, HDMX, MGC5370, MGC71221, hdm2; Mdm2 p53 binding protein homolog (mouse); K06643 transformed 3T3 cell double minute 2, p53-binding protein [EC:6.3.2.19]
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:472 ATM, AT1, ATA, ATC, ATD, ATDC, ATE, DKFZp781A0353, MGC74674, TEL1, TELO1; ataxia telangiectasia mutated (EC:2.7.11.1); K04728 ataxia telangectasia mutated family protein [EC:2.7.11.1]
hsa:5111 PCNA, MGC8367; proliferating cell nuclear antigen; K04802 proliferating cell nuclear antigen
hsa:545 ATR, FRP1, MEC1, SCKL, SCKL1; ataxia telangiectasia and Rad3 related (EC:2.7.11.1); K06640 ataxia telangiectasia and Rad3 related [EC:2.7.11.1]
hsa:5591 PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350; protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1); K06642 DNA-dependent protein kinase catalytic subunit [EC:2.7.11.1]
hsa:5925 RB1, OSRC, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein
hsa:5934 RBL2, FLJ26459, P130, Rb2; retinoblastoma-like 2 (p130); K04681 retinoblastoma-like
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:6502 SKP2, FBL1, FBXL1, FLB1, MGC1366; S-phase kinase-associated protein 2 (p45); K03875 F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2)
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:7465 WEE1, DKFZp686I18166, FLJ16446, WEE1A, WEE1hu; WEE1 homolog (S. pombe) (EC:2.7.10.2); K06632 wee1-like protein kinase [EC:2.7.11.1]
hsa:7529 YWHAB, GW128, HS1, KCIP-1, YWHAA; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7531 YWHAE, 14-3-3E, FLJ45465, FLJ53559, KCIP-1, MDCR, MDS; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7532 YWHAG, 14-3-3GAMMA; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7533 YWHAH, YWHA1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7534 YWHAZ, 14-3-3-zeta, KCIP-1, MGC111427, MGC126532, MGC138156, YWHAD; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:85417 CCNB3; cyclin B3; K05868 cyclin B
hsa:890 CCNA2, CCN1, CCNA; cyclin A2; K06627 cyclin A
hsa:8900 CCNA1; cyclin A1; K06627 cyclin A
hsa:891 CCNB1, CCNB; cyclin B1; K05868 cyclin B
hsa:896 CCND3; cyclin D3; K10152 cyclin D3
hsa:898 CCNE1, CCNE; cyclin E1; K06626 cyclin E
hsa:902 CCNH, CAK, p34, p37; cyclin H; K06634 cyclin H
hsa:9133 CCNB2, HsT17299; cyclin B2; K05868 cyclin B
hsa:983 CDK1, CDC2, CDC28A, DKFZp686L20222, MGC111195, P34CDC2; cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22); K02087 cyclin-dependent kinase 1 [EC:2.7.11.22]
hsa:990 CDC6, CDC18L, HsCDC18, HsCDC6; cell division cycle 6 homolog (S. cerevisiae); K02213 cell division control protein 6
hsa:991 CDC20, CDC20A, MGC102824, bA276H19.3, p55CDC; cell division cycle 20 homolog (S. cerevisiae); K03363 cell division cycle 20, cofactor of APC complex
hsa:995 CDC25C, CDC25; cell division cycle 25 homolog C (S. pombe) (EC:3.1.3.48); K05867 cell division cycle 25C [EC:3.1.3.48]
hsa:9978 RBX1, BA554C12.1, FLJ60363, MGC13357, MGC1481, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1

hsa04662 B cell receptor signaling pathway - Homo sapiens (human) (50)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1380 CR2, C3DR, CD21, SLEB9; complement component (3d/Epstein Barr virus) receptor 2; K04012 complement component (3d/Epstein Barr virus) receptor 2
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b
hsa:2353 FOS, AP-1, C-FOS; FBJ murine osteosarcoma viral oncogene homolog; K04379 proto-oncogene protein c-fos
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4067 LYN, FLJ26625, JTK8; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2); K05854 tyrosine-protein kinase Lyn [EC:2.7.10.2]
hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4775 NFATC3, NFAT4, NFATX; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4776 NFATC4, NF-ATc4, NFAT3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4793 NFKBIB, IKBB, TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; K02581 NF-kappa-B inhibitor beta
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:8519 IFITM1, 9-27, CD225, IFI17, LEU13; interferon induced transmembrane protein 1 (9-27); K06566 interferon induced transmembrane protein
hsa:933 CD22, FLJ22814, MGC130020, SIGLEC-2, SIGLEC2; CD22 molecule; K06467 CD22 antigen
hsa:974 CD79B, B29, IGB; CD79b molecule, immunoglobulin-associated beta; K06507 CD79B antigen
hsa:975 CD81, CVID6, S5.7, TAPA1, TSPAN28; CD81 molecule; K06508 CD81 antigen

hsa04914 Progesterone-mediated oocyte maturation - Homo sapiens (human) (48)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1017 CDK2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22]
hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2770 GNAI1, Gi; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1; K04630 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide
hsa:3320 HSP90AA1, FLJ31884, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2; heat shock protein 90kDa alpha (cytosolic), class A member 1; K04079 molecular chaperone HtpG
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3480 IGF1R, CD221, IGFIR, IGFR, JTK13, MGC142170, MGC142172, MGC18216; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]
hsa:3630 INS, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:5139 PDE3A, CGI-PDE; phosphodiesterase 3A, cGMP-inhibited (EC:3.1.4.17); K13296 cGMP-inhibited 3',5'-cyclic phosphodiesterase [EC:3.1.4.17]
hsa:5140 PDE3B, HcGIP1, cGIPDE1; phosphodiesterase 3B, cGMP-inhibited (EC:3.1.4.17); K13296 cGMP-inhibited 3',5'-cyclic phosphodiesterase [EC:3.1.4.17]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:85417 CCNB3; cyclin B3; K05868 cyclin B
hsa:890 CCNA2, CCN1, CCNA; cyclin A2; K06627 cyclin A
hsa:8900 CCNA1; cyclin A1; K06627 cyclin A
hsa:891 CCNB1, CCNB; cyclin B1; K05868 cyclin B
hsa:9133 CCNB2, HsT17299; cyclin B2; K05868 cyclin B
hsa:983 CDK1, CDC2, CDC28A, DKFZp686L20222, MGC111195, P34CDC2; cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22); K02087 cyclin-dependent kinase 1 [EC:2.7.11.22]
hsa:995 CDC25C, CDC25; cell division cycle 25 homolog C (S. pombe) (EC:3.1.3.48); K05867 cell division cycle 25C [EC:3.1.3.48]

hsa04666 Fc gamma R-mediated phagocytosis - Homo sapiens (human) (46)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:10451 VAV3, FLJ40431; vav 3 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:1072 CFL1, CFL; cofilin 1 (non-muscle); K05765 cofilin
hsa:1073 CFL2, NEM7; cofilin 2 (muscle); K05765 cofilin
hsa:1794 DOCK2, FLJ46592, KIAA0209; dedicator of cytokinesis 2; K12367 dedicator of cytokinesis 2
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I
hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b
hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:255189 PLA2G4F, DKFZp666G192, DKFZp781B229, PLA2G4FZ; phospholipase A2, group IVF (EC:3.1.1.4)
hsa:283748 PLA2G4D, cPLA2delta; phospholipase A2, group IVD (cytosolic) (EC:3.1.1.4)
hsa:2934 GSN, DKFZp313L0718; gelsolin; K05768 gelsolin
hsa:3055 HCK, JTK9; hemopoietic cell kinase (EC:2.7.10.2); K08893 hemopoietic cell kinase [EC:2.7.10.2]
hsa:382 ARF6, DKFZp564M0264; ADP-ribosylation factor 6; K07941 ADP-ribosylation factor 6
hsa:4067 LYN, FLJ26625, JTK8; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2); K05854 tyrosine-protein kinase Lyn [EC:2.7.10.2]
hsa:5058 PAK1, MGC130000, MGC130001, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5580 PRKCD, MAY1, MGC49908, PKCD, nPKC-delta; protein kinase C, delta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5581 PRKCE, MGC125656, MGC125657, PKCE, nPKC-epsilon; protein kinase C, epsilon (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5788 PTPRC, B220, CD45, CD45R, GP180, LCA, LY5, T200; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48); K06478 protein tyrosine phosphatase, receptor type, C [EC:3.1.3.48]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:6198 RPS6KB1, PS6K, S6K, S6K1, STK14A, p70(S6K)-alpha, p70-S6K, p70-alpha; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1]
hsa:653361 NCF1, FLJ79451, NCF1A, NOXO2, SH3PXD1A, p47phox; neutrophil cytosolic factor 1; K08011 neutrophil cytosolic factor 1
hsa:7409 VAV1, VAV; vav 1 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor; K05730 vav oncogene
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8976 WASL, DKFZp779G0847, MGC48327, N-WASP, NWASP; Wiskott-Aldrich syndrome-like; K05747 Wiskott-Aldrich syndrome protein
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa00230 Purine metabolism - Homo sapiens (human) (46)



hsa:100 ADA; adenosine deaminase (EC:3.5.4.4); K01488 adenosine deaminase [EC:3.5.4.4]
hsa:10621 POLR3F, MGC13517, RPC39, RPC6; polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa; K03025 DNA-directed RNA polymerase III subunit C34 [EC:2.7.7.6]
hsa:10622 POLR3G, RPC32, RPC7; polymerase (RNA) III (DNA directed) polypeptide G (32kD); K03024 DNA-directed RNA polymerase III subunit C31 [EC:2.7.7.6]
hsa:10623 POLR3C, RPC3, RPC62; polymerase (RNA) III (DNA directed) polypeptide C (62kD); K03023 DNA-directed RNA polymerase III subunit C3 [EC:2.7.7.6]
hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:10846 PDE10A, FLJ11894, FLJ25677, HSPDE10A; phosphodiesterase 10A (EC:3.1.4.35 3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:11128 POLR3A, RPC1, RPC155, hRPC155; polymerase (RNA) III (DNA directed) polypeptide A, 155kDa (EC:2.7.7.6); K03018 DNA-directed RNA polymerase III subunit C1 [EC:2.7.7.6]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:171568 POLR3H, KIAA1665, MGC111097, MGC29654, RPC22.9, RPC8; polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) (EC:2.7.7.6); K03022 DNA-directed RNA polymerase III subunit C25 [EC:2.7.7.6]
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:3704 ITPA, C20orf37, HLC14-06-P, ITPase, dJ794I6.3; inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (EC:3.6.1.19); K01519 nucleoside-triphosphate pyrophosphatase [EC:3.6.1.19]
hsa:50940 PDE11A, FLJ23693, MGC133355, MGC133356, PPNAD2; phosphodiesterase 11A (EC:3.1.4.35 3.1.4.17); K13298 dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 [EC:3.1.4.17 3.1.4.35]
hsa:5136 PDE1A, HCAM1, HSPDE1A, MGC26303; phosphodiesterase 1A, calmodulin-dependent (EC:3.1.4.17); K13755 calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5137 PDE1C, Hcam3; phosphodiesterase 1C, calmodulin-dependent 70kDa (EC:3.1.4.17); K13755 calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5138 PDE2A, PDE2A1, PED2A4; phosphodiesterase 2A, cGMP-stimulated (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5139 PDE3A, CGI-PDE; phosphodiesterase 3A, cGMP-inhibited (EC:3.1.4.17); K13296 cGMP-inhibited 3',5'-cyclic phosphodiesterase [EC:3.1.4.17]
hsa:5140 PDE3B, HcGIP1, cGIPDE1; phosphodiesterase 3B, cGMP-inhibited (EC:3.1.4.17); K13296 cGMP-inhibited 3',5'-cyclic phosphodiesterase [EC:3.1.4.17]
hsa:5141 PDE4A, DPDE2, PDE4, PDE46; phosphodiesterase 4A, cAMP-specific (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5142 PDE4B, DKFZp686F2182, DPDE4, MGC126529, PDE4B5, PDEIVB; phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5143 PDE4C, DPDE1, MGC126222; phosphodiesterase 4C, cAMP-specific (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5144 PDE4D, DKFZp686M11213, DPDE3, FLJ97311, HSPDE4D, PDE4DN2, STRK1; phosphodiesterase 4D, cAMP-specific (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5150 PDE7A, HCP1, PDE7; phosphodiesterase 7A (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5151 PDE8A, FLJ16150, HsT19550; phosphodiesterase 8A (EC:3.1.4.17); K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5153 PDE1B, PDE1B1, PDES1B; phosphodiesterase 1B, calmodulin-dependent (EC:3.1.4.17); K13755 calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:51728 POLR3K, C11, C11-RNP3, RPC10, RPC11, RPC12.5, hRPC11; polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa; K03019 DNA-directed RNA polymerase III subunit C11 [EC:2.7.7.6]
hsa:5426 POLE, DKFZp434F222, FLJ21434, POLE1; polymerase (DNA directed), epsilon (EC:2.7.7.7); K02324 DNA polymerase epsilon subunit 1 [EC:2.7.7.7]
hsa:5430 POLR2A, MGC75453, POLR2, POLRA, RPB1, RPBh1, RPO2, RPOL2, RpIILS, hRPB220, hsRPB1; polymerase (RNA) II (DNA directed) polypeptide A, 220kDa (EC:2.7.7.6 2.7.7.48); K03006 DNA-directed RNA polymerase II subunit A [EC:2.7.7.6]
hsa:5431 POLR2B, POL2RB, RPB2, hRPB140, hsRPB2; polymerase (RNA) II (DNA directed) polypeptide B, 140kDa (EC:2.7.7.6); K03010 DNA-directed RNA polymerase II subunit B [EC:2.7.7.6]
hsa:5432 POLR2C, RPB3, RPB31, hRPB33, hsRPB3; polymerase (RNA) II (DNA directed) polypeptide C, 33kDa (EC:2.7.7.6); K03011 DNA-directed RNA polymerase II subunit C
hsa:5433 POLR2D, HSRBP4, HSRPB4, RBP4, RPB16; polymerase (RNA) II (DNA directed) polypeptide D (EC:2.7.7.6); K03012 DNA-directed RNA polymerase II subunit D
hsa:5434 POLR2E, RPABC1, RPB5, XAP4, hRPB25, hsRPB5; polymerase (RNA) II (DNA directed) polypeptide E, 25kDa (EC:2.7.7.6); K03013 DNA-directed RNA polymerase II subunit E
hsa:5435 POLR2F, HRBP14.4, POLRF, RPABC2, RPB14.4, RPB6; polymerase (RNA) II (DNA directed) polypeptide F (EC:2.7.7.6); K03014 DNA-directed RNA Polymerase II subunit F
hsa:5436 POLR2G, MGC138367, MGC138369, RPB19, RPB7, hRPB19, hsRPB7; polymerase (RNA) II (DNA directed) polypeptide G (EC:2.7.7.6); K03015 DNA-directed RNA polymerase II subunit G
hsa:5437 POLR2H, RPABC3, RPB17, RPB8, hsRPB8; polymerase (RNA) II (DNA directed) polypeptide H (EC:2.7.7.6); K03016 DNA-directed RNA polymerase II subunit H
hsa:5438 POLR2I, RPB9, hRPB14.5; polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa (EC:2.7.7.6); K03017 DNA-directed RNA polymerase II subunit I
hsa:5439 POLR2J, MGC71910, POLR2J1, RPB11, RPB11A, RPB11m, hRPB14; polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa (EC:2.7.7.6); K03008 DNA-directed RNA polymerase II subunit J
hsa:5440 POLR2K, ABC10-alpha, RPABC4, RPB10alpha, RPB12, RPB7.0, hRPB7.0, hsRPB10a; polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa (EC:2.7.7.6); K03009 DNA-directed RNA Polymerase II subunit K
hsa:5441 POLR2L, RBP10, RPABC5, RPB10, RPB10beta, RPB7.6, hRPB7.6, hsRPB10b; polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa (EC:2.7.7.6); K03007 DNA-directed RNA Polymerase II subunit L
hsa:55703 POLR3B, C128, DKFZp686B10117, FLJ10388, RPC2; polymerase (RNA) III (DNA directed) polypeptide B (EC:2.7.7.6); K03021 DNA-directed RNA polymerase III subunit C2 [EC:2.7.7.6]
hsa:661 POLR3D, BN51T, RPC4, RPC53, TSBN51; polymerase (RNA) III (DNA directed) polypeptide D, 44kDa (EC:2.7.7.6); K03026 DNA-directed RNA polymerase III subunit C4 [EC:2.7.7.6]

hsa05212 Pancreatic cancer - Homo sapiens (human) (46) 



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1869 E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K06620 E2F transcription factor 1/3
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3716 JAK1, JAK1A, JAK1B, JTK3; Janus kinase 1 (EC:2.7.10.2); K11217 Janus kinase 1 [EC:2.7.10.2]
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4087 SMAD2, JV18, JV18-1, MADH2, MADR2, MGC22139, MGC34440, hMAD-2, hSMAD2; SMAD family member 2; K04500 SMAD, mothers against DPP 2/3
hsa:4088 SMAD3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396; SMAD family member 3; K04500 SMAD, mothers against DPP 2/3
hsa:4089 SMAD4, DPC4, JIP, MADH4; SMAD family member 4; K04501 SMAD, mothers against DPP 4
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5888 RAD51, BRCC5, HRAD51, HsRad51, HsT16930, RAD51A, RECA; RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae); K04482 DNA repair protein RAD51
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5925 RB1, OSRC, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:598 BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, DKFZp781P2092, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X)
hsa:6772 STAT1, DKFZp686B04100, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:7039 TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:7422 VEGFA, MGC70609, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A/B, PGF
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:9459 ARHGEF6, COOL2, Cool-2, KIAA0006, MRX46, PIXA, alpha-PIX, alphaPIX; Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6; K05729 Rho guanine nucleotide exchange factor 6
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa04720 Long-term potentiation - Homo sapiens (human) (45)



hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:2905 GRIN2C, NMDAR2C, NR2C; glutamate receptor, ionotropic, N-methyl D-aspartate 2C; K05211 glutamate receptor, ionotropic, N-methyl-D-aspartate 2C
hsa:2906 GRIN2D, EB11, NMDAR2D, NR2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; K05212 glutamate receptor, ionotropic, N-methyl-D-aspartate 2D
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:468 ATF4, CREB-2, CREB2, TAXREB67, TXREB; activating transcription factor 4 (tax-responsive enhancer element B67); K04374 activating transcription factor 4
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5499 PPP1CA, MGC15877, MGC1674, PP-1A, PP1alpha, PPP1A; protein phosphatase 1, catalytic subunit, alpha isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5500 PPP1CB, MGC3672, PP-1B, PP1beta, PPP1CD; protein phosphatase 1, catalytic subunit, beta isozyme (EC:3.1.3.16 3.1.3.53); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5501 PPP1CC, PP1gamma, PPP1G; protein phosphatase 1, catalytic subunit, gamma isozyme (EC:3.1.3.16); K06269 protein phosphatase 1, catalytic subunit [EC:3.1.3.16]
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:815 CAMK2A, CAMKA, KIAA0968; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:816 CAMK2B, CAM2, CAMK2, CAMKB, MGC29528; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]

hsa05010 Alzheimer's disease - Homo sapiens (human) (45) HIV Dementia Pubmed



hsa:1020 CDK5, PSSALRE; cyclin-dependent kinase 5 (EC:2.7.11.22); K02090 cyclin-dependent kinase 5 [EC:2.7.11.22]
hsa:1537 CYC1, UQCR4; cytochrome c-1; K00413 ubiquinol-cytochrome c reductase cytochrome c1 subunit [EC:1.10.2.2]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:2905 GRIN2C, NMDAR2C, NR2C; glutamate receptor, ionotropic, N-methyl D-aspartate 2C; K05211 glutamate receptor, ionotropic, N-methyl-D-aspartate 2C
hsa:2906 GRIN2D, EB11, NMDAR2D, NR2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; K05212 glutamate receptor, ionotropic, N-methyl-D-aspartate 2D
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:317 APAF1, APAF-1, CED4, DKFZp781B1145; apoptotic peptidase activating factor 1; K02084 apoptotic protease-activating factor
hsa:348 APOE, AD2, LDLCQ5, LPG, MGC1571; apolipoprotein E; K04524 apolipoprotein E
hsa:351 APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN2; amyloid beta (A4) precursor protein; K04520 amyloid beta (A4) protein
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:4035 LRP1, A2MR, APOER, APR, CD91, FLJ16451, IGFBP3R, LRP, MGC88725, TGFBR5; low density lipoprotein receptor-related protein 1; K04550 low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor)
hsa:4311 MME, CALLA, CD10, DKFZp686O16152, MGC126681, MGC126707, NEP; membrane metallo-endopeptidase (EC:3.4.24.11); K01389 neprilysin [EC:3.4.24.11]
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:54205 CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:637 BID, FP497, MGC15319, MGC42355; BH3 interacting domain death agonist; K04726 BH3 interacting domain death agonist
hsa:6390 SDHB, FLJ92337, IP, PGL4, SDH, SDH1, SDH2, SDHIP; succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (EC:1.3.5.1); K00235 succinate dehydrogenase (ubiquinone) iron-sulfur protein [EC:1.3.5.1]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:823 CAPN1, CANP, CANP1, CANPL1, muCANP, muCL; calpain 1, (mu/I) large subunit (EC:3.4.22.52); K01367 calpain-1 [EC:3.4.22.52]
hsa:824 CAPN2, CANP2, CANPL2, CANPml, FLJ39928, mCANP; calpain 2, (m/II) large subunit (EC:3.4.22.53); K03853 calpain-2 [EC:3.4.22.53]
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:8851 CDK5R1, CDK5P35, CDK5R, MGC33831, NCK5A, p23, p25, p35, p35nck5a; cyclin-dependent kinase 5, regulatory subunit 1 (p35); K11716 cyclin-dependent kinase 5 activator 1

hsa05220 Chronic myeloid leukemia - Homo sapiens (human) (45)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:1026 CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A
hsa:1027 CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1869 E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K06620 E2F transcription factor 1/3
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:3065 HDAC1, DKFZp686H12203, GON-10, HD1, RPD3, RPD3L1; histone deacetylase 1 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4088 SMAD3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396; SMAD family member 3; K04500 SMAD, mothers against DPP 2/3
hsa:4089 SMAD4, DPC4, JIP, MADH4; SMAD family member 4; K04501 SMAD, mothers against DPP 4
hsa:4193 MDM2, HDMX, MGC5370, MGC71221, hdm2; Mdm2 p53 binding protein homolog (mouse); K06643 transformed 3T3 cell double minute 2, p53-binding protein [EC:6.3.2.19]
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:53358 SHC3, DKFZp686H1544, FLJ45325, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K06279 src homology 2 domain-containing transforming protein C
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5781 PTPN11, BPTP3, CFC, MGC14433, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2; protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48); K07293 protein tyrosine phosphatase, non-receptor type 11 [EC:3.1.3.48]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5925 RB1, OSRC, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:598 BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, DKFZp781P2092, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X)
hsa:6464 SHC1, FLJ26504, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 src homology 2 domain-containing transforming protein C
hsa:6776 STAT5A, MGF, STAT5; signal transducer and activator of transcription 5A; K11223 signal transducer and activator of transcription 5A
hsa:6777 STAT5B, STAT5; signal transducer and activator of transcription 5B; K11224 signal transducer and activator of transcription 5B
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:867 CBL, C-CBL, CBL2, RNF55; Cas-Br-M (murine) ecotropic retroviral transforming sequence; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]

hsa04612 Antigen processing and presentation - Homo sapiens (human) (44)



hsa:10197 PSME3, Ki, PA28-gamma, PA28G, REG-GAMMA; proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki); K06698 proteasome activator subunit 3 (PA28 gamma)
hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:2923 PDIA3, ER60, ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC; protein disulfide isomerase family A, member 3 (EC:5.3.4.1); K08056 protein disulfide isomerase family A, member 3 [EC:5.3.4.1]
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I
hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I
hsa:3135 HLA-G, MHC-G; major histocompatibility complex, class I, G; K06751 major histocompatibility complex, class I
hsa:3303 HSPA1A, FLJ54303, FLJ54370, FLJ54392, FLJ54408, FLJ75127, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1, HSPA1B; heat shock 70kDa protein 1A; K03283 heat shock 70kDa protein 1/8
hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8
hsa:3306 HSPA2, HSP70-2, HSP70-3; heat shock 70kDa protein 2; K03283 heat shock 70kDa protein 1/8
hsa:3308 HSPA4, APG-2, HS24/P52, MGC131852, RY, hsp70, hsp70RY; heat shock 70kDa protein 4; K09489 heat shock 70kDa protein 4
hsa:3309 HSPA5, BIP, FLJ26106, GRP78, MIF2; heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa); K09490 heat shock 70kDa protein 5
hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8
hsa:3312 HSPA8, HSC54, HSC70, HSC71, HSP71, HSP73, HSPA10, LAP1, MGC131511, MGC29929, NIP71; heat shock 70kDa protein 8; K03283 heat shock 70kDa protein 1/8
hsa:3320 HSP90AA1, FLJ31884, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2; heat shock protein 90kDa alpha (cytosolic), class A member 1; K04079 molecular chaperone HtpG
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:4261 CIITA, C2TA, CIITAIV, MHC2TA, NLRA; class II, major histocompatibility complex, transactivator; K08060 class II, major histocompatibility complex, transactivator
hsa:567 B2M; beta-2-microglobulin; K08055 beta-2-microglobulin
hsa:5720 PSME1, IFI5111, MGC8628, PA28A, PA28alpha, REGalpha; proteasome (prosome, macropain) activator subunit 1 (PA28 alpha); K06696 proteasome activator subunit 1 (PA28 alpha)
hsa:5721 PSME2, PA28B, PA28beta, REGbeta; proteasome (prosome, macropain) activator subunit 2 (PA28 beta); K06697 proteasome activator subunit 2 (PA28 beta)
hsa:6890 TAP1, ABC17, ABCB2, APT1, D6S114E, FLJ26666, FLJ41500, PSF1, RING4, TAP1*0102N, TAP1N; transporter 1, ATP-binding cassette, sub-family B (MDR/TAP); K05653 ATP-binding cassette, subfamily B (MDR/TAP), member 2
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:811 CALR, CRT, FLJ26680, RO, SSA, cC1qR; calreticulin; K08057 calreticulin
hsa:821 CANX, CNX, FLJ26570, IP90, P90; calnexin; K08054 calnexin
hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen
hsa:925 CD8A, CD8, Leu2, MAL, p32; CD8a molecule; K06458 CD8A antigen, alpha polypeptide
hsa:926 CD8B, CD8B1, LEU2, LY3, LYT3, MGC119115, P37; CD8b molecule; K06459 CD8B antigen, beta polypeptide
hsa:972 CD74, DHLAG, HLADG, II, Ia-GAMMA; CD74 molecule, major histocompatibility complex, class II invariant chain; K06505 CD74 antigen

hsa05214 Glioma - Homo sapiens (human) (44)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:1026 CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A
hsa:1869 E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K06620 E2F transcription factor 1/3
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2475 MTOR, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3480 IGF1R, CD221, IGFIR, IGFR, JTK13, MGC142170, MGC142172, MGC18216; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4193 MDM2, HDMX, MGC5370, MGC71221, hdm2; Mdm2 p53 binding protein homolog (mouse); K06643 transformed 3T3 cell double minute 2, p53-binding protein [EC:6.3.2.19]
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:53358 SHC3, DKFZp686H1544, FLJ45325, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K06279 src homology 2 domain-containing transforming protein C
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5925 RB1, OSRC, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:6464 SHC1, FLJ26504, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 src homology 2 domain-containing transforming protein C
hsa:7039 TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:815 CAMK2A, CAMKA, KIAA0968; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:816 CAMK2B, CAM2, CAMK2, CAMKB, MGC29528; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]

hsa04916 Melanogenesis - Homo sapiens (human) (44)



hsa:10488 CREB3, LUMAN, LZIP, MGC15333, MGC19782; cAMP responsive element binding protein 3; K09048 cAMP response element-binding protein 3
hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1906 EDN1, ET1, HDLCQ7, PPET1; endothelin 1; K05227 endothelin
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:2770 GNAI1, Gi; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1; K04630 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide
hsa:2775 GNAO1, DKFZp686O0962, G-ALPHA-o, GNAO; guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O; K04534 guanine nucleotide binding protein (G protein), alpha o polypeptide
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5443 POMC, ACTH, CLIP, LPH, MSH, NPP, POC; proopiomelanocortin; K05228 proopiomelanocortin
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:6934 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:815 CAMK2A, CAMKA, KIAA0968; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:816 CAMK2B, CAM2, CAMK2, CAMKB, MGC29528; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]

hsa04972 Pancreatic secretion - Homo sapiens (human) (43)



hsa:1056 CEL, BAL, BSDL, BSSL, CELL, CEase, FAP, FAPP, LIPA, MODY8; carboxyl ester lipase (bile salt-stimulated lipase) (EC:3.1.1.13 3.1.1.3); K12298 bile salt-stimulated lipase [EC:3.1.1.3 3.1.1.13]
hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:1179 CLCA1, CACC, CACC1, CLCRG1, CaCC-1, FLJ95147, GOB5, hCLCA1, hCaCC-1; chloride channel accessory 1; K05027 calcium-activated chloride channel family member 1
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:22802 CLCA4, CaCC, CaCC2, MGC142247, MGC142249; chloride channel accessory 4; K05030 calcium-activated chloride channel family member 4
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:3778 KCNMA1, BKTM, DKFZp686K1437, KCa1.1, MGC71881, MaxiK, SAKCA, SLO, SLO-ALPHA, SLO1, bA205K10.1, mSLO1; potassium large conductance calcium-activated channel, subfamily M, alpha member 1; K04936 potassium large conductance calcium-activated channel subfamily M alpha member 1
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5644 PRSS1, DKFZp779A0837, FLJ57296, MGC120175, MGC149362, TRP1, TRY1, TRY4, TRYP1; protease, serine, 1 (trypsin 1) (EC:3.4.21.4); K01312 trypsin [EC:3.4.21.4]
hsa:5645 PRSS2, MGC111183, MGC120174, MGC120175, TRY2, TRY8, TRYP2; protease, serine, 2 (trypsin 2) (EC:3.4.21.4); K01312 trypsin [EC:3.4.21.4]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8766 RAB11A, MGC1490, YL8; RAB11A, member RAS oncogene family; K07904 Ras-related protein Rab-11A
hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]
hsa:9635 CLCA2, CACC, CACC3, CLCRG2, CaCC-3, FLJ97885; chloride channel accessory 2; K05028 calcium-activated chloride channel family member 2

hsa04730 Long-term depression - Homo sapiens (human) (42)



hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:2770 GNAI1, Gi; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1; K04630 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide
hsa:2775 GNAO1, DKFZp686O0962, G-ALPHA-o, GNAO; guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O; K04534 guanine nucleotide binding protein (G protein), alpha o polypeptide
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3480 IGF1R, CD221, IGFIR, IGFR, JTK13, MGC142170, MGC142172, MGC18216; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4067 LYN, FLJ26625, JTK8; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2); K05854 tyrosine-protein kinase Lyn [EC:2.7.10.2]
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5515 PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C; protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5516 PPP2CB, PP2Abeta, PP2CB; protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5518 PPP2R1A, MGC786, PP2A-Aalpha, PP2AAALPHA, PR65A; protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5519 PPP2R1B, MGC26454, PP2A-Abeta, PR65B; protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]

hsa05210 Colorectal cancer - Homo sapiens (human) (40)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2353 FOS, AP-1, C-FOS; FBJ murine osteosarcoma viral oncogene homolog; K04379 proto-oncogene protein c-fos
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:332 BIRC5, API4, EPR-1; baculoviral IAP repeat-containing 5; K08731 baculoviral IAP repeat-containing 5
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:4087 SMAD2, JV18, JV18-1, MADH2, MADR2, MGC22139, MGC34440, hMAD-2, hSMAD2; SMAD family member 2; K04500 SMAD, mothers against DPP 2/3
hsa:4088 SMAD3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396; SMAD family member 3; K04500 SMAD, mothers against DPP 2/3
hsa:4089 SMAD4, DPC4, JIP, MADH4; SMAD family member 4; K04501 SMAD, mothers against DPP 4
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:54205 CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:581 BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX, membrane protein (BCL2-associated)
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:6934 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]

hsa04141 Protein processing in endoplasmic reticulum - Homo sapiens (human) (39)



hsa:10130 PDIA6, ERP5, P5, TXNDC7; protein disulfide isomerase family A, member 6 (EC:5.3.4.1); K09584 protein disulfide-isomerase A6 [EC:5.3.4.1]
hsa:10905 MAN1A2, MAN1B; mannosidase, alpha, class 1A, member 2 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:11253 MAN1B1, ERMan1, MANA-ER; mannosidase, alpha, class 1B, member 1 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:1649 DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153, MGC4154; DNA-damage-inducible transcript 3; K04452 DNA damage-inducible transcript 3
hsa:1965 EIF2S1, EIF-2, EIF-2A, EIF-2alpha, EIF2, EIF2A; eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa; K03237 translation initiation factor eIF-2 alpha subunit
hsa:23193 GANAB, G2AN, GLUII, KIAA0088; glucosidase, alpha; neutral AB (EC:3.2.1.84); K05546 alpha 1,3-glucosidase [EC:3.2.1.84]
hsa:2923 PDIA3, ER60, ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC; protein disulfide isomerase family A, member 3 (EC:5.3.4.1); K08056 protein disulfide isomerase family A, member 3 [EC:5.3.4.1]
hsa:3300 DNAJB2, HSJ1, HSPF3; DnaJ (Hsp40) homolog, subfamily B, member 2; K09508 DnaJ homolog subfamily B member 2
hsa:3303 HSPA1A, FLJ54303, FLJ54370, FLJ54392, FLJ54408, FLJ75127, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1, HSPA1B; heat shock 70kDa protein 1A; K03283 heat shock 70kDa protein 1/8
hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8
hsa:3306 HSPA2, HSP70-2, HSP70-3; heat shock 70kDa protein 2; K03283 heat shock 70kDa protein 1/8
hsa:3309 HSPA5, BIP, FLJ26106, GRP78, MIF2; heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa); K09490 heat shock 70kDa protein 5
hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8
hsa:3312 HSPA8, HSC54, HSC70, HSC71, HSP71, HSP73, HSPA10, LAP1, MGC131511, MGC29929, NIP71; heat shock 70kDa protein 8; K03283 heat shock 70kDa protein 1/8
hsa:3320 HSP90AA1, FLJ31884, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2; heat shock protein 90kDa alpha (cytosolic), class A member 1; K04079 molecular chaperone HtpG
hsa:3337 DNAJB1, HSPF1, Hdj1, Hsp40, RSPH16B, Sis1; DnaJ (Hsp40) homolog, subfamily B, member 1; K09507 DnaJ homolog subfamily B member 1
hsa:3998 LMAN1, ERGIC-53, ERGIC53, F5F8D, FMFD1, MCFD1, MR60, gp58; lectin, mannose-binding, 1; K10080 lectin, mannose-binding 1
hsa:4121 MAN1A1, HUMM3, HUMM9, MAN9; mannosidase, alpha, class 1A, member 1 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:4217 MAP3K5, ASK1, MAPKKK5, MEKK5; mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25); K04426 mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
hsa:468 ATF4, CREB-2, CREB2, TAXREB67, TXREB; activating transcription factor 4 (tax-responsive enhancer element B67); K04374 activating transcription factor 4
hsa:5034 P4HB, DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PHDB, PO4DB, PO4HB, PROHB; prolyl 4-hydroxylase, beta polypeptide (EC:5.3.4.1); K09580 protein disulfide-isomerase A1 [EC:5.3.4.1]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5609 MAP2K7, Jnkk2, MAPKK7, MKK7, PRKMK7; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
hsa:5610 EIF2AK2, EIF2AK1, MGC126524, PKR, PRKR; eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1); K08860 eukaryotic translation initiation factor 2-alpha kinase [EC:2.7.11.1]
hsa:57134 MAN1C1, HMIC, MAN1A3, MAN1C, pp6318; mannosidase, alpha, class 1C, member 1 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:573 BAG1, HAP, RAP46; BCL2-associated athanogene; K09555 BCL2-associated athanogene 1
hsa:581 BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX, membrane protein (BCL2-associated)
hsa:5886 RAD23A, HHR23A, MGC111083; RAD23 homolog A (S. cerevisiae); K10839 UV excision repair protein RAD23
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:7321 UBE2D1, E2(17)KB1, SFT, UBC4/5, UBCH5, UBCH5A; ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) (EC:6.3.2.19); K06689 ubiquitin-conjugating enzyme E2 D/E [EC:6.3.2.19]
hsa:7841 MOGS, CDG2B, GCS1; mannosyl-oligosaccharide glucosidase (EC:3.2.1.106); K01228 mannosyl-oligosaccharide glucosidase [EC:3.2.1.106]
hsa:811 CALR, CRT, FLJ26680, RO, SSA, cC1qR; calreticulin; K08057 calreticulin
hsa:821 CANX, CNX, FLJ26570, IP90, P90; calnexin; K08054 calnexin
hsa:823 CAPN1, CANP, CANP1, CANPL1, muCANP, muCL; calpain 1, (mu/I) large subunit (EC:3.4.22.52); K01367 calpain-1 [EC:3.4.22.52]
hsa:824 CAPN2, CANP2, CANPL2, CANPml, FLJ39928, mCANP; calpain 2, (m/II) large subunit (EC:3.4.22.53); K03853 calpain-2 [EC:3.4.22.53]
hsa:9601 PDIA4, ERP70, ERP72, ERp-72; protein disulfide isomerase family A, member 4 (EC:5.3.4.1); K09582 protein disulfide-isomerase A4 [EC:5.3.4.1]
hsa:9978 RBX1, BA554C12.1, FLJ60363, MGC13357, MGC1481, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1

hsa03050 Proteasome - Homo sapiens (human) (39)



hsa:10197 PSME3, Ki, PA28-gamma, PA28G, REG-GAMMA; proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki); K06698 proteasome activator subunit 3 (PA28 gamma)
hsa:23198 PSME4, FLJ21864, KIAA0077, MGC138374, MGC142228, PA200; proteasome (prosome, macropain) activator subunit 4; K06699 proteasome activator subunit 4
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:5682 PSMA1, HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30; proteasome (prosome, macropain) subunit, alpha type, 1 (EC:3.4.25.1); K02725 20S proteasome subunit alpha 6 [EC:3.4.25.1]
hsa:5683 PSMA2, HC3, MU, PMSA2, PSC2; proteasome (prosome, macropain) subunit, alpha type, 2 (EC:3.4.25.1); K02726 20S proteasome subunit alpha 2 [EC:3.4.25.1]
hsa:5684 PSMA3, HC8, MGC12306, MGC32631, PSC3; proteasome (prosome, macropain) subunit, alpha type, 3 (EC:3.4.25.1); K02727 20S proteasome subunit alpha 7 [EC:3.4.25.1]
hsa:5685 PSMA4, HC9, HsT17706, MGC111191, MGC12467, MGC24813, PSC9; proteasome (prosome, macropain) subunit, alpha type, 4 (EC:3.4.25.1); K02728 20S proteasome subunit alpha 3 [EC:3.4.25.1]
hsa:5686 PSMA5, FLJ42315, MGC117302, MGC125802, MGC125803, MGC125804, PSC5, ZETA; proteasome (prosome, macropain) subunit, alpha type, 5 (EC:3.4.25.1); K02729 20S proteasome subunit alpha 5 [EC:3.4.25.1]
hsa:5687 PSMA6, IOTA, MGC22756, MGC2333, MGC23846, PROS27, p27K; proteasome (prosome, macropain) subunit, alpha type, 6 (EC:3.4.25.1); K02730 20S proteasome subunit alpha 1 [EC:3.4.25.1]
hsa:5688 PSMA7, C6, HSPC, MGC3755, RC6-1, XAPC7; proteasome (prosome, macropain) subunit, alpha type, 7 (EC:3.4.25.1); K02731 20S proteasome subunit alpha 4 [EC:3.4.25.1]
hsa:5689 PSMB1, FLJ25321, HC5, KIAA1838, PMSB1, PSC5; proteasome (prosome, macropain) subunit, beta type, 1 (EC:3.4.25.1); K02732 20S proteasome subunit beta 6 [EC:3.4.25.1]
hsa:5690 PSMB2, HC7-I, MGC104215, MGC126885; proteasome (prosome, macropain) subunit, beta type, 2 (EC:3.4.25.1); K02734 20S proteasome subunit beta 4 [EC:3.4.25.1]
hsa:5691 PSMB3, HC10-II, MGC4147; proteasome (prosome, macropain) subunit, beta type, 3 (EC:3.4.25.1); K02735 20S proteasome subunit beta 3 [EC:3.4.25.1]
hsa:5692 PSMB4, HN3, HsN3, PROS-26, PROS26; proteasome (prosome, macropain) subunit, beta type, 4 (EC:3.4.25.1); K02736 20S proteasome subunit beta 7 [EC:3.4.25.1]
hsa:5693 PSMB5, LMPX, MB1, MGC104214, X; proteasome (prosome, macropain) subunit, beta type, 5 (EC:3.4.25.1); K02737 20S proteasome subunit beta 5 [EC:3.4.25.1]
hsa:5694 PSMB6, DELTA, LMPY, MGC5169, Y; proteasome (prosome, macropain) subunit, beta type, 6 (EC:3.4.25.1); K02738 20S proteasome subunit beta 1 [EC:3.4.25.1]
hsa:5695 PSMB7, Z; proteasome (prosome, macropain) subunit, beta type, 7 (EC:3.4.25.1); K02739 20S proteasome subunit beta 2 [EC:3.4.25.1]
hsa:5696 PSMB8, D6S216, D6S216E, LMP7, MGC1491, PSMB5i, RING10; proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) (EC:3.4.25.1); K02740 20S proteasome subunit beta 8 [EC:3.4.25.1]
hsa:5698 PSMB9, LMP2, MGC70470, PSMB6i, RING12, beta1i; proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) (EC:3.4.25.1); K02741 20S proteasome subunit beta 9 [EC:3.4.25.1]
hsa:5699 PSMB10, FLJ00366, LMP10, MECL1, MGC1665, beta2i; proteasome (prosome, macropain) subunit, beta type, 10 (EC:3.4.25.1); K02733 20S proteasome subunit beta 10 [EC:3.4.25.1]
hsa:5700 PSMC1, MGC24583, MGC8541, P26S4, S4, p56; proteasome (prosome, macropain) 26S subunit, ATPase, 1; K03062 26S proteasome regulatory subunit T2
hsa:5701 PSMC2, MGC3004, MSS1, Nbla10058, S7; proteasome (prosome, macropain) 26S subunit, ATPase, 2; K03061 26S proteasome regulatory subunit T1
hsa:5702 PSMC3, MGC8487, TBP1; proteasome (prosome, macropain) 26S subunit, ATPase, 3; K03065 26S proteasome regulatory subunit T5
hsa:5704 PSMC4, MGC13687, MGC23214, MGC8570, MIP224, S6, TBP7; proteasome (prosome, macropain) 26S subunit, ATPase, 4; K03063 26S proteasome regulatory subunit T3
hsa:5705 PSMC5, S8, SUG-1, SUG1, TBP10, TRIP1, p45, p45/SUG; proteasome (prosome, macropain) 26S subunit, ATPase, 5; K03066 26S proteasome regulatory subunit T6
hsa:5706 PSMC6, CADP44, MGC12520, P44, SUG2, p42; proteasome (prosome, macropain) 26S subunit, ATPase, 6; K03064 26S proteasome regulatory subunit T4
hsa:5707 PSMD1, MGC133040, MGC133041, P112, Rpn2, S1; proteasome (prosome, macropain) 26S subunit, non-ATPase, 1; K03032 26S proteasome regulatory subunit N2
hsa:5708 PSMD2, MGC14274, P97, Rpn1, S2, TRAP2; proteasome (prosome, macropain) 26S subunit, non-ATPase, 2; K03028 26S proteasome regulatory subunit N1
hsa:5709 PSMD3, P58, RPN3, S3, TSTA2; proteasome (prosome, macropain) 26S subunit, non-ATPase, 3; K03033 26S proteasome regulatory subunit N3
hsa:5710 PSMD4, AF, AF-1, ASF, MCB1, Rpn10, S5A, pUB-R5; proteasome (prosome, macropain) 26S subunit, non-ATPase, 4; K03029 26S proteasome regulatory subunit N10
hsa:5713 PSMD7, MOV34, P40, Rpn8, S12; proteasome (prosome, macropain) 26S subunit, non-ATPase, 7; K03038 26S proteasome regulatory subunit N8
hsa:5714 PSMD8, HIP6, HYPF, MGC1660, Nin1p, Rpn12, S14, p31; proteasome (prosome, macropain) 26S subunit, non-ATPase, 8; K03031 26S proteasome regulatory subunit N12
hsa:5717 PSMD11, MGC3844, Rpn6, S9, p44.5; proteasome (prosome, macropain) 26S subunit, non-ATPase, 11; K03036 26S proteasome regulatory subunit N6
hsa:5718 PSMD12, MGC75406, Rpn5, p55; proteasome (prosome, macropain) 26S subunit, non-ATPase, 12; K03035 26S proteasome regulatory subunit N5
hsa:5719 PSMD13, HSPC027, Rpn9, S11, p40.5; proteasome (prosome, macropain) 26S subunit, non-ATPase, 13; K03039 26S proteasome regulatory subunit N9
hsa:5720 PSME1, IFI5111, MGC8628, PA28A, PA28alpha, REGalpha; proteasome (prosome, macropain) activator subunit 1 (PA28 alpha); K06696 proteasome activator subunit 1 (PA28 alpha)
hsa:5721 PSME2, PA28B, PA28beta, REGbeta; proteasome (prosome, macropain) activator subunit 2 (PA28 beta); K06697 proteasome activator subunit 2 (PA28 beta)
hsa:9491 PSMF1, PI31; proteasome (prosome, macropain) inhibitor subunit 1 (PI31); K06700 proteasome inhibitor subunit 1 (PI31)
hsa:9861 PSMD6, KIAA0107, Rpn7, S10, SGA-113M, p44S10; proteasome (prosome, macropain) 26S subunit, non-ATPase, 6; K03037 26S proteasome regulatory subunit N7

hsa05414 Dilated cardiomyopathy - Homo sapiens (human) (38)



hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:1674 DES, CMD1I, CSM1, CSM2, FLJ12025, FLJ39719, FLJ41013, FLJ41793; desmin; K07610 desmin
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:2010 EMD, EDMD, LEMD5, STA; emerin; K12569 emerin
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3655 ITGA6, CD49f, DKFZp686J01244, FLJ18737, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6
hsa:3675 ITGA3, CD49C, FLJ34631, FLJ34704, GAP-B3, GAPB3, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5
hsa:3685 ITGAV, CD51, DKFZp686A08142, MSK8, VNRA; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); K06487 integrin alpha V
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3691 ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4
hsa:3693 ITGB5, FLJ26658; integrin, beta 5; K06588 integrin beta 5
hsa:3908 LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2
hsa:4000 LMNA, CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL, FPLD, HGPS, IDC, LDP1, LFP, LGMD1B, LMN1, LMNC, LMNL1, PRO1; lamin A/C; K12641 lamin A/C
hsa:4624 MYH6, ASD3, CMD1EE, CMH14, MYHC, MYHCA, alpha-MHC; myosin, heavy chain 6, cardiac muscle, alpha; K10352 myosin heavy chain
hsa:4625 MYH7, CMD1S, CMH1, DKFZp451F047, MGC138376, MGC138378, MPD1, MYHCB, SPMD, SPMM; myosin, heavy chain 7, cardiac muscle, beta; K10352 myosin heavy chain
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:70 ACTC1, ACTC, ASD5, CMD1R, CMH11, LVNC4; actin, alpha, cardiac muscle 1; K12314 actin, alpha cardiac muscle
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7134 TNNC1, CMD1Z, CMH13, TN-C, TNC, TNNC; troponin C type 1 (slow); K05865 troponin C, slow skeletal and cardiac muscles
hsa:7168 TPM1, C15orf13, CMD1Y, HTM-alpha, TMSA; tropomyosin 1 (alpha); K10373 tropomyosin 1
hsa:7169 TPM2, AMCD1, DA1, DA2B, NEM4, TMSB; tropomyosin 2 (beta); K10374 tropomyosin 2
hsa:7170 TPM3, FLJ41118, MGC14582, MGC3261, MGC72094, NEM1, OK/SW-cl.5, TM-5, TM3, TM30, TM30nm, TPMsk3, TRK, hscp30; tropomyosin 3; K09290 tropomyosin 3

hsa04512 ECM-receptor interaction - Homo sapiens (human) (37)



hsa:10319 LAMC3, DKFZp434E202; laminin, gamma 3; K06247 laminin, gamma 3
hsa:1277 COL1A1, OI4; collagen, type I, alpha 1; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1278 COL1A2, OI4; collagen, type I, alpha 2; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1281 COL3A1, EDS4A, FLJ34534; collagen, type III, alpha 1; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1282 COL4A1, arresten; collagen, type IV, alpha 1; K06237 collagen, type IV, alpha
hsa:1284 COL4A2, DKFZp686I14213, FLJ22259; collagen, type IV, alpha 2; K06237 collagen, type IV, alpha
hsa:1286 COL4A4, CA44; collagen, type IV, alpha 4; K06237 collagen, type IV, alpha
hsa:1287 COL4A5, ASLN, ATS, CA54, MGC167109, MGC42377; collagen, type IV, alpha 5; K06237 collagen, type IV, alpha
hsa:22798 LAMB4; laminin, beta 4; K06245 laminin, beta 4
hsa:2335 FN1, CIG, DKFZp686F10164, DKFZp686H0342, DKFZp686I1370, DKFZp686O13149, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF; fibronectin 1; K05717 fibronectin 1
hsa:284217 LAMA1, LAMA; laminin, alpha 1; K05637 laminin, alpha 1/2
hsa:3339 HSPG2, PLC, PRCAN, SJA, SJS, SJS1; heparan sulfate proteoglycan 2; K06255 heparan sulfate proteoglycan 2 (perlecan)
hsa:3655 ITGA6, CD49f, DKFZp686J01244, FLJ18737, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6
hsa:3675 ITGA3, CD49C, FLJ34631, FLJ34704, GAP-B3, GAPB3, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5
hsa:3685 ITGAV, CD51, DKFZp686A08142, MSK8, VNRA; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); K06487 integrin alpha V
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3691 ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4
hsa:3693 ITGB5, FLJ26658; integrin, beta 5; K06588 integrin beta 5
hsa:3908 LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2
hsa:3909 LAMA3, BM600, E170, LAMNA, LOCS, lama3a; laminin, alpha 3; K06240 laminin, alpha 3/5
hsa:3910 LAMA4, DKFZp686D23145, LAMA3, LAMA4*-1; laminin, alpha 4; K06241 laminin, alpha 4
hsa:3911 LAMA5, KIAA1907; laminin, alpha 5; K06240 laminin, alpha 3/5
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:3913 LAMB2, LAMS; laminin, beta 2 (laminin S); K06243 laminin, beta 2
hsa:3914 LAMB3, BM600-125KDA, FLJ99565, LAM5, LAMNB1; laminin, beta 3; K06244 laminin, beta 3
hsa:3915 LAMC1, LAMB2, MGC87297; laminin, gamma 1 (formerly LAMB2); K05635 laminin, gamma 1
hsa:3918 LAMC2, B2T, BM600, CSF, EBR2, EBR2A, LAMB2T, LAMNB2, MGC138491, MGC141938; laminin, gamma 2; K06246 laminin, gamma 2
hsa:6382 SDC1, CD138, SDC, SYND1, syndecan; syndecan 1; K06257 syndecan
hsa:6383 SDC2, HSPG, HSPG1, SYND2; syndecan 2; K06257 syndecan
hsa:6385 SDC4, MGC22217, SYND4; syndecan 4; K06257 syndecan
hsa:7057 THBS1, THBS, THBS-1, TSP, TSP-1, TSP1; thrombospondin 1; K04659 thrombospondin
hsa:7448 VTN, V75, VN, VNT; vitronectin; K06251 vitronectin
hsa:960 CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MGC10468, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen
hsa:9672 SDC3, SDCN, SYND3; syndecan 3; K06257 syndecan

hsa05150 Staphylococcus aureus infection - Homo sapiens (human) (37)



hsa:2204 FCAR, CD89; Fc fragment of IgA, receptor for; K06513 CD89 antigen
hsa:2209 FCGR1A, CD64, CD64A, FCRI, FLJ18345, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I
hsa:2212 FCGR2A, CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, FcGR, IGFR2, MGC23887, MGC30032; Fc fragment of IgG, low affinity IIa, receptor (CD32); K06472 low affinity immunoglobulin gamma Fc region receptor II-a
hsa:2213 FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2; Fc fragment of IgG, low affinity IIb, receptor (CD32); K12560 low affinity immunoglobulin gamma Fc region receptor II-b
hsa:2214 FCGR3A, CD16, CD16A, FCG3, FCGR3, FCGRIII, FCR-10, FCRIII, FCRIIIA, IGFR3; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:2215 FCGR3B, CD16, CD16b, FCG3, FCGR3; Fc fragment of IgG, low affinity IIIb, receptor (CD16b); K06463 low affinity immunoglobulin gamma Fc region receptor III
hsa:2357 FPR1, FMLP, FPR; formyl peptide receptor 1; K04172 formyl peptide receptor 1
hsa:2358 FPR2, ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH1, FPRH2, FPRL1, HM63, LXA4R; formyl peptide receptor 2; K04173 formyl peptide receptor-like
hsa:3075 CFH, AHUS1, AMBP1, ARMD4, ARMS1, CFHL3, FH, FHL1, HF, HF1, HF2, HUS, MGC88246; complement factor H; K04004 complement factor H
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L
hsa:3684 ITGAM, CD11B, CR3A, MAC-1, MAC1A, MGC117044, MO1A, SLEB6; integrin, alpha M (complement component 3 receptor 3 subunit); K06461 integrin alpha M
hsa:3689 ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); K06464 integrin beta 2
hsa:4153 MBL2, COLEC1, HSMBPC, MBL, MBP, MBP1, MGC116832, MGC116833; mannose-binding lectin (protein C) 2, soluble (opsonic defect); K03991 mannose-binding lectin
hsa:6403 SELP, CD62, CD62P, FLJ45155, GMP140, GRMP, LECAM3, PADGEM, PSEL; selectin P (granule membrane protein 140kDa, antigen CD62); K06496 selectin, platele
hsa:712 C1QA; complement component 1, q subcomponent, A chain; K03986 complement C1q subcomponent subunit A
hsa:713 C1QB; complement component 1, q subcomponent, B chain; K03987 complement C1q subcomponent subunit B
hsa:714 C1QC, C1Q-C, C1QG, FLJ27103; complement component 1, q subcomponent, C chain; K03988 complement C1q subcomponent subunit C
hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3
hsa:721 C4B, C4B1, C4B12, C4B2, C4B3, C4B5, C4F, CH, CO4, CPAMD3, FLJ60561, MGC164979; complement component 4B (Chido blood group); K03989 complement component 4
hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5
hsa:728 C5AR1, C5A, C5AR, C5R1, CD88; complement component 5a receptor 1; K04010 C5a anaphylatoxin chemotactic receptor

hsa05320 Autoimmune thyroid disease - Homo sapiens (human) (36)



hsa:1493 CTLA4, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, ICOS, IDDM12; cytotoxic T-lymphocyte-associated protein 4; K06538 cytotoxic T-lymphocyte-associated protein 4
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I
hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I
hsa:3135 HLA-G, MHC-G; major histocompatibility complex, class I, G; K06751 major histocompatibility complex, class I
hsa:3439 IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@, MGC138207, MGC138505, MGC138507; interferon, alpha 1; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3444 IFNA7, IFN-alphaJ, IFNA-J; interferon, alpha 7; K05414 interferon, alpha
hsa:3449 IFNA16, IFN-alphaO; interferon, alpha 16; K05414 interferon, alpha
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen
hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5

hsa04940 Type I diabetes mellitus - Homo sapiens (human) (36)



hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I
hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I
hsa:3135 HLA-G, MHC-G; major histocompatibility complex, class I, G; K06751 major histocompatibility complex, class I
hsa:3329 HSPD1, CPN60, GROEL, HLD4, HSP60, HSP65, HuCHA60, SPG13; heat shock 60kDa protein 1 (chaperonin); K04077 chaperonin GroEL
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3630 INS, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin
hsa:4049 LTA, LT, TNFB, TNFSF1; lymphotoxin alpha (TNF superfamily, member 1); K05468 lymphotoxin alpha (TNF superfamily, member 1)
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen
hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen

hsa05330 Allograft rejection - Homo sapiens (human) (35)



hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I
hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I
hsa:3135 HLA-G, MHC-G; major histocompatibility complex, class I, G; K06751 major histocompatibility complex, class I
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen
hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5

hsa05014 Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human) (35)



hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:2876 GPX1, GSHPX1, MGC14399, MGC88245; glutathione peroxidase 1 (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:2905 GRIN2C, NMDAR2C, NR2C; glutamate receptor, ionotropic, N-methyl D-aspartate 2C; K05211 glutamate receptor, ionotropic, N-methyl-D-aspartate 2C
hsa:2906 GRIN2D, EB11, NMDAR2D, NR2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; K05212 glutamate receptor, ionotropic, N-methyl-D-aspartate 2D
hsa:317 APAF1, APAF-1, CED4, DKFZp781B1145; apoptotic peptidase activating factor 1; K02084 apoptotic protease-activating factor
hsa:4217 MAP3K5, ASK1, MAPKKK5, MEKK5; mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25); K04426 mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:54205 CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:581 BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX, membrane protein (BCL2-associated)
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:596 BCL2, Bcl-2; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2
hsa:598 BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, DKFZp781P2092, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X)
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:637 BID, FP497, MGC15319, MGC42355; BH3 interacting domain death agonist; K04726 BH3 interacting domain death agonist
hsa:6506 SLC1A2, EAAT2, GLT-1; solute carrier family 1 (glial high affinity glutamate transporter), member 2; K05613 solute carrier family 1 (glial high affinity glutamate transporter), member 2
hsa:6647 SOD1, ALS, ALS1, IPOA, SOD, homodimer; superoxide dismutase 1, soluble (EC:1.15.1.1); K04565 Cu/Zn superoxide dismutase [EC:1.15.1.1]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7133 TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR; tumor necrosis factor receptor superfamily, member 1B; K05141 tumor necrosis factor receptor superfamily member 1B
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:834 CASP1, ICE, IL1BC, P45; caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (EC:3.4.22.36); K01370 caspase 1 [EC:3.4.22.36]
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:847 CAT, MGC138422, MGC138424; catalase (EC:1.11.1.6); K03781 catalase [EC:1.11.1.6]

hsa05221 Acute myeloid leukemia - Homo sapiens (human) (34)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2475 MTOR, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3815 KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5371 PML, MYL, PP8675, RNF71, TRIM19; promyelocytic leukemia; K10054 probable transcription factor PML
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6198 RPS6KB1, PS6K, S6K, S6K1, STK14A, p70(S6K)-alpha, p70-S6K, p70-alpha; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1]
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:6776 STAT5A, MGF, STAT5; signal transducer and activator of transcription 5A; K11223 signal transducer and activator of transcription 5A
hsa:6777 STAT5B, STAT5; signal transducer and activator of transcription 5B; K11224 signal transducer and activator of transcription 5B
hsa:6934 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2
hsa:8900 CCNA1; cyclin A1; K06627 cyclin A

hsa05130 Pathogenic Escherichia coli infection - Homo sapiens (human) (34)



hsa:10376 TUBA1B, K-ALPHA-1; tubulin, alpha 1b; K07374 tubulin alpha
hsa:10381 TUBB3, CFEOM3A, TUBB4, beta-4; tubulin, beta 3; K07375 tubulin beta
hsa:10382 TUBB4, TUBB5, beta-5; tubulin, beta 4; K07375 tubulin beta
hsa:10383 TUBB2C, TUBB2; tubulin, beta 2C; K07375 tubulin beta
hsa:10971 YWHAQ, 14-3-3, 1C5, HS1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:203068 TUBB, M40, MGC117247, MGC16435, OK/SW-cl.56, TUBB1, TUBB5; tubulin, beta; K07375 tubulin beta
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:347688 TUBB8, FLJ40100; tubulin, beta 8; K07375 tubulin beta
hsa:347733 TUBB2B, DKFZp566F223, FLJ98847, MGC8685, bA506K6.1; tubulin, beta 2B; K07375 tubulin beta
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:4691 NCL, C23, FLJ45706, FLJ59041; nucleolin; K11294 nucleolin
hsa:4950 OCLN; occludin (EC:2.1.1.67); K06088 occludin
hsa:51807 TUBA8, TUBAL2; tubulin, alpha 8; K07374 tubulin alpha
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:56604 TUBB4Q; tubulin, beta polypeptide 4, member Q; K07375 tubulin beta
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:7277 TUBA4A, FLJ30169, H2-ALPHA, TUBA1; tubulin, alpha 4a; K07374 tubulin alpha
hsa:7278 TUBA3C, TUBA2, TUBA3D, bA408E5.3; tubulin, alpha 3c; K07374 tubulin alpha
hsa:7280 TUBB2A, TUBB, TUBB2, dJ40E16.7; tubulin, beta 2A; K07375 tubulin beta
hsa:7430 EZR, CVIL, CVL, DKFZp762H157, FLJ26216, MGC1584, VIL2; ezrin; K08007 villin 2 (ezrin)
hsa:7534 YWHAZ, 14-3-3-zeta, KCIP-1, MGC111427, MGC126532, MGC138156, YWHAD; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; K06630 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7846 TUBA1A, B-ALPHA-1, FLJ25113, LIS3, TUBA3; tubulin, alpha 1a; K07374 tubulin alpha
hsa:81027 TUBB1; tubulin, beta 1; K07375 tubulin beta
hsa:84617 TUBB6, HsT1601, MGC132410, MGC4083, TUBB-5; tubulin, beta 6; K07375 tubulin beta
hsa:84790 TUBA1C, MGC10851, MGC14580, TUBA6, bcm948; tubulin, alpha 1c; K07374 tubulin alpha
hsa:8976 WASL, DKFZp779G0847, MGC48327, N-WASP, NWASP; Wiskott-Aldrich syndrome-like; K05747 Wiskott-Aldrich syndrome protein
hsa:9076 CLDN1, CLD1, ILVASC, SEMP1; claudin 1; K06087 claudin
hsa:929 CD14; CD14 molecule; K04391 CD14 antigen
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42
hsa:999 CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin

hsa05223 Non-small cell lung cancer - Homo sapiens (human) (34)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:1869 E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K06620 E2F transcription factor 1/3
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2309 FOXO3, AF6q21, DKFZp781A0677, FKHRL1, FKHRL1P2, FOXO2, FOXO3A, MGC12739, MGC31925; forkhead box O3; K09408 forkhead box protein O3
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5925 RB1, OSRC, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:7039 TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]

hsa05211 Renal cell carcinoma - Homo sapiens (human) (34)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:3082 HGF, DFNB39, F-TCF, HGFB, HPTA, SF; hepatocyte growth factor (hepapoietin A; scatter factor); K05460 hepatocyte growth factor
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5058 PAK1, MGC130000, MGC130001, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1]
hsa:5062 PAK2, PAK65, PAKgamma; p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1); K04410 p21-activated kinase 2 [EC:2.7.11.1]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5781 PTPN11, BPTP3, CFC, MGC14433, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2; protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48); K07293 protein tyrosine phosphatase, non-receptor type 11 [EC:3.1.3.48]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:6921 TCEB1, SIII; transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C); K03872 transcription elongation factor B, polypeptide 1
hsa:6923 TCEB2, ELOB, SIII; transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B); K03873 transcription elongation factor B, polypeptide 2
hsa:7039 TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7422 VEGFA, MGC70609, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A/B, PGF
hsa:9978 RBX1, BA554C12.1, FLJ60363, MGC13357, MGC1481, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa05218 Melanoma - Homo sapiens (human) (34)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:1026 CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A
hsa:1869 E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K06620 E2F transcription factor 1/3
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2246 FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1; fibroblast growth factor 1 (acidic); K04358 fibroblast growth factor
hsa:2247 FGF2, BFGF, FGFB, HBGF-2; fibroblast growth factor 2 (basic); K04358 fibroblast growth factor
hsa:3082 HGF, DFNB39, F-TCF, HGFB, HPTA, SF; hepatocyte growth factor (hepapoietin A; scatter factor); K05460 hepatocyte growth factor
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3480 IGF1R, CD221, IGFIR, IGFR, JTK13, MGC142170, MGC142172, MGC18216; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4193 MDM2, HDMX, MGC5370, MGC71221, hdm2; Mdm2 p53 binding protein homolog (mouse); K06643 transformed 3T3 cell double minute 2, p53-binding protein [EC:6.3.2.19]
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5925 RB1, OSRC, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:999 CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin

hsa05213 Endometrial cancer - Homo sapiens (human) (33)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1495 CTNNA1, CAP102, FLJ36832, FLJ52416; catenin (cadherin-associated protein), alpha 1, 102kDa; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2002 ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2309 FOXO3, AF6q21, DKFZp781A0677, FKHRL1, FKHRL1P2, FOXO2, FOXO3A, MGC12739, MGC31925; forkhead box O3; K09408 forkhead box protein O3
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:572 BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:6934 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:999 CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin

hsa04115 p53 signaling pathway - Homo sapiens (human) (33)



hsa:1017 CDK2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22]
hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:1026 CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A
hsa:1111 CHEK1, CHK1; CHK1 checkpoint homolog (S. pombe) (EC:2.7.11.1); K02216 serine/threonine-protein kinase Chk1 [EC:2.7.11.1]
hsa:11200 CHEK2, CDS1, CHK2, HuCds1, LFS2, PP1425, RAD53; CHK2 checkpoint homolog (S. pombe) (EC:2.7.11.1); K06641 serine/threonine-protein kinase Chk2 [EC:2.7.11.1]
hsa:1647 GADD45A, DDIT1, GADD45; growth arrest and DNA-damage-inducible, alpha; K04402 growth arrest and DNA-damage-inducible protein
hsa:27113 BBC3, FLJ42994, JFY1, PUMA; BCL2 binding component 3; K10132 BCL2-binding component 3
hsa:317 APAF1, APAF-1, CED4, DKFZp781B1145; apoptotic peptidase activating factor 1; K02084 apoptotic protease-activating factor
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3732 CD82, 4F9, C33, GR15, IA4, KAI1, R2, SAR2, ST6, TSPAN27; CD82 molecule; K06509 kangai 1
hsa:4193 MDM2, HDMX, MGC5370, MGC71221, hdm2; Mdm2 p53 binding protein homolog (mouse); K06643 transformed 3T3 cell double minute 2, p53-binding protein [EC:6.3.2.19]
hsa:472 ATM, AT1, ATA, ATC, ATD, ATDC, ATE, DKFZp781A0353, MGC74674, TEL1, TELO1; ataxia telangiectasia mutated (EC:2.7.11.1); K04728 ataxia telangectasia mutated family protein [EC:2.7.11.1]
hsa:5054 SERPINE1, PAI, PAI-1, PAI1, PLANH1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; K03982 plasminogen activator inhibitor-1
hsa:54205 CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c
hsa:545 ATR, FRP1, MEC1, SCKL, SCKL1; ataxia telangiectasia and Rad3 related (EC:2.7.11.1); K06640 ataxia telangiectasia and Rad3 related [EC:2.7.11.1]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:581 BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX, membrane protein (BCL2-associated)
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:637 BID, FP497, MGC15319, MGC42355; BH3 interacting domain death agonist; K04726 BH3 interacting domain death agonist
hsa:7057 THBS1, THBS, THBS-1, TSP, TSP-1, TSP1; thrombospondin 1; K04659 thrombospondin
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:7161 TP73, P73; tumor protein p73; K10148 tumor protein p73
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]
hsa:85417 CCNB3; cyclin B3; K05868 cyclin B
hsa:8795 TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9; tumor necrosis factor receptor superfamily, member 10b; K04722 tumor necrosis factor receptor superfamily member 10
hsa:891 CCNB1, CCNB; cyclin B1; K05868 cyclin B
hsa:896 CCND3; cyclin D3; K10152 cyclin D3
hsa:898 CCNE1, CCNE; cyclin E1; K06626 cyclin E
hsa:9133 CCNB2, HsT17299; cyclin B2; K05868 cyclin B
hsa:983 CDK1, CDC2, CDC28A, DKFZp686L20222, MGC111195, P34CDC2; cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22); K02087 cyclin-dependent kinase 1 [EC:2.7.11.22]

hsa04070 Phosphatidylinositol signaling system - Homo sapiens (human) (32)



hsa:113026 PLCD3, MGC71172; phospholipase C, delta 3 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:51196 PLCE1, FLJ23659, KIAA1516, MGC167842, NPHS3, PLCE, PPLC; phospholipase C, epsilon 1 (EC:3.1.4.11); K05860 phospholipase C, epsilon
hsa:5286 PIK3C2A, CPK, DKFZp686L193, MGC142218, PI3-K-C2(ALPHA), PI3-K-C2A; phosphoinositide-3-kinase, class 2, alpha polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5287 PIK3C2B, C2-PI3K, DKFZp686G16234; phosphoinositide-3-kinase, class 2, beta polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5288 PIK3C2G, MGC163149, PI3K-C2GAMMA; phosphoinositide-3-kinase, class 2, gamma polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5289 PIK3C3, MGC61518, VPS34, hVps34; phosphoinositide-3-kinase, class 3 (EC:2.7.1.137); K00914 phosphatidylinositol 3-kinase [EC:2.7.1.137]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5333 PLCD1; phospholipase C, delta 1 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:56623 INPP5E, CORS1, JBTS1, MGC117201, MORMS, PPI5PIV; inositol polyphosphate-5-phosphatase, 72 kDa (EC:3.1.3.36); K01099 phosphatidylinositol-bisphosphatase [EC:3.1.3.36]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:84812 PLCD4, MGC12837; phospholipase C, delta 4 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:89869 PLCZ1, MGC149685, NYD-SP27, PLCzeta; phospholipase C, zeta 1 (EC:3.1.4.11); K05861 phospholipase C, zeta

hsa05332 Graft-versus-host disease - Homo sapiens (human) (32)



hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3106 HLA-B, AS, HLA-B27, HLA-B73, HLAB, MGC111087, SPDA1; major histocompatibility complex, class I, B; K06751 major histocompatibility complex, class I
hsa:3107 HLA-C, D6S204, FLJ27082, HLA-Cw, HLA-JY3, HLC-C, PSORS1; major histocompatibility complex, class I, C; K06751 major histocompatibility complex, class I
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3133 HLA-E, DKFZp686P19218, EA1.2, EA2.1, HLA-6.2, MHC, QA1; major histocompatibility complex, class I, E; K06751 major histocompatibility complex, class I
hsa:3134 HLA-F, CDA12, HLA-5.4, HLA-CDA12, HLAF; major histocompatibility complex, class I, F; K06751 major histocompatibility complex, class I
hsa:3135 HLA-G, MHC-G; major histocompatibility complex, class I, G; K06751 major histocompatibility complex, class I
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:5551 PRF1, FLH2, HPLH2, MGC65093, P1, PFN1, PFP; perforin 1 (pore forming protein); K07818 perforin 1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen
hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen

hsa04360 Axon guidance - Homo sapiens (human) (31)



hsa:1020 CDK5, PSSALRE; cyclin-dependent kinase 5 (EC:2.7.11.22); K02090 cyclin-dependent kinase 5 [EC:2.7.11.22]
hsa:10507 SEMA4D, C9orf164, CD100, FLJ33485, FLJ34282, FLJ39737, FLJ46484, M-sema-G, MGC169138, MGC169141, SEMAJ, coll-4; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D; K06521 semaphorin 4
hsa:1072 CFL1, CFL; cofilin 1 (non-muscle); K05765 cofilin
hsa:1073 CFL2, NEM7; cofilin 2 (muscle); K05765 cofilin
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:2770 GNAI1, Gi; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1; K04630 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:4772 NFATC1, MGC138448, NF-ATC, NFAT2, NFATc; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4773 NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4775 NFATC3, NFAT4, NFATX; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4776 NFATC4, NF-ATc4, NFAT3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4; K04446 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5058 PAK1, MGC130000, MGC130001, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1]
hsa:5062 PAK2, PAK65, PAKgamma; p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1); K04410 p21-activated kinase 2 [EC:2.7.11.1]
hsa:5530 PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5532 PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5533 PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 protein phosphatase 3, catalytic subunit [EC:3.1.3.16]
hsa:5534 PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5535 PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 protein phosphatase 3, regulatory subunit
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:6387 CXCL12, IRH, PBSF, SCYB12, SDF1, SDF1A, SDF1B, TLSF, TPAR1; chemokine (C-X-C motif) ligand 12; K10031 C-X-C motif chemokine 12
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa04672 Intestinal immune network for IgA production - Homo sapiens (human) (31)



hsa:10673 TNFSF13B, BAFF, BLYS, CD257, DTL, TALL-1, TALL1, THANK, TNFSF20, ZTNF4; tumor necrosis factor (ligand) superfamily, member 13b; K05476 tumor necrosis factor (ligand) superfamily, member 13B
hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3558 IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3600 IL15, IL-15, MGC9721; interleukin 15; K05433 interleukin 15
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:57379 AICDA, AID, ARP2, CDA2, HIGM2; activation-induced cytidine deaminase (EC:3.5.4.5); K10989 activation-induced cytidine deaminase [EC:3.5.4.5]
hsa:6387 CXCL12, IRH, PBSF, SCYB12, SDF1, SDF1A, SDF1B, TLSF, TPAR1; chemokine (C-X-C motif) ligand 12; K10031 C-X-C motif chemokine 12
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:9020 MAP3K14, FTDCR1B, HS, HSNIK, NIK; mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25); K04466 mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
hsa:940 CD28, MGC138290, Tp44; CD28 molecule; K06470 CD28 antigen
hsa:941 CD80, B7, BB1, CD28LG, CD28LG1, LAB7; CD80 molecule; K05412 CD80 antigen
hsa:942 CD86, B7-2, B70, CD28LG2, LAB72, MGC34413; CD86 molecule; K05413 CD86 antigen
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5

hsa04622 RIG-I-like receptor signaling pathway - Homo sapiens (human) (31)



hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1654 DDX3X, DBX, DDX14, DDX3, HLP2; DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked (EC:3.6.4.13); K11594 ATP-dependent RNA helicase [EC:3.6.4.13]
hsa:3439 IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@, MGC138207, MGC138505, MGC138507; interferon, alpha 1; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3444 IFNA7, IFN-alphaJ, IFNA-J; interferon, alpha 7; K05414 interferon, alpha
hsa:3449 IFNA16, IFN-alphaO; interferon, alpha 16; K05414 interferon, alpha
hsa:3456 IFNB1, IFB, IFF, IFNB, MGC96956; interferon, beta 1, fibroblast; K05415 interferon, beta
hsa:3467 IFNW1; interferon, omega 1; K05440 interferon, omega 1
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3627 CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1; chemokine (C-X-C motif) ligand 10; K12671 C-X-C motif chemokine 10
hsa:3661 IRF3; interferon regulatory factor 3; K05411 interferon regulatory factor 3
hsa:3665 IRF7, IRF-7H, IRF7A; interferon regulatory factor 7; K09447 interferon regulatory factor 7
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4793 NFKBIB, IKBB, TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; K02581 NF-kappa-B inhibitor beta
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]
hsa:8717 TRADD, Hs.89862, MGC11078; TNFRSF1A-associated via death domain; K03171 tnfrsf1a-associated via death domain
hsa:9636 ISG15, G1P2, IFI15, IP17, UCRP, hUCRP; ISG15 ubiquitin-like modifier; K12159 ubiquitin cross-reactive protein
hsa:9641 IKBKE, IKK-E, IKK-i, IKKE, IKKI, KIAA0151, MGC125294, MGC125295, MGC125297; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (EC:2.7.11.10); K07211 inhibitor of nuclear factor kappa-B kinase epsilon subunit [EC:2.7.11.10]

hsa04971 Gastric acid secretion - Homo sapiens (human) (31)



hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:2770 GNAI1, Gi; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1; K04630 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:6750 SST, SMST; somatostatin; K05237 somatostatin
hsa:7430 EZR, CVIL, CVL, DKFZp762H157, FLJ26216, MGC1584, VIL2; ezrin; K08007 villin 2 (ezrin)
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:815 CAMK2A, CAMKA, KIAA0968; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:816 CAMK2B, CAM2, CAMK2, CAMKB, MGC29528; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]

hsa05120 Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human) (30)



hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1445 CSK, MGC117393; c-src tyrosine kinase (EC:2.7.10.2); K05728 c-src tyrosine kinase [EC:2.7.10.2]
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2919 CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha); K05505 C-X-C motif chemokine 1/2/3
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3725 JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1
hsa:4067 LYN, FLJ26625, JTK8; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2); K05854 tyrosine-protein kinase Lyn [EC:2.7.10.2]
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:5058 PAK1, MGC130000, MGC130001, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1]
hsa:51606 ATP6V1H, MSTP042, NBP1, SFD, SFDalpha, SFDbeta, VMA13; ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H (EC:3.6.3.14); K02144 V-type H+-transporting ATPase 54 kD subunit [EC:3.6.3.14]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5781 PTPN11, BPTP3, CFC, MGC14433, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2; protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48); K07293 protein tyrosine phosphatase, non-receptor type 11 [EC:3.1.3.48]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:6714 SRC, ASV, SRC1, c-SRC, p60-Src; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (EC:2.7.10.2); K05704 proto-oncogene tyrosine-protein kinase Src [EC:2.7.10.2]
hsa:7082 TJP1, DKFZp686M05161, MGC133289, ZO-1; tight junction protein 1 (zona occludens 1); K05701 tight junction protein 1
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:9020 MAP3K14, FTDCR1B, HS, HSNIK, NIK; mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25); K04466 mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa05131 Shigellosis - Homo sapiens (human) (30)



hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:1445 CSK, MGC117393; c-src tyrosine kinase (EC:2.7.10.2); K05728 c-src tyrosine kinase [EC:2.7.10.2]
hsa:23291 FBXW11, BTRC2, BTRCP2, FBW1B, FBXW1B, Fbw11, Hos, KIAA0696; F-box and WD repeat domain containing 11; K03362 F-box and WD-40 domain protein 1/11
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:391 RHOG, ARHG, MGC125835, MGC125836; ras homolog gene family, member G (rho G); K07863 Ras homolog gene family, member G
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4793 NFKBIB, IKBB, TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; K02581 NF-kappa-B inhibitor beta
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:7414 VCL, CMD1W, CMH15, MVCL; vinculin; K05700 vinculin
hsa:8945 BTRC, BETA-TRCP, FBW1A, FBXW1, FBXW1A, FWD1, MGC4643, bTrCP, bTrCP1, betaTrCP; beta-transducin repeat containing; K03362 F-box and WD-40 domain protein 1/11
hsa:8976 WASL, DKFZp779G0847, MGC48327, N-WASP, NWASP; Wiskott-Aldrich syndrome-like; K05747 Wiskott-Aldrich syndrome protein
hsa:960 CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MGC10468, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen
hsa:9844 ELMO1, CED-12, CED12, ELMO-1, KIAA0281, MGC126406; engulfment and cell motility 1; K12366 engulfment and cell motility protein 1
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42

hsa04520 Adherens junction - Homo sapiens (human) (30)



hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:1457 CSNK2A1, CK2A1, CKII; casein kinase 2, alpha 1 polypeptide (EC:2.7.11.1); K03097 casein kinase 2, alpha polypeptide [EC:2.7.11.1]
hsa:1459 CSNK2A2, CK2A2, CSNK2A1, FLJ43934; casein kinase 2, alpha prime polypeptide (EC:2.7.11.1); K03097 casein kinase 2, alpha polypeptide [EC:2.7.11.1]
hsa:1460 CSNK2B, CK2B, CK2N, CSK2B, G5A, MGC138222, MGC138224; casein kinase 2, beta polypeptide (EC:2.7.11.1); K03115 casein kinase 2, beta polypeptide
hsa:1495 CTNNA1, CAP102, FLJ36832, FLJ52416; catenin (cadherin-associated protein), alpha 1, 102kDa; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3480 IGF1R, CD221, IGFIR, IGFR, JTK13, MGC142170, MGC142172, MGC18216; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:4087 SMAD2, JV18, JV18-1, MADH2, MADR2, MGC22139, MGC34440, hMAD-2, hSMAD2; SMAD family member 2; K04500 SMAD, mothers against DPP 2/3
hsa:4088 SMAD3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396; SMAD family member 3; K04500 SMAD, mothers against DPP 2/3
hsa:4089 SMAD4, DPC4, JIP, MADH4; SMAD family member 4; K04501 SMAD, mothers against DPP 4
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5787 PTPRB, DKFZp686E2262, DKFZp686H15164, FLJ44133, HPTP-BETA, HPTPB, MGC142023, MGC59935, PTPB, R-PTP-BETA, VEPTP; protein tyrosine phosphatase, receptor type, B (EC:3.1.3.48); K05694 protein tyrosine phosphatase, receptor type, B [EC:3.1.3.48]
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:5880 RAC2, EN-7, Gx, HSPC022; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:6714 SRC, ASV, SRC1, c-SRC, p60-Src; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (EC:2.7.10.2); K05704 proto-oncogene tyrosine-protein kinase Src [EC:2.7.10.2]
hsa:6934 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2
hsa:7082 TJP1, DKFZp686M05161, MGC133289, ZO-1; tight junction protein 1 (zona occludens 1); K05701 tight junction protein 1
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:7414 VCL, CMD1W, CMH15, MVCL; vinculin; K05700 vinculin
hsa:81 ACTN4, ACTININ-4, DKFZp686K23158, FSGS, FSGS1; actinin, alpha 4; K05699 actinin alpha
hsa:87 ACTN1, FLJ40884, FLJ54432; actinin, alpha 1; K05699 actinin alpha
hsa:8976 WASL, DKFZp779G0847, MGC48327, N-WASP, NWASP; Wiskott-Aldrich syndrome-like; K05747 Wiskott-Aldrich syndrome protein
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42
hsa:999 CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin

hsa04970 Salivary secretion - Homo sapiens (human) (30)



hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:1755 DMBT1, FLJ61058, GP340, MGC164738, muclin; deleted in malignant brain tumors 1; K13912 deleted in malignant brain tumors 1 protein
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:3708 ITPR1, DKFZp313E1334, DKFZp313N1434, INSP3R1, IP3R, IP3R1, SCA15, SCA16; inositol 1,4,5-triphosphate receptor, type 1; K04958 inositol 1,4,5-triphosphate receptor type 1
hsa:3709 ITPR2, IP3R2; inositol 1,4,5-triphosphate receptor, type 2; K04959 inositol 1,4,5-triphosphate receptor type 2
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:3778 KCNMA1, BKTM, DKFZp686K1437, KCa1.1, MGC71881, MaxiK, SAKCA, SLO, SLO-ALPHA, SLO1, bA205K10.1, mSLO1; potassium large conductance calcium-activated channel, subfamily M, alpha member 1; K04936 potassium large conductance calcium-activated channel subfamily M alpha member 1
hsa:3783 KCNN4, IK1, IKCA1, KCA4, KCa3.1, SK4, hIKCa1, hKCa4, hSK4; potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4; K04945 potassium intermediate/small conductance calcium-activated channel subfamily N member 4
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]

hsa05100 Bacterial invasion of epithelial cells - Homo sapiens (human) (30)



hsa:1213 CLTC, CHC, CHC17, CLH-17, CLTCL2, Hc, KIAA0034; clathrin, heavy chain (Hc); K04646 clathrin, heavy polypeptide
hsa:1495 CTNNA1, CAP102, FLJ36832, FLJ52416; catenin (cadherin-associated protein), alpha 1, 102kDa; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:2335 FN1, CIG, DKFZp686F10164, DKFZp686H0342, DKFZp686I1370, DKFZp686O13149, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF; fibronectin 1; K05717 fibronectin 1
hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:391 RHOG, ARHG, MGC125835, MGC125836; ras homolog gene family, member G (rho G); K07863 Ras homolog gene family, member G
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:53358 SHC3, DKFZp686H1544, FLJ45325, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K06279 src homology 2 domain-containing transforming protein C
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:5829 PXN, FLJ16691; paxillin; K05760 paxillin
hsa:5879 RAC1, MGC111543, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:6464 SHC1, FLJ26504, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 src homology 2 domain-containing transforming protein C
hsa:6714 SRC, ASV, SRC1, c-SRC, p60-Src; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (EC:2.7.10.2); K05704 proto-oncogene tyrosine-protein kinase Src [EC:2.7.10.2]
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:7414 VCL, CMD1W, CMH15, MVCL; vinculin; K05700 vinculin
hsa:857 CAV1, BSCL3, CGL3, MSTP085, VIP21; caveolin 1, caveolae protein, 22kDa; K06278 caveolin 1
hsa:867 CBL, C-CBL, CBL2, RNF55; Cas-Br-M (murine) ecotropic retroviral transforming sequence; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:8976 WASL, DKFZp779G0847, MGC48327, N-WASP, NWASP; Wiskott-Aldrich syndrome-like; K05747 Wiskott-Aldrich syndrome protein
hsa:9564 BCAR1, CAS, CAS1, CASS1, CRKAS, FLJ12176, FLJ45059, P130Cas; breast cancer anti-estrogen resistance 1; K05726 breast cancer anti-estrogen resistance 1
hsa:9844 ELMO1, CED-12, CED12, ELMO-1, KIAA0281, MGC126406; engulfment and cell motility 1; K12366 engulfment and cell motility protein 1
hsa:998 CDC42, CDC42Hs, G25K; cell division cycle 42 (GTP binding protein, 25kDa); K04393 cell division control protein 42
hsa:999 CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin

hsa05410 Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human) (30)



hsa:1636 ACE, ACE1, CD143, DCP, DCP1, MGC26566, MVCD3; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1); K01283 peptidyl-dipeptidase A [EC:3.4.15.1]
hsa:1674 DES, CMD1I, CSM1, CSM2, FLJ12025, FLJ39719, FLJ41013, FLJ41793; desmin; K07610 desmin
hsa:2010 EMD, EDMD, LEMD5, STA; emerin; K12569 emerin
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3655 ITGA6, CD49f, DKFZp686J01244, FLJ18737, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6
hsa:3675 ITGA3, CD49C, FLJ34631, FLJ34704, GAP-B3, GAPB3, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5
hsa:3685 ITGAV, CD51, DKFZp686A08142, MSK8, VNRA; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); K06487 integrin alpha V
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3691 ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4
hsa:3693 ITGB5, FLJ26658; integrin, beta 5; K06588 integrin beta 5
hsa:3908 LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2
hsa:4000 LMNA, CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL, FPLD, HGPS, IDC, LDP1, LFP, LGMD1B, LMN1, LMNC, LMNL1, PRO1; lamin A/C; K12641 lamin A/C
hsa:4624 MYH6, ASD3, CMD1EE, CMH14, MYHC, MYHCA, alpha-MHC; myosin, heavy chain 6, cardiac muscle, alpha; K10352 myosin heavy chain
hsa:4625 MYH7, CMD1S, CMH1, DKFZp451F047, MGC138376, MGC138378, MPD1, MYHCB, SPMD, SPMM; myosin, heavy chain 7, cardiac muscle, beta; K10352 myosin heavy chain
hsa:51422 PRKAG2, AAKG, AAKG2, CMH6, H91620p, WPWS; protein kinase, AMP-activated, gamma 2 non-catalytic subunit; K07200 5'-AMP-activated protein kinase, regulatory gamma subunit
hsa:5571 PRKAG1, AMPKG, MGC8666; protein kinase, AMP-activated, gamma 1 non-catalytic subunit; K07200 5'-AMP-activated protein kinase, regulatory gamma subunit
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:70 ACTC1, ACTC, ASD5, CMD1R, CMH11, LVNC4; actin, alpha, cardiac muscle 1; K12314 actin, alpha cardiac muscle
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7134 TNNC1, CMD1Z, CMH13, TN-C, TNC, TNNC; troponin C type 1 (slow); K05865 troponin C, slow skeletal and cardiac muscles
hsa:7168 TPM1, C15orf13, CMD1Y, HTM-alpha, TMSA; tropomyosin 1 (alpha); K10373 tropomyosin 1
hsa:7169 TPM2, AMCD1, DA1, DA2B, NEM4, TMSB; tropomyosin 2 (beta); K10374 tropomyosin 2
hsa:7170 TPM3, FLJ41118, MGC14582, MGC3261, MGC72094, NEM1, OK/SW-cl.5, TM-5, TM3, TM30, TM30nm, TPMsk3, TRK, hscp30; tropomyosin 3; K09290 tropomyosin 3

hsa04623 Cytosolic DNA-sensing pathway - Homo sapiens (human) (29)



hsa:103 ADAR, ADAR1, DRADA, DSH, DSRAD, G1P1, IFI-4, IFI4, K88DSRBP, P136; adenosine deaminase, RNA-specific; K12968 double-stranded RNA-specific adenosine deaminase [EC:3.5.4.-]
hsa:10621 POLR3F, MGC13517, RPC39, RPC6; polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa; K03025 DNA-directed RNA polymerase III subunit C34 [EC:2.7.7.6]
hsa:10622 POLR3G, RPC32, RPC7; polymerase (RNA) III (DNA directed) polypeptide G (32kD); K03024 DNA-directed RNA polymerase III subunit C31 [EC:2.7.7.6]
hsa:10623 POLR3C, RPC3, RPC62; polymerase (RNA) III (DNA directed) polypeptide C (62kD); K03023 DNA-directed RNA polymerase III subunit C3 [EC:2.7.7.6]
hsa:11128 POLR3A, RPC1, RPC155, hRPC155; polymerase (RNA) III (DNA directed) polypeptide A, 155kDa (EC:2.7.7.6); K03018 DNA-directed RNA polymerase III subunit C1 [EC:2.7.7.6]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:171568 POLR3H, KIAA1665, MGC111097, MGC29654, RPC22.9, RPC8; polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) (EC:2.7.7.6); K03022 DNA-directed RNA polymerase III subunit C25 [EC:2.7.7.6]
hsa:3439 IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@, MGC138207, MGC138505, MGC138507; interferon, alpha 1; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3444 IFNA7, IFN-alphaJ, IFNA-J; interferon, alpha 7; K05414 interferon, alpha
hsa:3449 IFNA16, IFN-alphaO; interferon, alpha 16; K05414 interferon, alpha
hsa:3456 IFNB1, IFB, IFF, IFNB, MGC96956; interferon, beta 1, fibroblast; K05415 interferon, beta
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3627 CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1; chemokine (C-X-C motif) ligand 10; K12671 C-X-C motif chemokine 10
hsa:3661 IRF3; interferon regulatory factor 3; K05411 interferon regulatory factor 3
hsa:3665 IRF7, IRF-7H, IRF7A; interferon regulatory factor 7; K09447 interferon regulatory factor 7
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4793 NFKBIB, IKBB, TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; K02581 NF-kappa-B inhibitor beta
hsa:51728 POLR3K, C11, C11-RNP3, RPC10, RPC11, RPC12.5, hRPC11; polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa; K03019 DNA-directed RNA polymerase III subunit C11 [EC:2.7.7.6]
hsa:55703 POLR3B, C128, DKFZp686B10117, FLJ10388, RPC2; polymerase (RNA) III (DNA directed) polypeptide B (EC:2.7.7.6); K03021 DNA-directed RNA polymerase III subunit C2 [EC:2.7.7.6]
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6351 CCL4, ACT2, AT744.1, G-26, LAG1, MGC104418, MGC126025, MGC126026, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4; chemokine (C-C motif) ligand 4; K12964 C-C motif chemokine 4
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:661 POLR3D, BN51T, RPC4, RPC53, TSBN51; polymerase (RNA) III (DNA directed) polypeptide D, 44kDa (EC:2.7.7.6); K03026 DNA-directed RNA polymerase III subunit C4 [EC:2.7.7.6]
hsa:834 CASP1, ICE, IL1BC, P45; caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (EC:3.4.22.36); K01370 caspase 1 [EC:3.4.22.36]
hsa:9641 IKBKE, IKK-E, IKK-i, IKKE, IKKI, KIAA0151, MGC125294, MGC125295, MGC125297; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (EC:2.7.11.10); K07211 inhibitor of nuclear factor kappa-B kinase epsilon subunit [EC:2.7.11.10]

hsa05144 Malaria - Homo sapiens (human) (28)



hsa:2993 GYPA, CD235a, GPA, GPErik, GPSAT, GpMiIII, HGpMiIII, HGpMiV, HGpMiX, HGpMiXI, HGpSta(C), MN, MNS, PAS-2; glycophorin A (MNS blood group); K06575 glycophorin
hsa:3082 HGF, DFNB39, F-TCF, HGFB, HPTA, SF; hepatocyte growth factor (hepapoietin A; scatter factor); K05460 hepatocyte growth factor
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3683 ITGAL, CD11A, LFA-1, LFA1A; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); K05718 integrin alpha L
hsa:3689 ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7; integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); K06464 integrin beta 2
hsa:4035 LRP1, A2MR, APOER, APR, CD91, FLJ16451, IGFBP3R, LRP, MGC88725, TGFBR5; low density lipoprotein receptor-related protein 1; K04550 low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor)
hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:6382 SDC1, CD138, SDC, SYND1, syndecan; syndecan 1; K06257 syndecan
hsa:6383 SDC2, HSPG, HSPG1, SYND2; syndecan 2; K06257 syndecan
hsa:6385 SDC4, MGC22217, SYND4; syndecan 4; K06257 syndecan
hsa:6401 SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2; selectin E; K06494 selectin, endothelial cell
hsa:6403 SELP, CD62, CD62P, FLJ45155, GMP140, GRMP, LECAM3, PADGEM, PSEL; selectin P (granule membrane protein 140kDa, antigen CD62); K06496 selectin, platele
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7057 THBS1, THBS, THBS-1, TSP, TSP-1, TSP1; thrombospondin 1; K04659 thrombospondin
hsa:7099 TLR4, ARMD10, CD284, TOLL, hToll; toll-like receptor 4; K10160 toll-like receptor 4
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7412 VCAM1, CD106, DKFZp779G2333, INCAM-100, MGC99561; vascular cell adhesion molecule 1; K06527 vascular cell adhesion molecule 1
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5
hsa:9672 SDC3, SDCN, SYND3; syndecan 3; K06257 syndecan
hsa:975 CD81, CVID6, S5.7, TAPA1, TSPAN28; CD81 molecule; K06508 CD81 antigen

hsa04350 TGF-beta signaling pathway - Homo sapiens (human) (28)



hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:1874 E2F4, E2F-4; E2F transcription factor 4, p107/p130-binding; K04682 E2F transcription factor 4/5
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:3397 ID1, ID, bHLHb24; inhibitor of DNA binding 1, dominant negative helix-loop-helix protein; K04680 inhibitor of DNA binding, dominant negative helix-loop-helix protein
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:387 RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog gene family, member A; K04513 Ras homolog gene family, member A
hsa:4087 SMAD2, JV18, JV18-1, MADH2, MADR2, MGC22139, MGC34440, hMAD-2, hSMAD2; SMAD family member 2; K04500 SMAD, mothers against DPP 2/3
hsa:4088 SMAD3, DKFZp586N0721, DKFZp686J10186, HSPC193, HsT17436, JV15-2, MADH3, MGC60396; SMAD family member 3; K04500 SMAD, mothers against DPP 2/3
hsa:4089 SMAD4, DPC4, JIP, MADH4; SMAD family member 4; K04501 SMAD, mothers against DPP 4
hsa:4091 SMAD6, HsT17432, MADH6, MADH7; SMAD family member 6; K04677 SMAD, mothers against DPP 6/7
hsa:4092 SMAD7, CRCS3, FLJ16482, MADH7, MADH8; SMAD family member 7; K04677 SMAD, mothers against DPP 6/7
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:5515 PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C; protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5516 PPP2CB, PP2Abeta, PP2CB; protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5518 PPP2R1A, MGC786, PP2A-Aalpha, PP2AAALPHA, PR65A; protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5519 PPP2R1B, MGC26454, PP2A-Abeta, PR65B; protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5934 RBL2, FLJ26459, P130, Rb2; retinoblastoma-like 2 (p130); K04681 retinoblastoma-like
hsa:6198 RPS6KB1, PS6K, S6K, S6K1, STK14A, p70(S6K)-alpha, p70-S6K, p70-alpha; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1]
hsa:650 BMP2, BMP2A; bone morphogenetic protein 2; K04662 bone morphogenetic protein 2/4
hsa:659 BMPR2, BMPR-II, BMPR3, BMR2, BRK-3, FLJ41585, FLJ76945, PPH1, T-ALK; bone morphogenetic protein receptor, type II (serine/threonine kinase) (EC:2.7.11.30); K04671 bone morphogenetic protein receptor type-2 [EC:2.7.11.30]
hsa:6667 SP1; Sp1 transcription factor; K04684 transcription factor Sp1
hsa:7040 TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1
hsa:7042 TGFB2, MGC116892, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2
hsa:7057 THBS1, THBS, THBS-1, TSP, TSP-1, TSP1; thrombospondin 1; K04659 thrombospondin
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:9978 RBX1, BA554C12.1, FLJ60363, MGC13357, MGC1481, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1

hsa04621 NOD-like receptor signaling pathway - Homo sapiens (human) (28)



hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:1432 MAPK14, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA; mitogen-activated protein kinase 14 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:22861 NLRP1, CARD7, CLR17.1, DEFCAP, DEFCAP-L/S, DKFZp586O1822, KIAA0926, NAC, NALP1, PP1044, SLEV1, VAMAS1; NLR family, pyrin domain containing 1; K12798 NACHT, LRR and PYD domains-containing protein 1
hsa:2919 CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha); K05505 C-X-C motif chemokine 1/2/3
hsa:329 BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat-containing 2; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:330 BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat-containing 3; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:3320 HSP90AA1, FLJ31884, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2; heat shock protein 90kDa alpha (cytosolic), class A member 1; K04079 molecular chaperone HtpG
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4793 NFKBIB, IKBB, TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; K02581 NF-kappa-B inhibitor beta
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5600 MAPK11, P38B, P38BETA2, PRKM11, SAPK2, SAPK2B, p38-2, p38Beta; mitogen-activated protein kinase 11 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5603 MAPK13, MGC99536, PRKM13, SAPK4, p38delta; mitogen-activated protein kinase 13 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6300 MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3; mitogen-activated protein kinase 12 (EC:2.7.11.24); K04441 p38 MAP kinase [EC:2.7.11.24]
hsa:6347 CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF; chemokine (C-C motif) ligand 2; K14624 C-C motif chemokine 2
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:834 CASP1, ICE, IL1BC, P45; caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (EC:3.4.22.36); K01370 caspase 1 [EC:3.4.22.36]
hsa:841 CASP8, ALPS2B, CAP4, Casp-8, FLICE, FLJ17672, MACH, MCH5, MGC78473; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61]

hsa04080 Neuroactive ligand-receptor interaction - Homo sapiens (human) (27)



hsa:1134 CHRNA1, ACHRA, ACHRD, CHRNA, CMS2A, FCCMS, SCCMS; cholinergic receptor, nicotinic, alpha 1 (muscle); K04803 nicotinic acetylcholine receptor alpha-1 (muscle)
hsa:1140 CHRNB1, ACHRB, CHRNB, CMS1D, CMS2A, FLJ57107, SCCMS; cholinergic receptor, nicotinic, beta 1 (muscle); K04812 nicotinic acetylcholine receptor beta-1 (muscle)
hsa:1141 CHRNB2, EFNL3, nAChRB2; cholinergic receptor, nicotinic, beta 2 (neuronal); K04813 nicotinic acetylcholine receptor beta-2 (neuronal)
hsa:116443 GRIN3A, FLJ45414, NMDAR-L, NR3A; glutamate receptor, ionotropic, N-methyl-D-aspartate 3A; K05213 glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
hsa:116444 GRIN3B, NR3B; glutamate receptor, ionotropic, N-methyl-D-aspartate 3B; K05214 glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
hsa:135 ADORA2A, ADORA2, RDC8, hA2aR; adenosine A2a receptor; K04266 adenosine receptor A2a
hsa:187 APLNR, AGTRL1, APJ, APJR, FLJ90771, FLJ96609, HG11, MGC45246; apelin receptor; K04174 apelin receptor
hsa:2147 F2, PT; coagulation factor II (thrombin) (EC:3.4.21.5); K01313 coagulation factor II (thrombin) [EC:3.4.21.5]
hsa:2357 FPR1, FMLP, FPR; formyl peptide receptor 1; K04172 formyl peptide receptor 1
hsa:2358 FPR2, ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH1, FPRH2, FPRL1, HM63, LXA4R; formyl peptide receptor 2; K04173 formyl peptide receptor-like
hsa:2568 GABRP, MGC126386, MGC126387; gamma-aminobutyric acid (GABA) A receptor, pi; K05189 gamma-aminobutyric acid (GABA) A receptor pi
hsa:2688 GH1, GH, GH-N, GHN, IGHD1B, hGH-N; growth hormone 1; K05438 growth hormone
hsa:2902 GRIN1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2904 GRIN2B, MGC142178, MGC142180, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor, ionotropic, N-methyl-D-aspartate 2B
hsa:2905 GRIN2C, NMDAR2C, NR2C; glutamate receptor, ionotropic, N-methyl D-aspartate 2C; K05211 glutamate receptor, ionotropic, N-methyl-D-aspartate 2C
hsa:2906 GRIN2D, EB11, NMDAR2D, NR2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; K05212 glutamate receptor, ionotropic, N-methyl-D-aspartate 2D
hsa:2908 NR3C1, GCCR, GCR, GR, GRL; nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor); K05771 glucocorticoid receptor
hsa:2911 GRM1, GPRC1A, GRM1A, MGLUR1, MGLUR1A, mGlu1; glutamate receptor, metabotropic 1; K04604 metabotropic glutamate receptor 1/5
hsa:3001 GZMA, CTLA3, HFSP; granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) (EC:3.4.21.78); K01352 granzyme A [EC:3.4.21.78]
hsa:4986 OPRK1, KOR, OPRK; opioid receptor, kappa 1; K04214 opioid receptor kappa 1
hsa:4988 OPRM1, KIAA0403, LMOR, MOR, MOR1, OPRM; opioid receptor, mu 1; K04215 opioid receptor mu 1
hsa:5644 PRSS1, DKFZp779A0837, FLJ57296, MGC120175, MGC149362, TRP1, TRY1, TRY4, TRYP1; protease, serine, 1 (trypsin 1) (EC:3.4.21.4); K01312 trypsin [EC:3.4.21.4]
hsa:5645 PRSS2, MGC111183, MGC120174, MGC120175, TRY2, TRY8, TRYP2; protease, serine, 2 (trypsin 2) (EC:3.4.21.4); K01312 trypsin [EC:3.4.21.4]
hsa:7067 THRA, AR7, EAR7, ERB-T-1, ERBA, ERBA1, MGC000261, MGC43240, NR1A1, THRA1, THRA2, c-ERBA-1; thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian); K05547 thyroid hormone receptor alpha
hsa:728 C5AR1, C5A, C5AR, C5R1, CD88; complement component 5a receptor 1; K04010 C5a anaphylatoxin chemotactic receptor
hsa:7433 VIPR1, FLJ41949, HVR1, II, PACAP-R-2, RDC1, V1RG, VAPC1, VIPR, VIRG, VPAC1, VPCAP1R; vasoactive intestinal peptide receptor 1; K04589 vasoactive intestinal peptide receptor 1

hsa04920 Adipocytokine signaling pathway - Homo sapiens (human) (27)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1147 CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase alpha subunit [EC:2.7.11.10]
hsa:126129 CPT1C, CATL1, CPT1-B, CPT1P, CPTI-B, CPTIC, FLJ23809; carnitine palmitoyltransferase 1C (EC:2.3.1.21); K08765 carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
hsa:1374 CPT1A, CPT1, CPT1-L, L-CPT1; carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21); K08765 carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
hsa:1375 CPT1B, CPT1-M, CPT1M, CPTI, CPTI-M, FLJ55729, FLJ58750, KIAA1670, M-CPT1, MCCPT1, MCPT1; carnitine palmitoyltransferase 1B (muscle) (EC:2.3.1.21); K08765 carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2475 MTOR, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:4790 NFKB1, DKFZp686C01211, EBP-1, KBF1, MGC54151, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:4792 NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha
hsa:4793 NFKBIB, IKBB, TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; K02581 NF-kappa-B inhibitor beta
hsa:5105 PCK1, MGC22652, PEPCK-C, PEPCK1, PEPCKC; phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32]
hsa:51422 PRKAG2, AAKG, AAKG2, CMH6, H91620p, WPWS; protein kinase, AMP-activated, gamma 2 non-catalytic subunit; K07200 5'-AMP-activated protein kinase, regulatory gamma subunit
hsa:5443 POMC, ACTH, CLIP, LPH, MSH, NPP, POC; proopiomelanocortin; K05228 proopiomelanocortin
hsa:5571 PRKAG1, AMPKG, MGC8666; protein kinase, AMP-activated, gamma 1 non-catalytic subunit; K07200 5'-AMP-activated protein kinase, regulatory gamma subunit
hsa:5588 PRKCQ, MGC126514, MGC141919, PRKCT, nPKC-theta; protein kinase C, theta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5781 PTPN11, BPTP3, CFC, MGC14433, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2; protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48); K07293 protein tyrosine phosphatase, non-receptor type 11 [EC:3.1.3.48]
hsa:5970 RELA, MGC131774, NFKB3, p65; v-rel reticuloendotheliosis viral oncogene homolog A (avian); K04735 transcription factor p65
hsa:6774 STAT3, APRF, FLJ20882, HIES, MGC16063; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7132 TNFRSF1A, CD120a, FPF, MGC19588, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A
hsa:7133 TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR; tumor necrosis factor receptor superfamily, member 1B; K05141 tumor necrosis factor receptor superfamily member 1B
hsa:8717 TRADD, Hs.89862, MGC11078; TNFRSF1A-associated via death domain; K03171 tnfrsf1a-associated via death domain

hsa05219 Bladder cancer - Homo sapiens (human) (25)



hsa:1019 CDK4, CMM3, MGC14458, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]
hsa:1026 CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A
hsa:1869 E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K06620 E2F transcription factor 1/3
hsa:1950 EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor
hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3576 IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; interleukin 8; K10030 interleukin 8
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4193 MDM2, HDMX, MGC5370, MGC71221, hdm2; Mdm2 p53 binding protein homolog (mouse); K06643 transformed 3T3 cell double minute 2, p53-binding protein [EC:6.3.2.19]
hsa:4312 MMP1, CLG, CLGN; matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7); K01388 matrix metalloproteinase-1 (interstitial collagenase) [EC:3.4.24.7]
hsa:4313 MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]
hsa:4318 MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5894 RAF1, CRAF, NS5, Raf-1, c-Raf; v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5925 RB1, OSRC, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:7057 THBS1, THBS, THBS-1, TSP, TSP-1, TSP1; thrombospondin 1; K04659 thrombospondin
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:7422 VEGFA, MGC70609, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A/B, PGF
hsa:999 CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin

hsa05020 Prion diseases - Homo sapiens (human) (25)



hsa:1958 EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225; early growth response 1; K09203 early growth response protein 1
hsa:2002 ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3303 HSPA1A, FLJ54303, FLJ54370, FLJ54392, FLJ54408, FLJ75127, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1, HSPA1B; heat shock 70kDa protein 1A; K03283 heat shock 70kDa protein 1/8
hsa:3309 HSPA5, BIP, FLJ26106, GRP78, MIF2; heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa); K09490 heat shock 70kDa protein 5
hsa:3552 IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1, alpha
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3915 LAMC1, LAMB2, MGC87297; laminin, gamma 1 (formerly LAMB2); K05635 laminin, gamma 1
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:5621 PRNP, ASCR, CD230, CJD, GSS, MGC26679, PRIP, PrP, PrP27-30, PrP33-35C, PrPc, prion; prion protein; K05634 prion protein
hsa:581 BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX, membrane protein (BCL2-associated)
hsa:6352 CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228; chemokine (C-C motif) ligand 5; K12499 C-C motif chemokine 5
hsa:6647 SOD1, ALS, ALS1, IPOA, SOD, homodimer; superoxide dismutase 1, soluble (EC:1.15.1.1); K04565 Cu/Zn superoxide dismutase [EC:1.15.1.1]
hsa:712 C1QA; complement component 1, q subcomponent, A chain; K03986 complement C1q subcomponent subunit A
hsa:713 C1QB; complement component 1, q subcomponent, B chain; K03987 complement C1q subcomponent subunit B
hsa:714 C1QC, C1Q-C, C1QG, FLJ27103; complement component 1, q subcomponent, C chain; K03988 complement C1q subcomponent subunit C
hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5
hsa:735 C9; complement component 9; K04000 complement component 9

hsa00590 Arachidonic acid metabolism - Homo sapiens (human) (23)



hsa:240 ALOX5, 5-LO, 5-LOX, 5LPG, LOG5, MGC163204; arachidonate 5-lipoxygenase (EC:1.13.11.34); K00461 arachidonate 5-lipoxygenase [EC:1.13.11.34]
hsa:257202 GPX6, GPX5p, GPXP3, GPx-6, GSHPx-6, dJ1186N24, dJ1186N24.1; glutathione peroxidase 6 (olfactory) (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:2876 GPX1, GSHPX1, MGC14399, MGC88245; glutathione peroxidase 1 (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2877 GPX2, GI-GPx, GPRP, GSHPX-GI, GSHPx-2; glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2878 GPX3, GPx-P, GSHPx-3, GSHPx-P; glutathione peroxidase 3 (plasma) (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2880 GPX5; glutathione peroxidase 5 (epididymal androgen-related protein) (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2882 GPX7, CL683, FLJ14777, GPX6, GPx-7, GSHPx-7, NPGPx; glutathione peroxidase 7 (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5742 PTGS1, COX1, COX3, PCOX1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS; prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K00509 prostaglandin-endoperoxide synthase 1 [EC:1.14.99.1]
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]
hsa:9536 PTGES, MGC10317, MGST-IV, MGST1-L1, MGST1L1, MPGES, PGES, PIG12, PP102, PP1294, TP53I12, mPGES-1; prostaglandin E synthase (EC:5.3.99.3); K05309 prostaglandin-E synthase [EC:5.3.99.3]

hsa03022 Basal transcription factors - Homo sapiens (human) (23)



hsa:2957 GTF2A1, MGC129969, MGC129970, TF2A1, TFIIA; general transcription factor IIA, 1, 19/37kDa; K03122 transcription initiation factor TFIIA large subunit
hsa:2958 GTF2A2, HsT18745, TF2A2, TFIIA; general transcription factor IIA, 2, 12kDa; K03123 transcription initiation factor TFIIA small subunit
hsa:2959 GTF2B, TF2B, TFIIB; general transcription factor IIB; K03124 transcription initiation factor TFIIB
hsa:2960 GTF2E1, FE, TF2E1, TFIIE-A; general transcription factor IIE, polypeptide 1, alpha 56kDa; K03136 transcription initiation factor TFIIE alpha subunit
hsa:2961 GTF2E2, FE, TF2E2, TFIIE-B; general transcription factor IIE, polypeptide 2, beta 34kDa; K03137 transcription initiation factor TFIIE beta subunit
hsa:2962 GTF2F1, BTF4, RAP74, TF2F1, TFIIF; general transcription factor IIF, polypeptide 1, 74kDa; K03138 transcription initiation factor TFIIF alpha subunit
hsa:2963 GTF2F2, BTF4, RAP30, TF2F2, TFIIF; general transcription factor IIF, polypeptide 2, 30kDa (EC:3.6.4.12); K03139 transcription initiation factor TFIIF beta subunit
hsa:2965 GTF2H1, BTF2, TFB1, TFIIH; general transcription factor IIH, polypeptide 1, 62kDa; K03141 transcription initiation factor TFIIH subunit H1
hsa:2966 GTF2H2, BTF2, BTF2P44, MGC102806, T-BTF2P44, TFIIH; general transcription factor IIH, polypeptide 2, 44kDa; K03142 transcription initiation factor TFIIH subunit H2
hsa:2967 GTF2H3, BTF2, TFB4, TFIIH; general transcription factor IIH, polypeptide 3, 34kDa; K03143 transcription initiation factor TFIIH subunit H3
hsa:2968 GTF2H4, TFB2, TFIIH; general transcription factor IIH, polypeptide 4, 52kDa; K03144 transcription initiation factor TFIIH subunit H4
hsa:6872 TAF1, BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, N-TAF1, NSCL2, OF, P250, TAF2A, TAFII250, XDP; TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa (EC:2.7.11.1); K03125 transcription initiation factor TFIID subunit D1
hsa:6873 TAF2, CIF150, TAF2B, TAFII150; TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa; K03128 transcription initiation factor TFIID subunit D2
hsa:6874 TAF4, FLJ41943, TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135; TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa; K03129 transcription initiation factor TFIID subunit D3
hsa:6877 TAF5, TAF2D, TAFII100; TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 100kDa; K03130 transcription initiation factor TFIID subunit D4
hsa:6878 TAF6, DKFZp781E21155, MGC:8964, TAF(II)70, TAF(II)80, TAF2E, TAFII-70, TAFII-80, TAFII70, TAFII80, TAFII85; TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa; K03131 transcription initiation factor TFIID subunit D5
hsa:6879 TAF7, TAF2F, TAFII55; TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa; K03132 transcription initiation factor TFIID subunit D6
hsa:6880 TAF9, AK6, CGI-137, CINAP, CIP, MGC1603, MGC3647, MGC5067, MGC:1603, MGC:3647, MGC:5067, TAF2G, TAFII31, TAFII32, TAFIID32, hCINAP; TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa (EC:2.7.4.3); K14535 transcription initiation factor TFIID subunit D7 / adenylate kinase [EC:2.7.4.3]
hsa:6881 TAF10, TAF2A, TAF2H, TAFII30; TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa; K03134 transcription initiation factor TFIID subunit D8
hsa:6882 TAF11, MGC:15243, TAF2I, TAFII28; TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa; K03135 transcription initiation factor TFIID subunit D9
hsa:6883 TAF12, TAF2J, TAFII20; TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa; K03126 transcription initiation factor TFIID subunit D10
hsa:6884 TAF13, MGC22425, TAF2K, TAFII18; TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa; K03127 transcription initiation factor TFIID subunit D11
hsa:6908 TBP, GTF2D, GTF2D1, HDL4, MGC117320, MGC126054, MGC126055, SCA17, TFIID; TATA box binding protein; K03120 transcription initiation factor TFIID TATA-box-binding protein

hsa03420 Nucleotide excision repair - Homo sapiens (human) (23)



hsa:1022 CDK7, CAK1, CDKN7, MO15, STK1, p39MO15; cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22); K02202 cyclin-dependent kinase 7 [EC:2.7.11.22]
hsa:1069 CETN2, CALT, CEN2; centrin, EF-hand protein, 2; K10840 centrin-2
hsa:2068 ERCC2, COFS2, EM9, MGC102762, MGC126218, MGC126219, TTD, XPD; excision repair cross-complementing rodent repair deficiency, complementation group 2 (EC:3.6.4.12); K10844 DNA excision repair protein ERCC-2 [EC:3.6.4.12]
hsa:2071 ERCC3, BTF2, GTF2H, RAD25, TFIIH, XPB; excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) (EC:3.6.4.12); K10843 DNA excision repair protein ERCC-3 [EC:3.6.4.12]
hsa:2965 GTF2H1, BTF2, TFB1, TFIIH; general transcription factor IIH, polypeptide 1, 62kDa; K03141 transcription initiation factor TFIIH subunit H1
hsa:2966 GTF2H2, BTF2, BTF2P44, MGC102806, T-BTF2P44, TFIIH; general transcription factor IIH, polypeptide 2, 44kDa; K03142 transcription initiation factor TFIIH subunit H2
hsa:2967 GTF2H3, BTF2, TFB4, TFIIH; general transcription factor IIH, polypeptide 3, 34kDa; K03143 transcription initiation factor TFIIH subunit H3
hsa:2968 GTF2H4, TFB2, TFIIH; general transcription factor IIH, polypeptide 4, 52kDa; K03144 transcription initiation factor TFIIH subunit H4
hsa:29935 RPA4, HSU24186, MGC120333, MGC120334; replication protein A4, 30kDa; K10741 replication factor A4
hsa:4331 MNAT1, CAP35, MAT1, RNF66, TFB3; menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis); K10842 CDK-activating kinase assembly factor MAT1
hsa:5111 PCNA, MGC8367; proliferating cell nuclear antigen; K04802 proliferating cell nuclear antigen
hsa:5426 POLE, DKFZp434F222, FLJ21434, POLE1; polymerase (DNA directed), epsilon (EC:2.7.7.7); K02324 DNA polymerase epsilon subunit 1 [EC:2.7.7.7]
hsa:5886 RAD23A, HHR23A, MGC111083; RAD23 homolog A (S. cerevisiae); K10839 UV excision repair protein RAD23
hsa:5981 RFC1, A1, MGC51786, MHCBFB, PO-GA, RECC1, RFC, RFC140; replication factor C (activator 1) 1, 145kDa; K10754 replication factor C subunit 1
hsa:5982 RFC2, A1, MGC3665, RFC40; replication factor C (activator 1) 2, 40kDa; K10755 replication factor C subunit 2/4
hsa:5983 RFC3, MGC5276, RFC38; replication factor C (activator 1) 3, 38kDa; K10756 replication factor C subunit 3/5
hsa:5984 RFC4, A1, MGC27291, RFC37; replication factor C (activator 1) 4, 37kDa; K10755 replication factor C subunit 2/4
hsa:5985 RFC5, MGC1155, RFC36; replication factor C (activator 1) 5, 36.5kDa; K10756 replication factor C subunit 3/5
hsa:6117 RPA1, HSSB, MST075, REPA1, RF-A, RP-A, RPA70; replication protein A1, 70kDa; K07466 replication factor A1
hsa:6118 RPA2, REPA2, RPA32; replication protein A2, 32kDa; K10739 replication factor A2
hsa:6119 RPA3, REPA3; replication protein A3, 14kDa; K10740 replication factor A3
hsa:902 CCNH, CAK, p34, p37; cyclin H; K06634 cyclin H
hsa:9978 RBX1, BA554C12.1, FLJ60363, MGC13357, MGC1481, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1

hsa00240 Pyrimidine metabolism - Homo sapiens (human) (22)



hsa:10621 POLR3F, MGC13517, RPC39, RPC6; polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa; K03025 DNA-directed RNA polymerase III subunit C34 [EC:2.7.7.6]
hsa:10622 POLR3G, RPC32, RPC7; polymerase (RNA) III (DNA directed) polypeptide G (32kD); K03024 DNA-directed RNA polymerase III subunit C31 [EC:2.7.7.6]
hsa:10623 POLR3C, RPC3, RPC62; polymerase (RNA) III (DNA directed) polypeptide C (62kD); K03023 DNA-directed RNA polymerase III subunit C3 [EC:2.7.7.6]
hsa:11128 POLR3A, RPC1, RPC155, hRPC155; polymerase (RNA) III (DNA directed) polypeptide A, 155kDa (EC:2.7.7.6); K03018 DNA-directed RNA polymerase III subunit C1 [EC:2.7.7.6]
hsa:171568 POLR3H, KIAA1665, MGC111097, MGC29654, RPC22.9, RPC8; polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) (EC:2.7.7.6); K03022 DNA-directed RNA polymerase III subunit C25 [EC:2.7.7.6]
hsa:3704 ITPA, C20orf37, HLC14-06-P, ITPase, dJ794I6.3; inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (EC:3.6.1.19); K01519 nucleoside-triphosphate pyrophosphatase [EC:3.6.1.19]
hsa:51728 POLR3K, C11, C11-RNP3, RPC10, RPC11, RPC12.5, hRPC11; polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa; K03019 DNA-directed RNA polymerase III subunit C11 [EC:2.7.7.6]
hsa:5426 POLE, DKFZp434F222, FLJ21434, POLE1; polymerase (DNA directed), epsilon (EC:2.7.7.7); K02324 DNA polymerase epsilon subunit 1 [EC:2.7.7.7]
hsa:5430 POLR2A, MGC75453, POLR2, POLRA, RPB1, RPBh1, RPO2, RPOL2, RpIILS, hRPB220, hsRPB1; polymerase (RNA) II (DNA directed) polypeptide A, 220kDa (EC:2.7.7.6 2.7.7.48); K03006 DNA-directed RNA polymerase II subunit A [EC:2.7.7.6]
hsa:5431 POLR2B, POL2RB, RPB2, hRPB140, hsRPB2; polymerase (RNA) II (DNA directed) polypeptide B, 140kDa (EC:2.7.7.6); K03010 DNA-directed RNA polymerase II subunit B [EC:2.7.7.6]
hsa:5432 POLR2C, RPB3, RPB31, hRPB33, hsRPB3; polymerase (RNA) II (DNA directed) polypeptide C, 33kDa (EC:2.7.7.6); K03011 DNA-directed RNA polymerase II subunit C
hsa:5433 POLR2D, HSRBP4, HSRPB4, RBP4, RPB16; polymerase (RNA) II (DNA directed) polypeptide D (EC:2.7.7.6); K03012 DNA-directed RNA polymerase II subunit D
hsa:5434 POLR2E, RPABC1, RPB5, XAP4, hRPB25, hsRPB5; polymerase (RNA) II (DNA directed) polypeptide E, 25kDa (EC:2.7.7.6); K03013 DNA-directed RNA polymerase II subunit E
hsa:5435 POLR2F, HRBP14.4, POLRF, RPABC2, RPB14.4, RPB6; polymerase (RNA) II (DNA directed) polypeptide F (EC:2.7.7.6); K03014 DNA-directed RNA Polymerase II subunit F
hsa:5436 POLR2G, MGC138367, MGC138369, RPB19, RPB7, hRPB19, hsRPB7; polymerase (RNA) II (DNA directed) polypeptide G (EC:2.7.7.6); K03015 DNA-directed RNA polymerase II subunit G
hsa:5437 POLR2H, RPABC3, RPB17, RPB8, hsRPB8; polymerase (RNA) II (DNA directed) polypeptide H (EC:2.7.7.6); K03016 DNA-directed RNA polymerase II subunit H
hsa:5438 POLR2I, RPB9, hRPB14.5; polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa (EC:2.7.7.6); K03017 DNA-directed RNA polymerase II subunit I
hsa:5439 POLR2J, MGC71910, POLR2J1, RPB11, RPB11A, RPB11m, hRPB14; polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa (EC:2.7.7.6); K03008 DNA-directed RNA polymerase II subunit J
hsa:5440 POLR2K, ABC10-alpha, RPABC4, RPB10alpha, RPB12, RPB7.0, hRPB7.0, hsRPB10a; polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa (EC:2.7.7.6); K03009 DNA-directed RNA Polymerase II subunit K
hsa:5441 POLR2L, RBP10, RPABC5, RPB10, RPB10beta, RPB7.6, hRPB7.6, hsRPB10b; polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa (EC:2.7.7.6); K03007 DNA-directed RNA Polymerase II subunit L
hsa:55703 POLR3B, C128, DKFZp686B10117, FLJ10388, RPC2; polymerase (RNA) III (DNA directed) polypeptide B (EC:2.7.7.6); K03021 DNA-directed RNA polymerase III subunit C2 [EC:2.7.7.6]
hsa:661 POLR3D, BN51T, RPC4, RPC53, TSBN51; polymerase (RNA) III (DNA directed) polypeptide D, 44kDa (EC:2.7.7.6); K03026 DNA-directed RNA polymerase III subunit C4 [EC:2.7.7.6]

hsa04142 Lysosome - Homo sapiens (human) (22)



hsa:10053 AP1M2, AP1-mu2, HSMU1B, MU-1B, MU1B, mu2; adaptor-related protein complex 1, mu 2 subunit; K12393 AP-1 complex subunit mu
hsa:10947 AP3M2, AP47B, CLA20, P47B; adaptor-related protein complex 3, mu 2 subunit; K12398 AP-3 complex subunit mu
hsa:1174 AP1S1, AP19, CLAPS1, FLJ92436, SIGMA1A, WUGSC:H_DJ0747G18.2; adaptor-related protein complex 1, sigma 1 subunit; K12394 AP-1 complex subunit sigma 1/2
hsa:1213 CLTC, CHC, CHC17, CLH-17, CLTCL2, Hc, KIAA0034; clathrin, heavy chain (Hc); K04646 clathrin, heavy polypeptide
hsa:130340 AP1S3; adaptor-related protein complex 1, sigma 3 subunit; K12395 AP-1 complex subunit sigma-3
hsa:1509 CTSD, CLN10, CPSD, MGC2311; cathepsin D (EC:3.4.23.5); K01379 cathepsin D [EC:3.4.23.5]
hsa:1510 CTSE, CATE; cathepsin E (EC:3.4.23.34); K01382 cathepsin E [EC:3.4.23.34]
hsa:162 AP1B1, ADTB1, AP105A, BAM22, CLAPB2; adaptor-related protein complex 1, beta 1 subunit; K12392 AP-1 complex subunit beta-1
hsa:164 AP1G1, ADTG, CLAPG1, MGC18255; adaptor-related protein complex 1, gamma 1 subunit; K12391 AP-1 complex subunit gamma-1
hsa:2548 GAA, LYAG; glucosidase, alpha; acid (EC:3.2.1.20); K12316 lysosomal alpha-glucosidase [EC:3.2.1.20]
hsa:2629 GBA, GBA1, GCB, GLUC; glucosidase, beta, acid (EC:3.2.1.45); K01201 glucosylceramidase [EC:3.2.1.45]
hsa:26985 AP3M1, MGC22164; adaptor-related protein complex 3, mu 1 subunit; K12398 AP-3 complex subunit mu
hsa:3916 LAMP1, CD107a, LAMPA, LGP120; lysosomal-associated membrane protein 1; K06528 lysosomal-associated membrane protein 1/2
hsa:4125 MAN2B1, LAMAN, MANB; mannosidase, alpha, class 2B, member 1 (EC:3.2.1.24); K12311 lysosomal alpha-mannosidase [EC:3.2.1.24]
hsa:4126 MANBA, MANB1; mannosidase, beta A, lysosomal (EC:3.2.1.25); K01192 beta-mannosidase [EC:3.2.1.25]
hsa:4758 NEU1, FLJ93471, NANH, NEU, SIAL1; sialidase 1 (lysosomal sialidase) (EC:3.2.1.18); K01186 sialidase-1 [EC:3.2.1.18]
hsa:51606 ATP6V1H, MSTP042, NBP1, SFD, SFDalpha, SFDbeta, VMA13; ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H (EC:3.6.3.14); K02144 V-type H+-transporting ATPase 54 kD subunit [EC:3.6.3.14]
hsa:6609 SMPD1, ASM, ASMASE, NPD; sphingomyelin phosphodiesterase 1, acid lysosomal (EC:3.1.4.12); K12350 sphingomyelin phosphodiesterase [EC:3.1.4.12]
hsa:8905 AP1S2, MGC:1902, MRX59, SIGMA1B; adaptor-related protein complex 1, sigma 2 subunit; K12394 AP-1 complex subunit sigma 1/2
hsa:8907 AP1M1, AP47, CLAPM2, CLTNM, MU-1A; adaptor-related protein complex 1, mu 1 subunit; K12393 AP-1 complex subunit mu
hsa:8943 AP3D1, ADTD, hBLVR; adaptor-related protein complex 3, delta 1 subunit; K12396 AP-3 complex subunit delta-1
hsa:967 CD63, LAMP-3, ME491, MLA1, OMA81H, TSPAN30; CD63 molecule; K06497 CD63 antigen

hsa03013 RNA transport - Homo sapiens (human) (22)



hsa:11097 NUPL2, CG1, NLP-1, NLP_1, hCG1; nucleoporin like 2; K14321 nucleoporin-like protein 2
hsa:1915 EEF1A1, CCS-3, CCS3, EE1A1, EEF-1, EEF1A, EF-Tu, EF1A, FLJ25721, GRAF-1EF, HNGC:16303, LENG7, MGC102687, MGC131894, MGC16224, PTI1, eEF1A-1; eukaryotic translation elongation factor 1 alpha 1; K03231 elongation factor EF-1 alpha subunit [EC:3.6.5.3]
hsa:1917 EEF1A2, EEF1AL, EF-1-alpha-2, EF1A, FLJ41696, HS1, STN, STNL; eukaryotic translation elongation factor 1 alpha 2; K03231 elongation factor EF-1 alpha subunit [EC:3.6.5.3]
hsa:1965 EIF2S1, EIF-2, EIF-2A, EIF-2alpha, EIF2, EIF2A; eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa; K03237 translation initiation factor eIF-2 alpha subunit
hsa:1968 EIF2S3, EIF2, EIF2G, EIF2gamma, eIF-2gA; eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa; K03242 translation initiation factor eIF-2 gamma subunit
hsa:1977 EIF4E, CBP, EIF4E1, EIF4EL1, EIF4F, MGC111573; eukaryotic translation initiation factor 4E; K03259 translation initiation factor eIF-4E
hsa:1981 EIF4G1, DKFZp686A1451, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220; eukaryotic translation initiation factor 4 gamma, 1; K03260 translation initiation factor eIF-4F
hsa:23636 NUP62, DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, SNDI, p62; nucleoporin 62kDa; K14306 nuclear pore complex protein Nup62
hsa:26986 PABPC1, PAB1, PABP, PABP1, PABPC2, PABPL1; poly(A) binding protein, cytoplasmic 1; K13126 polyadenylate-binding protein
hsa:3837 KPNB1, IMB1, IPO1, IPOB, Impnb, MGC2155, MGC2156, MGC2157, NTF97; karyopherin (importin) beta 1; K14293 importin subunit beta-1
hsa:4928 NUP98, ADIR2, NUP196, NUP96; nucleoporin 98kDa; K14297 nuclear pore complex protein Nup98-Nup96
hsa:53371 NUP54, MGC13407; nucleoporin 54kDa; K14308 nuclear pore complex protein Nup54
hsa:5901 RAN, ARA24, Gsp1, TC4; RAN, member RAS oncogene family; K07936 GTP-binding nuclear protein Ran
hsa:7329 UBE2I, C358B7.1, P18, UBC9; ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) (EC:6.3.2.19); K10577 ubiquitin-conjugating enzyme E2 I [EC:6.3.2.19]
hsa:7341 SUMO1, DAP1, GMP1, OFC10, PIC1, SENP2, SMT3, SMT3C, SMT3H3, UBL1; SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae); K12160 small ubiquitin-related modifier
hsa:7514 XPO1, CRM1, DKFZp686B1823, emb; exportin 1 (CRM1 homolog, yeast); K14290 exportin-1
hsa:79902 NUP85, FLJ12549, Nup75; nucleoporin 85kDa; K14304 nuclear pore complex protein Nup85
hsa:8021 NUP214, CAIN, CAN, D9S46E, MGC104525, N214; nucleoporin 214kDa; K14317 nuclear pore complex protein Nup214
hsa:8487 SIP1, GEMIN2, SIP1-delta; survival of motor neuron protein interacting protein 1; K13130 survival of motor neuron protein-interacting protein 1
hsa:8894 EIF2S2, DKFZp686L18198, EIF2, EIF2B, EIF2beta, MGC8508; eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa; K03238 translation initiation factor eIF-2 beta subunit
hsa:9669 EIF5B, DKFZp434I036, FLJ10524, IF2, KIAA0741; eukaryotic translation initiation factor 5B; K03243 translation initiation factor eIF-5B
hsa:9972 NUP153, HNUP153, N153; nucleoporin 153kDa; K14296 nuclear pore complex protein Nup153

hsa05143 African trypanosomiasis - Homo sapiens (human) (22)



hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:335 APOA1, MGC117399; apolipoprotein A-I; K08757 apolipoprotein A-I
hsa:3383 ICAM1, BB2, CD54, P3.58; intercellular adhesion molecule 1; K06490 intercellular adhesion molecule 1
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:355 FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas (TNF receptor superfamily, member 6); K04390 tumor necrosis factor receptor superfamily member 6
hsa:3553 IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1, beta
hsa:356 FASLG, APT1LG1, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor superfamily, member 6
hsa:3569 IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6 (interferon, beta 2); K05405 interleukin 6
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3592 IL12A, CLMF, IL-12A, NFSK, NKSF1, P35; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); K05406 interleukin 12A
hsa:3593 IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); K05425 interleukin 12B
hsa:3620 IDO1, IDO, INDO; indoleamine 2,3-dioxygenase 1 (EC:1.13.11.52); K00463 indoleamine 2,3-dioxygenase [EC:1.13.11.52]
hsa:3910 LAMA4, DKFZp686D23145, LAMA3, LAMA4*-1; laminin, alpha 4; K06241 laminin, alpha 4
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:6401 SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2; selectin E; K06494 selectin, endothelial cell
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:7412 VCAM1, CD106, DKFZp779G2333, INCAM-100, MGC99561; vascular cell adhesion molecule 1; K06527 vascular cell adhesion molecule 1

hsa04120 Ubiquitin mediated proteolysis - Homo sapiens (human) (22)



hsa:22954 TRIM32, BBS11, HT2A, LGMD2H, TATIP; tripartite motif-containing 32; K10607 tripartite motif-containing protein 32 [EC:6.3.2.19]
hsa:23291 FBXW11, BTRC2, BTRCP2, FBW1B, FBXW1B, Fbw11, Hos, KIAA0696; F-box and WD repeat domain containing 11; K03362 F-box and WD-40 domain protein 1/11
hsa:329 BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat-containing 2; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:330 BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat-containing 3; K04725 baculoviral IAP repeat-containing 2/3/4
hsa:4193 MDM2, HDMX, MGC5370, MGC71221, hdm2; Mdm2 p53 binding protein homolog (mouse); K06643 transformed 3T3 cell double minute 2, p53-binding protein [EC:6.3.2.19]
hsa:4734 NEDD4, KIAA0093, MGC176705, NEDD4-1, RPF1; neural precursor cell expressed, developmentally down-regulated 4 (EC:6.3.2.-); K10591 E3 ubiquitin-protein ligase NEDD4 [EC:6.3.2.19]
hsa:5371 PML, MYL, PP8675, RNF71, TRIM19; promyelocytic leukemia; K10054 probable transcription factor PML
hsa:6502 SKP2, FBL1, FBXL1, FLB1, MGC1366; S-phase kinase-associated protein 2 (p45); K03875 F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2)
hsa:672 BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PSCP, RNF53; breast cancer 1, early onset; K10605 breast cancer type 1 susceptibility protein
hsa:6921 TCEB1, SIII; transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C); K03872 transcription elongation factor B, polypeptide 1
hsa:6923 TCEB2, ELOB, SIII; transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B); K03873 transcription elongation factor B, polypeptide 2
hsa:7317 UBA1, A1S9, A1S9T, A1ST, AMCX1, GXP1, MGC4781, POC20, SMAX2, UBA1A, UBE1, UBE1X; ubiquitin-like modifier activating enzyme 1 (EC:6.3.2.19); K03178 ubiquitin-activating enzyme E1 [EC:6.3.2.19]
hsa:7321 UBE2D1, E2(17)KB1, SFT, UBC4/5, UBCH5, UBCH5A; ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) (EC:6.3.2.19); K06689 ubiquitin-conjugating enzyme E2 D/E [EC:6.3.2.19]
hsa:7329 UBE2I, C358B7.1, P18, UBC9; ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) (EC:6.3.2.19); K10577 ubiquitin-conjugating enzyme E2 I [EC:6.3.2.19]
hsa:7332 UBE2L3, E2-F1, L-UBC, UBCH7, UbcM4; ubiquitin-conjugating enzyme E2L 3 (EC:6.3.2.19); K04552 ubiquitin-conjugating enzyme E2 L3 [EC:6.3.2.19]
hsa:8065 CUL5, VACM-1, VACM1; cullin 5; K10612 cullin 5
hsa:83737 ITCH, AIF4, AIP4, NAPP1, dJ468O1.1; itchy E3 ubiquitin protein ligase homolog (mouse); K05632 atrophin-1 interacting protein 4 [EC:6.3.2.19]
hsa:8651 SOCS1, CIS1, CISH1, JAB, SOCS-1, SSI-1, SSI1, TIP3; suppressor of cytokine signaling 1; K04694 suppressor of cytokine signaling 1
hsa:867 CBL, C-CBL, CBL2, RNF55; Cas-Br-M (murine) ecotropic retroviral transforming sequence; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19]
hsa:8945 BTRC, BETA-TRCP, FBW1A, FBXW1, FBXW1A, FWD1, MGC4643, bTrCP, bTrCP1, betaTrCP; beta-transducin repeat containing; K03362 F-box and WD-40 domain protein 1/11
hsa:991 CDC20, CDC20A, MGC102824, bA276H19.3, p55CDC; cell division cycle 20 homolog (S. cerevisiae); K03363 cell division cycle 20, cofactor of APC complex
hsa:9978 RBX1, BA554C12.1, FLJ60363, MGC13357, MGC1481, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1

hsa05310 Asthma - Homo sapiens (human) (22)



hsa:3108 HLA-DMA, D6S222E, DMA, HLADM, RING6; major histocompatibility complex, class II, DM alpha; K06752 major histocompatibility complex, class II
hsa:3109 HLA-DMB, D6S221E, RING7; major histocompatibility complex, class II, DM beta; K06752 major histocompatibility complex, class II
hsa:3111 HLA-DOA, HLA-DNA, HLA-DZA, HLADZ; major histocompatibility complex, class II, DO alpha; K06752 major histocompatibility complex, class II
hsa:3112 HLA-DOB, DOB, FLJ57033; major histocompatibility complex, class II, DO beta; K06752 major histocompatibility complex, class II
hsa:3113 HLA-DPA1, HLA-DP1A, HLADP, HLASB, PLT1; major histocompatibility complex, class II, DP alpha 1; K06752 major histocompatibility complex, class II
hsa:3115 HLA-DPB1, DPB1, HLA-DP1B, HLA-DPB; major histocompatibility complex, class II, DP beta 1; K06752 major histocompatibility complex, class II
hsa:3117 HLA-DQA1, CD, CELIAC1, DQ-A1, FLJ27088, FLJ27328, GSE, HLA-DQA, MGC149527; major histocompatibility complex, class II, DQ alpha 1; K06752 major histocompatibility complex, class II
hsa:3118 HLA-DQA2, DX-ALPHA, HLA-DXA; major histocompatibility complex, class II, DQ alpha 2; K06752 major histocompatibility complex, class II
hsa:3119 HLA-DQB1, CELIAC1, HLA-DQB, IDDM1; major histocompatibility complex, class II, DQ beta 1; K06752 major histocompatibility complex, class II
hsa:3122 HLA-DRA, FLJ51114, HLA-DRA1, MLRW; major histocompatibility complex, class II, DR alpha; K06752 major histocompatibility complex, class II
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3125 HLA-DRB3, HLA-DR3B, HLA-DRB1, MGC117330; major histocompatibility complex, class II, DR beta 3; K06752 major histocompatibility complex, class II
hsa:3126 HLA-DRB4, DR-13, DR-14, DR13, DR14, DRB4, HLA-DR4B; major histocompatibility complex, class II, DR beta 4; K06752 major histocompatibility complex, class II
hsa:3127 HLA-DRB5, FLJ76359, HLA-DRB; major histocompatibility complex, class II, DR beta 5; K06752 major histocompatibility complex, class II
hsa:3562 IL3, IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF; interleukin 3 (colony-stimulating factor, multiple); K04736 interleukin 3
hsa:3565 IL4, BCGF-1, BCGF1, BSF1, IL-4, MGC79402; interleukin 4; K05430 interleukin 4
hsa:3586 IL10, CSIF, IL-10, IL10A, MGC126450, MGC126451, TGIF; interleukin 10; K05443 interleukin 10
hsa:3596 IL13, ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600; interleukin 13; K05435 interleukin 13
hsa:6356 CCL11, MGC22554, SCYA11; chemokine (C-C motif) ligand 11; K05509 C-C motif chemokine 7/8/11/12/13
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5

hsa03040 Spliceosome - Homo sapiens (human) (22)



hsa:10262 SF3B4, Hsh49, MGC10828, SAP49, SF3b49; splicing factor 3b, subunit 4, 49kDa; K12831 splicing factor 3B subunit 4
hsa:10915 TCERG1, CA150, MGC133200, TAF2S, Urn1; transcription elongation regulator 1; K12824 transcription elongation regulator 1
hsa:10992 SF3B2, Cus1, SAP145, SF3B145, SF3b1, SF3b150; splicing factor 3b, subunit 2, 145kDa; K12829 splicing factor 3B subunit 2
hsa:22938 SNW1, Bx42, MGC119379, NCOA-62, PRPF45, Prp45, SKIIP, SKIP; SNW domain containing 1; K06063 SNW domain-containing protein 1
hsa:3178 HNRNPA1, HNRPA1, MGC102835, hnRNP_A1, hnRNP-A1; heterogeneous nuclear ribonucleoprotein A1; K12741 heterogeneous nuclear ribonucleoprotein A1/A3
hsa:3190 HNRNPK, CSBP, FLJ41122, HNRPK, TUNP; heterogeneous nuclear ribonucleoprotein K; K12886 heterogeneous nuclear ribonucleoprotein K
hsa:3303 HSPA1A, FLJ54303, FLJ54370, FLJ54392, FLJ54408, FLJ75127, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1, HSPA1B; heat shock 70kDa protein 1A; K03283 heat shock 70kDa protein 1/8
hsa:3304 HSPA1B, FLJ54328, HSP70-1B, HSP70-2, HSPA1A; heat shock 70kDa protein 1B; K03283 heat shock 70kDa protein 1/8
hsa:3306 HSPA2, HSP70-2, HSP70-3; heat shock 70kDa protein 2; K03283 heat shock 70kDa protein 1/8
hsa:3310 HSPA6; heat shock 70kDa protein 6 (HSP70B'); K03283 heat shock 70kDa protein 1/8
hsa:3312 HSPA8, HSC54, HSC70, HSC71, HSP71, HSP73, HSPA10, LAP1, MGC131511, MGC29929, NIP71; heat shock 70kDa protein 8; K03283 heat shock 70kDa protein 1/8
hsa:6426 SRSF1, ASF, FLJ53078, MGC5228, SF2, SF2p33, SFRS1, SRp30a; serine/arginine-rich splicing factor 1; K12890 splicing factor, arginine/serine-rich 1/9
hsa:6427 SRSF2, PR264, SC-35, SC35, SFRS2, SFRS2A, SRp30b; serine/arginine-rich splicing factor 2; K12891 splicing factor, arginine/serine-rich 2
hsa:6430 SRSF5, HRS, SFRS5, SRP40; serine/arginine-rich splicing factor 5; K12893 splicing factor, arginine/serine-rich 4/5/6
hsa:6432 SRSF7, 9G8, AAG3, SFRS7; serine/arginine-rich splicing factor 7; K12896 splicing factor, arginine/serine-rich 7
hsa:6626 SNRPA, Mud1, U1-A, U1A; small nuclear ribonucleoprotein polypeptide A; K11091 U1 small nuclear ribonucleoprotein A
hsa:6627 SNRPA1, Lea1; small nuclear ribonucleoprotein polypeptide A'; K11092 U2 small nuclear ribonucleoprotein A'
hsa:6628 SNRPB, COD, SNRPB1, Sm-B/B', SmB/B', SmB/SmB', snRNP-B; small nuclear ribonucleoprotein polypeptides B and B1; K11086 small nuclear ribonucleoprotein B and B'
hsa:6629 SNRPB2, MGC24807, MGC45309, Msl1; small nuclear ribonucleoprotein polypeptide B; K11094 U2 small nuclear ribonucleoprotein B''
hsa:6632 SNRPD1, HsT2456, SMD1, SNRPD, Sm-D1; small nuclear ribonucleoprotein D1 polypeptide 16kDa; K11087 small nuclear ribonucleoprotein D1
hsa:6633 SNRPD2, SMD2, SNRPD1, Sm-D2; small nuclear ribonucleoprotein D2 polypeptide 16.5kDa; K11096 small nuclear ribonucleoprotein D2
hsa:6634 SNRPD3, SMD3, Sm-D3; small nuclear ribonucleoprotein D3 polypeptide 18kDa; K11088 small nuclear ribonucleoprotein D3

hsa00562 Inositol phosphate metabolism - Homo sapiens (human) (21)



hsa:113026 PLCD3, MGC71172; phospholipase C, delta 3 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:23236 PLCB1, FLJ45792, PI-PLC, PLC-154, PLC-I, PLC154; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:51196 PLCE1, FLJ23659, KIAA1516, MGC167842, NPHS3, PLCE, PPLC; phospholipase C, epsilon 1 (EC:3.1.4.11); K05860 phospholipase C, epsilon
hsa:5286 PIK3C2A, CPK, DKFZp686L193, MGC142218, PI3-K-C2(ALPHA), PI3-K-C2A; phosphoinositide-3-kinase, class 2, alpha polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5287 PIK3C2B, C2-PI3K, DKFZp686G16234; phosphoinositide-3-kinase, class 2, beta polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5288 PIK3C2G, MGC163149, PI3K-C2GAMMA; phosphoinositide-3-kinase, class 2, gamma polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5289 PIK3C3, MGC61518, VPS34, hVps34; phosphoinositide-3-kinase, class 3 (EC:2.7.1.137); K00914 phosphatidylinositol 3-kinase [EC:2.7.1.137]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5331 PLCB3, FLJ37084; phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5332 PLCB4, FLJ16169, PI-PLC; phospholipase C, beta 4 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5333 PLCD1; phospholipase C, delta 1 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:56623 INPP5E, CORS1, JBTS1, MGC117201, MORMS, PPI5PIV; inositol polyphosphate-5-phosphatase, 72 kDa (EC:3.1.3.36); K01099 phosphatidylinositol-bisphosphatase [EC:3.1.3.36]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:84812 PLCD4, MGC12837; phospholipase C, delta 4 (EC:3.1.4.11); K05857 phospholipase C, delta [EC:3.1.4.11]
hsa:89869 PLCZ1, MGC149685, NYD-SP27, PLCzeta; phospholipase C, zeta 1 (EC:3.1.4.11); K05861 phospholipase C, zeta

hsa05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human) (20)



hsa:1495 CTNNA1, CAP102, FLJ36832, FLJ52416; catenin (cadherin-associated protein), alpha 1, 102kDa; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1674 DES, CMD1I, CSM1, CSM2, FLJ12025, FLJ39719, FLJ41013, FLJ41793; desmin; K07610 desmin
hsa:2010 EMD, EDMD, LEMD5, STA; emerin; K12569 emerin
hsa:3655 ITGA6, CD49f, DKFZp686J01244, FLJ18737, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6
hsa:3675 ITGA3, CD49C, FLJ34631, FLJ34704, GAP-B3, GAPB3, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3678 ITGA5, CD49e, FNRA, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5
hsa:3685 ITGAV, CD51, DKFZp686A08142, MSK8, VNRA; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); K06487 integrin alpha V
hsa:3688 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3691 ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4
hsa:3693 ITGB5, FLJ26658; integrin, beta 5; K06588 integrin beta 5
hsa:3908 LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2
hsa:4000 LMNA, CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL, FPLD, HGPS, IDC, LDP1, LFP, LGMD1B, LMN1, LMNC, LMNL1, PRO1; lamin A/C; K12641 lamin A/C
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:6934 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:81 ACTN4, ACTININ-4, DKFZp686K23158, FSGS, FSGS1; actinin, alpha 4; K05699 actinin alpha
hsa:87 ACTN1, FLJ40884, FLJ54432; actinin, alpha 1; K05699 actinin alpha

hsa04610 Complement and coagulation cascades - Homo sapiens (human) (20)



hsa:1380 CR2, C3DR, CD21, SLEB9; complement component (3d/Epstein Barr virus) receptor 2; K04012 complement component (3d/Epstein Barr virus) receptor 2
hsa:1604 CD55, CR, CROM, DAF, TC; CD55 molecule, decay accelerating factor for complement (Cromer blood group); K04006 decay accelerating factor
hsa:2 A2M, CPAMD5, DKFZp779B086, S863-7; alpha-2-macroglobulin; K03910 alpha-2-macroglobulin
hsa:2147 F2, PT; coagulation factor II (thrombin) (EC:3.4.21.5); K01313 coagulation factor II (thrombin) [EC:3.4.21.5]
hsa:3075 CFH, AHUS1, AMBP1, ARMD4, ARMS1, CFHL3, FH, FHL1, HF, HF1, HF2, HUS, MGC88246; complement factor H; K04004 complement factor H
hsa:4153 MBL2, COLEC1, HSMBPC, MBL, MBP, MBP1, MGC116832, MGC116833; mannose-binding lectin (protein C) 2, soluble (opsonic defect); K03991 mannose-binding lectin
hsa:5054 SERPINE1, PAI, PAI-1, PAI1, PLANH1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; K03982 plasminogen activator inhibitor-1
hsa:5265 SERPINA1, A1A, A1AT, AAT, MGC23330, MGC9222, PI, PI1, PRO2275, alpha1AT; serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1; K03984 alpha-1-antitrypsin
hsa:5328 PLAU, ATF, UPA, URK, u-PA; plasminogen activator, urokinase (EC:3.4.21.73); K01348 urokinase plasminogen activator [EC:3.4.21.73]
hsa:5329 PLAUR, CD87, U-PAR, UPAR, URKR; plasminogen activator, urokinase receptor; K03985 plasminogen activator, urokinase receptor
hsa:710 SERPING1, C1IN, C1INH, C1NH, HAE1, HAE2; serpin peptidase inhibitor, clade G (C1 inhibitor), member 1; K04001 C1 inhibitor
hsa:712 C1QA; complement component 1, q subcomponent, A chain; K03986 complement C1q subcomponent subunit A
hsa:713 C1QB; complement component 1, q subcomponent, B chain; K03987 complement C1q subcomponent subunit B
hsa:714 C1QC, C1Q-C, C1QG, FLJ27103; complement component 1, q subcomponent, C chain; K03988 complement C1q subcomponent subunit C
hsa:718 C3, AHUS5, ARMD9, ASP, CPAMD1; complement component 3 (EC:3.4.21.43); K03990 complement component 3
hsa:721 C4B, C4B1, C4B12, C4B2, C4B3, C4B5, C4F, CH, CO4, CPAMD3, FLJ60561, MGC164979; complement component 4B (Chido blood group); K03989 complement component 4
hsa:727 C5, CPAMD4, FLJ17816, FLJ17822, MGC142298; complement component 5; K03994 complement component 5
hsa:728 C5AR1, C5A, C5AR, C5R1, CD88; complement component 5a receptor 1; K04010 C5a anaphylatoxin chemotactic receptor
hsa:735 C9; complement component 9; K04000 complement component 9
hsa:966 CD59, 16.3A5, 1F5, EJ16, EJ30, EL32, FLJ38134, FLJ92039, G344, HRF-20, HRF20, MAC-IP, MACIF, MEM43, MGC2354, MIC11, MIN1, MIN2, MIN3, MIRL, MSK21, p18-20; CD59 molecule, complement regulatory protein; K04008 CD59 antigen

hsa03020 RNA polymerase - Homo sapiens (human) (20)



hsa:10621 POLR3F, MGC13517, RPC39, RPC6; polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa; K03025 DNA-directed RNA polymerase III subunit C34 [EC:2.7.7.6]
hsa:10622 POLR3G, RPC32, RPC7; polymerase (RNA) III (DNA directed) polypeptide G (32kD); K03024 DNA-directed RNA polymerase III subunit C31 [EC:2.7.7.6]
hsa:10623 POLR3C, RPC3, RPC62; polymerase (RNA) III (DNA directed) polypeptide C (62kD); K03023 DNA-directed RNA polymerase III subunit C3 [EC:2.7.7.6]
hsa:11128 POLR3A, RPC1, RPC155, hRPC155; polymerase (RNA) III (DNA directed) polypeptide A, 155kDa (EC:2.7.7.6); K03018 DNA-directed RNA polymerase III subunit C1 [EC:2.7.7.6]
hsa:171568 POLR3H, KIAA1665, MGC111097, MGC29654, RPC22.9, RPC8; polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) (EC:2.7.7.6); K03022 DNA-directed RNA polymerase III subunit C25 [EC:2.7.7.6]
hsa:51728 POLR3K, C11, C11-RNP3, RPC10, RPC11, RPC12.5, hRPC11; polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa; K03019 DNA-directed RNA polymerase III subunit C11 [EC:2.7.7.6]
hsa:5430 POLR2A, MGC75453, POLR2, POLRA, RPB1, RPBh1, RPO2, RPOL2, RpIILS, hRPB220, hsRPB1; polymerase (RNA) II (DNA directed) polypeptide A, 220kDa (EC:2.7.7.6 2.7.7.48); K03006 DNA-directed RNA polymerase II subunit A [EC:2.7.7.6]
hsa:5431 POLR2B, POL2RB, RPB2, hRPB140, hsRPB2; polymerase (RNA) II (DNA directed) polypeptide B, 140kDa (EC:2.7.7.6); K03010 DNA-directed RNA polymerase II subunit B [EC:2.7.7.6]
hsa:5432 POLR2C, RPB3, RPB31, hRPB33, hsRPB3; polymerase (RNA) II (DNA directed) polypeptide C, 33kDa (EC:2.7.7.6); K03011 DNA-directed RNA polymerase II subunit C
hsa:5433 POLR2D, HSRBP4, HSRPB4, RBP4, RPB16; polymerase (RNA) II (DNA directed) polypeptide D (EC:2.7.7.6); K03012 DNA-directed RNA polymerase II subunit D
hsa:5434 POLR2E, RPABC1, RPB5, XAP4, hRPB25, hsRPB5; polymerase (RNA) II (DNA directed) polypeptide E, 25kDa (EC:2.7.7.6); K03013 DNA-directed RNA polymerase II subunit E
hsa:5435 POLR2F, HRBP14.4, POLRF, RPABC2, RPB14.4, RPB6; polymerase (RNA) II (DNA directed) polypeptide F (EC:2.7.7.6); K03014 DNA-directed RNA Polymerase II subunit F
hsa:5436 POLR2G, MGC138367, MGC138369, RPB19, RPB7, hRPB19, hsRPB7; polymerase (RNA) II (DNA directed) polypeptide G (EC:2.7.7.6); K03015 DNA-directed RNA polymerase II subunit G
hsa:5437 POLR2H, RPABC3, RPB17, RPB8, hsRPB8; polymerase (RNA) II (DNA directed) polypeptide H (EC:2.7.7.6); K03016 DNA-directed RNA polymerase II subunit H
hsa:5438 POLR2I, RPB9, hRPB14.5; polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa (EC:2.7.7.6); K03017 DNA-directed RNA polymerase II subunit I
hsa:5439 POLR2J, MGC71910, POLR2J1, RPB11, RPB11A, RPB11m, hRPB14; polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa (EC:2.7.7.6); K03008 DNA-directed RNA polymerase II subunit J
hsa:5440 POLR2K, ABC10-alpha, RPABC4, RPB10alpha, RPB12, RPB7.0, hRPB7.0, hsRPB10a; polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa (EC:2.7.7.6); K03009 DNA-directed RNA Polymerase II subunit K
hsa:5441 POLR2L, RBP10, RPABC5, RPB10, RPB10beta, RPB7.6, hRPB7.6, hsRPB10b; polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa (EC:2.7.7.6); K03007 DNA-directed RNA Polymerase II subunit L
hsa:55703 POLR3B, C128, DKFZp686B10117, FLJ10388, RPC2; polymerase (RNA) III (DNA directed) polypeptide B (EC:2.7.7.6); K03021 DNA-directed RNA polymerase III subunit C2 [EC:2.7.7.6]
hsa:661 POLR3D, BN51T, RPC4, RPC53, TSBN51; polymerase (RNA) III (DNA directed) polypeptide D, 44kDa (EC:2.7.7.6); K03026 DNA-directed RNA polymerase III subunit C4 [EC:2.7.7.6]

hsa04976 Bile secretion - Homo sapiens (human) (19)



hsa:107 ADCY1, AC1; adenylate cyclase 1 (brain) (EC:4.6.1.1); K08041 adenylate cyclase 1 [EC:4.6.1.1]
hsa:108 ADCY2, AC2, FLJ16822, FLJ45092, HBAC2, KIAA1060, MGC133314; adenylate cyclase 2 (brain) (EC:4.6.1.1); K08042 adenylate cyclase 2 [EC:4.6.1.1]
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:111 ADCY5, AC5; adenylate cyclase 5 (EC:4.6.1.1); K08045 adenylate cyclase 5 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:113 ADCY7, AC7, FLJ36387, KIAA0037; adenylate cyclase 7 (EC:4.6.1.1); K08047 adenylate cyclase 7 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:3156 HMGCR, LDLCQ3; 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34); K00021 hydroxymethylglutaryl-CoA reductase (NADPH) [EC:1.1.1.34]
hsa:3781 KCNN2, KCa2.2, SK2, SKCA2, hSK2; potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2; K04943 potassium intermediate/small conductance calcium-activated channel subfamily N member 2
hsa:3949 LDLR, FH, FHC, LDLCQ2; low density lipoprotein receptor; K12473 low-density lipoprotein receptor
hsa:5243 ABCB1, ABC20, CD243, CLCS, GP170, MDR1, MGC163296, P-GP, PGY1; ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44); K05658 ATP-binding cassette, subfamily B (MDR/TAP), member 1
hsa:5244 ABCB4, ABC21, GBD1, MDR2, MDR2/3, MDR3, PFIC-3, PGY3; ATP-binding cassette, sub-family B (MDR/TAP), member 4 (EC:3.6.3.44); K05659 ATP-binding cassette, subfamily B (MDR/TAP), member 4
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:6523 SLC5A1, D22S675, NAGT, SGLT1; solute carrier family 5 (sodium/glucose cotransporter), member 1; K14158 solute carrier family 5 (sodium/glucose cotransporter), member 1
hsa:6580 SLC22A1, HOCT1, OCT1, oct1_cds; solute carrier family 22 (organic cation transporter), member 1; K08198 MFS transporter, OCT family, solute carrier family 22 (organic cation transporter), member 1

hsa03015 mRNA surveillance pathway - Homo sapiens (human) (19)



hsa:10914 PAPOLA, MGC5378, PAP; poly(A) polymerase alpha (EC:2.7.7.19); K14376 poly(A) polymerase [EC:2.7.7.19]
hsa:26986 PABPC1, PAB1, PABP, PABP1, PABPC2, PABPL1; poly(A) binding protein, cytoplasmic 1; K13126 polyadenylate-binding protein
hsa:51692 CPSF3, CPSF, CPSF-73, CPSF73, YSH1; cleavage and polyadenylation specific factor 3, 73kDa; K14403 cleavage and polyadenylation specificity factor subunit 3 [EC:3.1.27.-]
hsa:5515 PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C; protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5516 PPP2CB, PP2Abeta, PP2CB; protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16); K04382 protein phosphatase 2 (formerly 2A), catalytic subunit [EC:3.1.3.16]
hsa:5518 PPP2R1A, MGC786, PP2A-Aalpha, PP2AAALPHA, PR65A; protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5519 PPP2R1B, MGC26454, PP2A-Abeta, PR65B; protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16); K03456 protein phosphatase 2 (formerly 2A), regulatory subunit A
hsa:5520 PPP2R2A, B55A, B55ALPHA, DKFZp686N05117, FLJ26613, FLJ41727, MGC52248, PR52A, PR55A; protein phosphatase 2, regulatory subunit B, alpha (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5521 PPP2R2B, B55BETA, FLJ95686, MGC24888, PP2AB55BETA, PP2ABBETA, PP2APR55B, PP2APR55BETA, PR2AB55BETA, PR2ABBETA, PR2APR55BETA, PR52B, PR55-BETA, PR55BETA, SCA12; protein phosphatase 2, regulatory subunit B, beta (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5522 PPP2R2C, B55-GAMMA, IMYPNO, IMYPNO1, MGC33570, PR52, PR55G; protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5523 PPP2R3A, PPP2R3, PR130, PR72; protein phosphatase 2, regulatory subunit B'', alpha (EC:3.1.3.16); K11583 protein phosphatase 2 (formerly 2A), regulatory subunit B''
hsa:5525 PPP2R5A, B56A, MGC131915, PR61A; protein phosphatase 2, regulatory subunit B', alpha; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5526 PPP2R5B, B56B, FLJ35411, PR61B; protein phosphatase 2, regulatory subunit B', beta; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5527 PPP2R5C, B56G, MGC23064, PR61G; protein phosphatase 2, regulatory subunit B', gamma; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5528 PPP2R5D, B56D, MGC2134, MGC8949; protein phosphatase 2, regulatory subunit B', delta; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:5529 PPP2R5E; protein phosphatase 2, regulatory subunit B', epsilon isoform; K11584 protein phosphatase 2 (formerly 2A), regulatory subunit B'
hsa:56903 PAPOLB, PAPT, TPAP; poly(A) polymerase beta (testis specific) (EC:2.7.7.19); K14376 poly(A) polymerase [EC:2.7.7.19]
hsa:64895 PAPOLG, FLJ11805, FLJ12972, FLJ13482, FLJ14187, MGC133307, MGC133308; poly(A) polymerase gamma (EC:2.7.7.19); K14376 poly(A) polymerase [EC:2.7.7.19]
hsa:8732 RNGTT, CAP1A, DKFZp686J2031, HCE, HCE1, hCAP; RNA guanylyltransferase and 5'-phosphatase (EC:2.7.7.50 3.1.3.33); K13917 mRNA-capping enzyme [EC:2.7.7.50 3.1.3.33]

hsa04930 Type II diabetes mellitus - Homo sapiens (human) (19)



hsa:2475 MTOR, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein
hsa:3551 IKBKB, FLJ33771, FLJ36218, FLJ38368, FLJ40509, IKK-beta, IKK2, IKKB, MGC131801, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase beta subunit [EC:2.7.11.10]
hsa:3630 INS, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5580 PRKCD, MAY1, MGC49908, PKCD, nPKC-delta; protein kinase C, delta (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5581 PRKCE, MGC125656, MGC125657, PKCE, nPKC-epsilon; protein kinase C, epsilon (EC:2.7.11.13); K06068 novel protein kinase C [EC:2.7.11.13]
hsa:5590 PRKCZ, PKC-ZETA, PKC2; protein kinase C, zeta (EC:2.7.11.13); K06069 atypical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5599 MAPK8, JNK, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5601 MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:5602 MAPK10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24]
hsa:7124 TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2
hsa:8651 SOCS1, CIS1, CISH1, JAB, SOCS-1, SSI-1, SSI1, TIP3; suppressor of cytokine signaling 1; K04694 suppressor of cytokine signaling 1

hsa00510 N-Glycan biosynthesis - Homo sapiens (human) (18)




hsa:10905 MAN1A2, MAN1B; mannosidase, alpha, class 1A, member 2 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:11253 MAN1B1, ERMan1, MANA-ER; mannosidase, alpha, class 1B, member 1 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:11282 MGAT4B, GNT-IV, GNT-IVB; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B (EC:2.4.1.145); K00738 alpha-1,3-mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferase A/B [EC:2.4.1.145]
hsa:11320 MGAT4A, GNT-IV, GNT-IVA; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A (EC:2.4.1.145); K00738 alpha-1,3-mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferase A/B [EC:2.4.1.145]
hsa:146664 MGAT5B, FLJ25132, GnT-IX, GnT-VB, KIAA2008; mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B (EC:2.4.1.155); K09661 mannosyl alpha-1,6-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B [EC:2.4.1.-]
hsa:23193 GANAB, G2AN, GLUII, KIAA0088; glucosidase, alpha; neutral AB (EC:3.2.1.84); K05546 alpha 1,3-glucosidase [EC:3.2.1.84]
hsa:2530 FUT8, MGC26465; fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (EC:2.4.1.68); K00717 glycoprotein 6-alpha-L-fucosyltransferase [EC:2.4.1.68]
hsa:25834 MGAT4C, GNTIVH, HGNT-IV-H; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) (EC:2.4.1.145); K13748 alpha-1,3-mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferase C [EC:2.4.1.201 2.4.1.145]
hsa:2683 B4GALT1, B4GAL-T1, CDG2D, DKFZp686N19253, GGTB2, GT1, GTB, MGC50983, beta4Gal-T1; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07966 beta-1,4-galactosyltransferase 1 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]
hsa:4121 MAN1A1, HUMM3, HUMM9, MAN9; mannosidase, alpha, class 1A, member 1 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:4122 MAN2A2, MANA2X; mannosidase, alpha, class 2A, member 2 (EC:3.2.1.114); K01231 alpha-mannosidase II [EC:3.2.1.114]
hsa:4124 MAN2A1, GOLIM7, MANA2, MANII; mannosidase, alpha, class 2A, member 1 (EC:3.2.1.114); K01231 alpha-mannosidase II [EC:3.2.1.114]
hsa:4247 MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2; mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143); K00736 alpha-1,6-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase [EC:2.4.1.143]
hsa:57134 MAN1C1, HMIC, MAN1A3, MAN1C, pp6318; mannosidase, alpha, class 1C, member 1 (EC:3.2.1.113); K01230 mannosyl-oligosaccharide alpha-1,2-mannosidase [EC:3.2.1.113]
hsa:7841 MOGS, CDG2B, GCS1; mannosyl-oligosaccharide glucosidase (EC:3.2.1.106); K01228 mannosyl-oligosaccharide glucosidase [EC:3.2.1.106]
hsa:79868 ALG13, CXorf45, FLJ23018, FLJ31785, GLT28D1, MDS031, MGC12423, YGL047W; asparagine-linked glycosylation 13 homolog (S. cerevisiae) (EC:2.4.1.141); K07432 beta-1,4-N-acetylglucosaminyltransferase [EC:2.4.1.141]
hsa:8703 B4GALT3, beta4Gal-T3; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 (EC:2.4.1.90 2.4.1.38); K07968 beta-1,4-galactosyltransferase 3 [EC:2.4.1.90 2.4.1.38 2.4.1.-]
hsa:8704 B4GALT2, B4Gal-T2, B4Gal-T3, beta4Gal-T2; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07967 beta-1,4-galactosyltransferase 2 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]

hsa05340 Primary immunodeficiency - Homo sapiens (human) (18)



hsa:100 ADA; adenosine deaminase (EC:3.5.4.4); K01488 adenosine deaminase [EC:3.5.4.4]
hsa:3561 IL2RG, CD132, IL-2RG, IMD4, P64, SCIDX, SCIDX1; interleukin 2 receptor, gamma; K05070 interleukin 2 receptor gamma
hsa:3575 IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA; interleukin 7 receptor; K05072 interleukin 7 receptor
hsa:3718 JAK3, JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK; Janus kinase 3 (EC:2.7.10.2); K11218 Janus kinase 3 [EC:2.7.10.2]
hsa:3932 LCK, LSK, YT16, p56lck, pp58lck; lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2); K05856 lymphocyte-specific protein tyrosine kinase [EC:2.7.10.2]
hsa:4261 CIITA, C2TA, CIITAIV, MHC2TA, NLRA; class II, major histocompatibility complex, transactivator; K08060 class II, major histocompatibility complex, transactivator
hsa:57379 AICDA, AID, ARP2, CDA2, HIGM2; activation-induced cytidine deaminase (EC:3.5.4.5); K10989 activation-induced cytidine deaminase [EC:3.5.4.5]
hsa:5788 PTPRC, B220, CD45, CD45R, GP180, LCA, LY5, T200; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48); K06478 protein tyrosine phosphatase, receptor type, C [EC:3.1.3.48]
hsa:6890 TAP1, ABC17, ABCB2, APT1, D6S114E, FLJ26666, FLJ41500, PSF1, RING4, TAP1*0102N, TAP1N; transporter 1, ATP-binding cassette, sub-family B (MDR/TAP); K05653 ATP-binding cassette, subfamily B (MDR/TAP), member 2
hsa:7374 UNG, DGU, DKFZp781L1143, HIGM4, UDG, UNG1, UNG15, UNG2; uracil-DNA glycosylase (EC:3.2.2.27); K03648 uracil-DNA glycosylase [EC:3.2.2.-]
hsa:7535 ZAP70, FLJ17670, FLJ17679, SRK, STD, TZK, ZAP-70; zeta-chain (TCR) associated protein kinase 70kDa (EC:2.7.10.2); K07360 zeta-chain (TCR) associated protein kinase [EC:2.7.10.2]
hsa:915 CD3D, CD3-DELTA, T3D; CD3d molecule, delta (CD3-TCR complex); K06450 CD3D antigen, delta polypeptide
hsa:916 CD3E, FLJ18683, T3E, TCRE; CD3e molecule, epsilon (CD3-TCR complex); K06451 CD3E antigen, epsilon polypeptide
hsa:920 CD4, CD4mut; CD4 molecule; K06454 CD4 antigen
hsa:925 CD8A, CD8, Leu2, MAL, p32; CD8a molecule; K06458 CD8A antigen, alpha polypeptide
hsa:926 CD8B, CD8B1, LEU2, LY3, LYT3, MGC119115, P37; CD8b molecule; K06459 CD8B antigen, beta polypeptide
hsa:958 CD40, Bp50, CDW40, MGC9013, TNFRSF5, p50; CD40 molecule, TNF receptor superfamily member 5; K03160 tumor necrosis factor receptor superfamily member 5
hsa:959 CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L; CD40 ligand; K03161 tumor necrosis factor (ligand) superfamily, member 5

hsa04150 mTOR signaling pathway - Homo sapiens (human) (17)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:1977 EIF4E, CBP, EIF4E1, EIF4EL1, EIF4F, MGC111573; eukaryotic translation initiation factor 4E; K03259 translation initiation factor eIF-4E
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:2475 MTOR, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein
hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3630 INS, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:6198 RPS6KB1, PS6K, S6K, S6K1, STK14A, p70(S6K)-alpha, p70-S6K, p70-alpha; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1]
hsa:7422 VEGFA, MGC70609, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A/B, PGF

hsa05110 Vibrio cholerae infection - Homo sapiens (human) (17)



hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:375 ARF1; ADP-ribosylation factor 1; K07937 ADP-ribosylation factor 1
hsa:51606 ATP6V1H, MSTP042, NBP1, SFD, SFDalpha, SFDbeta, VMA13; ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H (EC:3.6.3.14); K02144 V-type H+-transporting ATPase 54 kD subunit [EC:3.6.3.14]
hsa:5335 PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5336 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phospholipase C, gamma [EC:3.1.4.11]
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:60 ACTB, PS1TP5BP1; actin, beta; K05692 actin beta/gamma 1
hsa:7082 TJP1, DKFZp686M05161, MGC133289, ZO-1; tight junction protein 1 (zona occludens 1); K05701 tight junction protein 1
hsa:71 ACTG1, ACT, ACTG, DFNA20, DFNA26; actin, gamma 1; K05692 actin beta/gamma 1
hsa:9414 TJP2, MGC26306, X104, ZO2; tight junction protein 2 (zona occludens 2); K06098 tight junction protein 2
hsa:9601 PDIA4, ERP70, ERP72, ERp-72; protein disulfide isomerase family A, member 4 (EC:5.3.4.1); K09582 protein disulfide-isomerase A4 [EC:5.3.4.1]

hsa04975 Fat digestion and absorption - Homo sapiens (human) (16)



hsa:1056 CEL, BAL, BSDL, BSSL, CELL, CEase, FAP, FAPP, LIPA, MODY8; carboxyl ester lipase (bile salt-stimulated lipase) (EC:3.1.1.13 3.1.1.3); K12298 bile salt-stimulated lipase [EC:3.1.1.3 3.1.1.13]
hsa:19 ABCA1, ABC-1, ABC1, CERP, FLJ14958, HDLDT1, MGC164864, MGC165011, TGD; ATP-binding cassette, sub-family A (ABC1), member 1; K05641 ATP-binding cassette, subfamily A (ABC1), member 1
hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:335 APOA1, MGC117399; apolipoprotein A-I; K08757 apolipoprotein A-I
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]

hsa05216 Thyroid cancer - Homo sapiens (human) (15)



hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4609 MYC, MRTL, bHLHe39, c-Myc; v-myc myelocytomatosis viral oncogene homolog (avian); K04377 Myc proto-oncogene protein
hsa:4893 NRAS, ALPS4, N-ras, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas
hsa:5468 PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
hsa:5605 MAP2K2, FLJ26075, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
hsa:595 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1
hsa:6934 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53
hsa:7170 TPM3, FLJ41118, MGC14582, MGC3261, MGC72094, NEM1, OK/SW-cl.5, TM-5, TM3, TM30, TM30nm, TPMsk3, TRK, hscp30; tropomyosin 3; K09290 tropomyosin 3
hsa:999 CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin

hsa00565 Ether lipid metabolism - Homo sapiens (human) (15)



hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5048 PAFAH1B1, LIS1, LIS2, MDCR, MDS, PAFAH; platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) (EC:3.1.1.47); K01062 1-alkyl-2-acetylglycerophosphocholine esterase [EC:3.1.1.47]
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:7941 PLA2G7, LDL-PLA2, LP-PLA2, PAFAH; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (EC:3.1.1.47); K01062 1-alkyl-2-acetylglycerophosphocholine esterase [EC:3.1.1.47]
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]

hsa04960 Aldosterone-regulated sodium reabsorption - Homo sapiens (human) (14)



hsa:3479 IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1
hsa:3630 INS, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5582 PRKCG, MGC57564, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]

hsa00592 alpha-Linolenic acid metabolism - Homo sapiens (human) (13)



hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]

hsa03030 DNA replication - Homo sapiens (human) (13)



hsa:2237 FEN1, FEN-1, MF1, RAD2; flap structure-specific endonuclease 1; K04799 flap endonuclease-1 [EC:3.-.-.-]
hsa:29935 RPA4, HSU24186, MGC120333, MGC120334; replication protein A4, 30kDa; K10741 replication factor A4
hsa:5111 PCNA, MGC8367; proliferating cell nuclear antigen; K04802 proliferating cell nuclear antigen
hsa:5426 POLE, DKFZp434F222, FLJ21434, POLE1; polymerase (DNA directed), epsilon (EC:2.7.7.7); K02324 DNA polymerase epsilon subunit 1 [EC:2.7.7.7]
hsa:5981 RFC1, A1, MGC51786, MHCBFB, PO-GA, RECC1, RFC, RFC140; replication factor C (activator 1) 1, 145kDa; K10754 replication factor C subunit 1
hsa:5982 RFC2, A1, MGC3665, RFC40; replication factor C (activator 1) 2, 40kDa; K10755 replication factor C subunit 2/4
hsa:5983 RFC3, MGC5276, RFC38; replication factor C (activator 1) 3, 38kDa; K10756 replication factor C subunit 3/5
hsa:5984 RFC4, A1, MGC27291, RFC37; replication factor C (activator 1) 4, 37kDa; K10755 replication factor C subunit 2/4
hsa:5985 RFC5, MGC1155, RFC36; replication factor C (activator 1) 5, 36.5kDa; K10756 replication factor C subunit 3/5
hsa:6117 RPA1, HSSB, MST075, REPA1, RF-A, RP-A, RPA70; replication protein A1, 70kDa; K07466 replication factor A1
hsa:6118 RPA2, REPA2, RPA32; replication protein A2, 32kDa; K10739 replication factor A2
hsa:6119 RPA3, REPA3; replication protein A3, 14kDa; K10740 replication factor A3
hsa:6742 SSBP1, Mt-SSB, 
SOSS-B1, SSBP, mtSSB; single-stranded DNA binding protein 1; K03111 single-strand DNA-binding protein

hsa04740 Olfactory transduction - Homo sapiens (human) (13)



hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:1179 CLCA1, CACC, CACC1, CLCRG1, CaCC-1, FLJ95147, GOB5, hCLCA1, hCaCC-1; chloride channel accessory 1; K05027 calcium-activated chloride channel family member 1
hsa:22802 CLCA4, CaCC, CaCC2, MGC142247, MGC142249; chloride channel accessory 4; K05030 calcium-activated chloride channel family member 4
hsa:5137 PDE1C, Hcam3; phosphodiesterase 1C, calmodulin-dependent 70kDa (EC:3.1.4.17); K13755 calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:815 CAMK2A, CAMKA, KIAA0968; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:816 CAMK2B, CAM2, CAMK2, CAMKB, MGC29528; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17]
hsa:9635 CLCA2, CACC, CACC3, CLCRG2, CaCC-3, FLJ97885; chloride channel accessory 2; K05028 calcium-activated chloride channel family member 2

hsa05012 Parkinson's disease - Homo sapiens (human) (13)



hsa:1537 CYC1, UQCR4; cytochrome c-1; K00413 ubiquinol-cytochrome c reductase cytochrome c1 subunit [EC:1.10.2.2]
hsa:291 SLC25A4, AAC1, ANT, ANT1, PEO2, PEO3, T1; solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4; K05863 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator)
hsa:317 APAF1, APAF-1, CED4, DKFZp781B1145; apoptotic peptidase activating factor 1; K02084 apoptotic protease-activating factor
hsa:54205 CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c
hsa:6390 SDHB, FLJ92337, IP, PGL4, SDH, SDH1, SDH2, SDHIP; succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (EC:1.3.5.1); K00235 succinate dehydrogenase (ubiquinone) iron-sulfur protein [EC:1.3.5.1]
hsa:6531 SLC6A3, DAT, DAT1; solute carrier family 6 (neurotransmitter transporter, dopamine), member 3; K05036 solute carrier family 6 (neurotransmitter transporter, dopamine) member 3
hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2]
hsa:7314 UBB, FLJ25987, MGC8385, RPS27A, UBA52, UBC; ubiquitin B; K04551 ubiquitin B
hsa:7317 UBA1, A1S9, A1S9T, A1ST, AMCX1, GXP1, MGC4781, POC20, SMAX2, UBA1A, UBE1, UBE1X; ubiquitin-like modifier activating enzyme 1 (EC:6.3.2.19); K03178 ubiquitin-activating enzyme E1 [EC:6.3.2.19]
hsa:7332 UBE2L3, E2-F1, L-UBC, UBCH7, UbcM4; ubiquitin-conjugating enzyme E2L 3 (EC:6.3.2.19); K04552 ubiquitin-conjugating enzyme E2 L3 [EC:6.3.2.19]
hsa:7416 VDAC1, MGC111064, PORIN, VDAC-1; voltage-dependent anion channel 1; K05862 voltage-dependent anion channel
hsa:836 CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56]
hsa:842 CASP9, APAF-3, APAF3, CASPASE-9c, ICE-LAP6, MCH6; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62]

hsa00564 Glycerophospholipid metabolism - Homo sapiens (human) (13)


hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]

hsa04974 Protein digestion and absorption - Homo sapiens (human) (13)



hsa:1277 COL1A1, OI4; collagen, type I, alpha 1; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1278 COL1A2, OI4; collagen, type I, alpha 2; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1281 COL3A1, EDS4A, FLJ34534; collagen, type III, alpha 1; K06236 collagen, type I/II/III/V/XI, alpha
hsa:1282 COL4A1, arresten; collagen, type IV, alpha 1; K06237 collagen, type IV, alpha
hsa:1284 COL4A2, DKFZp686I14213, FLJ22259; collagen, type IV, alpha 2; K06237 collagen, type IV, alpha
hsa:1286 COL4A4, CA44; collagen, type IV, alpha 4; K06237 collagen, type IV, alpha
hsa:1287 COL4A5, ASLN, ATS, CA54, MGC167109, MGC42377; collagen, type IV, alpha 5; K06237 collagen, type IV, alpha
hsa:1803 DPP4, ADABP, ADCP2, CD26, DPPIV, TP103; dipeptidyl-peptidase 4 (EC:3.4.14.5); K01278 dipeptidyl-peptidase 4 [EC:3.4.14.5]
hsa:3783 KCNN4, IK1, IKCA1, KCA4, KCa3.1, SK4, hIKCa1, hKCa4, hSK4; potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4; K04945 potassium intermediate/small conductance calcium-activated channel subfamily N member 4
hsa:4311 MME, CALLA, CD10, DKFZp686O16152, MGC126681, MGC126707, NEP; membrane metallo-endopeptidase (EC:3.4.24.11); K01389 neprilysin [EC:3.4.24.11]
hsa:5644 PRSS1, DKFZp779A0837, FLJ57296, MGC120175, MGC149362, TRP1, TRY1, TRY4, TRYP1; protease, serine, 1 (trypsin 1) (EC:3.4.21.4); K01312 trypsin [EC:3.4.21.4]
hsa:5645 PRSS2, MGC111183, MGC120174, MGC120175, TRY2, TRY8, TRYP2; protease, serine, 2 (trypsin 2) (EC:3.4.21.4); K01312 trypsin [EC:3.4.21.4]
hsa:6520 SLC3A2, 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE; solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2; K06519 solute carrier family 3, member 2

hsa00591 Linoleic acid metabolism - Homo sapiens (human) (13)



hsa:26279 PLA2G2D, SPLASH, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:30814 PLA2G2E; phospholipase A2, group IIE (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:50487 PLA2G3, GIII-SPLA2, SPLA2III; phospholipase A2, group III (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5319 PLA2G1B, MGC119834, MGC119835, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5320 PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5322 PLA2G5, DKFZp686C2294, GV-PLA2, MGC46205, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:64600 PLA2G2F, FLJ25429, FLJ36326; phospholipase A2, group IIF (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:81579 PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8399 PLA2G10, GXPLA2, GXSPLA2, MGC119918, MGC119919, MGC133367, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:84647 PLA2G12B, GXIIB, GXIIIsPLA2, MGC138151, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8681 JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K01047 phospholipase A2 [EC:3.1.1.4]

hsa04973 Carbohydrate digestion and absorption - Homo sapiens (human) (12)



hsa:10000 AKT3, DKFZp434N0250, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:207 AKT1, AKT, MGC99656, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:208 AKT2, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]
hsa:5290 PIK3CA, MGC142161, MGC142163, PI3K, p110-alpha; phosphoinositide-3-kinase, catalytic, alpha polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5291 PIK3CB, DKFZp779K1237, MGC133043, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphoinositide-3-kinase, catalytic, beta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5293 PIK3CD, P110DELTA, PI3K, p110D; phosphoinositide-3-kinase, catalytic, delta polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5295 PIK3R1, GRB1, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5296 PIK3R2, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:6523 SLC5A1, D22S675, NAGT, SGLT1; solute carrier family 5 (sodium/glucose cotransporter), member 1; K14158 solute carrier family 5 (sodium/glucose cotransporter), member 1

hsa00533 Glycosaminoglycan biosynthesis - keratan sulfate - Homo sapiens (human) (12)



hsa:10164 CHST4, GST3, GlcNAc6ST2, HECGLCNAC6ST, LSST; carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4; K04746 carbohydrate 6-sulfotransferase 4 [EC:2.8.2.-]
hsa:2530 FUT8, MGC26465; fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (EC:2.4.1.68); K00717 glycoprotein 6-alpha-L-fucosyltransferase [EC:2.4.1.68]
hsa:2683 B4GALT1, B4GAL-T1, CDG2D, DKFZp686N19253, GGTB2, GT1, GTB, MGC50983, beta4Gal-T1; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07966 beta-1,4-galactosyltransferase 1 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]
hsa:4166 CHST6, MCDC1; carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6; K09671 carbohydrate 6-sulfotransferase 6 [EC:2.8.2.-]
hsa:6482 ST3GAL1, DKFZp666E036, DKFZp779K2051, FLJ36548, Gal-NAc6S, MGC9183, SIAT4A, SIATFL, ST3GalA, ST3GalA.1, ST3GalIA, ST3GalIA,1, ST3O; ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4); K00780 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4A) [EC:2.4.99.4]
hsa:6483 ST3GAL2, Gal-NAc6S, SIAT4B, ST3GALII, ST3GalA.2; ST3 beta-galactoside alpha-2,3-sialyltransferase 2 (EC:2.4.99.4); K03368 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4B) [EC:2.4.99.4]
hsa:6487 ST3GAL3, SIAT6, ST3GALII, ST3GalIII, ST3N; ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (EC:2.4.99.6); K00781 N-acetyllactosaminide alpha-2,3-sialyltransferase (sialyltransferase 6) [EC:2.4.99.6]
hsa:8534 CHST1, C6ST, KS6ST, KSGal6ST; carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 (EC:2.8.2.21); K01022 keratan sulfate 6-sulfotransferase 1 [EC:2.8.2.21]
hsa:8702 B4GALT4, B4Gal-T4, beta4Gal-T4; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 (EC:2.4.1.90); K07969 beta-1,4-galactosyltransferase 4 [EC:2.4.1.90 2.4.1.-]
hsa:8703 B4GALT3, beta4Gal-T3; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 (EC:2.4.1.90 2.4.1.38); K07968 beta-1,4-galactosyltransferase 3 [EC:2.4.1.90 2.4.1.38 2.4.1.-]
hsa:8704 B4GALT2, B4Gal-T2, B4Gal-T3, beta4Gal-T2; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07967 beta-1,4-galactosyltransferase 2 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]
hsa:9435 CHST2, C6ST, GST-2, GST2, Gn6ST-1; carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2; K04745 carbohydrate 6-sulfotransferase 2 [EC:2.8.2.-]

hsa03430 Mismatch repair - Homo sapiens (human) (11)



hsa:29935 RPA4, HSU24186, MGC120333, MGC120334; replication protein A4, 30kDa; K10741 replication factor A4
hsa:5111 PCNA, MGC8367; proliferating cell nuclear antigen; K04802 proliferating cell nuclear antigen
hsa:5981 RFC1, A1, MGC51786, MHCBFB, PO-GA, RECC1, RFC, RFC140; replication factor C (activator 1) 1, 145kDa; K10754 replication factor C subunit 1
hsa:5982 RFC2, A1, MGC3665, RFC40; replication factor C (activator 1) 2, 40kDa; K10755 replication factor C subunit 2/4
hsa:5983 RFC3, MGC5276, RFC38; replication factor C (activator 1) 3, 38kDa; K10756 replication factor C subunit 3/5
hsa:5984 RFC4, A1, MGC27291, RFC37; replication factor C (activator 1) 4, 37kDa; K10755 replication factor C subunit 2/4
hsa:5985 RFC5, MGC1155, RFC36; replication factor C (activator 1) 5, 36.5kDa; K10756 replication factor C subunit 3/5
hsa:6117 RPA1, HSSB, MST075, REPA1, RF-A, RP-A, RPA70; replication protein A1, 70kDa; K07466 replication factor A1
hsa:6118 RPA2, REPA2, RPA32; replication protein A2, 32kDa; K10739 replication factor A2
hsa:6119 RPA3, REPA3; replication protein A3, 14kDa; K10740 replication factor A3
hsa:6742 SSBP1, Mt-SSB, SOSS-B1, SSBP, mtSSB; single-stranded DNA binding protein 1; K03111 single-strand DNA-binding protein

hsa04962 Vasopressin-regulated water reabsorption - Homo sapiens (human) (10)



hsa:10488 CREB3, LUMAN, LZIP, MGC15333, MGC19782; cAMP responsive element binding protein 3; K09048 cAMP response element-binding protein 3
hsa:109 ADCY3, AC3, KIAA0511; adenylate cyclase 3 (EC:4.6.1.1); K08043 adenylate cyclase 3 [EC:4.6.1.1]
hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:115 ADCY9, AC9, FLJ12046; adenylate cyclase 9 (EC:4.6.1.1); K08049 adenylate cyclase 9 [EC:4.6.1.1]
hsa:1385 CREB1, CREB, MGC9284; cAMP responsive element binding protein 1; K05870 cAMP response element-binding protein 1
hsa:396 ARHGDIA, GDIA1, MGC117248, RHOGDI, RHOGDI-1; Rho GDP dissociation inhibitor (GDI) alpha; K12462 Rho GDP-dissociation inhibitor
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:8766 RAB11A, MGC1490, YL8; RAB11A, member RAS oncogene family; K07904 Ras-related protein Rab-11A

hsa00600 Sphingolipid metabolism - Homo sapiens (human) (10)



hsa:10825 NEU3, FLJ12388, SIAL3; sialidase 3 (membrane sialidase) (EC:3.2.1.18); K12357 sialidase-2/3/4 [EC:3.2.1.18]
hsa:2629 GBA, GBA1, GCB, GLUC; glucosidase, beta, acid (EC:3.2.1.45); K01201 glucosylceramidase [EC:3.2.1.45]
hsa:4758 NEU1, FLJ93471, NANH, NEU, SIAL1; sialidase 1 (lysosomal sialidase) (EC:3.2.1.18); K01186 sialidase-1 [EC:3.2.1.18]
hsa:4759 NEU2, MGC129579, SIAL2; sialidase 2 (cytosolic sialidase) (EC:3.2.1.18); K12357 sialidase-2/3/4 [EC:3.2.1.18]
hsa:55512 SMPD3, FLJ22593, MGC138443, NSMASE2; sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (EC:3.1.4.12); K12352 sphingomyelin phosphodiesterase 3 [EC:3.1.4.12]
hsa:55627 SMPD4, FLJ20297, FLJ20756, KIAA1418, NET13, NSMASE-3, NSMASE3; sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3) (EC:3.1.4.12); K12353 sphingomyelin phosphodiesterase 4 [EC:3.1.4.12]
hsa:6609 SMPD1, ASM, ASMASE, NPD; sphingomyelin phosphodiesterase 1, acid lysosomal (EC:3.1.4.12); K12350 sphingomyelin phosphodiesterase [EC:3.1.4.12]
hsa:6610 SMPD2, ISC1, NSMASE, NSMASE1; sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase) (EC:3.1.4.12); K12351 sphingomyelin phosphodiesterase 2 [EC:3.1.4.12]
hsa:7368 UGT8, CGT, UGT4; UDP glycosyltransferase 8 (EC:2.4.1.45); K04628 2-hydroxyacylsphingosine 1-beta-galactosyltransferase [EC:2.4.1.45]
hsa:9331 B4GALT6, B4Gal-T6, beta4Gal-T6; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6; K07553 beta-1,4-galactosyltransferase 6 [EC:2.4.1.-]

hsa04340 Hedgehog signaling pathway - Homo sapiens (human) (9)



hsa:23291 FBXW11, BTRC2, BTRCP2, FBW1B, FBXW1B, Fbw11, Hos, KIAA0696; F-box and WD repeat domain containing 11; K03362 F-box and WD-40 domain protein 1/11
hsa:2619 GAS1; growth arrest-specific 1; K06232 growth arrest-specific 1
hsa:2736 GLI2, HPE9, THP1, THP2; GLI family zinc finger 2; K06230 zinc finger protein GLI
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:650 BMP2, BMP2A; bone morphogenetic protein 2; K04662 bone morphogenetic protein 2/4
hsa:8945 BTRC, BETA-TRCP, FBW1A, FBXW1, FBXW1A, FWD1, MGC4643, bTrCP, bTrCP1, betaTrCP; beta-transducin repeat containing; K03362 F-box and WD-40 domain protein 1/11

hsa00480 Glutathione metabolism - Homo sapiens (human) (9)


Pubmed
hsa:2539 G6PD, G6PD1; glucose-6-phosphate dehydrogenase (EC:1.1.1.49); K00036 glucose-6-phosphate 1-dehydrogenase [EC:1.1.1.49]
hsa:257202 GPX6, GPX5p, GPXP3, GPx-6, GSHPx-6, dJ1186N24, dJ1186N24.1; glutathione peroxidase 6 (olfactory) (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2876 GPX1, GSHPX1, MGC14399, MGC88245; glutathione peroxidase 1 (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2877 GPX2, GI-GPx, GPRP, GSHPX-GI, GSHPx-2; glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2878 GPX3, GPx-P, GSHPx-3, GSHPx-P; glutathione peroxidase 3 (plasma) (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2879 GPX4, MCSP, PHGPx, snGPx, snPHGPx; glutathione peroxidase 4 (phospholipid hydroperoxidase) (EC:1.11.1.12); K05361 phospholipid-hydroperoxide glutathione peroxidase [EC:1.11.1.12]
hsa:2880 GPX5; glutathione peroxidase 5 (epididymal androgen-related protein) (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2882 GPX7, CL683, FLJ14777, GPX6, GPx-7, GSHPx-7, NPGPx; glutathione peroxidase 7 (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2937 GSS, GSHS, MGC14098; glutathione synthetase (EC:6.3.2.3); K01920 glutathione synthase [EC:6.3.2.3]

hsa04742 Taste transduction - Homo sapiens (human) (9)



hsa:112 ADCY6, AC6, DKFZp779F075, KIAA0422; adenylate cyclase 6 (EC:4.6.1.1); K08046 adenylate cyclase 6 [EC:4.6.1.1]
hsa:114 ADCY8, AC8, ADCY3, HBAC1; adenylate cyclase 8 (brain) (EC:4.6.1.1); K08048 adenylate cyclase 8 [EC:4.6.1.1]
hsa:196883 ADCY4, AC4; adenylate cyclase 4 (EC:4.6.1.1); K08044 adenylate cyclase 4 [EC:4.6.1.1]
hsa:3710 ITPR3, FLJ36205, IP3R, IP3R3; inositol 1,4,5-triphosphate receptor, type 3; K04960 inositol 1,4,5-triphosphate receptor type 3
hsa:5136 PDE1A, HCAM1, HSPDE1A, MGC26303; phosphodiesterase 1A, calmodulin-dependent (EC:3.1.4.17); K13755 calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase [EC:3.1.4.17]
hsa:5330 PLCB2, FLJ38135; phospholipase C, beta 2 (EC:3.1.4.11); K05858 phospholipase C, beta [EC:3.1.4.11]
hsa:5566 PRKACA, MGC102831, MGC48865, PKACA; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5567 PRKACB, DKFZp781I2452, MGC41879, MGC9320, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]
hsa:5568 PRKACG, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11]

hsa00601 Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human) (9)



hsa:10317 B3GALT5, B3GalT-V, B3GalTx, B3T5, GLCT5, beta3Gal-T5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; K03877 beta-1,3-galactosyltransferase 5 [EC:2.4.1.-]
hsa:2683 B4GALT1, B4GAL-T1, CDG2D, DKFZp686N19253, GGTB2, GT1, GTB, MGC50983, beta4Gal-T1; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07966 beta-1,4-galactosyltransferase 1 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]
hsa:6484 ST3GAL4, CGS23, FLJ11867, FLJ46764, NANTA3, SAT3, SIAT4, SIAT4C, ST3GalIV, STZ; ST3 beta-galactoside alpha-2,3-sialyltransferase 4 (EC:2.4.99.4); K03494 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4C) [EC:2.4.99.4]
hsa:6487 ST3GAL3, SIAT6, ST3GALII, ST3GalIII, ST3N; ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (EC:2.4.99.6); K00781 N-acetyllactosaminide alpha-2,3-sialyltransferase (sialyltransferase 6) [EC:2.4.99.6]
hsa:8702 B4GALT4, B4Gal-T4, beta4Gal-T4; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 (EC:2.4.1.90); K07969 beta-1,4-galactosyltransferase 4 [EC:2.4.1.90 2.4.1.-]
hsa:8703 B4GALT3, beta4Gal-T3; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 (EC:2.4.1.90 2.4.1.38); K07968 beta-1,4-galactosyltransferase 3 [EC:2.4.1.90 2.4.1.38 2.4.1.-]
hsa:8704 B4GALT2, B4Gal-T2, B4Gal-T3, beta4Gal-T2; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07967 beta-1,4-galactosyltransferase 2 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]
hsa:8707 B3GALT2, BETA3GALT2, GLCT2, beta3Gal-T2; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2; K07820 beta-1,3-galactosyltransferase 2 [EC:2.4.1.-]
hsa:8708 B3GALT1, MGC126594, beta3Gal-T1; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 (EC:2.4.1.79); K07819 beta-1,3-galactosyltransferase 1 [EC:2.4.1.-]

hsa03410 Base excision repair - Homo sapiens (human) (9)



hsa:142 PARP1, ADPRT, ADPRT_1, ADPRT1, PARP, PARP-1, PPOL, pADPRT-1; poly (ADP-ribose) polymerase 1 (EC:2.4.2.30); K10798 poly [ADP-ribose] polymerase [EC:2.4.2.30]
hsa:143 PARP4, ADPRTL1, PARP-4, PARPL, PH5P, VAULT3, VPARP, VWA5C, p193; poly (ADP-ribose) polymerase family, member 4 (EC:2.4.2.30); K10798 poly [ADP-ribose] polymerase [EC:2.4.2.30]
hsa:2237 FEN1, FEN-1, MF1, RAD2; flap structure-specific endonuclease 1; K04799 flap endonuclease-1 [EC:3.-.-.-]
hsa:23583 SMUG1, FDG, HMUDG, MGC104370, UNG3; single-strand-selective monofunctional uracil-DNA glycosylase 1; K10800 single-strand selective monofunctional uracil DNA glycosylase [EC:3.2.2.-]
hsa:4968 OGG1, HMMH, HOGG1, MUTM, OGH1; 8-oxoguanine DNA glycosylase (EC:4.2.99.18); K03660 N-glycosylase/DNA lyase [EC:3.2.2.- 4.2.99.18]
hsa:5111 PCNA, MGC8367; proliferating cell nuclear antigen; K04802 proliferating cell nuclear antigen
hsa:5423 POLB, MGC125976; polymerase (DNA directed), beta (EC:2.7.7.7); K02330 DNA polymerase beta subunit [EC:2.7.7.7 4.2.99.-]
hsa:5426 POLE, DKFZp434F222, FLJ21434, POLE1; polymerase (DNA directed), epsilon (EC:2.7.7.7); K02324 DNA polymerase epsilon subunit 1 [EC:2.7.7.7]
hsa:7374 UNG, DGU, DKFZp781L1143, HIGM4, UDG, UNG1, UNG15, UNG2; uracil-DNA glycosylase (EC:3.2.2.27); K03648 uracil-DNA glycosylase [EC:3.2.2.-]

hsa03320 PPAR signaling pathway - Homo sapiens (human) (9)



hsa:126129 CPT1C, CATL1, CPT1-B, CPT1P, CPTI-B, CPTIC, FLJ23809; carnitine palmitoyltransferase 1C (EC:2.3.1.21); K08765 carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
hsa:1374 CPT1A, CPT1, CPT1-L, L-CPT1; carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21); K08765 carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
hsa:1375 CPT1B, CPT1-M, CPT1M, CPTI, CPTI-M, FLJ55729, FLJ58750, KIAA1670, M-CPT1, MCCPT1, MCPT1; carnitine palmitoyltransferase 1B (muscle) (EC:2.3.1.21); K08765 carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
hsa:1376 CPT2, CPT1, CPTASE; carnitine palmitoyltransferase 2 (EC:2.3.1.21); K08766 carnitine O-palmitoyltransferase 2 [EC:2.3.1.21]
hsa:335 APOA1, MGC117399; apolipoprotein A-I; K08757 apolipoprotein A-I
hsa:4312 MMP1, CLG, CLGN; matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7); K01388 matrix metalloproteinase-1 (interstitial collagenase) [EC:3.4.24.7]
hsa:5105 PCK1, MGC22652, PEPCK-C, PEPCK1, PEPCKC; phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32]
hsa:5468 PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma
hsa:7316 UBC, HMG20; ubiquitin C; K08770 ubiquitin C

hsa00010 Glycolysis / Gluconeogenesis - Homo sapiens (human) (8)



hsa:2023 ENO1, ENO1L1, MPB1, NNE, PPH; enolase 1, (alpha) (EC:4.2.1.11); K01689 enolase [EC:4.2.1.11]
hsa:2203 FBP1, FBP; fructose-1,6-bisphosphatase 1 (EC:3.1.3.11); K03841 fructose-1,6-bisphosphatase I [EC:3.1.3.11]
hsa:2821 GPI, AMF, DKFZp686C13233, GNPI, NLK, PGI, PHI, SA-36, SA36; glucose-6-phosphate isomerase (EC:5.3.1.9); K01810 glucose-6-phosphate isomerase [EC:5.3.1.9]
hsa:3939 LDHA, GSD11, LDH1, LDHM; lactate dehydrogenase A (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:3945 LDHB, LDH-H, TRG-5; lactate dehydrogenase B (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:3948 LDHC, CT32, LDH3, LDHX, MGC111073; lactate dehydrogenase C (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:5105 PCK1, MGC22652, PEPCK-C, PEPCK1, PEPCKC; phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32]
hsa:8789 FBP2, MGC142192; fructose-1,6-bisphosphatase 2 (EC:3.1.3.11); K03841 fructose-1,6-bisphosphatase I [EC:3.1.3.11]

hsa04330 Notch signaling pathway - Homo sapiens (human) (8)



hsa:1387 CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:171558 PTCRA, PT-ALPHA, PTA; pre T-cell antigen receptor alpha; K06056 pre T-cell antigen receptor alpha
hsa:2033 EP300, KAT3B, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48]
hsa:22938 SNW1, Bx42, MGC119379, NCOA-62, PRPF45, Prp45, SKIIP, SKIP; SNW domain containing 1; K06063 SNW domain-containing protein 1
hsa:2648 KAT2A, GCN5, GCN5L2, MGC102791, PCAF-b, hGCN5; K(lysine) acetyltransferase 2A (EC:2.3.1.48); K06062 histone acetyltransferase [EC:2.3.1.48]
hsa:3065 HDAC1, DKFZp686H12203, GON-10, HD1, RPD3, RPD3L1; histone deacetylase 1 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98]
hsa:4853 NOTCH2, AGS2, hN2; notch 2; K02599 Notch
hsa:8850 KAT2B, CAF, P, P/CAF, PCAF; K(lysine) acetyltransferase 2B (EC:2.3.1.48); K06062 histone acetyltransferase [EC:2.3.1.48]

hsa00514 Other types of O-glycan biosynthesis - Homo sapiens (human) (8)



hsa:146664 MGAT5B, FLJ25132, GnT-IX, GnT-VB, KIAA2008; mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B (EC:2.4.1.155); K09661 mannosyl alpha-1,6-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B [EC:2.4.1.-]
hsa:23127 GLT25D2, C1orf17, FLJ37771, FLJ37873, KIAA0584; glycosyltransferase 25 domain containing 2 (EC:2.4.1.50); K11703 collagen beta-1,O-galactosyltransferase [EC:2.4.1.50]
hsa:2683 B4GALT1, B4GAL-T1, CDG2D, DKFZp686N19253, GGTB2, GT1, GTB, MGC50983, beta4Gal-T1; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07966 beta-1,4-galactosyltransferase 1 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]
hsa:6487 ST3GAL3, SIAT6, ST3GALII, ST3GalIII, ST3N; ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (EC:2.4.99.6); K00781 N-acetyllactosaminide alpha-2,3-sialyltransferase (sialyltransferase 6) [EC:2.4.99.6]
hsa:79709 GLT25D1, FLJ22329, MGC117270; glycosyltransferase 25 domain containing 1 (EC:2.4.1.50); K11703 collagen beta-1,O-galactosyltransferase [EC:2.4.1.50]
hsa:8703 B4GALT3, beta4Gal-T3; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 (EC:2.4.1.90 2.4.1.38); K07968 beta-1,4-galactosyltransferase 3 [EC:2.4.1.90 2.4.1.38 2.4.1.-]
hsa:8704 B4GALT2, B4Gal-T2, B4Gal-T3, beta4Gal-T2; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07967 beta-1,4-galactosyltransferase 2 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]
hsa:9486 CHST10, HNK-1ST, HNK1ST, MGC17148; carbohydrate sulfotransferase 10; K09674 carbohydrate 3-sulfotransferase 10 [EC:2.8.2.-]

hsa00511 Other glycan degradation - Homo sapiens (human) (8)



hsa:10825 NEU3, FLJ12388, SIAL3; sialidase 3 (membrane sialidase) (EC:3.2.1.18); K12357 sialidase-2/3/4 [EC:3.2.1.18]
hsa:23324 MAN2B2, KIAA0935; mannosidase, alpha, class 2B, member 2 (EC:3.2.1.24); K12312 epididymis-specific alpha-mannosidase [EC:3.2.1.24]
hsa:2629 GBA, GBA1, GCB, GLUC; glucosidase, beta, acid (EC:3.2.1.45); K01201 glucosylceramidase [EC:3.2.1.45]
hsa:4123 MAN2C1, DKFZp686E23167, MAN6A8, MANA, MANA1, MGC87979; mannosidase, alpha, class 2C, member 1 (EC:3.2.1.24); K01191 alpha-mannosidase [EC:3.2.1.24]
hsa:4125 MAN2B1, LAMAN, MANB; mannosidase, alpha, class 2B, member 1 (EC:3.2.1.24); K12311 lysosomal alpha-mannosidase [EC:3.2.1.24]
hsa:4126 MANBA, MANB1; mannosidase, beta A, lysosomal (EC:3.2.1.25); K01192 beta-mannosidase [EC:3.2.1.25]
hsa:4758 NEU1, FLJ93471, NANH, NEU, SIAL1; sialidase 1 (lysosomal sialidase) (EC:3.2.1.18); K01186 sialidase-1 [EC:3.2.1.18]
hsa:4759 NEU2, MGC129579, SIAL2; sialidase 2 (cytosolic sialidase) (EC:3.2.1.18); K12357 sialidase-2/3/4 [EC:3.2.1.18]

hsa04260 Cardiac muscle contraction - Homo sapiens (human) (8)



hsa:1537 CYC1, UQCR4; cytochrome c-1; K00413 ubiquinol-cytochrome c reductase cytochrome c1 subunit [EC:1.10.2.2]
hsa:4624 MYH6, ASD3, CMD1EE, CMH14, MYHC, MYHCA, alpha-MHC; myosin, heavy chain 6, cardiac muscle, alpha; K10352 myosin heavy chain
hsa:4625 MYH7, CMD1S, CMH1, DKFZp451F047, MGC138376, MGC138378, MPD1, MYHCB, SPMD, SPMM; myosin, heavy chain 7, cardiac muscle, beta; K10352 myosin heavy chain
hsa:70 ACTC1, ACTC, ASD5, CMD1R, CMH11, LVNC4; actin, alpha, cardiac muscle 1; K12314 actin, alpha cardiac muscle
hsa:7134 TNNC1, CMD1Z, CMH13, TN-C, TNC, TNNC; troponin C type 1 (slow); K05865 troponin C, slow skeletal and cardiac muscles
hsa:7168 TPM1, C15orf13, CMD1Y, HTM-alpha, TMSA; tropomyosin 1 (alpha); K10373 tropomyosin 1
hsa:7169 TPM2, AMCD1, DA1, DA2B, NEM4, TMSB; tropomyosin 2 (beta); K10374 tropomyosin 2
hsa:7170 TPM3, FLJ41118, MGC14582, MGC3261, MGC72094, NEM1, OK/SW-cl.5, TM-5, TM3, TM30, TM30nm, TPMsk3, TRK, hscp30; tropomyosin 3; K09290 tropomyosin 3

hsa04140 Regulation of autophagy - Homo sapiens (human) (7)



hsa:3439 IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@, MGC138207, MGC138505, MGC138507; interferon, alpha 1; K05414 interferon, alpha
hsa:3440 IFNA2, IFN-alphaA, IFNA, INFA2, MGC125764, MGC125765; interferon, alpha 2; K05414 interferon, alpha
hsa:3444 IFNA7, IFN-alphaJ, IFNA-J; interferon, alpha 7; K05414 interferon, alpha
hsa:3449 IFNA16, IFN-alphaO; interferon, alpha 16; K05414 interferon, alpha
hsa:3458 IFNG, IFG, IFI; interferon, gamma; K04687 interferon, gamma
hsa:3630 INS, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin
hsa:5289 PIK3C3, MGC61518, VPS34, hVps34; phosphoinositide-3-kinase, class 3 (EC:2.7.1.137); K00914 phosphatidylinositol 3-kinase [EC:2.7.1.137]

hsa04320 Dorso-ventral axis formation - Homo sapiens (human) (7)


hsa:1956 EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]
hsa:2885 GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2
hsa:3845 KRAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas
hsa:4853 NOTCH2, AGS2, hN2; notch 2; K02599 Notch
hsa:5594 MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5595 MAPK3, ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 extracellular signal-regulated kinase 1/2 [EC:2.7.11.24]
hsa:5604 MAP2K1, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]

hsa03008 Ribosome biogenesis in eukaryotes - Homo sapiens (human) (6)



hsa:1457 CSNK2A1, CK2A1, CKII; casein kinase 2, alpha 1 polypeptide (EC:2.7.11.1); K03097 casein kinase 2, alpha polypeptide [EC:2.7.11.1]
hsa:1459 CSNK2A2, CK2A2, CSNK2A1, FLJ43934; casein kinase 2, alpha prime polypeptide (EC:2.7.11.1); K03097 casein kinase 2, alpha polypeptide [EC:2.7.11.1]
hsa:1460 CSNK2B, CK2B, CK2N, CSK2B, G5A, MGC138222, MGC138224; casein kinase 2, beta polypeptide (EC:2.7.11.1); K03115 casein kinase 2, beta polypeptide
hsa:5901 RAN, ARA24, Gsp1, TC4; RAN, member RAS oncogene family; K07936 GTP-binding nuclear protein Ran
hsa:6880 TAF9, AK6, CGI-137, CINAP, CIP, MGC1603, MGC3647, MGC5067, MGC:1603, MGC:3647, MGC:5067, TAF2G, TAFII31, TAFII32, TAFIID32, hCINAP; TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa (EC:2.7.4.3); K14535 transcription initiation factor TFIID subunit D7 / adenylate kinase [EC:2.7.4.3]
hsa:7514 XPO1, CRM1, DKFZp686B1823, emb; exportin 1 (CRM1 homolog, yeast); K14290 exportin-1

hsa02010 ABC transporters - Homo sapiens (human) (6)



hsa:19 ABCA1, ABC-1, ABC1, CERP, FLJ14958, HDLDT1, MGC164864, MGC165011, TGD; ATP-binding cassette, sub-family A (ABC1), member 1; K05641 ATP-binding cassette, subfamily A (ABC1), member 1
hsa:340273 ABCB5, ABCB5alpha, ABCB5beta, EST422562; ATP-binding cassette, sub-family B (MDR/TAP), member 5; K05660 ATP-binding cassette, subfamily B (MDR/TAP), member 5
hsa:4363 ABCC1, ABC29, ABCC, DKFZp686N04233, DKFZp781G125, GS-X, MRP, MRP1; ATP-binding cassette, sub-family C (CFTR/MRP), member 1; K05665 ATP-binding cassette, subfamily C (CFTR/MRP), member 1
hsa:5243 ABCB1, ABC20, CD243, CLCS, GP170, MDR1, MGC163296, P-GP, PGY1; ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44); K05658 ATP-binding cassette, subfamily B (MDR/TAP), member 1
hsa:5244 ABCB4, ABC21, GBD1, MDR2, MDR2/3, MDR3, PFIC-3, PGY3; ATP-binding cassette, sub-family B (MDR/TAP), member 4 (EC:3.6.3.44); K05659 ATP-binding cassette, subfamily B (MDR/TAP), member 4
hsa:6890 TAP1, ABC17, ABCB2, APT1, D6S114E, FLJ26666, FLJ41500, PSF1, RING4, TAP1*0102N, TAP1N; transporter 1, ATP-binding cassette, sub-family B (MDR/TAP); K05653 ATP-binding cassette, subfamily B (MDR/TAP), member 2

hsa05217 Basal cell carcinoma - Homo sapiens (human) (6)



hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:2736 GLI2, HPE9, THP1, THP2; GLI family zinc finger 2; K06230 zinc finger protein GLI
hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26]
hsa:650 BMP2, BMP2A; bone morphogenetic protein 2; K04662 bone morphogenetic protein 2/4
hsa:6934 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2
hsa:7157 TP53, FLJ92943, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53

hsa03440 Homologous recombination - Homo sapiens (human) (6)



hsa:29935 RPA4, HSU24186, MGC120333, MGC120334; replication protein A4, 30kDa; K10741 replication factor A4
hsa:5888 RAD51, BRCC5, HRAD51, HsRad51, HsT16930, RAD51A, RECA; RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae); K04482 DNA repair protein RAD51
hsa:6117 RPA1, HSSB, MST075, REPA1, RF-A, RP-A, RPA70; replication protein A1, 70kDa; K07466 replication factor A1
hsa:6118 RPA2, REPA2, RPA32; replication protein A2, 32kDa; K10739 replication factor A2
hsa:6119 RPA3, REPA3; replication protein A3, 14kDa; K10740 replication factor A3
hsa:6742 SSBP1, Mt-SSB, SOSS-B1, SSBP, mtSSB; single-stranded DNA binding protein 1; K03111 single-strand DNA-binding protein

hsa00620 Pyruvate metabolism - Homo sapiens (human) (5)



hsa:197257 LDHD, DLD, MGC57726; lactate dehydrogenase D (EC:1.1.2.4); K00102 D-lactate dehydrogenase (cytochrome) [EC:1.1.2.4]
hsa:3939 LDHA, GSD11, LDH1, LDHM; lactate dehydrogenase A (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:3945 LDHB, LDH-H, TRG-5; lactate dehydrogenase B (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:3948 LDHC, CT32, LDH3, LDHX, MGC111073; lactate dehydrogenase C (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:5105 PCK1, MGC22652, PEPCK-C, PEPCK1, PEPCKC; phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32]

hsa00330 Arginine and proline metabolism - Homo sapiens (human) (5)



hsa:262 AMD1, ADOMETDC, AMD, DKFZp313L1234, FLJ26964, SAMDC; adenosylmethionine decarboxylase 1 (EC:4.1.1.50); K01611 S-adenosylmethionine decarboxylase [EC:4.1.1.50]
hsa:4842 NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS; nitric oxide synthase 1 (neuronal) (EC:1.14.13.39); K13240 nitric-oxide synthase, brain [EC:1.14.13.39]
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:4846 NOS3, ECNOS, eNOS; nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39); K13242 nitric-oxide synthase, endothelial [EC:1.14.13.39]
hsa:6303 SAT1, DC21, KFSD, KFSDX, SAT, SSAT, SSAT-1; spermidine/spermine N1-acetyltransferase 1 (EC:2.3.1.57); K00657 diamine N-acetyltransferase [EC:2.3.1.57]

hsa04146 Peroxisome - Homo sapiens (human) (5)



hsa:10005 ACOT8, HNAACTE, PTE-1, PTE-2, PTE1, PTE2, hACTE-III, hTE; acyl-CoA thioesterase 8 (EC:3.1.2.27); K11992 acyl-CoA thioesterase 8 [EC:3.1.2.27]
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:6647 SOD1, ALS, ALS1, IPOA, SOD, homodimer; superoxide dismutase 1, soluble (EC:1.15.1.1); K04565 Cu/Zn superoxide dismutase [EC:1.15.1.1]
hsa:6648 SOD2, IPOB, MNSOD, MVCD6; superoxide dismutase 2, mitochondrial (EC:1.15.1.1); K04564 superoxide dismutase, Fe-Mn family [EC:1.15.1.1]
hsa:847 CAT, MGC138422, MGC138424; catalase (EC:1.11.1.6); K03781 catalase [EC:1.11.1.6]

hsa00052 Galactose metabolism - Homo sapiens (human) (4)



hsa:2548 GAA, LYAG; glucosidase, alpha; acid (EC:3.2.1.20); K12316 lysosomal alpha-glucosidase [EC:3.2.1.20]
hsa:2595 GANC, MGC138256; glucosidase, alpha; neutral C (EC:3.2.1.20); K12317 neutral alpha-glucosidase C [EC:3.2.1.20]
hsa:2683 B4GALT1, B4GAL-T1, CDG2D, DKFZp686N19253, GGTB2, GT1, GTB, MGC50983, beta4Gal-T1; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07966 beta-1,4-galactosyltransferase 1 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]
hsa:8704 B4GALT2, B4Gal-T2, B4Gal-T3, beta4Gal-T2; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (EC:2.4.1.22 2.4.1.90 2.4.1.38); K07967 beta-1,4-galactosyltransferase 2 [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]

hsa03018 RNA degradation - Homo sapiens (human) (4)



hsa:2023 ENO1, ENO1L1, MPB1, NNE, PPH; enolase 1, (alpha) (EC:4.2.1.11); K01689 enolase [EC:4.2.1.11]
hsa:26986 PABPC1, PAB1, PABP, PABP1, PABPC2, PABPL1; poly(A) binding protein, cytoplasmic 1; K13126 polyadenylate-binding protein
hsa:3313 HSPA9, CSA, GRP-75, GRP75, HSPA9B, MGC4500, MOT, MOT2, MTHSP75, PBP74; heat shock 70kDa protein 9 (mortalin); K04043 molecular chaperone DnaK
hsa:3329 HSPD1, CPN60, GROEL, HLD4, HSP60, HSP65, HuCHA60, SPG13; heat shock 60kDa protein 1 (chaperonin); K04077 chaperonin GroEL

hsa00030 Pentose phosphate pathway - Homo sapiens (human) (4)



hsa:2203 FBP1, FBP; fructose-1,6-bisphosphatase 1 (EC:3.1.3.11); K03841 fructose-1,6-bisphosphatase I [EC:3.1.3.11]
hsa:2539 G6PD, G6PD1; glucose-6-phosphate dehydrogenase (EC:1.1.1.49); K00036 glucose-6-phosphate 1-dehydrogenase [EC:1.1.1.49]
hsa:2821 GPI, AMF, DKFZp686C13233, GNPI, NLK, PGI, PHI, SA-36, SA36; glucose-6-phosphate isomerase (EC:5.3.1.9); K01810 glucose-6-phosphate isomerase [EC:5.3.1.9]
hsa:8789 FBP2, MGC142192; fructose-1,6-bisphosphatase 2 (EC:3.1.3.11); K03841 fructose-1,6-bisphosphatase I [EC:3.1.3.11]

hsa00270 Cysteine and methionine metabolism - Homo sapiens (human) (4)



hsa:262 AMD1, ADOMETDC, AMD, DKFZp313L1234, FLJ26964, SAMDC; adenosylmethionine decarboxylase 1 (EC:4.1.1.50); K01611 S-adenosylmethionine decarboxylase [EC:4.1.1.50]
hsa:3939 LDHA, GSD11, LDH1, LDHM; lactate dehydrogenase A (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:3945 LDHB, LDH-H, TRG-5; lactate dehydrogenase B (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:3948 LDHC, CT32, LDH3, LDHX, MGC111073; lactate dehydrogenase C (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]

hsa03450 Non-homologous end-joining - Homo sapiens (human) (4)



hsa:2237 FEN1, FEN-1, MF1, RAD2; flap structure-specific endonuclease 1; K04799 flap endonuclease-1 [EC:3.-.-.-]
hsa:2547 XRCC6, CTC75, CTCBF, G22P1, KU70, ML8, TLAA; X-ray repair complementing defective repair in Chinese hamster cells 6; K10884 ATP-dependent DNA helicase 2 subunit 1
hsa:5591 PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350; protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1); K06642 DNA-dependent protein kinase catalytic subunit [EC:2.7.11.1]
hsa:7520 XRCC5, FLJ39089, KARP-1, KARP1, KU80, KUB2, Ku86, NFIV; X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining); K10885 ATP-dependent DNA helicase 2 subunit 2

hsa00071 Fatty acid metabolism - Homo sapiens (human) (4)



hsa:126129 CPT1C, CATL1, CPT1-B, CPT1P, CPTI-B, CPTIC, FLJ23809; carnitine palmitoyltransferase 1C (EC:2.3.1.21); K08765 carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
hsa:1374 CPT1A, CPT1, CPT1-L, L-CPT1; carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21); K08765 carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
hsa:1375 CPT1B, CPT1-M, CPT1M, CPTI, CPTI-M, FLJ55729, FLJ58750, KIAA1670, M-CPT1, MCCPT1, MCPT1; carnitine palmitoyltransferase 1B (muscle) (EC:2.3.1.21); K08765 carnitine O-palmitoyltransferase 1 [EC:2.3.1.21]
hsa:1376 CPT2, CPT1, CPTASE; carnitine palmitoyltransferase 2 (EC:2.3.1.21); K08766 carnitine O-palmitoyltransferase 2 [EC:2.3.1.21]

hsa00500 Starch and sucrose metabolism - Homo sapiens (human) (4)



hsa:2548 GAA, LYAG; glucosidase, alpha; acid (EC:3.2.1.20); K12316 lysosomal alpha-glucosidase [EC:3.2.1.20]
hsa:2595 GANC, MGC138256; glucosidase, alpha; neutral C (EC:3.2.1.20); K12317 neutral alpha-glucosidase C [EC:3.2.1.20]
hsa:2821 GPI, AMF, DKFZp686C13233, GNPI, NLK, PGI, PHI, SA-36, SA36; glucose-6-phosphate isomerase (EC:5.3.1.9); K01810 glucose-6-phosphate isomerase [EC:5.3.1.9]
hsa:57733 GBA3, CBGL1, GLUC, KLrP, MGC104276, MGC126878; glucosidase, beta, acid 3 (cytosolic) (EC:3.2.1.21); K05350 beta-glucosidase [EC:3.2.1.21]

hsa00603 Glycosphingolipid biosynthesis - globo series - Homo sapiens (human) (4)



hsa:10317 B3GALT5, B3GalT-V, B3GalTx, B3T5, GLCT5, beta3Gal-T5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; K03877 beta-1,3-galactosyltransferase 5 [EC:2.4.1.-]
hsa:6482 ST3GAL1, DKFZp666E036, DKFZp779K2051, FLJ36548, Gal-NAc6S, MGC9183, SIAT4A, SIATFL, ST3GalA, ST3GalA.1, ST3GalIA, ST3GalIA,1, ST3O; ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4); K00780 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4A) [EC:2.4.99.4]
hsa:6483 ST3GAL2, Gal-NAc6S, SIAT4B, ST3GALII, ST3GalA.2; ST3 beta-galactoside alpha-2,3-sialyltransferase 2 (EC:2.4.99.4); K03368 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4B) [EC:2.4.99.4]
hsa:8706 B3GALNT1, B3GALT3, GLCT3, GLOB, Gb4Cer, P, P1, beta3Gal-T3, galT3; beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) (EC:2.4.1.79); K00719 galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase [EC:2.4.1.79]

hsa04744 Phototransduction - Homo sapiens (human) (3)



hsa:801 CALM1, CALM2, CALM3, CALML2, CAMI, DD132, PHKD; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:805 CALM2, CALM1, CALM3, CAMII, FLJ99410, PHKD, PHKD2; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin
hsa:808 CALM3, CALM1, CALM2, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin

hsa00640 Propanoate metabolism - Homo sapiens (human) (3)



hsa:3939 LDHA, GSD11, LDH1, LDHM; lactate dehydrogenase A (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:3945 LDHB, LDH-H, TRG-5; lactate dehydrogenase B (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]
hsa:3948 LDHC, CT32, LDH3, LDHX, MGC111073; lactate dehydrogenase C (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]

hsa00604 Glycosphingolipid biosynthesis - ganglio series - Homo sapiens (human) (3)



hsa:6482 ST3GAL1, DKFZp666E036, DKFZp779K2051, FLJ36548, Gal-NAc6S, MGC9183, SIAT4A, SIATFL, ST3GalA, ST3GalA.1, ST3GalIA, ST3GalIA,1, ST3O; ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4); K00780 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4A) [EC:2.4.99.4]
hsa:6483 ST3GAL2, Gal-NAc6S, SIAT4B, ST3GALII, ST3GalA.2; ST3 beta-galactoside alpha-2,3-sialyltransferase 2 (EC:2.4.99.4); K03368 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4B) [EC:2.4.99.4]
hsa:8705 B3GALT4, BETA3GALT4, GALT2, GALT4; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 (EC:2.4.1.62); K00715 ganglioside galactosyltransferase [EC:2.4.1.62]

hsa00380 Tryptophan metabolism - Homo sapiens (human) (3)



hsa:3620 IDO1, IDO, INDO; indoleamine 2,3-dioxygenase 1 (EC:1.13.11.52); K00463 indoleamine 2,3-dioxygenase [EC:1.13.11.52]
hsa:7453 WARS, GAMMA-2, IFI53, IFP53; tryptophanyl-tRNA synthetase (EC:6.1.1.2); K01867 tryptophanyl-tRNA synthetase [EC:6.1.1.2]
hsa:847 CAT, MGC138422, MGC138424; catalase (EC:1.11.1.6); K03781 catalase [EC:1.11.1.6]

hsa00790 Folate biosynthesis - Homo sapiens (human) (3)



hsa:248 ALPI, IAP; alkaline phosphatase, intestinal (EC:3.1.3.1); K01077 alkaline phosphatase [EC:3.1.3.1]
hsa:249 ALPL, AP-TNAP, APTNAP, FLJ40094, FLJ93059, HOPS, MGC161443, MGC167935, TNAP, TNSALP; alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1); K01077 alkaline phosphatase [EC:3.1.3.1]
hsa:250 ALPP, ALP, FLJ61142, PALP, PLAP; alkaline phosphatase, placental (EC:3.1.3.1); K01077 alkaline phosphatase [EC:3.1.3.1]

hsa04710 Circadian rhythm - mammal - Homo sapiens (human) (3)



hsa:23291 FBXW11, BTRC2, BTRCP2, FBW1B, FBXW1B, Fbw11, Hos, KIAA0696; F-box and WD repeat domain containing 11; K03362 F-box and WD-40 domain protein 1/11
hsa:8945 BTRC, BETA-TRCP, FBW1A, FBXW1, FBXW1A, FWD1, MGC4643, bTrCP, bTrCP1, betaTrCP; beta-transducin repeat containing; K03362 F-box and WD-40 domain protein 1/11
hsa:9978 RBX1, BA554C12.1, FLJ60363, MGC13357, MGC1481, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1

hsa00190 Oxidative phosphorylation - Homo sapiens (human) (3)


hsa:1537 CYC1, UQCR4; cytochrome c-1; K00413 ubiquinol-cytochrome c reductase cytochrome c1 subunit [EC:1.10.2.2]
hsa:51606 ATP6V1H, MSTP042, NBP1, SFD, SFDalpha, SFDbeta, VMA13; ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H (EC:3.6.3.14); K02144 V-type H+-transporting ATPase 54 kD subunit [EC:3.6.3.14]
hsa:6390 SDHB, FLJ92337, IP, PGL4, SDH, SDH1, SDH2, SDHIP; succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (EC:1.3.5.1); K00235 succinate dehydrogenase (ubiquinone) iron-sulfur protein [EC:1.3.5.1]

hsa00970 Aminoacyl-tRNA biosynthesis - Homo sapiens (human) (3)



hsa:23438 HARS2, HARSL, HARSR, HO3; histidyl-tRNA synthetase 2, mitochondrial (putative) (EC:6.1.1.21); K01892 histidyl-tRNA synthetase [EC:6.1.1.21]
hsa:3735 KARS, CMTRIB, KARS2, KIAA0070, KRS; lysyl-tRNA synthetase (EC:6.1.1.6); K04567 lysyl-tRNA synthetase, class II [EC:6.1.1.6]
hsa:7453 WARS, GAMMA-2, IFI53, IFP53; tryptophanyl-tRNA synthetase (EC:6.1.1.2); K01867 tryptophanyl-tRNA synthetase [EC:6.1.1.2]

hsa00100 Steroid biosynthesis - Homo sapiens (human) (3)



hsa:1056 CEL, BAL, BSDL, BSSL, CELL, CEase, FAP, FAPP, LIPA, MODY8; carboxyl ester lipase (bile salt-stimulated lipase) (EC:3.1.1.13 3.1.1.3); K12298 bile salt-stimulated lipase [EC:3.1.1.3 3.1.1.13]
hsa:1594 CYP27B1, CP2B, CYP1, CYP1alpha, CYP27B, P450c1, PDDR, VDD1, VDDR, VDDRI, VDR; cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13); K07438 cytochrome P450, family 27, subfamily B (25-hydroxyvitamin D3 1alpha-hydroxylase) [EC:1.14.13.13]
hsa:1595 CYP51A1, CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1; cytochrome P450, family 51, subfamily A, polypeptide 1 (EC:1.14.13.70); K05917 cytochrome P450, family 51 (sterol 14-demethylase) [EC:1.14.13.70]

hsa04614 Renin-angiotensin system - Homo sapiens (human) (2)

hsa:1636 ACE, ACE1, CD143, DCP, DCP1, MGC26566, MVCD3; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1); K01283 peptidyl-dipeptidase A [EC:3.4.15.1]
hsa:4311 MME, CALLA, CD10, DKFZp686O16152, MGC126681, MGC126707, NEP; membrane metallo-endopeptidase (EC:3.4.24.11); K01389 neprilysin [EC:3.4.24.11]

hsa00532 Glycosaminoglycan biosynthesis - chondroitin sulfate - Homo sapiens (human) (2)

hsa:56548 CHST7, C6ST-2; carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 (EC:2.8.2.17); K04743 chondroitin 6-sulfotransferase 7 [EC:2.8.2.17]
hsa:9469 CHST3, C6ST, C6ST1, HSD; carbohydrate (chondroitin 6) sulfotransferase 3 (EC:2.8.2.17); K01020 chondroitin 6-sulfotransferase 3 [EC:2.8.2.17]

hsa00020 Citrate cycle (TCA cycle) - Homo sapiens (human) (2)

hsa:5105 PCK1, MGC22652, PEPCK-C, PEPCK1, PEPCKC; phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32]
hsa:6390 SDHB, FLJ92337, IP, PGL4, SDH, SDH1, SDH2, SDHIP; succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (EC:1.3.5.1); K00235 succinate dehydrogenase (ubiquinone) iron-sulfur protein [EC:1.3.5.1]

hsa03010 Ribosome - Homo sapiens (human) (2)

hsa:6122 RPL3, MGC104284, TARBP-B; ribosomal protein L3; K02925 large subunit ribosomal protein L3e
hsa:6125 RPL5, DBA6, MGC117339; ribosomal protein L5; K02932 large subunit ribosomal protein L5e

hsa00512 Mucin type O-Glycan biosynthesis - Homo sapiens (human) (2)

hsa:6482 ST3GAL1, DKFZp666E036, DKFZp779K2051, FLJ36548, Gal-NAc6S, MGC9183, SIAT4A, SIATFL, ST3GalA, ST3GalA.1, ST3GalIA, ST3GalIA,1, ST3O; ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4); K00780 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4A) [EC:2.4.99.4]
hsa:6483 ST3GAL2, Gal-NAc6S, SIAT4B, ST3GALII, ST3GalA.2; ST3 beta-galactoside alpha-2,3-sialyltransferase 2 (EC:2.4.99.4); K03368 beta-galactoside alpha-2,3-sialyltransferase (sialyltransferase 4B) [EC:2.4.99.4]

hsa03060 Protein export - Homo sapiens (human) (2)

hsa:3309 HSPA5, BIP, FLJ26106, GRP78, MIF2; heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa); K09490 heat shock 70kDa protein 5
hsa:6726 SRP9, ALURBP, MGC110981; signal recognition particle 9kDa; K03109 signal recognition particle subunit SRP9

hsa00051 Fructose and mannose metabolism - Homo sapiens (human) (2)

hsa:2203 FBP1, FBP; fructose-1,6-bisphosphatase 1 (EC:3.1.3.11); K03841 fructose-1,6-bisphosphatase I [EC:3.1.3.11]
hsa:8789 FBP2, MGC142192; fructose-1,6-bisphosphatase 2 (EC:3.1.3.11); K03841 fructose-1,6-bisphosphatase I [EC:3.1.3.11]

hsa00310 Lysine degradation - Homo sapiens (human) (2)

hsa:23127 GLT25D2, C1orf17, FLJ37771, FLJ37873, KIAA0584; glycosyltransferase 25 domain containing 2 (EC:2.4.1.50); K11703 collagen beta-1,O-galactosyltransferase [EC:2.4.1.50]
hsa:79709 GLT25D1, FLJ22329, MGC117270; glycosyltransferase 25 domain containing 1 (EC:2.4.1.50); K11703 collagen beta-1,O-galactosyltransferase [EC:2.4.1.50]

hsa04977 Vitamin digestion and absorption - Homo sapiens (human) (2)

hsa:335 APOA1, MGC117399; apolipoprotein A-I; K08757 apolipoprotein A-I
hsa:4363 ABCC1, ABC29, ABCC, DKFZp686N04233, DKFZp781G125, GS-X, MRP, MRP1; ATP-binding cassette, sub-family C (CFTR/MRP), member 1; K05665 ATP-binding cassette, subfamily C (CFTR/MRP), member 1

hsa00983 Drug metabolism - other enzymes - Homo sapiens (human) (1)

hsa:3704 ITPA, C20orf37, HLC14-06-P, ITPase, dJ794I6.3; inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (EC:3.6.1.19); K01519 nucleoside-triphosphate pyrophosphatase [EC:3.6.1.19]

hsa00460 Cyanoamino acid metabolism - Homo sapiens (human) (1)

hsa:57733 GBA3, CBGL1, GLUC, KLrP, MGC104276, MGC126878; glucosidase, beta, acid 3 (cytosolic) (EC:3.2.1.21); K05350 beta-glucosidase [EC:3.2.1.21]

hsa04964 Proximal tubule bicarbonate reclamation - Homo sapiens (human) (1)

hsa:5105 PCK1, MGC22652, PEPCK-C, PEPCK1, PEPCKC; phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32]

hsa00900 Terpenoid backbone biosynthesis - Homo sapiens (human) (1)

hsa:3156 HMGCR, LDLCQ3; 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34); K00021 hydroxymethylglutaryl-CoA reductase (NADPH) [EC:1.1.1.34]

hsa00520 Amino sugar and nucleotide sugar metabolism - Homo sapiens (human) (1)

hsa:2821 GPI, AMF, DKFZp686C13233, GNPI, NLK, PGI, PHI, SA-36, SA36; glucose-6-phosphate isomerase (EC:5.3.1.9); K01810 glucose-6-phosphate isomerase [EC:5.3.1.9]

hsa00760 Nicotinate and nicotinamide metabolism - Homo sapiens (human) (1)

hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]

hsa04950 Maturity onset diabetes of the young - Homo sapiens (human) (1)

hsa:3630 INS, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin

hsa00350 Tyrosine metabolism - Homo sapiens (human) (1)

hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2]

hsa00531 Glycosaminoglycan degradation - Homo sapiens (human) (1)

hsa:10855 HPSE, HPA, HPA1, HPR1, HPSE1, HSE1; heparanase; K07964 heparanase 1 [EC:3.2.1.-]

hsa00860 Porphyrin and chlorophyll metabolism - Homo sapiens (human) (1)

hsa:3163 HMOX2, HO-2; heme oxygenase (decycling) 2 (EC:1.14.99.3); K00510 heme oxygenase [EC:1.14.99.3]

hsa00561 Glycerolipid metabolism - Homo sapiens (human) (1)

hsa:1056 CEL, BAL, BSDL, BSSL, CELL, CEase, FAP, FAPP, LIPA, MODY8; carboxyl ester lipase (bile salt-stimulated lipase) (EC:3.1.1.13 3.1.1.3); K12298 bile salt-stimulated lipase [EC:3.1.1.3 3.1.1.13]